Professional Documents
Culture Documents
PROGRAMME
ECR 2015 will be a green meeting designed
to meet environmental sustainability criteria set
by the Österreichisches Umweltzeichen
(Austria’s national eco-friendly certificate).
Coordination
ESR Office, Neutorgasse 9, 1010 Vienna, Austria
Phone: (+ 43 1) 533 40 64-0
E-mail: communications@myESR.org
www.myESR.org
Managing Editor: Julia Patuzzi
Art Direction: Petra Mühlmann, Andreasz Diesenreiter
Layout: Barbara Biegl
Photo Credits: Unless otherwise indicated all pictures
© ESR – European Society of Radiology
All data as per date of publication: February 2015
ESR accepts no responsibility for errors or misprints.
WILLKOMMEN
IN WIEN
1
Timetable
08:30 9:00 09:30 10:00 10:30 11:00 11:30 12:00 12:15 13:00 13:30 14:00
Wednesday, March 4
E³ - ECR Academies
1 E³ - ECR Academies
2 Late-Breaking Clinical Trials
Josef Lissner
E³ 518, E³ 519, E³ 520, E³ 521 E³ 620, E³ 621 Honorary Lecture
E³ - Rising Stars Programme E³ - Rising Stars Programme James A. Brink; US
Basic Session 1 Basic Session 2
Thursday, March 5
5 6
MC 528
Joint Session: ESR/EFSUMB
E³ - ECR Academies
9 10
ESR meets the Republic of Korea Nikola Tesla
E³ 1318, E³ 1321, E³ 1322 Honorary Lecture
E³ - EDiR Prep Session E³ - ECR Academies Anne G. Osborn; US
E³ 1422
Saturday, March 7
E³ 1323
E³ - ECR Master Class E³ - EDiR Prep Session Junior Image
E³ 1326 E³ 1423 Interpretation Quiz
E³ - Rising Stars Programme E³ - Rising Stars Programme
Basic Session 5 E³ - The Beauty of Basic Knowledge
Basic Session 4 E³ 24D, E³ 25D
Refresher Courses (1300) Scientific Sessions (1400)
Bracco Symposium
Joint Session: ESR/EORTC Multimedia Classroom MM 14 GE Healthcare Symposium
Philips Symposia
ESR Patient
E³ - ECR Academies
13 Advisory Group Session
RTF Highlighted Lectures
14:00 14:30 15:00 15:30 16:00 16:30 17:00 17:30 17:45 18:00 18:30 19:00
Wednesday, March 4
Scientific Sessions (300) E³ - ECR Academy Opening Ceremony
E³ 418
Siemens Healthcare Special Focus Session Presentation of Honorary Members:
Symposium - Breast Care Day SF 4 N. Reed Dunnick; US
Professional Challenges Sessions Tae-Hwan Lim; KR
PC 4a, PC 4b Anne G. Osborn; US
Refresher Courses (400)
E³ - ECR Academies
3 Siemens Healthcare
Symposium - Breast Care Day
E³ - ECR Academies
4
E³ 720, E³ 721 E³ 818, E³ 819, E³ 820, E³ 821
E³ - Rising Stars Programme E³ - ECR Master Class
Student Session 1 E³ 826
Thursday, March 5
E³ - Rising Stars Programme
Scientific Sessions (700) Student Session 2
Multimedia Classroom MM 7 Special Focus Sessions
SF 8a, SF 8b, SF 8c
ESOR Session Professional Challenges Sessions
EuroSafe Imaging Session PC 8a, PC 8b
EIBIR Session Pros & Cons Session PS 827
Joint Course: ESR/RSNA Multidisciplinary Session MS 8
MC 728 Refresher Courses (800)
Friday, March 6
EIBIR Session E³ - Rising Stars Programme
Basic Session 3
Joint Session: ESR/ESMRMB State of the Art Symposium
MIR @ ECR SA 12
Special Focus Session
GE Healthcare Russia Symposium SF 12
Hologic Symposium Professional Challenges Sessions
HIMSS Symposium PC 12a, PC 12b
Refresher Courses (1200)
E³ - ECR Academies
11 Multimedia Classroom MM 12
MIR @ ECR
E³ - ECR Academies
12
E³ 1518, E³ 1521, E³ 1522 E³ 1618, E³ 1621, E³ 1622
E³ - EDiR Prep Session E³ - EDiR Prep Session
Saturday, March 7
E³ 1523 E³ 1623
E³ - ECR Master Class E³ - ECR Master Classes
E³ 1526 E³ 1626a, E³ 1626b, E³ 1626c
E³ - Rising Stars Programme State of the Art Symposium
Student Final Session SA 16
New Horizon Session Special Focus Session
NH 15 SF 16
Special Focus Session Multidisciplinary Session
SF 15 MS 16
Refresher Courses (1500)
Multimedia Classroom MM 15
EuroSafe Imaging Session
Joint Session: ESR/ESTRO
19
www.myESR.org Final Programme | ECR 2015 3
Information
Title Title
Table of
Contents
Welcome Scientific Programme
by the ESR President . . . . . . . . . . . . . . . . . . . . . . . . . 6 ESR/EFRS meets Sessions . . . . . . . . . . . . . . . . . . . 85
by the ECR 2015 Congress President . . . . . . . . . . . 8 New Horizons Sessions . . . . . . . . . . . . . . . . . . . . . . 89
State of the Art Symposia . . . . . . . . . . . . . . . . . . . . 91
General Information Special Focus Sessions . . . . . . . . . . . . . . . . . . . . . . 93
Information from A to Z . . . . . . . . . . . . . . . . . . . . . . 12 Professional Challenges Sessions . . . . . . . . . . . . . 97
CME at ECR 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Multidisciplinary Sessions . . . . . . . . . . . . . . . . . . . 101
Headline Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 European Excellence in Education (E3) . . . . . . . . 103
(Junior) Image Interpretation Quizzes . . . . . . . . . 26 Rising Stars Programme . . . . . . . . . . . . . . . . 105
MIR @ ECR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 European Diploma Prep Sessions . . . . . . . . 111
EPOS™ – Scientific Exhibition . . . . . . . . . . . . . . . . . 28 The Beauty of Basic Knowledge . . . . . . . . . 113
Social Media Guide . . . . . . . . . . . . . . . . . . . . . . . . . . 31 ECR Academies . . . . . . . . . . . . . . . . . . . . . . . . 115
Free Publications . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 ECR Master Classes . . . . . . . . . . . . . . . . . . . . . 123
Green Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 Mini Course . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
ECR 2015 welcomes its industry partners . . . . . . 35 Pros & Cons Session . . . . . . . . . . . . . . . . . . . . . . . 129
Invest in the Youth . . . . . . . . . . . . . . . . . . . . . . . . . . 36 Multimedia Classroom . . . . . . . . . . . . . . . . . . . . . . 131
ESR Journals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 Refresher Courses / Scientific Sessions . . . . . . . 133
Underground Map . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 Abdominal and Gastrointestinal . . . . . . . . . . 134
Breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
Floor Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 Cardiac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
Chest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
Dignitaries Computer Applications. . . . . . . . . . . . . . . . . . 142
Honorary Member N. Reed Dunnick . . . . . . . . . . . 54 Molecular Imaging . . . . . . . . . . . . . . . . . . . . . 143
Honorary Member Tae-Hwan Lim . . . . . . . . . . . . . 55 Genitourinary . . . . . . . . . . . . . . . . . . . . . . . . . . 144
Honorary Member & Honorary Lecturer Head and Neck . . . . . . . . . . . . . . . . . . . . . . . . 146
Anne G. Osborn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56 Interventional Radiology . . . . . . . . . . . . . . . . 147
Gold Medallist Claus D. Claussen . . . . . . . . . . . . . . 57 Musculoskeletal . . . . . . . . . . . . . . . . . . . . . . . 149
Gold Medallist Yves Menu . . . . . . . . . . . . . . . . . . . . 58 Neuro . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
Gold Medallist András Palkó . . . . . . . . . . . . . . . . . . 59 Paediatric . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153
Honorary Lecturer Gerald Antoch . . . . . . . . . . . . . . 60 Physics in Radiology . . . . . . . . . . . . . . . . . . . . 154
Honorary Lecturer James A. Brink . . . . . . . . . . . . . 61 Radiographers . . . . . . . . . . . . . . . . . . . . . . . . . 155
Vascular . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
Committees Oncologic Imaging . . . . . . . . . . . . . . . . . . . . . 158
ESR Executive Council . . . . . . . . . . . . . . . . . . . . . . . 64 Emergency Radiology. . . . . . . . . . . . . . . . . . . 159
Congress Committee. . . . . . . . . . . . . . . . . . . . . . . . . 65 Joint Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
Programme Planning Committee . . . . . . . . . . . . . . 65
Scientific Subcommittees . . . . . . . . . . . . . . . . . . . . 66 Educational & Scientific Programme
Topic Coordinators. . . . . . . . . . . . . . . . . . . . . . . . . . . 69 Postgraduate Educational Programme . . . . . . . . 169
Scientific Sessions and
Programme Overviews Late-Breaking Clinical Trials . . . . . . . . . . . . . . . . . 241
Wednesday, March 4 . . . . . . . . . . . . . . . . . . . . . . . . . 72 List of Authors and Co-Authors. . . . . . . . . . . . . . . 315
Thursday, March 5 . . . . . . . . . . . . . . . . . . . . . . . . . . . 74 List of Moderators . . . . . . . . . . . . . . . . . . . . . . . . . . 347
Friday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
Saturday, March 7 . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
Sunday, March 8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
As president of the European Society of Radiology (ESR) it is my great This has been a year of big numbers. The ESR has hit a record high in the
privilege to welcome you to our annual meeting, the European Congress number of Institutional Member Societies (44), our flagship journal, Euro-
of Radiology (ECR). pean Radiology, has achieved its highest Impact Factor ever (4.338) and,
most significantly, the number of individual ESR members has climbed
The ECR is an annual event that the whole international radiological com- to 62,793, consolidating our status as the largest radiological society in
munity looks forward to, whether they are attending for the first time the world. The third International Day of Radiology (IDOR) celebrated on
or returning aer the positive experience of previous years. The interna- November 8, in collaboration with RSNA and ACR, has also set a new
tional radiological community considers the ECR to be the event that can record of 128 participating Societies from 68 countries. Another high
truly meet their requirements in terms of being brought up to date with figure this year was the 3,474 people who were able to enjoy ECR 2014
radiological science and technology. thanks to the expansion of our online streaming service, ECR Live. At ECR
2015, nearly every lecture will be broadcast live and made available to
The ECR is always a wonderful event but, as I wrote in the ECR 2015 watch on demand aerwards. I very much hope that many of you will
preliminary programme, it is made extra-special this year by marking the make good use of that opportunity and factor some post-congress view-
10th anniversary of the European Society of Radiology. ing into your ECR schedule.
Every year the ECR programme is different than the previous one and it is The ESR has always considered education to be one of its main activi-
enriched with new initiatives carried out thanks to the valuable support ties. Year aer year we have developed new educational activities and
of the men and women from the Congress Committee, the Programme consolidated existing ones. The European School of Radiology (ESOR )
Planning Committee, the Scientific Committee and Subcommittees, and in its eighth year of activity, has continued to grow and now offers an
the ESR Office staff. This year, numerous initiatives have deeply modified even more diverse range of educational opportunities than ever before,
the congress programme while of course leaving intact its high scien- not only in Europe, but also in Asia, the Middle East and Latin America.
tific standards. Sincere thanks go to Professor Bernd Hamm, the ECR Following the success of the ESR Learning Centre established in Barce-
2015 Congress President, and to those who worked with him throughout lona in 2013, we are taking steps to expand this project further, with
almost two years of preparation for the congress. additional centres being opened in Vienna and Bogotá. The opening of
a learning centre in Colombia in particular will help us to reach out to
The ECR also represents the handover point from one ESR President to more than 12,000 individual ESR members living in Latin America. A new
the next. So, for me, it is the conclusion of a year lived with great enthu- multifunctional educational ‘e-learning platform’ will be launched at ECR
siasm, a year during which I received more than I gave. In this time, the 2015, with educational materials structured according to the European
constant and fruitful collaboration with the Board of Directors and the Training Curriculum (ETC).
Executive Council, efficiently supported by the extraordinary ESR staff,
has enabled the achievement of projects that were started in previous The ETC is a living document and an updated version will be released
years, the consolidation of initiatives that were begun last year; and the next March. The European Diploma in Radiology (EDiR) established as a
launching of new activities that I hope will be continued in future years. complement to national qualification processes is also gaining in signif-
icance, as shown by over 130 candidates at the next EDiR examination
during ECR 2015.
Advances in Information Technology (IT) have revolutionised healthcare in Another initiative in favour of the less affluent European countries is ‘ESR
general and within radiology in particular, but have also created new chal- Support’, with which we aim to improve access to radiological training
lenges regarding data volume, standardisation, data protection, etc., which and educational resources for aspiring physicians and scientists, and to
require harmonisation efforts on a European scale. The ESR has called ensure better healthcare for future generations by providing better train-
upon the EU institutions to endorse the development of Clinical Decision ing opportunities in radiology in less affluent regions.
Support (CDS) systems to improve clinical workflow, appropriateness cri-
teria, and training for referrers, to support the harmonisation of coding and Finally I would like to give you a very warm welcome to ECR 2015. I hope
terminology and to revise the legal framework for teleradiology. you will all return home having spent your days updating your professional
and scientific knowledge, exploring technological innovations and enjoy-
One of the goals I set myself at the beginning of my presidency was to ing the wonderful atmosphere of the city of Vienna in good company.
draw the national societies closer by intensifying dialogue with them. For
this reason, the ESR approached its European national societies regard-
ing holding ‘National Society meets ESR’ sessions at their national con-
gresses, based on the model of the traditional ‘ESR meets’ sessions held
at the ECR since 2005, in order to further strengthen and improve the
relationship between national societies and the ESR.
Lorenzo Bonomo
ESR President
It is a great honour for me to welcome you to the European Congress of The ESR marks its tenth anniversary at ECR 2015, and I am delighted that
Radiology (ECR) 2015, the annual meeting of the European Society of we will be celebrating this decade of remarkable achievements together.
Radiology (ESR). As an attendee of every ECR over the last 25 years, I The internal borders of Europe have been re-drawn many times over the
have seen the meeting evolve significantly. I have watched the crowds in centuries, and as a resident of Berlin, the location of one of the most
the entrance hall and the audiences in the lecture rooms swell to a point infamous boundaries in the world, I am very much aware of the negative
where the ECR now regularly attracts more than 20,000 participants. I am effect such divisions can have. It is one of the strongest virtues of the ESR
confident that this year will be no exception, because the ECR’s deserved that we work hard to overcome barriers and to ensure that everyone can
reputation is not only for high scientific quality but also for constant be afforded the same opportunities as each other.
innovation in science, education, interactivity, and networking. The 2,935
abstracts we received for this year’s event – the highest number in ECR One aspect of the ECR that encapsulates this idea of providing opportu-
history – is a great example of that reputation. This very encouraging nities is the long-running and very popular Invest in the Youth initiative.
show of enthusiasm from the radiological community underlines the This year, I am pleased to say that the ESR has decided to put even more
meeting’s position as one of the best and most popular medical events into this project than usual and we have therefore been able to invite
in the world. twice the number of applicants who were invited last year. This is not
only excellent news for the participants, but for us as a specialty. The
If you have seen the ECR 2015 poster, then you will know that the motto ECR can have a fantastic impact on young people, reinforcing their con-
for this year’s congress is ‘radiology without borders’. Today, more than nection to radiology and stimulating their careers. The more chances like
ever before, our specialty transcends the boundaries between countries. this we can provide, the better it is for us as a community, for progress
Wherever we are in the world, we have always been united by our profes- in radiological research, and ultimately for the patients who we are all
sion and the effort we all make to drive our field forward, but now we are working to serve.
increasingly working together in a practical sense too; sharing informa-
tion, learning directly from each other and literally helping each other. I An important innovative development this year is the restructuring of the
think the ECR is the perfect reflection of this spirit. At the congress there session formats. With the exception of Refresher Courses, most of the
are no boundaries; we are all united by our passion for the specialty. educational sessions at the ECR are now grouped under the heading of E³
– European Excellence in Education, and they are now arranged accord-
You may also have noticed that the ECR 2015 poster includes a map of ing to the different levels defined by the European Training Curriculum for
Europe. It is true that in recent years the ECR has become a global event, Radiology. The E³ programme is divided into five branches – Rising Stars,
attracting attendees from far and wide, and really benefitting from the European Diploma Prep Sessions, The Beauty of Basic Knowledge, ECR
huge range of different experience that is brought together under one Academies, and ECR Master Classes – which reflect the different levels
roof. But it is worth remembering that this is the annual meeting of the of education in radiology, as well as the different stages of an individual’s
European Society of Radiology and this is where our heart is. professional career.
General
Information
EFOMP (European Federation of Organisations for Medical Physics) EUROPEAN BOARD OF RADIOLOGY EBR
WORKSHOP Visit the EBR Booth in the entrance hall to learn all about the European
This workshop is the 17th in the series of EFOMP Workshops on ‘New Diploma in Radiology (EDiR), how to apply, and where and when the next
Technology in Diagnostic Radiology’. This year’s workshop is entitled ‘Mul- exams will take place.
ti-energy imaging: from physics to diagnosis’. It has been organised by www.myEBR.org
EFOMP in collaboration with the ESR to address the current and future
technological requirements for radiology imaging equipment (please refer
to pages 163–164).
EUROPEAN DIPLOMA IN RADIOLOGY EDiR The programmes will be concluded with a self-assessment test, published
An examination for the European Diploma in Radiology is being held at in the new platform ‘ESR Education on demand’. ECR delegates can access
ECR 2015. The electronic-based written examination takes place on Tues- the platform and the self-assessment tests through the work stations in
day, March 3, in the ECR Live & EPOS™ Lounge on the 1st level, whereas the ECR Live & EPOS™ Lounge (1st level).
the case-based oral examinations take place Wednesday, March 4 to
Friday, March 6, in various rooms on the entrance level in the M Building The ECR Academies consist of a series of four to six sessions relevant
(See Floor Plan M Building on page 50). to a particular area of radiology. This may be a classic organ-based field
Success in the examination certifies a standard of radiological knowledge or a technically oriented area of another field related to radiology, such as
deemed appropriate by the ESR for independent practise in general management. Each ECR Academy spans several days, in which the different
radiology. facets of the area in question are covered by experts in the field. An ECR
www.myEBR.org Academy is a coherent course in which the different sessions complement
one another in order to reflect the entirety of the field.
EUROPEAN EXCELLENCE IN EDUCATION E3 The ECR Academies are particularly suited to general radiologists or radi-
The E3 programme emphasises the importance of lifelong learning. It ologists with a subspecialisation.
covers the entire range of educational issues, from undergraduate medical All programmes (apart from Interactive Teaching Sessions) will be con-
education to subspecialised continuing professional development. cluded with a self-assessment test, published in the new platform ‘ESR
The E3 programme consists of the following five branches, which reflect Education on demand’. ECR delegates can access the platform and the
the different levels of education in radiology, as well as the different stages self-assessment tests through the work stations in the ECR Live & EPOS™
of an individual’s professional career: Lounge (1st level).
Rising Stars Programme, European Diploma Prep Sessions, The Beauty of
Basic Knowledge, ECR Academies, ECR Master Classes. The ECR Master Classes focus on continuous professional develop-
ment and lifelong learning. The classes are designed for subspecialised
The European Diploma Prep Sessions aim to prepare prospective radiologists seeking cutting-edge information in their particular fields of
candidates for the European Diploma in Radiology (EDiR). interest. They are held by experts in the field and reflect state-of-the-art
They are also suitable for residents who want an overview of the various knowledge, as well as emerging trends.
topics relevant to imaging and for those preparing for their national board During the ECR, one ECR Master Class is offered for each subspecialty in
examinations. radiology (CIRSE [one on vascular and one on interventional radiology],
The content of the programme reflects Level I and Level II European ESCR, ESER, ESGAR, ESHNR, ESMOFIR, ESNR, ESOI, ESPR, ESSR, ESTI,
Training Curriculum for Radiology (ETC) learning objectives across a two- ESUR, EUSOBI).
year cycle. The sessions are held in close cooperation with the European
Board of Radiology (EBR). ‘EUROPEAN RADIOLOGY’
Each of the six sessions is led by three lecturers and moderated by one European Radiology is Europe’s number one journal in general radiology.
chairman. See page 39.
The Beauty of Basic Knowledge programmes focus on knowledge EUROPEAN SCHOOL OF RADIOLOGY ESOR BOOTH
essential to the daily practice of radiology. The format of these sessions Visit the ESOR Booth in the entrance hall for the latest news on the
reflects the tradition of conventional teaching sessions, in which an experi- European School of Radiology. In addition, there is an ESOR Info Desk in
enced teacher shares his or her insights into a topic of particular relevance the Rising Stars Lounge.
with a group of attendees.
A Beauty of Basic Knowledge session typically consists of a 45-minute EUROSAFE IMAGING
lecture held by one speaker (plus 15 minutes for conclusions and discus- EuroSafe Imaging is the ESR’s latest initiative in radiation protection. It aims
sion). The teaching format is usually case based with some interaction to promote the safe and appropriate use of medical imaging in Europe and
with the attendees. around the world. Please visit the EuroSafe Imaging Poster Exhibition
The content of the sessions is mostly tied to the Level I and Level II in the ECR Live & EPOS™ Lounge on the 1st level, with submissions from all
European Training Curriculum for Radiology (ETC) learning objectives. The over Europe. And stop by the EuroSafe Imaging Booth in the entrance
Beauty of Basic Knowledge sessions are suited to residents and board-cer- hall to learn all about this important initiative.
tified radiologists who want to refresh their knowledge in basic topics of
imaging and image-guided therapy.
OPENING CEREMONY
Wednesday, March 4
17:45–19:00, Room A
Red Bull Flying Bach © Erwin Polanc / Red Bull Content Pool
NEW HORIZONS SESSIONS The Preview Centre is located on the 1st level, next to the ECR Live &
The aim of the New Horizons Sessions is to provide practitioners with EPOS™ Lounge.
an overview of the new developments in a specific area of practice e.g. Opening hours:
specialty, technique, or disease. These developments may become routine Tuesday, March 3: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00
within a few years, or may indicate a new direction for research and clinical Wednesday, March 4 to Sunday, March 8: . . . . . . . . . . . . . . . . 07:30–18:00
application. There are three New Horizons Sessions at ECR 2015, entitled
‘Image-guided interventions of the prostate’, ‘Optical molecular imaging: a Please note that only digital material will be accepted for oral presentations.
new dimension for radiology’ and ‘Comprehensive personalised imaging of Presenters may submit their presentation material, with their login details,
cardiothoracic diseases’. Session places are allocated on a first-come, first- prior to the congress. All material must be in English and be provided on
served basis. Please refer to page 90 for the programme of the sessions. CD-ROM, DVD or USB devices. All presentations will be transferred to the
session rooms electronically.
OPENING CEREMONY The material remains the property of the speakers.
The ECR 2015 Opening Ceremony will take place Wednesday, March 4,
17:45–19:00 in Room A. ESR Honorary Membership will be awarded to PROFESSIONAL CHALLENGES SESSIONS
N. Reed Dunnick, Tae-Hwan Lim and Anne G. Osborn. These sessions are intended to communicate and exchange issues on
radiological training and education, research networking, radiological man-
agement and professional developments. This year’s topics are ‘Radiol-
ogist: imager or doctor?’, ‘What are the concrete benefits of structured
reporting?’, ‘Looking into the future of radiology’, ‘Imaging biobanks: from
genomic to radiomic in the era of personalised medicine’, ‘Integration
of imaging biomarker activities on a European level’, ‘Imaging in popu-
lation-based studies’, ‘Personalised medicine in radiology’, ‘Harmonised
approach for imaging in Europe: myth or reality?’ and ‘Medicolegal aspects
in daily practice’.
Places are allocated on a first-come, first-served basis.
Please refer to pages 97–99 for the sessions’ programme.
RADIOLOGY TRAINEES FORUM RTF RISING STARS LOUNGE / RESIDENTS & STUDENTS LOUNGE
The RTF promotes and coordinates the efforts of radiology trainees at a The Rising Stars Lounge for residents and students is located on the 2nd
European level in order to improve the progress of radiology and related level. In the lounge you will find information on the European School of
sciences. One of the RTF’s most important goals is to provide an equal level Radiology, the European Diploma of Radiology and the Radiology Trainees
of radiological knowledge and skills for radiology trainees all over Europe. Forum.
Highlighted Lectures organised by the RTF will be given on Saturday, Don’t miss the Meet & Greet Sessions with ESR President Lorenzo
March 7, 10:30–12:00 in Room M (see page 109). Bonomo (Friday, March 6, 13:20–13:40) and ECR 2015 Congress President
The RTF General Assembly takes place on Friday, March 6, 10:15–12:45, Bernd Hamm (Thursday, March 5, 09:30–10:00).
in Meeting Room 1.85 (1st level). For more detailed information please
visit the RTF Meeting Point in the Rising Stars & RTF Lounge on RISING STARS PROGRAMME
the 2nd level. See pages 105–109.
Don’t miss the Meet & Greet Sessions with ESR President Lorenzo
Bonomo (Friday, March 6, 13:20–13:40) and ECR 2015 Congress Presi- SATELLITE SYMPOSIA
dent Bernd Hamm (Thursday, March 5, 09:30–10:00) in the Rising Stars Industrial Satellite Symposia are presented by international companies.
& RTF Lounge. Please note that Satellite Symposia are no longer CME-accredited. Places
And join us at the RTF Quiz with Quizmaster Prof. José Cáceres on Thursday, are allocated on a first-come, first-served basis.
March 5, 13:30–14:30 in the Rising Stars & RTF Lounge. See separate booklet for details.
Take the
European Diploma in Radiology
EDiR
YOUR PASSPORT
TO A BETTER CAREER
Next Exams:
Warsaw, Poland: April 16–17
(exclusive for Members of the Polish Medical Society of Radiology)
ESR Learning Centre Barcelona, Spain: June
(International edition, open to all countries)
Malmö, Sweden: September, 8–9
(exclusive for members of the Societies of Radiology in Nordic Countries)
JFR, Paris, France: October
(exclusive for members of the French Society of Radiology)
TURKRAD, Antalya, Turkey: November
(exclusive for members of the Turkish Society or Radiology)
www.myEBR.org
diploma@myEBR.org
20 ECR 2015 | Final Programme www.myESR.org
General Information
If your country is not included in this list, it may be because they have a The combined participation and evaluation questionnaire is of great
different system or no mandatory CME at all. For more information, please value to the organising committee when selecting topics for future ECRs.
consult your national jurisdiction. Evaluation forms differ depending on the type of scientific event.
Scientific Exhibition
1. Enter EPOS™ (Electronic Presentation Online System) on one of the 160
laptops in the ECR Live & EPOS™ Lounge and view posters.
2. Log in to www.webges.com/cslide/ecr2015/myevaluations/login or use
the ECR 2015 app to evaluate the session.
3. Fill out this form completely aer visiting the electronic scientific
exhibition.
CME CONFIRMATION
Every participant will be able to view and print their own personal record
of attendance via the internet in the MyUserArea on the condition that
the above procedures have been carried out.
This service will be available from two weeks aer the congress
via the MyUserArea on the ESR website (www.myESR.org).
Please note that your Personal ID, which is printed on your badge, is
required for login.
The printout of your record should be submitted to your national juris-
diction (usually responsible for accreditation) for approval of your CME
points. Please note that the record of attendance will be issued only to
the participant. It will not be supplied to any accreditation agency or other
organisation.
Headline Sessions
24 ECR 2015 | Final Programme www.myESR.org
General
Headline
Information
Sessions
The Image Interpretation sessions, two traditional highlights of every ECR, provide both education and entertainment.
Two panels of distinguished radiologists will share their knowledge and diagnosis strategies with you.
The slogan for this year’s ‘senior’ quiz is ‘Couples for Europe’. Radiologists will challenge each other in an enjoyable and
exciting competition where they will face some tricky cases.
In the ‘junior’ quiz, with its theme ‘Battle for the audience’, the panellists will compete with each other in teams.
While solving a variety of cases, the moderator will guarantee a scientifically challenging and entertaining session.
Both quizzes will be interactive with the use of an electronic voting system via one’s own device
(smartphone, tablet or laptop) at no costs.
MIR @ ECR
Management in Radiology is a subcommittee of the ESR Quality, Safety and Standards Committee.
Those involved in the field of healthcare are experiencing a time of increasing pressure, stress and change.
The demand for efficiency and effectiveness in all business and administrative matters is constantly growing.
MIR addresses current challenges and provides a forum for education and the exchange of ideas and concepts.
ESR THANKS ALL REVIEWERS Sofia Gourtsoyianni; London/UK Annie Paterson; Belfast/UK
We cordially thank the members of the Scientific Ali Guermazi; Boston/US Luis J. Pina Insausti; Pamplona/ES
Subcommittees (see pages 66–68) and the Katja Pinker-Domenig; Vienna/AT
Andreas Hansch; Jena/DE
EPOS Reviewers who reviewed abstracts and Tadeusz J. Popiela; Krakow/PL
Birgitta Hansson; Stockholm/SE
graded electronic posters in the past months, Panos K. Prassopoulos; Alexandroupolis/GR
Johannes Heverhagen; Bern/CH
establishing the basis for presenting the awards. Lorenzo Preda; Milan/IT
Jérome Hodel; Paris/FR
Stefan Puig; Vienna/AT
(in alphabetical order) Anna Maria Ierardi; Marsala/IT
Emilio Quaia; Trieste/IT
Emel Ada; Izmir/TR Alan Jackson; Manchester/UK
Helen C. Addley; Cambridge/UK Daniele Regge; Candiolo-Torino/IT
Tobias Jakobs; Munich/DE
Hojjat Ahmadzadehfar; Bonn/DE Soraya Robinson; Vienna/AT
Jarl A. Jakobsen; Oslo/NO
Angel Alberich-Bayarri; Valencia/ES Janeth Romero; Boston/US
Ehymia Alexopoulou; Athens/GR Nektarios Kalyvas; Athens/GR Alejandro Rovira-Canellas; Barcelona/ES
Hatem Alkadhi; Zurich/CH Aikaterini Kanavaki; Geneva/CH Reinhard Rzanny; Jena/DE
Paraskevi Argyropoulou; Alexandroupolis/GR Ara Kassarjian; Majadahonda, Madrid/ES
Roberto Sanz-Requena; Valencia/ES
Irina Arkhipova; Moscow/RU Caroline Keyzer; Brussels/BE
Martina Scharitzer; Vienna/AT
Loukas G. Astrakas; Ioannina/GR Friedrich Knollmann; Sacramento/US
Karl Schürmann; Aachen/DE
Paraskevi Kosta; Ioannina/GR
Nuria Bargalló Alabart; Barcelona/ES Teik Choon See; Cambridge/UK
Elmar Kotter; Freiburg/DE
Irene Bargellini; Pisa/IT Ashley Shaw; Cambridge/UK
Karl-Friedrich Kreitner; Mainz/DE
Antonio Barile; L’Aquila/IT Martin J. Shelly; Dublin/IE
Miltiadis Krokidis; Cambridge/UK
Antonio Basile; Catania/IT Paul Sijens; Groningen/NL
Gorka Bastarrika; Toronto/CA Andrea Laghi; Latina/IT Gustavo N. Simao; Ribeirao Preto/BR
Tobias Baumann; Freiburg/DE Andrea Lakatos; Miskolc/HU Stefan Steens; Nijmegen/NL
Kunwar S.S. Bhatia; Hong Kong/HK Marc Lemmerling; Beervelde/BE Wolfram Stiller; Heidelberg/DE
Johan G. Blickman; Rochester/US Eva Llopis; Alzira-Valencia/ES Misa Sumi; Nagasaki/JP
Einat Blumfield; New York/US Roberto Llorens; Valencia/ES
Denis Tack; Braine-L’Alleud/BE
Alessandro Bozzao; Roma/IT Elizabeth Loney; Bradford/UK
Adele Taibbi; Palermo/IT
Ioana Gabriela Lupescu; Bucharest/RO
Cem Calli; Izmir/TR Stuart A. Taylor; London/UK
Fabrizio Calliada; Pavia/IT Andreas Mahnken; Marburg/DE Gail Thornbury; Belfast/UK
Robert S.D. Campbell; Liverpool/UK Lorenzo Mannelli; New York/US Michael Toepker; Vienna/AT
Davide Caramella; Pisa/IT Katharina Marten-Engelke; Göttingen/DE Michael Torkzad; Milford/UK
Nelson M.G. Caserta; Campinas/BR Celso Matos; Brussels/BE Ioannis A. Tsalafoutas; Athens/GR
Josephine McHugo; Birmingham/UK Dimitrios K. Tsetis; Iraklion/GR
John Damilakis; Iraklion/GR Frederick J.A. Meijer; Nijmegen/NL Athina Tsili; Ioannina/GR
Adelard I. B. De Backer; Ghent/BE Elena Mershina; Moscow/RU
Albert de Roos; Leiden/NL Sara Upponi; Cambridge/UK
Peter Mildenberger; Mainz/DE
Savas Deereos; Alexandroupolis/GR Manabu Minami; Ibaraki/JP Edwin J. Van Beek; Edinburgh/UK
Stefan Delorme; Heidelberg/DE Penelope L. Moyle; Cambridge/UK Will J.M. van der Putten; Galway/IE
Valdair F. Muglia; Ribeirao Preto/BR Berit Verbist; Leiden/NL
Olle Ekberg; Malmö/SE
Johny A. Verschakelen; Leuven/BE
Stephanie Nougaret; St Clement de Riviere/FR
Yann Fargeaudou; Clichy/FR
Matthew G. Wallis; Cambridge/UK
Eduardo F.C. Fleury; Sao Paulo/BR Amaka Offiah; Sheffield/UK
Dag Wormanns; Berlin/DE
Anastasia Fotiadou; Huntingdon/UK Anastasia Oikonomou; Toronto/CA
Klaus Wörtler; Munich/DE
Ferdinand Frauscher; Innsbruck/AT Yumiko Oishi Tanaka; Tsukuba/JP
Ximena Wortsman; Santiago/CL
Susan Freeman; Cambridge/UK Mihaela Onu; Bucharest/RO
Petra Wunderlich; Radebeul/DE
Matthew T.G. Gaskarth; Cambridge/UK Leo Pallwein-Prettner; Linz/AT
Vasilis Xydis; Ioannina/GR
Jonn-Terje Geitung; Bergen/NO Miguel Palm; Maastricht/NL
Abraham Ghiatas; Ekali-Athens/GR Valeria Panebianco; Rome/IT Giulia Zamboni; Verona/IT
Anastasia Glantzouni; Ioannina/GR Gerald Pärtan; Vienna/AT Anastasia Zikou; Ioannina/GR
Enjoy Vienna’s
cultural highlights
www.albertina.at
Free Publications
We are of course grateful for the enthusiasm of our friends in the publishing
industry for making the Free Publications initiative possible, and allowing
us to provide ECR participants with the chance to pick up some literature
and broaden their medical imaging horizons.
LET’S
KEEP OUR
CONGRESS
GREEN
The ECR 2015 will be a green meeting designed to meet environmental sustainability criteria
set by the ‘Federal Ministry of Agriculture, Forestry, Environment and Water Management’
(Austria’s national eco-friendly certificate).
We encourage our employees, partners and customers to adopt practices that promote
awareness of environmental conservation and sustainable use and we endeavour to adhere
to these principles throughout our entire enterprise.
Here are some ways you can contribute to our goal of becoming a green meeting:
• If possible, please choose an environmentally friendly form of transport like
public transport or car sharing
• Please follow your hotel’s eco-friendly advice (e.g. changing towels and bed sheets only
when necessary) and please switch off all lights and electronic devices when
leaving your hotel room
• Please choose drinks served in glass, food served on reusable dishes and avoid cans, plastic
bottles and products in disposable packaging
• Please dispose of your waste (PET, glass, paper, residual waste, metal)
by using the separate bins in your hotel and at the congress venue.
• Please use online registration and non-printed media instead of paper
• Please return your badge to the info point aer the congress has ended
We’re not saying it’ll be easy, but we know that it’ll be worth it.
Bracco Imaging
2STAR:
Carestream Health
Alpinion Medical Systems
Esaote
Paramed Medical Systems
Fujifilm Europe
Shimadzu Europa
GE Healthcare
Swissray Medical
Guerbet
Vinno Technology
Hitachi Medical Systems Europe
‘ESR MEETS’ COUNTRIES
Philips Healthcare Each year the ECR places a special focus on its ‘ESR meets’ countries –
in 2015 namely Germany, Republic of Korea and Turkey – with particular
Samsung Medison emphasis on their scientific and technological developments. The ESR,
industry companies and the national societies work closely together to
Siemens Healthcare highlight these countries.
Additionally, we are proud to present you the ‘ESR meets’ partner discipline;
Toshiba EAU (European Association of Urology).
ESR Journals
EUROPEAN RADIOLOGY
European Radiology at your fingertips!
Carry Europe’s leading radiology journal with you wherever you go – with
the European Radiology App – download the app from iTunes or via
the QR code below.
European Radiology is the official journal of the ESR and official organ
of numerous subspecialty organisations. It acts as a flagship, publishing
original scientific papers in the radiological field with an Impact Factor
of 4.338 for 2013.
www.european-radiology.org
www.i3-journal.org
www.myESR.org
Vienna International Busterminal
Customer Service Centre
(U3 Erdberg)
Infopoints
Ticket Sales ECR STOP:
A
C
Kaisermühlen /
V
Vienna Int. Centre
Park & Ride
Customise
your congress!
Plan and personalise your ECR 2015 experience
with the Interactive Programme Planner.
The IPP offers a great, convenient way to explore the whole ECR programme
online and create a custom timetable. You can search or browse for sessions
and posters, read full abstracts, create a personal calendar, and even print your own
personalised Book of Abstracts. It’s also optimised for mobile devices, meaning you can
keep every detail that’s important to you exactly where you need it – right in your hand.
Plan your own personalised congress and you’ll never lose track again ...
ipp.myESR.org
42 ECR 2015 | Final Programme www.myESR.org
Floor Plans
Floor Plans
OFFICE
1
CHE
CK
T
Room BROADCAST ZONE
Partner Publishers
Partner Publishers
Room
CHECOAT
COACK 2
E2 F1 TOSHIBA
Industry Workshop
BROADCAST ROOM Room 0.90
ths
Soc
Boo
hs
iety
Room
Soc
Room
oot
ie t
iety
Boo
yB
yB
ie t
Soc
ths
SIEMENS
oot
Soc
E1 F2 Industry Workshop
hs
Room 0.93
ESR MEETS
ESR
WELCOME
LOUNGE
S BAG
S
BAG
BU
MB INTERNET
uild
CORNER
PRE SINES
SS S C
ing
OFF ENT
AND
ICE RE
R
M OE
E egis
Mondial 68
o
W- s a
Info
S xhib trat
MB1
Exp nd
Austrian M OE
MAerviceitors’ion
Airlines
M4
M6
Travel Service 69
M OE 61
Arts & Culture M OE 60
Restaurant M OE 59
Reservations M OE 58
M5
100 79 75
NETWORK
RECREATION ZONE 6
AREA EXHIBITION
www.myESR.org
Floor Plans
CONGRESS
OFFICE
Partner Publishers
Partner Publishers
CHE
COACK 2
1
CHECOAT
CK
T
Room Room BROADCAST ZONE
E2 F1 TOSHIBA
Industry Workshop
BROADCAST ROOM Room 0.90
ths
Soc
Boo
iety
hs
Room
Soc
Room
oot
iety
Boo
ie t
E1
yB
F2 SIEMENS
yB
S oc
ths
ie t
oot
Soc
Industry Workshop
hs
Room 0.93
ESR MEETS
REG
ION IST
RAT RAT
IST ION
REG
S
ie t
y B oooc ie t
S o co o t h s ths y
B
So
re Boociety
ksto ths
Boo
ESR
WELCOME
S
LOUNGE BAG
MB
uild
PRE SINES
BAG S
BU
SS S C
ing
OFF ENT
ICE RE
AND
MAerviceitors’ion
S xhib trat
E egis
W- s a
R
Exp nd
Info
Mondial
o
Austrian
Airlines
Travel Service
Restaurant
Reservations
= CASH DISPENSER / ATM
TO / FROM UNDERGROUND
NETWORK
RECREATION ZONE 6
AREA EXHIBITION
SSR DIA
Meeting Room 1.86
Q
OOM
CLA LTIME
MU om
Ro
Room Room
M N
BROADCAST ZONE EXPO GALLERY
BROADCAST ZONE
MAMMOTOME
Industry Workshop
Room 1.98
GIOTTO IMS
Industry Workshop Room
Room L8 Room L1
STUDIO 2015
HOLOGIC Room
Industry Workshop
Room L7 L2
PREVIEW
CENTRE ECR LIVE &
FREE PUBLICATIONS & EPOSTM LOUNGE POSTER EXHIBITION
FUTURE MEETINGS
BR
RS
OA
S TA
DC
NG
Room Room
ING
AS
FL &
OU
TZ
C
RIS
ON
RT
E
BROADCAST ROOM Meeting Room 2.95
Room
OFF
.66
ICE
3–3
S3
3.4
.77
S
–3.
ICE
OFF
97
15
–3.
.12
Meeting Room 3.34
S3
PRESIDENTS’
OFF
BR
OA
DC
T
AS
Room Room
RAN
TZ
TAU G K
ON
E
RES
3
CK COA
T CHE TC
HEC
COA K4
Room
D1
T
EXP O
OE
Room
D2
EXPO FOYER D
TO EXPO
B/C/E
EXPO E
EXPO C
EXPO B
INTERNET
CORNER
A
RANC V
ENT
M OE
LEV CE MB1
68
EL
M4
M6
M OE
69
M OE 61
M OE 60
M OE 59
M OE 58
M5
M OE M OE M OE
100 79 75
M OE M OE M OE M OE
27 07 05 03
EDIR EXAMINATION AREA
All Rooms on this level, with the exception of Room MB1 and the Diploma Zone - are Meeting Rooms.
BROADCAST ZONE
MB 2
MB 4
MB 3
BROADCAST ZONE
MB 5
ESR Dignitaries
ESR Dignitaries
ESR Dignitaries
N. Reed Dunnick N. Reed Dunnick is the Fred Jenner Hodges Professor of Radiol-
ogy and chair of the department of radiology at the University of
Ann Arbor, MI/US Michigan Health System in Ann Arbor. He served as the 2014 pres-
ident of the Radiological Society of North America.
Honorary Member Graduating with a medical degree from Cornell University Medical
College in 1969, he went on to spend two years in internal medicine
at the University of Rochester’s Strong Memorial Hospital in New
York before taking up a radiology residency at Stanford University
school of Medicine in California, where he served as chief resident
in his final year. He was appointed assistant professor at Stanford in
1976, and later that year he took up a post in the diagnostic radiol-
ogy department at the National Institutes of Health. He then moved
to Duke University Medical Center, where he held a number of posts
between 1980 and 1992, including professor of radiology, chief of
uroradiology and director of the division of diagnostic imaging.
ESR Dignitaries
ESR Dignitaries
ESR Dignitaries
Over the last four decades, he has been one of the pioneers in
developing and introducing new imaging modalities, together with
his team, into clinical practice; dynamic-CT (1980), gadolinium
contrast MRI (1983), cardiac CT (1998), 3T MRI (2000), whole-
body MRI (2004 ). With a particular interest in MR/PET, Prof.
Claussen has been involved in the development of hybrid MR/PET
imaging technology since 2006, which has major potential in the
field of molecular imaging. Over the last ten years, together with In recognition of his pioneering
Prof. Pichler, he has built up one of Europe’s largest and most suc- work in novel imaging technology
cessful preclinical molecular imaging laboratories in Tübingen. and his dedication to strengthening
ties between radiologists in Europe,
He has published in a large range of highly regarded peer-reviewed Professor Claus D. Claussen, from
scientific journals, including the New England Journal of Medi-
cine, Nature Medicine, Circulation, JACC, Radiology and European
Tübingen, Germany, will be awarded the
Radiology. He has also served as a reviewer for Radiology, Euro- Gold Medal of the European Society of
pean Radiology and the Journal of Nuclear Medicine. Radiology at ECR 2015.
Prof. Claussen also works to support international cooperation and
has served as president of the German Radiological Society and
the European Society of Gastrointestinal and Abdominal Radiolo-
gy’s congress in 1999. He is president of the Society for Promot-
ing Biotechnology and Medical Technology South-West Germany,
Stuttgart, and served as chairman of the ESR’s Ethical Compliance
Subcommittee until autumn 2014.
At ECR 2015 Prof. Claussen will receive the Gold Medal of the
European Society of Radiology.
ESR Dignitaries
Yves Menu Yves Menu is professor of radiology and chairman of the depart-
ment of radiology at Saint Antoine Hospital, Pierre & Marie Curie
Paris/FR University in Paris, France.
Gold Medallist Originally from Dijon in the east of France, Prof. Menu graduated
from the University of Paris VI Medical School in 1976, and began
his residency in neurosurgery, endocrinology and radiology at the
Assistance Publique Hôpitaux de Paris and University of Paris in
1977. He became a board certified radiologist in 1981 and then
a fellow at Beaujon Hospital’s department of radiology in Clichy.
At Beaujon Hospital, he was promoted to professor of radiology,
and in 1990 he was appointed chairman of the department of
radiology at Bichat Hospital in Paris. He returned to Beaujon Hos-
pital in 1993 and served as chairman of the radiology department
until 2003, when he assumed until 2008 the post of chairman of
Bicêtre Hospital’s department of radiology and professor of radiol-
ogy at the University of Paris XI.
At ECR 2015 Prof. Menu will receive the Gold Medal of the
European Society of Radiology.
ESR Dignitaries
Prof. Palkó has been an active member of the ESR for many years
and served on the ESR’s Board of Directors between 2009 and
2013 and as president in 2012. Since its foundation, Prof. Palkó
has been actively involved in the work of the European School of
Radiology and now serves as editor-in-chief of the ESR Education
on Demand service. He is also a member of the European Society
of Abdominal and Gastrointestinal Radiology and currently serves In recognition of his dedication to
as its secretary-general. international cooperation and relations,
as well as his outstanding contribution
During his long and distinguished career, Prof Palkó has published to radiological education, Professor
91 articles in peer-reviewed journals and 31 book chapters. He has András Palkó, from Szeged, Hungary,
also delivered more than 200 invited lectures around the world.
He has received widespread recognition for his achievements and
will be awarded the Gold Medal of
contributions to radiology, having previously been awarded honor- the European Society of Radiology at
ary membership by the Austrian, French, Irish, Polish, Romanian, ECR 2015.
and Serbian radiological societies, as well as the Radiological Soci-
ety of North America.
At ECR 2015 Prof. Palkó will receive the Gold Medal of the
European Society of Radiology.
ESR Dignitaries
Honorary Lecturer Aer completing his medical training, Prof. Antoch began work-
ing in general surgery before starting his training in diagnostic and
interventional radiology at Essen University Hospital. He became a
board certified radiologist in 2004. From 2004 to 2008, he worked
as a consultant radiologist and became vice chairman of the
department of radiology at Essen University Hospital in 2008. In
2010 he was appointed chairman of the department of diagnostic
and interventional radiology at Düsseldorf University Hospital.
At ECR 2015, Prof. Antoch will deliver the Wilhelm Conrad Rönt-
gen Honorary Lecture entitled ‘Hybrid imaging: let the two
worlds of radiology and nuclear medicine come together’.
ESR Dignitaries
At ECR 2015, Prof. Brink will deliver the Josef Lissner Honorary
Lecture entitled ‘Is the ‘Art of Medicine’ dead in the era of
population health management?’.
ESR Dignitaries
myESR.org
62 ECR 2015 | Final Programme www.myESR.org
ECR 2015 Committees
Scientific Subcommittees
Committees
Congress Committee
Scientific Subcommittees
Scientific Subcommittees
Scientific Subcommittees
PAEDIATRIC VASCULAR
The ESR would like to thank the ESPR for their cooperation on this subcommittee The ESR would like to thank CIRSE for their cooperation on this subcommittee
Scientific Subcommittees
www.buchkontor.at
Title
Programme
Overviews
Wednesday, March 4
Room/ A B C Z M N Studio 2015 L1 L2
2nd Level 2nd Level 2nd Level 2nd Level 1st Level 1st Level 1st Level 1st Level 1st Level
Time (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
E³ 121 RC 101 SF 1a RC 113 RC 105
08:30- E³ - ECR Abdominal Special Focus Physics in Computer
Academies: Viscera Session Radiology Applications
09:00 Interactive Pitfalls in Acute Cone-beam CT Mobile IT in
Teaching interpretation in gastrointestinal radiology
Sessions pancreatic imaging tract emergencies:
09:00- Changes of the an update
09:30 gastrointestinal
tract aer
treatment
09:30-
10:00
10:00-
10:30
E³ 221 SS 201a SS 202a SS 206 SS 201b SS 203a SY 1 SS 215
10:30- E³ - ECR Abdominal Breast Molecular Gastrointestinal Cardiac Siemens Vascular
Academies: Viscera Imaging for Imaging Tract Tissue Healthcare Pre- and post-
11:00 Interactive Liver MRI neoadjuvant Clinical molecular Improving characterisation and interventional
Teaching chemotherapy imaging abdominopelvic Bayer HealthCare work-up
Sessions imaging: Joint
11:00- The treated breast: technical aspects Satellite
11:30 what you need to Symposium*
know
11:30-
12:00
12:00-
12:30 SY 2
Siemens
E³ 25A SY 6 SY 27 Healthcare
12:30- E³ - The Beauty of SuperSonic HIMSS and
Basic Knowledge: Imagine Satellite Bayer HealthCare
13:00 Breast Imaging Satellite Symposium* Joint
Breast ultrasound: Symposium* Satellite
a primer Symposium*
13:00- 12:15–13:45
13:30
13:30-
14:00
SS 302a SS 301a SS 302b SS 305 SS 301b SS 303a SY 3 SS 315
14:00- Breast Abdominal Breast Computer Gastrointestinal Cardiac Siemens Vascular
Breast density and Viscera Risk imaging and Applications Tract Coronary Healthcare Innovations in
14:30 imaging biomarkers Diffuse liver and stratification Imaging biomarkers Gastro-oesophageal atherosclerosis Satellite vascular imaging
pancreatic diseases and small bowel Symposium*
imaging
14:30-
15:00
15:00-
15:30
15:30-
16:00
RC 401 SF 4 PC 4b RC 411 SY 4
16:00- GI Tract Special Focus Professional Neuro Siemens
Misses and Session Challenges Imaging findings Healthcare
16:30 difficulties in Pancreatic lesions Session in treated brain Satellite
abdominal imaging - the solid, the What are the tumours Symposium*
cystic, and the concrete benefits
16:30- diffuse: benign or of structured
17:00 malignant? reporting?
17:00-
17:30
Registration: Tuesday, March 3: 12:00–18:00 / Wednesday, March 4: 07:00–18:00 / Thursday, March 5 to Sunday, March 8: 07:30–18:00
09:30- 09:30-
10:00 10:00
10:00- 10:00-
10:30 10:30
SS 210 SS 211a SS 216 SS 213 SS 202b SS 209 SS 207 SS 214 SS 208 SS 212 SS 203b SS 217 SS 211b
Musculoskeletal Neuro Oncologic Physics in Breast Interventional Genitourinary Radiographers 10:30- Head and Neck Paediatric Cardiac Emergency Neuro 10:30-
Intervention Inflammatory Imaging Radiology Axillary imaging and Radiology Gynaecological Musculoskeletal Advanced imaging Chest imaging and Heart rate: Radiology Vascular disorders,
and degenerative Thoracic oncology Advances in CT nodal staging Peripheral arterial malignancies radiography 11:00 in salivary glands dosimetry disorders and Emergency diagnosis and 11:00
disorders imaging and venous and lymph imaging issues imaging: treatment
interventions nodes, including how to be more
11:00- elastography precise 11:00-
11:30 11:30
11:30- 11:30-
12:00 12:00
12:00- 12:00-
12:30 12:30
E³ 24A LBCT SY 5
E³ - The Beauty of Late-Breaking Bayer HealthCare 12:30- 12:30-
Basic Knowledge: Clinical Trials Satellite
Skeletal Radiology Symposium* 13:00 13:00
Plain radiographs:
analysis and
interpretation 13:00- 13:00-
13:30 13:30
13:30- 13:30-
14:00 14:00
SS 310 SS 311a SS 316 SS 313 SS 304 SS 309 SS 307 SS 314 SS 308 SS 312 SS 303b SS 317 SS 311b
Musculoskeletal Neuro Oncologic Physics in Chest Interventional Genitourinary Radiographers 14:00- Head and Neck Paediatric Cardiac Emergency Neuro 14:00-
Fractures, spinal Brain trauma, Imaging Radiology Interventional Radiology Prostate MR Quality issues Temporal bone and Bone and so Cardiac function Radiology Hypertension and
injuries and spine degenerative and Molecular imaging Advances in MR procedures and Musculoskeletal imaging 14:30 temporomandibular tissue imaging and flow Update on imaging stenosis 14:30
spine diseases and new agents technology follow-up interventions joint imaging approach in trauma
and new MRI patients
14:30- techniques 14:30-
15:00 15:00
15:00- 15:00-
15:30 15:30
15:30- 15:30-
16:00 16:00
RC 410 PC 4a RC 402 RC 404 RC 408 RC 407 E³ 418 RC 415 RC 403 RC 409 RC 417 RC 412
Musculoskeletal Professional Breast Chest Head and Neck Genitourinary E³ - ECR 16:00- Vascular Cardiac Interventional Emergency Paediatric 16:00-
Trauma to the Challenges Radio-pathological HRCT - patterns in The orbit: Prostate imaging: Academies: Basic principles Quantification Radiology Radiology Imaging of foetus
paediatric skeleton Session correlation: chest radiology: you can‘t see what how I do it Hybrid Imaging 16:30 of varicose vein of myocardial Basic principles ‚Special patients‘ and infant 16:30
Radiologist: more important back to basics and you haven‘t learnt (basic) diagnosis and perfusion: of percutaneous in the
imager or doctor? than you thought beyond Scanners and endovascular which test is the tumour ablation emergency room:
tracers 16:30- treatment best (PET, MRI, when and how to 16:30-
17:00 MDCT)? image them? 17:00
17:00- 17:00-
17:30 17:30
Thursday, March 5
Today’s Highlights Room/ A B C Z M N Studio 2015 L1 L2
2nd Level 2nd Level 2nd Level 2nd Level 1st Level 1st Level 1st Level 1st Level 1st Level
Time (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
E³ 521 RC 501 SF 5 Joint Session of RC 513 E³ 519 E³ - Rising Stars
08:30-
Wednesday, March 4 09:00
E³ - ECR
Academies:
Interactive
Abdominal
Viscera
The many faces of
Special Focus
Session
Advanced
ESR and EFSUMB
Advances in
diagnostic
Physics in
Radiology
Artifacts and pitfalls
E³ - ECR
Academies:
Image-Guided
Programme
Basic 1:
Breast imaging
Teaching benign liver lesions applications in ultrasound: better in tomography Interventions in
Sessions ultrasound results through Oncology
09:00- What to look for integration Hepatic primary
Room A OPENING CEREMONY 09:30 aer treatment of tumours:
lung cancer ‚prime time‘ for
17:45–19:00 Prof. Bonomo & Prof. Hamm interventional
09:30- radiologists?
officially open ECR 2015 10:00
Presentation of Honorary Members
Musical Entertainment by Red Bull Flying Bach 10:00-
10:30
Room A E³ 121 E³ - ECR Academies:
E³ 621 SS 601a SS 602 SS 605 SS 601b SS 603a E³ - Rising Stars SS 615
08:30–10:00 Interactive Teaching Sessions 10:30- E³ - ECR Abdominal Breast Computer Gastrointestinal Cardiac Programme Vascular
Academies: Viscera Imaging techniques Applications Tract Myocardial Basic 2: Vascular imaging in
Changes of the gastrointestinal 11:00 Interactive Focal liver lesions and interventions Dose tracking: Inflammatory bowel infarction Neuroradiology systemic diseases
tract aer treatment Teaching
Sessions
assessment and
reduction of
disease and coronary
intervention
11:00- The treated liver artefacts
Room A E³ 221 E³ - ECR Academies: 11:30
10:30–12:00 Interactive Teaching Sessions
11:30-
The treated breast:
12:00
what you need to know
12:00-
Room B E³ 25A E³ - The Beauty of Basic Knowledge: 12:30 HL 1
Headline Session
12:30–13:30 Breast Imaging Josef Lissner -
Honorary Lecture E³ 25B SY 11 SY 10
Breast ultrasound: a primer 12:30- 12:15–12:45 E³ - The Beauty of Siemens Siemens
Basic Knowledge: Healthcare Healthcare
13:00 Breast Imaging Satellite Satellite
Room D1 E³ 24A E³ - The Beauty of Basic Knowledge: Cracking the Symposium* Symposium*
mystery of needles
12:30–13:30 Skeletal Radiology 13:00- and gauges
Plain radiographs: 13:30
analysis and interpretation
13:30-
Room D2 LBCT Late-Breaking Clinical Trials 14:00
12:30–13:30 E³ 721 SS 701a SS 702 SS 715 EuroSafe ESOR Session E³ - Rising Stars EIBIR Session 1
14:00- E³ - ECR Abdominal Breast Vascular Imaging Striving in Programme The complexity
Academies: Viscera Breast: Arteries and veins Session 1 radiological Student Session 1 of personalised
14:30
Room Z PC 4b What are the concrete benefits Interactive
Teaching
Liver steatosis and
fibrosis
diffusion-weighted
MR imaging (DWI)
Clinical Decision
Support: making
education breast care
Registration: 07:30–18:00
10:00- 10:00-
10:30 10:30
MM 6 SS 610a SS 611 SS 616 SS 612 SS 604 SS 609 SS 607a SS 610b SS 608 SS 607b SS 603b MC 628 E³ 620
Multimedia Musculoskeletal Neuro Oncologic Paediatric Chest Interventional Genitourinary Musculoskeletal 10:30- Head and Neck Genitourinary Cardiac Joint Course of E³ - ECR 10:30-
Classroom Shoulder, brachial Brain tumour (1) Imaging Foetal and Pulmonary nodule Radiology DWI in prostate Lower extremity (1) Oncologic imaging: Benign Valvular disease ESR and RSNA: Academies:
Cardiac CT (1) plexus Whole-body paediatric Neuro interventions cancer 11:00 CT, MRI and PET gynaecological Emergency Diagnostic 11:00
imaging of systemic neuroimaging pathology Radiology Urogenital
tumour spreading Chest emergencies Radiology
11:00- Retroperitoneum 11:00-
11:30 and adrenals 11:30
11:30- 11:30-
12:00 12:00
12:00- 12:00-
12:30 12:30
SY 8 SY 7 E³ 24B SY 12 SY 9
Bracco Bayer HealthCare E³ - The Beauty of Toshiba Medical GE Healthcare 12:30- 12:30-
Satellite Satellite Basic Knowledge: Systems Satellite
Symposium* Symposium* Skeletal Radiology Satellite Symposium* 13:00 13:00
The concept of Symposium*
degeneration:
the tendons 13:00- 13:00-
13:30 13:30
13:30- 13:30-
14:00 14:00
MM 7 SS 710 SS 711 SS 716 SS 713 SS 704 SS 709a SS 707 SS 709b SS 708 SS 701b SS 703 MC 728 E³ 720
Multimedia Musculoskeletal Neuro Oncologic Physics in Chest Interventional Genitourinary Interventional 14:00- Head and Neck Gastrointestinal Cardiac Joint Course of E³ - ECR 14:00-
Classroom Lower extremity (2) Brain tumour (2) Imaging Radiology Lung cancer: Radiology New frontiers and Radiology CT including cone Tract Work-up of ESR and RSNA: Academies:
CT angiography (1) Urogenital oncology Innovations in CT screening and TIPS and portal vein contrast agents in Biopsy techniques 14:30 beam CT: Colonic imaging coronary artery Emergency Diagnostic 14:30
technology staging intervention GU imaging and solid tumour image quality, disease Radiology Urogenital
ablation dosimetry and CNS emergencies Radiology
14:30- clinical applications Prostate 14:30-
15:00 15:00
15:00- 15:00-
15:30 15:30
15:30- 15:30-
16:00 16:00
MM 8 RC 810 SF 8b PC 8a SF 8c E³ 826 RC 808 RC 807 E³ 818 RC 815 RC 803 RC 809 MC 828 E³ 820
Multimedia Musculoskeletal Special Focus Professional Special Focus E³ - ECR Master Head and Neck Genitourinary E³ - ECR 16:00- Vascular Cardiac Interventional Joint Course of E³ - ECR 16:00-
Classroom The ankle and foot Session Challenges Session Classes Head and neck Lessons I learned Academies: EVAR endoleaks: Imaging of heart Radiology ESR and RSNA: Academies:
Oncologic imaging New frontiers Session Breast imaging Lung cancer staging imaging: from mistakes in Hybrid Imaging 16:30 imaging and failure Current trends Emergency Diagnostic 16:30
(1) in brain tumour Integration of modalities: don‘t sell your kidney and adrenal (basic) management in transarterial Radiology Urogenital
imaging imaging biomarker beyond the ultrasound yet! imaging Essentials of hybrid chemoembolisation General principles: Radiology
activities on a conventional imaging 16:30- (TACE) and paediatric and ENT Upper and lower 16:30-
European level 17:00 radioembolisation emergencies urinary tract 17:00
for HCC
17:00- 17:00-
17:30 17:30
* Not CME accredited Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–17:00
Friday, March 6
Today’s Highlights Room/ A B C Z M N Studio 2015 L1 L2
2nd Level 2nd Level 2nd Level 2nd Level 1st Level 1st Level 1st Level 1st Level 1st Level
Time (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
E³ 921 RC 901 SF 9a ESR Research in E³ 919 E³ - Rising Stars
08:30-
Thursday, March 5 09:00
E³ - ECR
Academies:
Interactive
Abdominal
Viscera
Technical advances
Special Focus
Session
Evaluation of
Education and
Training Session
Research for
E³ - ECR
Academies:
Image-Guided
Programme
Student Session 3
E³ - Rising Stars
Room L1 PC 8b Imaging in population-based 13:30- Programme
Ultrasound
16:00–17:30 studies 14:00 Workshop
I - FAST, lung,
IIQ EM 5 SY 22 SY 21 SY 28 Joint Session EIBIR Session 3 echo, intervention /
Room F1 PC 8a Integration of imaging biomarker 14:00- Image EFRS meets Hologic GE Healthcare HIMSS of the ESR and MITIGATE phantoms
Interpretation Germany Satellite Russia Satellite ESMRMB consortium:
16:00–17:30 activities on a European level 14:30 Quiz High-end and Symposium* Satellite Symposium* The ABC and 123 state of the art
Couples for Europe hybrid technology Symposium* of perfusion MRI: imaging and
Room D1 E³ 826 E³ - ECR Master Classes: in clinical and DSC, DCE and ASL therapy in GIST
14:30- research work of explained
16:00–17:30 Chest 15:00 radiographers in
Germany
Lung cancer staging
15:00-
15:30
15:30-
16:00
E³ 1221 EM 2 E³ 1222 PC 12b RC 1213 E³ 1219 E³ - Rising Stars
16:00- E³ - ECR ESR meets EAU E³ - ECR Professional Physics in E³ - ECR Programme
Academies: Joint ECR-EAU Academies: Challenges Radiology Academies: Basic 3:
16:30 Interactive prostate cancer Modern Imaging Session Good radiation Image-Guided Oncologic imaging
Teaching session of the GI Tract Medicolegal and bad radiation? Interventions in
Sessions Perianal fistula aspects in daily How to assess Oncology
16:30- Unexpected disease: practice and communicate The cutting-edge
17:00 findings all you need radiation risk technologies in
on brain MRI to know to patients and image-guided
referring physicians tumour therapy
17:00-
17:30
Registration: 07:30–18:00
09:30- 09:30-
10:00 10:00
10:00- 10:00-
10:30 10:30
MM 10 SS 1010a SS 1011 SS 1016 SS 1001 SS 1004 SS 1009 EF 2 SS 1014 SS 1008 SS 1012 SS 1003b SS 1010b E³ 1020
Multimedia Musculoskeletal Neuro Oncologic Gastrointestinal Chest Interventional EFOMP Workshop Radiographers 10:30- Head and Neck Paediatric Cardiac Musculoskeletal E³ - ECR 10:30-
Classroom Tumours, systemic Ischaemic stroke Imaging Tract Pulmonary Radiology Multi-energy Radiation dose Thyroid and Abdominal imaging Non-ischaemic Hand, upper Academies:
MDCT in diseases and (1) Advances in Rectal cancer and hypertension and Percutaneous imaging: optimisation 11:00 parathyroid imaging myocardial disease extremity Diagnostic 11:00
emergencies (1) muscles imaging metastatic anorectal imaging thromboembolic ablation in liver from physics to Urogenital
disease disease tumours diagnosis II Radiology
11:00- Emergencies 11:00-
11:30 11:30
11:30- 11:30-
12:00 12:00
12:00- 12:00-
12:30 12:30
SY 14 SY 13 E³ 24C SY 16 SY 15
Bracco Bayer HealthCare E³ - The Beauty of Guerbet GE Healthcare 12:30- 12:30-
Satellite and Basic Knowledge: Satellite Satellite
Symposium* Siemens Skeletal Radiology Symposium* Symposium* 13:00 13:00
Healthcare Inflammatory/
Joint Satellite infectious disorders MIR @ ECR
Symposium* Session 1 13:00- 13:00-
MIR:
best of professional 13:30 13:30
issues in radiology
13:30- 13:30-
14:00 14:00
MM 11 EuroSafe
Multimedia 14:00- Imaging 14:00-
Classroom Session 2
CT angiography (2) 14:30 EuroSafe imaging 14:30
call for action
14:30- 14:30-
15:00 15:00
Coffee break
15:00- 15:00-
15:30 15:30
MIR @ ECR
Session 2 15:30- 15:30-
Improving quality
and safety in 16:00 16:00
radiology
MM 12 RC 1210 SF 12 SA 12 PC 12a RC 1204 E³ 1226a E³ 1218 E³ 1226d E³ 1226c RC 1205 E³ 1226b RC 1212
Multimedia Musculoskeletal Special Focus State of the Art Professional Chest E³ - ECR Master E³ - ECR 16:00- E³ - ECR Master E³ - ECR Master Computer E³ - ECR Master Paediatric 16:00-
Classroom Sports injuries to Session Symposium Challenges Mediastinal disease Classes Academies: Classes Classes Applications Classes Hepatobiliary
Cardiac CT (2) the knee: Interventional Fleischner Session revisited Urogenital radiology Hybrid Imaging 16:30 Chemical exchange Cardiac MR imaging Update on Acute postoperative imaging in children 16:30
improving my radiology in venous guidelines for Harmonised in 2015: (advanced) saturation transfer computer-aided complications
report thromboembolism nodules: approach for beyond MR/PET - the future (CEST): diagnosis (CAD) in the abdomen:
and chronic venous theory and practice imaging in Europe: morphology? of hybrid imaging? 16:30- a new toy for from diagnosis 16:30-
disease myth or reality? 17:00 molecular imaging? to therapy 17:00
17:00- 17:00-
17:30 17:30
* Not CME accredited Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–17:00
Saturday, March 7
Today’s Highlights Room/ A B C Z M N Studio 2015 L1 L2
2nd Level 2nd Level 2nd Level 2nd Level 1st Level 1st Level 1st Level 1st Level 1st Level
Time (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
E³ 1321 RC 1301 E³ 1322 Joint Session RC 1313 E³ 1323 E³ - Rising Stars
08:30-
Friday, March 6 09:00
E³ - ECR
Academies:
Interactive
Abdominal
Viscera
Pancreatic
E³ - ECR
Academies:
Modern Imaging
of the ESR and
EORTC
Imaging in
Physics in
Radiology
IT tools for
E³ - European
Diploma Prep
Sessions
Programme
Basic 4:
Musculoskeletal
Teaching inflammation of the GI Tract multicenter clinical dose tracking Chest trauma
Sessions Imaging the oncological trials and workflow
09:00- Diagnostic postoperative optimisation
Room A HL 2 WILHELM CONRAD RÖNTGEN 09:30 evaluation of bone patient
tumours
12:15–12:45 HONORARY LECTURE 09:30-
Hybrid imaging: 10:00
let the two worlds of radiology and
nuclear medicine come together 10:00-
Gerald Antoch; Düsseldorf/DE 10:30
E³ 1422 EM 3 SS 1402 SS 1406 TF 1 E³ 1423 E³ - Rising Stars ESR-PAG 1
Room E1 PC 9 Personalised medicine 10:30- E³ - ECR ESR meets the Breast Molecular Radiology E³ - European Programme ESR Patient
Academies: Republic of Digital breast Imaging Trainees Forum Diploma Prep Basic 5: Advisory Group
08:30–10:00 in radiology 11:00 Modern Imaging Korea tomosynthesis: Experimental Highlighted Sessions Thoracic The challenges
of the GI Tract CT in lung cancer the new molecular imaging Lectures Gastrointestinal and emergencies of providing true
Inflammatory bowel screening and COPD mammography and exploratory abdominal patient-centred
Room E2 NH 9 Image-guided interventions 11:00- disease evaluation clinical studies care: moving
08:30–10:00 of the prostate 11:30 forward together
Registration: 07:30–18:00
Saturday, March 7
Q / Multimedia
Classroom E1 E2 F1 F2 D1 D2 G K Room/
ECR Master Classes
1st Level Entrance Level Entrance Level Entrance Level Entrance Level Lower Level Lower Level Lower Level Lower Level
(ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) Time
RC 1310 RC 1311 E³ 1326 RC 1302 RC 1304 RC 1314 RC 1307 E³ 1318
08:30-
Musculoskeletal
How I do and report
Neuro
Reporting spine
imaging studies
E³ - ECR Master
Classes
Imaging tumour
Breast
Tailoring breast
Chest
Occupational lung
cancer screening to diseases the known
Radiographers
Radiography and
evidence-based
Genitourinary
Female pelvic
imaging:
E³ - ECR
Academies:
Hybrid Imaging 09:00 Friday, March 6
phenotype: risk level and the less known research: how I do it? (advanced)
the future is now the way forward Advanced imaging
with tracers 09:00-
beyond FDG 09:30 Room MB 1 E³ 926c Vascular
09:30-
08:30–10:00 Uterine and prostate embolisation
10:00
Room MB 2 E³ 926a Paediatric
10:00- 08:30–10:00 Advances in paediatric imaging
10:30
Room MB 3 E³ 926b Interventional Radiology
MM 14 SS 1410 SS 1411 SS 1416 SS 1401 SS 1404 SS 1409 SS 1407 SS 1414
Multimedia Musculoskeletal Neuro Oncologic Gastrointestinal Chest Interventional Genitourinary Radiographers 10:30- 08:30–10:00 The leading role of interventional
Classroom Spine Ischaemic stroke Imaging Tract CT dose reduction Radiology Adrenal and kidney Dose management radiology in a major trauma centre
Oncologic imaging (2) Prostate cancer Abdominal and and MR indications Radioembolisation imaging in medical imaging 11:00
(2) imaging vascular imaging and
chemoembolisation
in liver tumours 11:00- Room G E³ 1226a Genitourinary
11:30 16:00–17:30 Urogenital radiology in 2015:
beyond morphology?
11:30-
12:00 Room MB 1 E³ 1226d Molecular Imaging
12:00-
16:00–17:30 Chemical exchange saturation
12:30
transfer (CEST):
a new toy for molecular imaging?
E³ 24D
E³ - The Beauty of 12:30-
Basic Knowledge:
13:00 Room MB 2 E³ 1226c Cardiac
Skeletal Radiology
Tumoural and 16:00–17:30 Cardiac MR imaging
pseudotumoural
MSK lesions 13:00-
13:30 Room MB 4 E³ 1226b Emergency Radiology
16:00–17:30 Acute postoperative complications
13:30- in the abdomen:
14:00 from diagnosis to therapy
MM 15 RC 1510 NH 15 SF 15 RC 1502 RC 1504 RC 1514 RC 1511 E³ 1518
Multimedia Musculoskeletal New Horizons Special Focus Breast Chest Radiographers Neuro E³ - ECR 14:00-
Classroom The hand and wrist Session Session Update on BI-RADS Pulmonary arterial CT from A to Z White spots Academies:
MDCT Optical molecular Cardiac CT: hypertension in the brain Hybrid Imaging 14:30
in emergencies
(2)
imaging:
a new dimension
for radiology
cutting edge
techniques
(advanced)
Advanced hybrid
imaging of brain 14:30-
Saturday, March 7
15:00
Sunday, March 8
Today’s Highlights Room/ A B C Z M N Studio 2015 L1 L2
2nd Level 2nd Level 2nd Level 2nd Level 1st Level 1st Level 1st Level 1st Level 1st Level
Time (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
E³ 1721 RC 1701 E³ 1722 EDiR talk RC 1712 Joint Session of E³ - Rising Stars
08:30-
Saturday, March 7 09:00
E³ - ECR
Academies:
Interactive
Abdominal
Viscera
Colorectal cancer
E³ - ECR
Academies:
Modern Imaging
FA(b)Q frequently
asked (burning)
questions - with
Paediatric
Imaging the head
and skull base
the ESR and ERS
Lung cancer
screening: why and
Programme
Basic 6:
Interventional
Teaching liver metastases: of the GI Tract answers how to implement radiology
Sessions assessing tumour Gastrointestinal a comprehensive
09:00- Cardiac CT: response stromal tumours preventive
Room A HL 3 NIKOLA TESLA HONORARY LECTURE 09:30 from stenosis (GIST) programme
assessment to risk
12:15–12:45 Brain tumour update 2015: stratification
09:30-
What’s new and why you should care 10:00
Anne G. Osborn; Salt Lake City, UT/US
10:00-
Room Z Joint Session of the ESR and EORTC 10:30
08:30–10:00 (European Organisation for Research and
E³ 1821 EM 4 SS 1802 SS 1805 SS 1801 E³ 1823 SS 1803 ESR-PAG 2
Treatment of Cancer) 10:30- E³ - ECR ESR meets Breast Computer Abdominal E³ - European Cardiac ESR Patient
Academies: Turkey Population-based Applications Viscera Diploma Prep Biomarkers in Advisory Group
Imaging in multicentre clinical 11:00 Interactive Turkey welcomes screening Data sharing and HCC diagnosis and Sessions cardiac imaging Communicating the
oncological trials Teaching
Sessions
ECR content-based data
retrieval
treatment Neuro results of radiologic
studies to patients:
11:00- Evaluation of from high-tech
Room B EM 3 ESR meets the Republic of Korea 11:30 patients with lung to human-touch
emphysema imaging
10:30–12:00 CT in lung cancer screening and
11:30-
COPD evaluation
12:00
Room A JIIQ JUNIOR IMAGE INTERPRETATION QUIZ 12:00-
E³ - Rising Stars
Programme
13:00–14:00 Battle for the Audience 12:30 Ultrasound
Workshop
IV – Abdomen
E³ 25E ESR
Room Z Joint Session of the ESR and ESTRO 12:30- E³ - The Beauty of General
(European Society for Radiotherapy and Oncology) 13:00 Basic Knowledge: Assembly
Breast Imaging
14:00–15:30 ESTRO 1 Non-surgical approach to early lung High risk lesions:
Case-Based
solving the
cancer: perspectives of imaging and 13:00- dilemma Diagnosis Training
Part I
radiation-based disciplines 13:30
13:00–14:00
16:00–17:30 ESTRO 2 Radiology and radiation oncology: 13:30- Case-Based
new chances for a partnership 14:00 Diagnosis Training
Interlude: Spot the
SS 1902a SS 1901a SS 1902b SS 1905 SS 1901b E³ 1923 implant - can you
Room E2 NH 15 Optical molecular imaging: 14:00- Breast Abdominal Breast Computer Abdominal E³ - European identify common
and unusual
14:00–15:30 a new dimension for radiology 14:30 Multiparametric
MRI and PET
Viscera
Pancreas: tumours,
Preoperative
imaging
Applications
Methods for image
Viscera
Liver CT and
Diploma Prep
Sessions medical devices
pancreatitis interpretation and ultrasound: Principles of inside the body?
Studio 2015 MS 16 Solving the crossword puzzle in reporting new techniques imaging and 14:00–14:30
14:30- radiation protection
16:00–17:30 diffuse interstitial lung disease (DILD) 15:00 Case-Based
Diagnosis Training
15:00- Part II
Room F1 SA 16 Controversies in comprehensive 14:30–15:30
16:00–17:30 imaging of coronary artery disease 15:30
Registration: 07:30–18:00
09:30-
10:00
10:00-
10:30
SS 1810 SS 1811 SS 1816 SS 1813 SS 1804 SS 1809 SS 1807 SS 1814
Musculoskeletal Neuro Oncologic Physics in Chest Interventional Genitourinary Radiographers 10:30-
Arthritis Brain epilepsy and Imaging Radiology Obstructive Radiology GU special topics Professional
inflammation Response Novel digital pulmonary diseases GI and abdominal challenges for 11:00
assessment: imaging techniques and reduced lung interventions radiographers
new concepts function
11:00-
11:30
11:30-
12:00
12:00-
12:30
E³ 24E
E³ - The Beauty of 12:30-
Basic Knowledge:
Skeletal Radiology 13:00
Metabolic,
endocrine and
marrow disease 13:00-
13:30
13:30-
14:00
SS 1910 SS 1911 SS 1916 SS 1913 SS 1904 SS 1909a SS 1907 SS 1909b
Musculoskeletal Neuro Oncologic Physics in Chest Interventional Genitourinary Interventional 14:00-
Knee Advanced imaging Imaging Radiology Infection, Radiology Urinary stones, Radiology
Oncologic imaging Patient and staff transplantation and Embolotherapy ureters and bladder Aortic interventions 14:30
of the GI tract dose studies quality issues pathology
14:30-
15:00
15:00-
15:30
83
ESR/EFRS meets
Sessions
Once again, the ESR will welcome three countries and a partner discipline to share
their expertise as part of the ‘ESR meets’ programme during ECR 2015, next March
in Vienna.
The national radiological societies of Germany, the Republic of Korea, and Turkey,
as well as the European Association of Urology (EAU), will present their most
recent scientific developments in joint sessions, and try to strengthen links
between professionals from different countries and disciplines. The European
Federation of Radiographer Societies (EFRS) will also host its own ‘meets’ session
for radiographers, in conjunction with their colleagues from Germany (German
Association of Medical Technologists and Analysts).
Both the ESR and the EFRS warmly welcome these societies, and hope to see ECR
delegates attend the sessions in large numbers.
85
Scientific Programme
www.mumok.at
89
Scientific Programme
91
Scientific Programme
93
Scientific Programme
97
Scientific Programme
www.kunsthauswien.com
101
Scientific Programme
Multidisciplinary Sessions
103
When you’ve checked in to ECR 2015 on
catch up with the latest #ECR2015 news on
become a fan and post us a photo on
and then check out our videos on
’ECR 2015’ on 4sq - twitter.com/myESR - facebook.com/myESR - youtube.com/myESR
3
E
Rising Stars
Programme
The Rising Stars Programme is designed especially for residents, students,
radiographers and trainee radiographers.
It consists of Basic Sessions, Student Sessions, Student Hands-on Workshops on
Ultrasound, Case-Based Diagnosis Training sessions, and the Radiology Trainees
Forum Programme including the RTF Highlighted Lectures and the RTF Quiz.
105
myESR.org/RisingStars
facebook.com/ESRRisingStars
Thursday, March 5, 08:30–10:00, Studio 2015 Saturday, March 7, 08:30–10:00, Studio 2015
Basic Session 1: Basic Session 4:
Breast imaging Musculoskeletal trauma
» Mammography [A-148] » Shoulder [A-504]
F.J. Gilbert; Cambridge/UK M. Zanetti; Zurich/CH
» Breast US [A-149] » Knee [A-505]
C.S. Balleyguier; Villejuif/FR K. Verstraete; Ghent/BE
» Breast MRI [A-150] » Ankle [A-506]
F. Sardanelli; San Donato Milanese/IT J. Kramer; Linz/AT
Thursday, March 5, 10:30–12:00, Studio 2015 Saturday, March 7, 10:30–12:00, Studio 2015
Basic Session 2: Basic Session 5:
Neuroradiology Thoracic emergencies
» Aging and degeneration in the brain [A-199] » Vascular [A-549]
B. Gómez-Ansón; Barcelona/ES T. Jargiello; Lublin/PL
» Brain trauma [A-200] » Pulmonary [A-550]
M. Stajgis; Poznan/PL C.M. Schaefer-Prokop; Amersfoort/NL
» Vascular malformations [A-201] » Cardiac [A-551]
P. Vilela; Almada/PT V.E. Sinitsyn; Moscow/RU
Thursday, March 5, 14:00–15:30, Studio 2015 Friday, March 6, 08:30–10:00, Studio 2015
Student Session 1 Student Session 3
» SWI or T2* – which MRI sequence to use » Gastrostomy tube insertion without the use
in the detection of cerebral microbleeds? of barium sulphate as a contrast medium reduces
The Karolinska Imaging Dementia Study radiation dose received by the patient in a paediatric
S. Shams; Stockholm/SE interventional radiology setting
» Background parenchymal enhancement on breast B.S. Kelly; Dublin/IE
MRI in women receiving chest radiotherapy » Abdominal x-rays during pregnancy
for childhood Hodgkin’s lymphoma P.-M. Boarescu; Cluj-Napoca/RO
W. Abutaleb; Cambridge/UK » An investigation into the cardiologists’ opinion/
» 3D quantitative assessment of lesion response awareness of radiation risk as part of routine patient
to MR-guided high-intensity focused ultrasound consent for cardiac interventional procedures
treatment of uterine fibroids I. Banerjee; Dublin/IE
J. Savic; Berlin/DE » Mammography phantoms experiment:
» Evaluation of choroid plexus with foetal MRI: is automatic mode the best for shooting?
what happens in ventriculomegaly? O. Alekseeva; Moscow/RU
C. Turam; Istanbul/TR » Mammographic screening and detection of breast
» Anatomic and morphometric variations arterial calcification as an independent predictor of
of the intracranial vertebrobasilar system coronary atherosclerotic disease in a single ethnic
on MSCT and MR angiography cohort of African American women
S. Jankovic; Nis/RS J.H. Nunez; Charleston, SC/US
Thursday, March 5, 16:00–17:30, Studio 2015 Friday, March 6, 10:30–12:00, Studio 2015
Student Session 2 Student Session 4
» The positive effects on CT reporting with » Teaching cross-sectional imaging to medical
a radiologist present at the initial clinical evaluation students using Apple iBooks:
of polytrauma a novel educational resource
V. Sanfilippo; Catania/IT M. Sia; London/UK
» An audit of the practices of reporting of staging » Sono4Students: peer-to-peer teaching ultrasound
CT scans in primary malignancies in a medical curriculum
R.D.T. Price; Birmingham/UK K. Baharian; Bonn/DE
» Reproducibility of a novel semi-automated soware » Student’s FAST learning and teaching project
programme for Pre-TAVR CT assessment M. Skoczyński; Lublin/PL
K. Rohan; Belfast/UK » Fuzzy clustering for the quantification of resting
» Analysing CT images of patients who died state network characteristics in single patients
aer thrombolysis Z. Klimaj; Budapest/HU
E. Tarjányi; Debrecen/HU » Development of a new image operation
» Trunk paediatric CT diagnostic reference levels system on screen using a Leap Motion sensor
D. Fernandes; Coimbra/PT for dental radiology
Y. Yasumoto; Maebashi-City/JP
Visiting Schools
Visiting Seminars
ESOR Courses for EDiR
Scholarship Programmes
Fellowship Programmes
Teach-the-Teachers Programme
Visiting Professorship Programme
Online Courses
Tutorials
myESR.org/esor
Education in partnership
3
E
European Diploma
Prep Sessions
The European Diploma Prep Sessions aim to prepare prospective candidates for
the European Diploma in Radiology (EDiR).
They are also suitable for residents who want an overview of the various topics
relevant to imaging and for those preparing for their national board examinations.
The content of the programme reflects Level I and Level II European Training
Curriculum (ETC) learning objectives across a two-year cycle. The sessions are held
in close cooperation with the European Board of Radiology (EBR).
Each of the six sessions is led by three lecturers and moderated by one chairman.
111
Scientific Programme
113
Scientific Programme
115
Scientific Programme
E3 – ECR Academies
Hybrid Imaging (basic) Hybrid Imaging (advanced)
The programme will be concluded with a self-assessment test, The programme will be concluded with a self-assessment test,
published in the new platform ‘ESR Education on demand’. published in the new platform ‘ESR Education on demand’.
ECR delegates can access the platform and the self-assessment tests ECR delegates can access the platform and the self-assessment tests
through the work stations in the ECR Live & EPOS™ Lounge (1st level). through the work stations in the ECR Live & EPOS™ Lounge (1st level).
E3 – ECR Academies
Image-Guided Interventions in Oncology
The programme will be concluded with a self-assessment test,
published in the new platform ‘ESR Education on demand’.
ECR delegates can access the platform and the self-assessment tests
through the work stations in the ECR Live & EPOS™ Lounge (1st level).
E3 – ECR Academies
Diagnostic Urogenital Radiology
The programme will be concluded with a self-assessment test,
published in the new platform ‘ESR Education on demand’.
ECR delegates can access the platform and the self-assessment tests
through the work stations in the ECR Live & EPOS™ Lounge (1st level).
E3 – ECR Academies
Modern Imaging of the GI Tract
The programme will be concluded with a self-assessment test,
published in the new platform ‘ESR Education on demand’.
ECR delegates can access the platform and the self-assessment tests
through the work stations in the ECR Live & EPOS™ Lounge (1st level).
E3 – ECR Academies
Interactive Teaching Sessions
E3 – ECR Academies
Interactive Teaching Sessions
» Visit www.staralliance.com/conventionsplus/delegates
» Under ‘Delegates login’ enter conventions code OS18S15
» The online booking tool opens in a separate window
The following Star Alliance airlines are offering special discounts for travel to/from Japan:
Austrian Airlines, Air India, Turkish Airlines, Scandinavian Airlines.
Please quote the following event code OS18S15 for ticket reservation.
3
E
ECR Master Classes
The ECR Master Classes focus on continuous professional development and lifelong
learning. The classes are designed for subspecialised radiologists seeking cutting-
edge information in their particular fields of interest. They are held by experts in the
field and reflect state-of-the-art knowledge, as well as emerging trends.
During the ECR, one ECR Master Class is offered for each subspecialty in radiology
(CIRSE [one on vascular and one on interventional radiology], ESCR, ESER, ESGAR,
ESHNR, ESMOFIR, ESNR, ESOI, ESPR, ESSR, ESTI, ESUR, EUSOBI).
123
Scientific Programme
127
Scientific Programme
Mini Course
Joint Course of the ESR and RSNA (Radiological Society of North America):
Emergency Radiology
Thursday, March 5, 08:30–10:00, Room MB 4 Thursday, March 5, 14:00–15:30, Room MB 4
MC 528 Abdominal emergencies MC 728 CNS emergencies
Moderator: A. Palkó; Szeged/HU Moderator: A. Palkó; Szeged/HU
A. Abdominal injuries [A-191] A. CNS trauma and neurovascular injury [A-228]
A. Palkó; Szeged/HU H.A. Rowley; Madison, WI/US
B. The enemy within: non-traumatic abdominal B. CNS non-traumatic emergencies [A-229]
emergencies [A-192] M. Smits; Rotterdam/NL
R.J. Zagoria; San Francisco, CA/US C. Interactive case discussion [A-230]
C. Interactive case discussion [A-193] H.A. Rowley; Madison, WI/US
A. Palkó; Szeged/HU M. Smits; Rotterdam/NL
R.J. Zagoria; San Francisco, CA/US
129
Multimedia
Classroom
Coordinators:
E. Neri; Pisa/IT
D. Regge; Turin/IT
Due to its remarkable success at ECR 2014, the Multimedia Classroom will take
place again at ECR 2015.
In this classroom, participants get a chance to solve cases on workstations
supplied by several different companies.
2D and 3D image review and processing at the workstation are essential steps
in the radiological workflow, which lead to the final diagnosis and report.
Every radiologists needs to be trained in these tasks.
Places are allocated on a first-come, first-served basis.
131
Scientific Programme
Multimedia Classroom
Accepted papers for oral presentation are presented in the Scientific Sessions.
Places are allocated on a first-come, first-served basis.
For the first time at ECR 2015, at the end of each Scientific Session, attendees will
be asked to vote, via smartphones or tablets, for their favourite paper. The presenter
of the most popular paper will be awarded a certificate by the session moderators.
133
Scientific Programme
www.esrlearningcentre.com
Joint
Sessions
161
Scientific Programme
Joint Sessions
Joint Sessions
Joint Sessions
Joint Sessions
Joint Sessions
Joint Sessions
Joint Sessions
Key to Abbreviations
CC Categorical Course
E3 European Excellence in Education
EF EFOMP Workshop
EM ESR meets Session
HL Honorary Lecture
MC Mini Course
MS Multidisciplinary Session
NH New Horizons Session
OL Opening Lecture
PC Professional Challenges Session
RC Refresher Course
SA State of the Art Symposium
SF Special Focus Session
TF Radiology Trainees Forum
169
Postgraduate Educational Programme
Wednesday
multi-slice CT (MSCT).
3. To learn about reconstruction techniques and image processing. Special Focus Session
4. To become acquainted with the important image quality parameters.
09:00 SF 1b Up-to-date imaging for hearing loss
A-013 B. Medical applications of cone-beam CT 08:30
M. Grass; Hamburg/DE
A-019 Chairman’s introduction
Learning Objectives: A. Trojanowska; Lublin/PL
1. To become acquainted with the applications of cone-beam CT.
2. To learn about systems’ designs and parameters. Session Objectives:
3. To understand image quality characteristics. 1. To understand the problem of conductive and sensorineural hearing
4. To learn how to use cone-beam images in image-guided loss and the role of radiologist in treatment planning.
interventions. 2. To discuss commonly used devices for hearing augmentation and
restoration and their radiological appearance.
09:30 3. To know how to evaluate images in cases of treatment failure.
A-014 C. 3D dentomaxillofacial imaging 08:35
H. Bosmans, A. Stratis, G. Zhang; Leuven/BE
A-020 New devices in the treatment of hearing loss
Learning Objectives: B. Ozgen Mocan; Ankara/TR
1. To become acquainted with cone-beam CT systems for
dentomaxillofacial imaging. Learning Objectives:
2. To learn about image quality characteristics. 1. To understand the mechanism of hearing loss.
3. To understand patient dose compared with other techniques in 2. To become familiar with treatment options.
dentomaxillofacial imaging. 3. To review most the most popular devices for hearing augmentation
and restoration.
09:00
08:30–10:00 Room N
A-021 Pre- and postoperative imaging in middle ear implants
E. Loney; Bradford/UK
Computer Applications Learning Objectives:
1. To learn how to image temporal bone prior to surgery and implant
RC 105 Mobile IT in radiology placement.
2. To review the most popular types of surgical procedures in the
08:30 middle ear.
A-015 Chairman’s introduction 3. To apprehend the typical appearance of reconstructed ossicular chain
E. Neri; Pisa/IT and possible complications.
Session Objectives:
1. To appreciate the current state of tablet technology and its practical
09:25
use in radiology. A-022 Pre- and postoperative imaging in inner ear and brainstem
2. To understand the pros and cons of the use of tablets. implants
3. To learn about specific critical areas of utilisation (DICOM images B. Verbist, J.H.M. Frijns; Leiden/NL
reading and teleradiology). Learning Objectives:
08:35 1. To know how to evaluate temporal bone in order to qualify for
implant placement.
A-016 A. Tablet-computers: a technical overview 2. To understand how cochlear and brainstem implants work.
J. Fernandez-Bayó; Sabadell/ES 3. To discuss possible complications and the role of imaging studies.
Learning Objectives:
1. To learn about the PC evolution: from desktops, to laptops and Panel discussion:
tablets. 09:50 Changing demands for imaging in hearing loss
2. To appreciate the versatile features of a tablet.
3. To understand the hardware features for display and networking.
08:58
A-017 B. Reading DICOM images on the tablet
O. Ratib; Geneva/CH
Learning Objectives:
1. To learn which DICOM readers are available for tablets.
2. To appreciate the local and remote approaches and the PACS/tablet
integration.
3. To understand the pros and cons of image quality and display.
08:35 09:21
A-024 CT arthrography: acceptable if MR availability is limited? A-030 C. Nuclear medicine: PET and other techniques
B. Vande Berg; Brussels/BE T. Barwick; London/UK
Learning Objectives: Learning Objectives:
1. To appreciate the current indications for CT arthrography and how 1. To learn the typical appearance on nodal metastatic disease on FDG.
they may evolve. 2. To recognise the pitfalls for interpretation.
2. To understand the technique and requirements for CT arthrography. 3. To become familiar with new radiotracers, including choline PET, for
3. To become familiar with the limitations of CT arthrography. the demonstration of nodal disease.
4. To recognise how CT arthrography complements other techniques.
Panel discussion:
09:00 09:44 When and how will imaging make diagnostic biopsy
A-025 MR arthrography: exquisite so tissue contrast unnecessary?
E.L. Rowbotham; Leeds/UK
Learning Objectives:
1. To appreciate the current indications for MR arthrography and how
08:30–10:00 Room F2
they may evolve.
2. To understand the technique and requirements for MR arthrography. Breast
3. To become familiar with the limitations of MR arthrography and
appreciate its pitfalls. RC 102 Breast ultrasound 2015
Moderator: K. Kinkel; Chêne-Bougeries/CH
09:25
A-026 MRI: when is it enough? 08:30
C.W.A. Pfirrmann; Zurich/CH
A-031 A. Evidence for screening in dense breasts
Learning Objectives: V. Girardi; Brescia/IT
1. To understand the limitations of non-arthrographic MRI. Learning Objectives:
2. To appreciate how MRI can be optimised to minimise the need for 1. To understand the masking effect of breast density negatively
invasive arthrographic techniques. impacting on sensitivity of screening mammography.
3. To recognise where MRI is enough and where arthrographic 2. To know the results of additional screening methods in women with
techniques are still needed. dense breasts.
3. To be aware of cost considerations for additional screening methods.
Panel discussion:
09:50 Can one technique ever fulfil all the roles? 09:00
How will our optimal techniques change in the next 5 years? A-032 B. Elastosonography: true advances or false hope?
C.S. Balleyguier; Villejuif/FR
Learning Objectives:
08:30–10:00 Room F1 1. To understand physical principles of elastosonography.
2. To become familiar with the technique of shear-wave
Oncologic Imaging elastosonography of the breast.
3. To appreciate reproducibility and clinical value of elastosonography
RC 116 How about the lymph nodes? in clinical practice.
08:30 09:30
A-027 Chairman’s introduction A-033 C. Nodal staging of breast cancer: still needed?
J.J. Fütterer; Nijmegen/NL S.C.E. Diepstraten; Utrecht/NL
Session Objectives: Learning Objectives:
1. To learn the criteria for nodal staging on CT, MRI and PET. 1. To know the current debate on sentinel node biopsy and axillary
2. To understand the pitfalls and challenges of nodal staging on lymph node dissection.
imaging. 2. To appreciate the clinical role of staging of the axilla using ultrasound
with selective ultrasound-guided needle biopsy.
3. To understand the need for discriminating between minimal versus
advanced nodal metastatic involvement.
Wednesday
1. To learn about the different collagen vascular diseases that affect
the lung.
2. To become familiar with pulmonary abnormalities due to collagen
Genitourinary
vascular diseases.
RC 107 Stone disease: new concepts
08:52
A-035 B. Large-vessel vasculitis 08:30
J. Vilar; Valencia/ES A-041 Chairman’s introduction
Learning Objectives: A. Magnusson; Uppsala/SE
1. To learn about the different types of large-vessel vasculitis. Session Objectives:
2. To become familiar with histopathological correlates in vasculitis. 1. To become familiar with accurate imaging modalities in patients with
3. To appreciate the different manifestations and imaging appearances flank pain or already known stone disease.
of large-vessel thoracic vasculitis. 2. To learn about therapeutic algorithm of stone disease.
09:15 08:35
A-036 C. HRCT patterns in pulmonary vasculitis A-042 A. From the Stone Age to the New Age
C.M. Schaefer-Prokop; Amersfoort/NL N.C. Cowan; Portsmouth/UK
Learning Objectives: Learning Objectives:
1. To learn when HRCT is of value in investigating 1. To become familiar with the symptoms, signs, risk factors and
pulmonary vasculitis. significance of stone disease in the urinary tract.
2. To appreciate the different appearances of pulmonary vasculitis 2. To understand the strengths and weaknesses of Stone Age to New
on HRCT. Age imaging techniques for stone disease.
3. To become familiar with a state-of-the-art diagnostic imaging
09:37 pathway for urinary tract
A-037 D. Inflammation and remodelling stone disease.
A.A. Bankier; Boston, MA/US
08:58
Learning Objectives:
1. To learn about the different causes of pulmonary inflammation. A-043 B. The contribution of imaging in planning urinary
2. To understand how the lung responds to inflammation. stone therapy
3. To become familiar with pulmonary changes following inflammation. U. Patel; London/UK
Learning Objectives:
1. To understand how stone morphology, constituency and intrarenal
08:30–10:00 Room D2 anatomy influence treatment of urinary tract stones.
2. To learn about how to carry out 3. CT reconstruction of the renal
Head and Neck collecting system, and understand key technical factors necessary for
recreating accurate anatomical or surgical maps.
RC 108 Head and neck emergency: for the 3. To understand what information the interventionist or urologist
needs for planning urinary stone therapy.
general radiologist or the patient?
Moderator: M. Díez Blanco; Santander/ES 09:21
A-044 C. Urolithiasis: changing concepts in medical and
08:30 surgical approach
A-038 A. Findings that can’t wait for follow-up G. Kramer; Vienna/AT
M.G. Mack; Munich/DE
Learning Objectives:
Learning Objectives: 1. To learn about new findings in epidemiology and pathogenesis of
1. To learn about vascular head and neck emergencies. urinary stone disease.
2. To understand the variable appearances of foreign bodies. 2. To become familiar with the usefulness of screening concepts.
3. To understand main pathways of skull base invasion. 3. To learn about the role of medical and new minimally invasive
treatment options.
09:00 4. To learn about post-treatment imaging algorithms.
A-039 B. Imaging infection: when, how and why?
M. Becker; Geneva/CH 09:44 How do density and/or volume of the stone in failure
Learning Objectives: dictate how to efficiently treat stone disease?
1. To learn how to choose and tailor imaging techniques according to
the clinical presentation.
2. To become familiar with neck spaces and spread of infection.
3. To be able to recognise complications.
Neuro Cardiac
RC 111 The paediatric brain and spine: RC 103 Hybrid cardiovascular imaging:
not only tumours where should we go?
Moderator: T.A.G.M. Huisman; Baltimore, MD/US Moderator: G. Feuchtner; Innsbruck/AT
08:30 08:30
A-045 A. Congenital abnormalities of the brain A-051 A. PET/CT: present state and future prospects
B. Ertl-Wagner; Munich/DE S.G. Nekolla; Munich/DE
Learning Objectives: Learning Objectives:
1. To become familiar with the typical clinical presentations of CBA. 1. To become aware of the present state of PET/CT in cardiovascular
2. To consolidate knowledge of the typical imaging patterns of the imaging.
major CBA. 2. To become familiar with appropriate indications for PET/CT studies
3. To explain the importance of a precise diagnosis in relation to of the heart.
potential therapy. 3. To learn about technical innovations in PET/CT imaging.
09:00 09:00
A-046 B. Paediatric brain neuro emergencies A-052 B. SPECT/CT: is it just PET/CT’s little brother?
M.I. Argyropoulou; Ioannina/GR M. Hacker; Vienna/AT
Learning Objectives: Learning Objectives:
1. To become familiar with the most common PNEs. 1. To appreciate the scope of information a SPECT/CT cardiac study
2. To learn how to make a differential diagnosis between different PNEs. can deliver.
3. To explain the diagnostic and therapeutic road map in PNEs. 2. To become familiar with protocols of SPECT/CT studies.
3. To learn a structured approach to performing and reporting a
09:30 SPECT/CT study.
A-047 C. The paediatric spine: tips and tricks
A. Rossi; Genoa/IT 09:30
Learning Objectives: A-053 C. MR/PET: do we really need it?
1. To learn the difference between benign and malignant paediatric H.H. Quick; Essen/DE
spine findings. Learning Objectives:
2. To understand the imaging strategy for paediatric spine emergencies. 1. To learn about technical requirements for performing cardiac
3. To become confident with the most common paediatric spine MR/PET studies.
emergencies. 2. To learn if cardiac MR/PET can be successfully performed
in clinical routine.
3. To become familiar with the principal advantages/disadvantages
08:30–10:00 Room MB 1 of MR/PET compared to other hybrid imaging technologies.
Molecular Imaging
08:30–10:00 Room MB 3
RC 106 Functional and multimodality Interventional Radiology
neuroimaging
Moderator: T.H. Helbich; Vienna/AT
RC 109 Image fusion for image-guided
08:30 interventions
A-049 A. MR/PET chances and challenges 08:30
V. Schulz; Aachen/DE
Learning Objectives: A-054 Chairman’s introduction
V. Bérczi; Budapest/HU
1. To understand the fundamentals of MR physics relevant to MR/PET
imaging. 08:35
2. To appreciate the advantages of MR/PET and its complementary role
in diagnostic neuroimaging. A-055 A. Cone-beam CT in vascular and non-vascular
3. To learn about the benefits and challenges of combined MR/PET. interventional procedures
T.F. Jakobs; Munich/DE
09:00 Learning Objectives:
A-050 B. Advanced MR neuroimaging techniques 1. To learn how to use cone-beam CT in guiding IR procedures.
M. Smits; Rotterdam/NL 2. To learn when to use this technique in oncologic biopsies and
Learning Objectives: ablations.
1. To learn about functional MRI (fMRI) and diffusion tensor imaging 3. To learn how to use this technique in improving efficacy and safety
(DTI). of intra-arterial procedures.
2. To understand the application of these techniques in the study of the
healthy and diseased human brain. 08:58
3. To learn about the brain’s activity and its connections. A-056 B. US image fusion
C. Ewertsen; Copenhagen/DK
09:30 Learning Objectives:
A-048 C. Clinical applications of PET/CT in neurology 1. To learn about the technologies used to fuse CT/US and
A.H. Jacobs; Münster/DE MRI/US images.
Learning Objectives: 2. To understand how to use them in clinical practice.
1. To become familiar with the role of PET/CT in neurology. 3. To understand the indications for these technologies in difficult cases.
2. To learn about radiotracers that can be used in neuroimaging.
3. To understand PET/CT applications in relationship to disease
presentations.
Wednesday
09:44 Practical and economic issues in using high-end guidance
for interventional radiology 09:00
A-063 B. The digestive tract
E. Alexopoulou; Athens/GR
08:30–10:00 Room MB 4 Learning Objectives:
1. To learn the basics of mechanisms related to autoimmune enteritis.
Emergency Radiology 2. To appreciate the role of US, CT and MRI.
3. To become familiar with imaging findings useful in the diagnosis.
RC 117 Polytrauma: comprehensive 09:30
management guidelines for imaging A-064 C. Multiple sclerosis in children
C. Adamsbaum, B. Husson, K. Deiva, M. Tardieu; Le Kremlin-Bicêtre/FR
08:30 Learning Objectives:
A-058 Chairman’s introduction: management priorities in 1. To understand the difference between children and adults.
patients aer polytrauma 2. To become familiar with imaging findings.
M. Stajgis; Poznan/PL 3. To learn about the principle differential diagnosis.
08:35
A-059 A. Chest and abdomen 10:30–12:00 Room A
M. Scaglione; Castel Volturno/IT
Learning Objectives: E³ - ECR Academies:
1. To understand the impact of imaging findings on patient
management.
Interactive Teaching Sessions
2. To learn about common classification and trauma scoring systems.
3. To be familiar with the most common, typical and atypical imaging E³ 221 The treated breast:
findings. what you need to know
08:59 10:30
A-060 B. Spine and pelvis A-065 A. Imaging aer treatment of benign breast conditions
F.H. Berger; Amsterdam/NL
J. Camps Herrero; Valencia/ES
Learning Objectives:
Learning Objectives:
1. To understand the pathomechanisms and practical classifications of
1. To understand common features related to breast surgery.
spinal and pelvic trauma.
2. To recognise changes related to non-surgical treatments.
2. To become familiar with image interpretation rules in the
traumatised spine and pelvis. 11:15
3. To learn about posttraumatic findings in CT and MR imaging. A-066 B. Imaging aer treatment of breast cancer
09:23 M.H. Fuchsjäger; Graz/AT
A-061 C. Extremities Learning Objectives:
U. Linsenmaier; Munich/DE 1. To understand common features related to breast surgery.
2. To recognise changes related to non-surgical treatments.
Learning Objectives:
1. To be familiar with life-threatening injuries and current classifications
systems.
12:30–13:30 Room B
2. To learn about imaging strategies and the role of different imaging
methods.
3. To comprehend imaging findings and their impact on patient
E³ - The Beauty of Basic Knowledge:
management. Breast Imaging
Panel discussion: E³ 25A Breast ultrasound: a primer
09:47 How to speed up the diagnosis and further management
of polytrauma patients Moderator: J. Camps Herrero; Alzira/ES
12:30
A-067 Breast ultrasound: a primer
A. Tardivon; Paris/FR
Learning Objectives:
1. To review the technical issues tied to a state-of-the-art US exam
and new developments.
2. To learn how to deal with the most common clinical situations
where breast US is involved.
3. To know the basic semiology of US lesions.
16:23 17:00
A-079 For the referring physician A-084 C. Treated brain tumours:
J.M.L. Bosmans; Ghent/BE progression or pseudoprogression?
Learning Objectives: P.C. Maly Sundgren; Lund/SE
1. To understand the needs of referring clinicians concerning content Learning Objectives:
and presentation of imaging results. 1. To understand the challenges and limitations of routine MRI
2. To become familiar with existing initiatives to meet referring in monitoring brain tumour treatment.
clinicians’ requirements. 2. To become familiar with the role of advanced imaging biomarkers
3. To learn about clinicians’ evaluations of SR in real life. for early assessment of treatment response.
16:41 3. To learn how to integrate routine and advance MRI into clinical
practice after tumour therapy.
A-080 For the patient
C.E. Kahn; Philadelphia, PA/US
Learning Objectives: 16:00–17:30 Room E1
Wednesday
1. To explore the impact of SR on patient care.
2. To learn about its role in supporting quality improvement and
patient safety.
Musculoskeletal
3. To describe how it enables clinical and translational research.
RC 410 Trauma to the paediatric skeleton
16:59 Moderator: K. Rosendahl; Bergen/NO
A-081 The ESR/RSNA structured reporting initiative
O. Ratib; Geneva/CH 16:00
Learning Objectives: A-085 A. Pelvis/hips
1. To understand the concept of SR using the MRRT IHE standard. N. Boutry, E. Amzallag-Bellenger; Lille/FR
2. To review the current status of the ESR/RSNA joint initiative. Learning Objectives:
3. To learn about the ESR/RSNA technical setup and how to participate 1. To become familiar with the types of injuries seen
in and benefit from it. in the paediatric pelvis/hips.
4. To learn about new trends in multilingual syntax management 2. To understand the strengths and weaknesses
and translation. of different imaging modalities.
Wednesday
of orbital masses.
3. To learn about different approaches to PET attenuation correction.
2. To learn an approach to differentiating orbital tumours.
3. To appreciate the typical imaging findings of benign and 16:30
malignant orbital neoplasm.
A-109 B. Radionuclides for PET/CT and MR/PET
M. Hacker; Vienna/AT
16:00–17:30 Room G Learning Objectives:
1. To understand the principle of FDG in oncology.
Genitourinary 2. To become familiar with non-FDG radionuclides and
their indications.
3. To consolidate knowledge of tracer kinetics.
RC 407 Prostate imaging: how I do it
17:00
16:00 A-110 C. Radiopharmaceuticals for SPECT/CT
A-104 Chairman’s introduction J.R. Ballinger; London/UK
H.-P. Schlemmer; Heidelberg/DE Learning Objectives:
Session Objectives: 1. To learn about the basic radionuclides for SPECT/CT.
1. To learn how to perform and interpret multiparametric MRI for best 2. To understand tracer kinetics in SPECT.
possible detection and biologic characterisation of cancer foci within 3. To appreciate SPECT tracers and their indications.
the prostate.
2. To become familiar with the current options of image-guided biopsy.
3. To understand the clinical relevance of multiparametric MRI for 16:00–17:30 Room MB 1
treatment decision-making during active surveillance and after
initial therapy. Vascular
16:05
A-105 A. Detection and assessment of aggressiveness
RC 415 Basic principles of varicose vein
P.A. Puech; Lille/FR diagnosis and endovascular treatment
Learning Objectives: Moderator: D. Karnabatidis; Patras/GR
1. To understand the different types of prostate cancer within the gland.
2. To become familiar with common pitfalls of prostate cancer 16:00
semiology at multiparametric MRI. A-111 A. Diagnostic cross-sectional imaging
3. To understand the MRI “biomarkers” of prostate cancer H. Hoppe; Berne/CH
aggressiveness. Learning Objectives:
16:28 1. To become familiar with the whole spectrum
of varicose vein pathology.
A-106 B. Image-guided biopsy and staging 2. To learn about technical principles of a state-of-the-art lower limb
F. Cornud, C. Escourrou, N.B. Delongchamps; Paris/FR venous ultrasonograhic study.
Learning Objectives: 3. To learn how to extrapolate ultrasonographic findings
1. To understand the techniques of prostate biopsy. into endovascular treatment.
2. To become familiar with the MR-guided and MR/TRUS
fusion approach. 16:30
3. To learn about the optimal imaging protocol for the staging A-112 B. Saphenous vein ablation
of prostate cancer. A. Rampoldi; Milan/IT
16:51 Learning Objectives:
1. To understand the principles of ablation therapy.
A-107 C. Role of imaging in active surveillance and detection 2. To learn the technique for ablation and how to avoid complications.
of recurrence 3. To learn about outcomes and complications.
V. Logager; Copenhagen/DK
Learning Objectives:
17:00
1. To learn about the role of multiparametric MRI in guiding therapy A-113 C. Ultrasound guided sclerotherapy
towards active surveillance. J. Brookes; London/UK
2. To learn about the imaging findings in local recurrence after Learning Objectives:
treatment. 1. To learn about the principles of venous sclerotheraphy.
3. To understand the impact in treatment planning as a consequence 2. To learn about technical principles of US-guided sclerosis
of these findings. of lower limb veins.
3. To learn about pros and cons of US-guided sclerosis versus
Panel discussion: endovascular ablation.
17:14 How can multiparametric MRI be implemented as clinical
standard across multiple centres?
16:00–17:30 Room MB 5
Paediatric
RC 412 Imaging of foetus and infant
Moderator: D. Prayer; Vienna/AT
16:00
A-125 A. Foetal neuro imaging
A. Rossi; Genoa/IT
Learning Objectives:
1. To learn how to perform prenatal brain MRI and to recognise normal
features at various gestational weeks.
2. To highlight the complementary role of brain MRI to prenatal
Wednesday
ultrasound for various indications, with a particular focus on the
problem of ventriculomegaly.
3. To familiarise oneself with the MRI features of the main congenital
malformations and clastic injury affecting the foetal brain.
16:30
A-126 B. Foetal body imaging
M. Cassart; Brussels/BE
Learning Objectives:
1. To have an overview of foetal abdominal diseases and malformations.
2. To learn about the complementary roles of US and MRI.
3. To understand how prenatal imaging helps in the management of the
foetus and the newborn.
17:00
A-127 C. Foetal and neonatal urinary tract imaging
C. Garel; Paris/FR
Learning Objectives:
1. To learn about the changing appearance of the urinary tract
throughout pregnancy and at birth.
2. To become familiar with the main causes of obstruction and
their possible impact on the kidneys.
3. To learn about the main causes of hyperechoic kidneys.
Thursday
08:30–10:00 Room B pancreatic pathologies.
4. To know the best indications for CEUS in the main pancreatic
Abdominal Viscera diseases.
5. To describe CEUS findings for the characterisation of focal
pancreatic masses.
RC 501 The many faces of benign liver lesions 6. To compare CEUS to CT and MRI findings in studying
Moderator: L. Grenacher; Heidelberg/DE pancreatic pathologies.
7. To discuss the possible different role of CEUS in the diagnostic
08:30 work-up of focal pancreatic lesions.
A-130 A. Vascular
M. Karcaaltincaba; Ankara/TR 08:53
Learning Objectives: A-135 Molecular ultrasound and dynamic contrast-enhanced US
1. To become familiar with typical and infrequent manifestations for antiangiogenic therapy monitoring
of benign hypervascular focal liver lesions. N. Lassau; Villejuif/FR
2. To learn how to differentiate between benign and malignant lesions. Learning Objectives:
3. To appreciate the limitations and complementary roles of CT 1. To understand physics and clinical potential of molecular imaging
and MR. and new markers with ultrasound.
09:00 2. To understand technologies of dynamic contrast-enhanced
ultrasound (DCEUS) and ways of quantification.
A-131 B. Cystic-Biliary 3. To describe the protocols and results of a large multicentre study
G. Brancatelli; Palermo/IT performed with quantitative DCEUS.
Learning Objectives: 4. To discuss application in routine clinical practice and future outlook.
1. To understand the features of congenital and infectious cystic
liver lesions. 09:11
2. To learn how to differentiate between benign and malignant A-136 State-of-the-art ultrasound technologies: elastography
cystic lesions. and microvascular imaging - are they useful?
A.K.P. Lim; London/UK
09:30
Learning Objectives:
A-132 C. Hepatocellular 1. To understand the physics and technologies of elastography
R.L. Baron; Chicago, IL/US
and microvascular imaging.
Learning Objectives: 2. To describe the differing elastography techniques
1. To understand the typical aspect of hepatocellular benign lesions and microvascular imaging.
on US, CT and MRI. 3. To detail the potential clinical utility of elastography
2. To learn when a liver-specific contrast medium can help us and microvascular imaging.
in the proper characterisation of hepatocellular benign liver lesions. 4. To discuss the evidence for the use of these technologies
3. To understand the classification of liver adenomas, prognosis and in routine clinical practice.
imaging characteristics.
09:29
A-137 ShearWave elastography, ultrafast Doppler and
image fusion
J.-M. Correas; Paris/FR
Learning Objectives:
1. To understand the physics and technologies of shearwave
elastography and ultrafast Doppler.
2. To describe the differing elastography techniques.
3. To detail the potential clinical utility of elastography and
image fusion.
4. To discuss the evidence for the use of these technologies in routine
clinical practice.
Thursday
3. To evaluate the prognostic impact and therapeutic implications
of phenotyping DCIS. Oncologic Imaging
08:56 RC 516 Gastro-entero-pancreatic
A-153 Diagnosing DCIS with MRI neuro-endocrine tumours (GEP-NET):
C.K. Kuhl; Aachen/DE
Learning Objectives:
a multidisciplinary update
1. To understand the pathophysiological basis of DCIS detection 08:30
in mammography and MRI.
2. To list imaging features of DCIS. A-159 Chairman’s introduction
3. To appreciate current and future applications of MRI A.E. Sundin; Uppsala/SE
for diagnosing DCIS. Session Objectives:
1. To become familiar with the clinical and pathological aspects of
09:18 GEP-NET.
A-154 Image-guided interventions for DCIS 2. To learn about the role of cross-sectional and nuclear medicine
R.M. Pijnappel; Utrecht/NL imaging techniques in GEP-NET.
Learning Objectives: 08:35
1. To learn about underestimation in core needle biopsy in comparison
with vacuum-assisted biopsy. A-160 A. Tumour biology, pathogenesis and classification
2. To understand the importance of pathologic proof of non-mass M.E. Pavel; Berlin/DE
enhancement on MRI. Learning Objectives:
3. To become familiar with low grade versus high grade DCIS. 1. To learn about the basic aspects of GEP-NET biology, pathogenesis
and classification.
Panel discussion: 2. To understand the epidemiology and current treatment options.
09:40 Patient with DCIS: how to plan her therapy in 2015? 3. To become familiar with rational clinical management.
08:58
08:30–10:00 Room E2 A-161 B. The current role of nuclear medicine
S. Fanti; Bologna/IT
Professional Challenges Session Learning Objectives:
1. To learn about the cellular properties and GEP-NET used in
molecular imaging.
PC 5a Looking into the future of radiology 2. To become familiar with the different modalities and new tracers
08:30 being used.
3. To learn about the performance of the different methods available.
A-155 Chairmen’s introduction
M.H. Fuchsjäger1, G. Paulo2; 1Graz/AT, 2Coimbra/PT 09:21
Session Objectives: A-162 C. Anatomical imaging: transabdominal US, endoscopic
1. To learn about external factors that influence radiology. US, MDCT and MRI: which is the most appropriate imaging
2. To become familiar with health economics concepts.
3. To understand the changing roles of the radiology professions.
approach?
V. Vilgrain, M. Ronot, M.-P. Vullierme, P. Ruszniewski; Clichy/FR
08:35 Learning Objectives:
A-156 Health technology assessment (HTA) 1. To learn how to recognise the specific imaging features of GEP-NET.
E.J. Adam; London/UK 2. To learn about the strengths and weaknesses of the different imaging
modalities.
Learning Objectives:
3. To understand the optimal use of the different imaging modalities in
1. To learn about HTA concepts.
relation to tumour location and staging.
2. To become familiar with the role of radiology professions in HTA.
3. To understand the influence of HTA on decision-making in the field
of radiology. Panel discussion:
09:44 The future of hybrid imaging
Thursday
other disorders. 3. To learn about the pros and cons of each modality.
3. To recognise imaging patterns that may mimic stroke clinically
and radiologically. 09:00
09:30 A-182 B. Indications for intervention
N. Kocer; Istanbul/TR
A-177 C. Cerebral perfusion studies in cerebrovascular disease: Learning Objectives:
techniques, indications and applications 1. To learn how to define the indication for treatment.
P.M. Parizel, F. De Belder, C. Venstermans, T. Van der Zijden, J. Huyskens, 2. To learn about the treatment decision-making process.
J. Van Goethem, L. van den Hauwe, M. Voormolen; Antwerp/BE
3. To learn about the classification of lesions and indications
Learning Objectives: for treatment.
1. To understand how imaging can help select patients for treatment
of acute ischaemic stroke. 09:30
2. To show the importance of collateral flow in ischaemic patients. A-183 C. Mechanical revascularisation
3. To explain the actual EBM treating patients with acute ischaemic T. van der Zijden, M. Voormolen, O. d’Archambeau, F. de Belder, C. Venstermans,
stroke. L. van den Hauwe, J. Van Goethem, P.M. Parizel; Edegem/BE
Learning Objectives:
1. To learn the difference between mechanical and pharmacological
08:30–10:00 Room K stroke treatment.
2. To learn about different mechanical revascularisation techniques.
E³ - ECR Academies: Hybrid Imaging (basic) 3. To learn how to manage complications.
09:30 09:00
A-186 C. Does CT have a role in diagnosing valvular disease? A-192 B. The enemy within:
G. Feuchtner; Innsbruck/AT non-traumatic abdominal emergencies
Learning Objectives: R.J. Zagoria; San Francisco, CA/US
1. To learn about state-of-the-art CT techniques to evaluate cardiac Learning Objectives:
valves at low dose. 1. To learn how to better analyse CT scans for non-traumatic causes of
2. To review CT appearance of the most common conditions causing abdominal pain.
valvular disease. 2. To learn about the CT signs and causes of bowel ischaemia.
3. To become familiar with the role of CT in the diagnosis and clinical 3. To learn about the CT findings of common causes of an ‘acute’
management. abdomen.
4. To learn about the imaging findings of acute, non-traumatic urinary
tract and GI tract emergencies.
08:30–10:00 Room MB 3
09:30
Interventional Radiology A-193 C. Interactive case discussion
A. Palkó1, R.J. Zagoria2; 1Szeged/HU, 2San Francisco, CA/US
RC 509 Percutaneous treatment of chronic Learning Objectives:
back pain and sciatica 1. To learn how to better analyse CT scans for traumatic and
non-traumatic causes of abdominal pain.
08:30 2. To learn about the CT signs and causes of bowel ischaemia
and injuries.
A-187 Chairman’s introduction 3. To learn about the CT findings of common causes of traumatic
A. Gangi; Strasbourg/FR
and non-traumatic ‘acute’ abdomen.
08:35 4. To learn about the imaging findings of acute, traumatic and
non-traumatic urinary tract and GI tract emergencies.
A-188 A. Sacroiliac joint syndrome
D.J. Wilson; Oxford/UK
Learning Objectives: 08:30–10:00 Room MB 5
1. To learn about relevant anatomy and clinical presentations
of the syndrome. E³ - ECR Academies:
2. To learn more about the available treatments.
3. To learn about clinical results and possible further developments. Diagnostic Urogenital Radiology
08:58
A-189 B. Facet joint syndrome
E³ 520 Kidney
A.D. Kelekis; Athens/GR Moderator: C. Nicolau; Barcelona/ES
Learning Objectives: 08:30
1. To understand the difference between facet joint and disc disease.
2. To learn about different treatment options for facet disease.
A-194 A. Differential diagnoses of cystic renal masses
M. Claudon; Vandoeuvre-les-Nancy/FR
3. To learn how to manage patients.
Learning Objectives:
09:21 1. To become familiar with the updated Bosniak classification.
A-190 C. Intervertebral disc syndrome 2. To learn about the differential diagnoses of complex cystic
D. Filippiadis; Athens/GR renal masses.
Learning Objectives: 3. To become familiar with typical surgical and non-surgical lesions.
1. To understand possible treatment techniques for disc disease. 09:00
2. To learn more about clinical and imaging findings in treatment.
3. To learn about published results on percutaneous disc treatment.
A-195 B. Differential diagnoses of solid renal masses
S.H. Kim; Seoul/KR
Panel discussion: Learning Objectives:
09:44 How can imaging methods identify candidates 1. To learn about the differential diagnoses of solid renal lesions.
for percutaneous therapy or surgery? 2. To become familiar with typical imaging findings of the renal cell
carcinoma subtypes.
3. To become familiar with potential criteria for active surveillance
08:30–10:00 Room MB 4 of solid renal masses.
09:30
Joint Course of ESR and RSNA A-196 C. Acute and chronic renal infection
(Radiological Society of North America): J. Lopes Dias; Lisbon/PT
Learning Objectives:
Emergency Radiology 1. To learn about the different etiologies of acute renal infection,
including typical imaging findings.
MC 528 Abdominal emergencies 2. To learn about the time-point and possibilities for interventions.
Moderator: A. Palkó; Szeged/HU 3. To understand the causes of chronic renal infection, including typical
imaging findings.
08:30
A-191 A. Abdominal injuries
A. Palkó; Szeged/HU
Learning Objectives:
1. To understand the significance of injury mechanism and its role
in the formation of consequent abdominal lesions and their
complications.
2. To learn about the role of proper imaging technique and diagnostic
algorithm in the sufficiently fast diagnosis of abdominal injuries.
3. To learn more about the typical and unusual findings of various
abdominal traumatic conditions.
Thursday
11:00
10:30–12:00 Room MB 4 A-206 B. Differential diagnoses of retroperitoneal masses
M.-F. Bellin, L. Rocher; Le Kremlin-Bicêtre/FR
Joint Course of ESR and RSNA Learning Objectives:
1. To be familiar with the typical imaging features
(Radiological Society of North America): of retroperitoneal lesions.
2. To learn about the differential diagnoses of benign and
Emergency Radiology malignant retroperitoneal masses.
3. To understand how recognise the exact extent
MC 628 Chest emergencies of retroperitoneal masses.
Moderator: A. Palkó; Szeged/HU
11:30
10:30 A-207 C. Differential diagnoses of adrenal lesions
G. Heinz-Peer; St. Pölten/AT
A-202 A. Thoracic injuries
M. Brink; Nijmegen/NL Learning Objectives:
Learning Objectives: 1. To learn about the imaging protocols of adrenal glands,
1. To learn how to differentiate traumatic aortic injuries from congenital including functional imaging.
variants that mimic injury, to distinguish minor from major aortic 2. To understand the typical imaging features of an adenoma
injuries, and to understand how injury classification can influence on CT and MRI.
management. 3. To become familiar with typical signs of malignancy.
2. To become familiar with the various CT appearances suggesting and
verifying major airway injury.
3. To understand the various CT appearances of blood/bleeding in the 12:15–12:45 Room A
chest and how the location, quantity of blood/bleeding and patient
clinical status determine initial treatment. Plenary Session
4. To appreciate the spectrum of cardiac injuries that can be diagnosed
on admission contrast-enhanced CT and those that require urgent HL 1 Josef Lissner - Honorary Lecture
intervention. Presiding: B. Hamm; Berlin/DE
11:00 12:15
A-203 B. Non-traumatic thoracic emergencies A-208 Is the ‘Art of Medicine’ dead in the era of population
C.M. Schaefer-Prokop; Amersfoort/NL
Learning Objectives:
health management?
J.A. Brink; Boston, MA/US
1. To illustrate typical CXR findings made in patients entering the
ER with acute dyspnoea and to learn when CT is indicated and Learning Objectives:
diagnostically useful. 1. To learn the principles of population health management.
2. To learn how to analyse and interpret HRCT patterns of pulmonary 2. To consider the impact of variation in the practice radiology
opacifications in patients with acute respiratory insufficiency. on population health.
3. To learn about radiological key features helpful for differential 3. To understand the potential roles that radiologists can play
diagnosis and how to integrate clinical information. to improve population health.
4. To study the impact of these changes on the art and science
of medicine.
15:17 Discussion
Thursday
P.R. Ros; Cleveland, OH/US
14:00–15:30 Room MB 4
14:55
A-222 E-learning portfolios: present and future
Joint Course of ESR and RSNA
M. Maas; Amsterdam/NL (Radiological Society of North America):
15:15 Awards Emergency Radiology
MC 728 CNS emergencies
14:00–15:30 Room L 1 Moderator: A. Palkó; Szeged/HU
Thursday
of population outcomes.
2. To evaluate the real impact of screening programmes in comparison A-246 Chairman’s introduction
with effectiveness of available therapies of breast cancer. A.D. Kelekis; Athens/GR
3. To outline a scenario for fighting against breast cancer Session Objectives:
without screening. 1. To become familiar with the several available image-guided
techniques for treating renal, lung and bone tumours.
16:50 2. To understand when image-guided techniques are clinically
A-242 Questions and answers indicated in the management of patients affected by renal, lung
F. Sardanelli1, N. Houssami2; 1San Donato Milanese/IT, 2Sydney/AU and bone tumours.
Learning Objectives: 3. To consolidate knowledge of clinical results available
The discussion will address the following issues: from the literature.
1. How much of the breast cancer mortality reduction in the last
decades can be attributed to screening? 16:03
2. Do we really have reliable estimates for overdiagnosis? A-247 A. Renal cell carcinoma: when and how can we compete
3. How can we reduce interval cancer rate? with surgeons
4. Are there technical or clinical improvements to be implemented R.F. Grasso; Rome/IT
in screening programmes? Learning Objectives:
5. Is the comparison between countries having/not having 1. To understand the current indications for ablation in renal cancer.
screening useful for understanding advantages/disadvantages 2. To learn about when radiofrequency ablation, microwaves ablation
of screening programmes? and cryo ablation are indicated.
6. What are the societal and ethical implications in stopping 3. To consolidate knowledge of results from personal experience
population screening mammography programmes? and the literature.
16:32
16:00–17:30 Room M A-248 B. Lung tumours: the clinical evidence for percutaneous
techniques
Multidisciplinary Session T. de Baère, F. Deschamps, L. Tselikas; Villejuif/FR
Learning Objectives:
MS 8 Critical limb ischaemia (CLI): 1. To understand the indications for percutaneous ablation in primary
limb salvage or life salvage? and metastatic disease.
2. To learn about technical issues.
16:00 3. To consolidate knowledge of results from literature.
A-243 Chairman’s introduction: 17:01
critical limb ischaemia in daily practise A-249 C. Image-guided therapies for bone tumours
J.A. Reekers; Amsterdam/NL A. Gangi; Strasbourg/FR
Session Objectives: Learning Objectives:
1. To learn what critical limb ischaemia is. 1. To understand how to select bone lesions to be ablated.
2. To understand what treatment options are available. 2. To learn about technical issues for both palliation and curative aims.
3. To appreciate a critical review of new technological treatment 3. To become familiar with clinical results.
developments.
16:20
A-244 Diagnostic imaging and outcome
M. Koelemay; Amsterdam/NL
Learning Objectives:
1. To learn about the value of diagnostic imaging.
2. To understand the outcome of treatment.
3. To appreciate how outcome can be tested.
4. To introduce Patient-Reported Outcome Measurements (PROM).
16:30 16:35
A-261 Multi-parametric MR tumour imaging in brain tumour A-266 Introduction to the Quantitative Imaging
diagnosis and monitoring European Task Force
M.A. Lucic; Sremska Kamenica/RS H.-U. Kauczor; Heidelberg/DE
Learning Objectives: Learning Objectives:
1. To become familiar with the use of MR perfusion, MR diffusion 1. To learn about existing activities in imaging biomarkers.
imaging and MR spectroscopy in brain tumour imaging. 2. To appreciate the importance of a new European structure for
2. To understand how these methods can add value to structural integrated imaging biomarker development.
MR imaging of brain tumours. 3. To acknowledge the benefit of imaging biomarkers for radiology.
3. To learn how multiparametric MR imaging can be used
in the differential diagnosis and prediction of treatment response 16:50
of brain tumours. A-267 Clinical validation of imaging biomarkers and their role
16:55 in European Medicine Agency (EMA) applications
O. Clément; Paris/FR
A-262 MR/PET in brain tumour diagnosis: the added value Learning Objectives:
of combining structural and molecular imaging 1. To learn about the role of clinical validation for imaging biomarkers.
F. Fraioli; London/UK 2. To understand how imaging biomarkers may become surrogate
Learning Objectives: endpoints in clinical trials.
1. To become familiar with the most important PET tracers currently 3. To become familiar with the requirements of the EMA.
used in brain tumour imaging.
2. To understand the different aspects of tumour metabolism that 17:05
can be measured with these tracers. A-268 The role of imaging biomarkers in the EORTC clinical trials
3. To learn about the advantages and pitfalls of simultaneous acquisition N.M. deSouza; Sutton/UK
of structural and molecular information in brain tumours using Learning Objectives:
PET MRI. 1. To learn about the EORTC’s role and its performance of clinical trials.
Thursday
2. To become familiar with the tasks and opportunities of the imaging
Panel discussion: group within the EORTC.
17:20 Modalities and parameters - what do we really need? 3. To understand how to implement imaging biomarkers
in the clinical EORTC trials.
16:55 17:00
A-272 Non-contrast MRI A-278 C. Lymph nodes: differential diagnosis and
P.A.T. Baltzer; Vienna/AT fine-needle aspiration
Learning Objectives: R. Maroldi; Brescia/IT
1. To become familiar with the current status of unenhanced MRI Learning Objectives:
techniques for detection and classification of breast lesions. 1. To get acquainted with normal and abnormal findings.
2. To understand possible clinical applications of unenhanced breast 2. To understand the patterns of nodal involvement.
MRI. 3. To learn about technique of fine needle aspiration.
3. To appreciate the limitations of unenhanced breast MRI.
Thursday
17:00 1. To become familiar with the diagnostic algorithm of heart failure
A-285 C. Indications for hybrid imaging in radiation therapy according to current guidelines.
planning 2. To learn the strengths and weaknesses of the different imaging
D. Georg; Vienna/AT techniques in heart failure patients.
3. To discuss the role of imaging techniques to guide clinicians
Learning Objectives:
in diagnosis, treatment and follow-up.
1. To become familiar with PET/CT-based radiation therapy planning.
2. To appreciate the information desired by the radiation oncologist. 16:28
3. To understand the effect of functional data on the target volume. A-291 B. Differentiating the causes for heart failure:
Panel discussion: is MRI the indisputable gold standard?
T. Leiner; Utrecht/NL
17:18 What does the individual gain from population imaging studies?
Learning Objectives:
1. To learn about MRI techniques to evaluate heart failure and
16:00–17:30 Room MB 1 its potential causes.
2. To learn a practical approach for differentiating the causes
Vascular of heart failure using MRI.
3. To become familiar with the role of MRI in the clinical management
and prognosis.
RC 815 EVAR endoleaks:
imaging and management 16:51
Moderator: F. Fanelli; Rome/IT A-292 C. SPECT as an alternative imaging technique
F. Bengel, F. Caobelli; Hannover/DE
16:00 Learning Objectives:
A-286 A. The role of US: Doppler, 3D US, CEUS 1. To learn about nuclear imaging techniques in the detection
U.K.M. Teichgräber; Jena/DE of heart failure.
2. To appreciate imaging findings in the diagnosis of heart failure
Learning Objectives:
and its causes.
1. To appreciate the rationale behind ultrasonographic imaging
3. To become familiar with the role of nuclear imaging
of EVAR endoleaks.
for diagnosis and prognosis in heart failure.
2. To become familiar with the principles
of each ultrasonographic modality.
3. To understand the relative indications Panel discussion:
of each ultrasonographic modality. 17:14 What is the preferred comprehensive imaging test
in heart failure?
16:30
A-287 B. CTA and MRA: current concepts
A. Bücker; Homburg a.d. Saar/DE
Learning Objectives:
1. To learn about the indications for CTA and MRA
in EVAR endoleak imaging.
2. To become familiar with technical aspects of each modality
in EVAR endoleak imaging.
3. To learn about the pros and cons of each modality.
16:00
A-297 A. General principles
U. Linsenmaier; Munich/DE
Learning Objectives:
1. To learn about general principles of diagnostic imaging in emergency
radiology in traumatic and non-traumatic emergencies.
2. To understand the etiology, background and management
of common radiological emergencies.
3. To appreciate the role, indications and protocols
for US, CR, MDCT in modern emergency radiology.
Friday
in liver and pancreatic diseases. Learning Objectives:
2. To understand the underlying pathophysiologic processes. 1. To learn what additional information is acquired by MRI with
3. To learn about the strengths and limitations of CEUS compared diffusion-weighted and perfusion sequences.
with CT and MRI in the study of focal liver lesions and 2. To appreciate the clinical importance of this examination in the early
pancreatic diseases. follow-up of head and neck cancer patients.
3. To learn how to interpret results and how to avoid mistakes.
09:00
A-306 B. MRI: diffusion, perfusion and elastography 09:25
B. Van Beers; Clichy/FR A-311 Post treatment imaging:
Learning Objectives: is PET a reliable indicator for tumour viability?
1. To learn about the technical requirements necessary S. Bisdas; Tübingen/DE
for diffusion-weighted MRI and how to avoid artefacts. Learning Objectives:
2. To learn about the technical requirements for CT and MRI perfusion. 1. To understand what additional information is provided by PET/CT
3. To become familiar with imaging biomarkers useful in the post-treatment setting.
in tumour evaluation. 2. To appreciate the clinical relevance of PET/CT and its effect
on patient management.
09:30 3. To learn how to interpret PET/CT examinations and how to avoid
A-307 C. Liver-specific contrast agents interpretation pitfalls.
B.J. Op de Beeck; Antwerp/BE
Learning Objectives: Panel discussion:
1. To learn about the principals and recent technical advances 09:50 Can we provide accurate information for the evaluation
in the use of liver-specific contrast agents for liver imaging. of treatment response?
2. To appreciate the similarities and differences between the classes
of contrast agents.
3. To become familiar with indications of liver-specific contrast
in biliary diseases.
4. To learn about future directions of MRI contrast agents.
08:55 09:11
A-324 Personalised prevention: A-330 Image-guided tumour ablations
population-based imaging and image-based screening H.U. Ahmed; London/UK
F. Bamberg; Tübingen/DE Learning Objectives:
Learning Objectives: 1. To present the pros and cons of different physical/chemical methods
1. To understand the concept of screening. that are used for focal therapy of prostate cancer.
2. To become familiar with population-based imaging. 2. To discuss patient selection criteria and show how tumour/prostate
3. To understand how imaging can improve personalised prevention. gland treatments are undertaken in practice.
3. To present the oncologic results of image-guided
09:15 prostate tumour ablations.
A-325 Integrated diagnostics: 09:31
towards one diagnostic department
A. Cuocolo, C. Nappi, E. Zampella; Naples/IT A-331 Prostate artery embolisation (PAE) for benign hypertrophy
F.C. Carnevale; Sao Paulo/BR
Learning Objectives:
Learning Objectives:
1. To understand the concept of biomarkers and their role
1. To understand the pros and cons of PAE in relation
in personalised medicine.
to other methods for treating benign hyperplasia.
2. To appreciate the differences and synergies between blood-
2. To discuss patient selection criteria and show how PAE
and tissue-based biomarkers and imaging biomarkers.
is undertaken.
3. To learn from other diagnostic departments about accuracy
3. To review the literature on complications, efficacy outcomes
and validation of biomarkers.
of urinary function, symptoms and quality of life and
09:35 on Long-term results.
A-326 Interventional radiology:
a paradigm for personalised medicine Panel discussion:
S.N. Goldberg; Jerusalem/IL 09:51 Do organ-sparing prostatic treatments make sense?
Learning Objectives:
1. To understand how functional imaging can improve tissue sampling. 08:30–10:00 Room F1
2. To appreciate the personalised approach in interventional radiology.
3. To become familiar with targeted therapies in interventional
radiology.
Oncologic Imaging
Panel discussion: RC 916 New insights in bone tumour imaging
09:55 How can we best accelerate the adoption
of personalised medicine in radiological practice? 08:30
A-332 Chairman’s introduction
D. Vanel; Bologna/IT
08:30–10:00 Room E2 Session Objectives:
Friday
1. To become familiar with the appearances and treatment strategies
New Horizons Session in bone tumours.
2. To learn about the role of current imaging techniques in management
NH 9 Image-guided interventions of bone tumours.
of the prostate 08:35
A-333 A. New insights in treatment-associated changes in
08:30 patients with bone tumours
A-327 Chairman’s introduction: defining the target C.R. Krestan; Vienna/AT
A.R. Padhani; London/UK
Learning Objectives:
Session Objectives: 1. To understand treatment strategies in bone tumours.
1. To introduce the concept of the index prostatic cancer lesion as 2. To learn the essentials in sarcoma imaging.
a valid target that determines patient therapy and outcomes. 3. To understand chemo- and radiation-induced bone marrow changes
2. To illustrate the concordance between the MRI-depicted and in patients with bone tumours.
histologically defined intraprostatic target.
08:58
08:35 A-334 B. New insights in staging and restaging musculoskeletal
A-328 MR-targeted prostate biopsy tumours introduction
J.J. Fütterer; Nijmegen/NL J.L. Bloem; Leiden/NL
Learning Objectives: Learning Objectives:
1. To understand the pros and cons of MRI-guided biopsies versus 1. To learn how to cooperate with physicist and technicians in
ultrasound approaches. optimising MR protocol.
2. To understand how to perform MRI-targeted biopsies. 2. To understand the role of MR imaging in staging and restaging.
3. To discuss patients selection and appreciate how MRI-targeted biopsy 3. To analyse clinical MR studies.
results affects management of patients with positive and
negative results. 09:21
08:53 A-335 C. New insights in hybrid imaging for multiple myeloma
G. Sommer; Basle/CH
A-329 MR-US fusion prostate biopsy
F. Cornud, C. Escourrou, N.B. Delongchamps; Paris/FR Learning Objectives:
1. To understand the current concepts of evaluation of multiple
Learning Objectives: myeloma with FDG PET/CT and MR/PET.
1. To understand the pros and cons of different US-guided biopsy 2. To understand the role of diffusion-weighted MR imaging
approaches. in patients with multiple myeloma.
2. To understand how to perform US-targeted biopsies.
3. To discuss patient selection and appreciate and how US-targeted
biopsies affect management of patients with positive and negative
Panel discussion:
results.
09:44 The future of bone tumour imaging
Friday
A-348 Chairman’s introduction
P. Sharp; Aberdeen/UK E³ 926c Uterine and prostate embolisation
Session Objectives: Moderator: T. Sabharwal; London/UK
1. To become familiar with the principles of multi-energy imaging.
2. To understand the applications of multi-energy CT. 08:30
3. To appreciate the advantages and limitations
of multi-energy imaging.
A-355 A. Symptomatic uterine fibroids
J.-P. Pelage; Caen/FR
08:35 Learning Objectives:
A-349 Image-based material decomposition with energy- 1. To understand clinical indications and contraindications
for UAE embolisation.
selective detectors in multi-energy CT: a review 2. To become familiar with the technique of uterine artery embolisation.
M. Kachelrieß; Heidelberg/DE
3. To learn about complications and outcomes.
Learning Objectives:
1. To understand how multi-energy CT can provide material 09:00
identification and differentiation. A-356 B. Benign hypertrophy of the prostate
2. To understand the effect of detector choice on material identification. H. Rio Tinto; Lisbon/PT
3. To understand the issues of radiation dose.
Learning Objectives:
09:05 1. To understand clinical indications and contraindications
for prostate artery embolisation.
A-350 Novel applications of multi-energy CT 2. To become familiar with the technique of prostate artery
J. Sosna; Jerusalem/IL
embolisation.
Learning Objectives: 3. To learn about complications and outcomes.
1. To become familiar with the concept of virtual non-enhanced images.
2. To explore image segmentation techniques. 09:30
3. To learn about image artefacts. A-357 C. Post-partum haemorrhage (PPH)
T.J. Kroencke; Augsburg/DE
09:35
Learning Objectives:
A-351 New frontiers in CT: functional and multi-energy imaging 1. To become familiar with the clinical background of PPH.
A. Persson; Linköping/SE
2. To learn about different endovascular techniques to treat PPH.
Learning Objectives: 3. To learn about complications and outcomes.
1. To appreciate the advantages and limitations of multi-energy CT.
2. To learn about functional imaging in CT.
3. To understand the problems of radiation dose
in these new techniques.
Friday
3. To understand to differentiate between benign surgical and R.W.R. Loose; Nuernberg/DE
non-surgical lesions.
Learning Objectives:
1. To learn about the concept of justifying radiological examinations
and interventions.
10:30–12:00 Room A
2. To understand the level of justification and associated radiation risks.
3. To understand the impact of the new European Basic Safety
E³ - ECR Academies: Standards (EU-BSS).
Interactive Teaching Sessions 11:03
A-377 Population-based MRI:
E³ 1021 Head and neck cancer aer treatment: SHIP (study of health in Pomerania) and
what you need to know the national cohort
K. Hegenscheid; Greifswald/DE
10:30
Learning Objectives:
A-372 A. Imaging aer surgical treatment 1. To present the objectives, concepts, and infrastructure
M. Lell; Erlangen/DE
of population-based imaging studies in Germany.
Learning Objectives: 2. To learn about the potential of population-based versus clinical
1. To become familiar with the different surgical techniques. imaging research.
2. To become familiar with the imaging findings after surgery. 3. To understand special ethical implications
of population-based imaging.
11:15
A-373 B. Imaging aer radiotherapy/chemotherapy 11:23
T. Beale; London/UK A-378 Interlude II: The Röntgenhaus:
Learning Objectives: Wilhelm Conrad Röntgen’s birthplace
1. To become familiar with common findings after medically treated B. Lewerich; Berlin/DE
head and neck tumours. Learning Objectives:
2. To become familiar with changes after radiotherapy for head and 1. To learn about the history of the 250-year-old house
neck tumours. where W.C. Roentgen was born.
2. To appreciate the importance of scientific landmarks f
or creating enduring public and political interest.
3. To invite and motivate radiologists to support the activities
of the Röntgen House Foundation.
11:31 11:05
A-379 MRI-PET: A new modality for clinical imaging A-388 Dual-energy CT in oncology
C.D. Claussen, N. Schwenzer; Tübingen/DE C.N. De Cecco; Rome/IT
Learning Objectives: Learning Objectives:
1. To understand the technical requirements of hybrid MR/PET. 1. To learn about the application of multi-energy CT in oncology.
2. To realise the impact of MR/PET on workflow. 2. To explore the possibilities of material identification and
3. To learn about potential clinical applications of MR/PET. differentiation with multi-energy imaging.
3. To appreciate the effect on the management of cancer patients.
Panel discussion:
11:51 Cross-linking radiology: opportunity or threat? 11:35
A-389 Clinical application of multi-energy imaging
in digital mammography
10:30–12:00 Room L 1 C. Dromain, J. Arfi-Rouche, A.-M. Tardivel, J.-R. Garbay, S. Delaloge,
C.S. Balleyguier; Villejuif/FR
EIBIR Session Learning Objectives:
1. To learn about the application of multi-energy imaging
EIBIR 2 What’s new in biomedical imaging to mammography.
2. To appreciate how multi-energy imaging compares
research: an update of EIBIR activities with other mammographic imaging modalities.
10:30
A-380 Chairman’s introduction 10:30–12:00 Room MB 5
G.P. Krestin; Rotterdam/NL
Friday
diagnosis in the acute, sub-acute and chronic phases of infection.
3. To become familiar with the spectrum of imaging features of 14:00
inflammatory disorders in the axial and peripheral skeleton. A-402 Perfusion MRI: DSC, DCE and ASL
L. Knutsson; Lund/SE
14:00–15:30 Room B Learning Objectives:
1. To understand the basic principles of dynamic susceptibility contrast
(DSC), dynamic contrast-enhanced (DCE) and arterial spin-labelling
EFRS meets Germany (ASL) perfusion MRI.
2. To know the perfusion MRI protocols and post-processing.
EM 5 High-end and hybrid technology 3. To know the parameters that are derived from perfusion MRI, e.g.
in clinical and research work of cerebral blood volume (CBV), cerebral blood flow (CBF), and ktrans.
radiographers in Germany 14:30
Presiding A-403 Clinical applications of brain perfusion MRI
C. Vandulek; Kaposvár/HU H.R. Jäger; London/UK
A. Ohmstede; Oldenburg/DE
Learning Objectives:
14:00 1. To know the current indications for brain perfusion MRI
in the clinical routine.
A-396 Introduction 2. To understand which perfusion MRI technique and parameters
C. Vandulek1, A. Ohmstede2; 1Kaposvár/HU, 2Oldenburg/DE
to use for which indication.
14:05 3. To learn about future applications of brain perfusion MRI
in clinical practice.
A-397 Teaching and learning with VERT
(Virtual Environment for Radiation Therapy Training)
C. Garske; Berlin/DE
Learning Objectives:
1. To learn about our work with VERT.
2. To understand the advantages of VERT.
3. To appreciate the better preparation of our students
for the practical course.
14:23
A-398 Selective Internal Radiation Therapy (SIRT)
B. Kulitzscher; Berlin/DE
Learning Objectives:
1. To learn about the procedure background.
2. To become familiar with the material used.
3. To appreciate the outcome of SIRT.
14:55 14:05
A-404 DCE-MRI in oncology - when is quantitative A-409 EuroSafe imaging call for action
imaging essential? G. Frija; Paris/FR
A.R. Padhani; London/UK Learning Objectives:
Learning Objectives: 1. To learn about EuroSafe Imaging’s strategy to establish
1. To show that the implementation of perfusion DCE-MRI into clinical a patient safety culture in Europe.
practice has been delayed/hindered by the complexities 2. To understand how EuroSafe Imaging’s Call for Action will
of the technical analysis. contribute towards the implementation of the IAEA and
2. To demonstrate that complex quantitative analysis has roles in WHO ‘Bonn Call for Action’.
validation, drug development and is needed for multiparametric 3. To learn more about the specific plan of activities
assessments. of EuroSafe Imaging.
3. To illustrate that the key role of quantitative DCE-MRI is in the 14:15
validation phase of biomarker development but that clinical
deployment can be reductive provided that sensitivity is maintained. A-410 EuroSafe imaging training and education activities
4. To discuss future work, which should focus on incorporating and data collection project “Are you EuroSafe?”
perfusion imaging as part of multiparametric assessments so as P. Vock; Spiegel/CH
to improve understanding of tumour heterogeneity, including Learning Objectives:
response in the era of targeted/precision medicine. 1. To have an overview of the EuroSafe imaging education activities.
2. To understand the importance of training and education
15:20 Panel discussion to improve radiation protection practices.
3. To learn more about CT practices in Europe based on the results
of the survey.
14:00–15:30 Room L 1 4. To understand what action needs to be taken as a result
of the data collection.
EIBIR Session 14:30
EIBIR 3 MITIGATE consortium: A-411 Role of radiographers in medical radiation protection
state of the art imaging and in the context of EuroSafe imaging
G. Paulo; Coimbra/PT
therapy in GIST Learning Objectives:
Moderators: S.O. Schönberg; Mannheim/DE, I. Virgolini; Innsbruck/AT 1. To understand the role of radiographers
in medical radiation protection.
14:00 2. To learn more about the ‘division of labour’ between radiologists
A-405 Selective internal radiotherapy in GIST patients and radiographers.
S.J. Diehl; Mannheim/DE 3. To learn more about the impact technical issues and quality
of equipment have on radiation protection.
14:30
A-406 Multimodal imaging in GIST 14:45
D.L. Longo; Turin/IT A-412 Role of medical physicists in medical radiation protection
in the context of EuroSafe imaging
15:00 J. Damilakis; Iraklion/GR
A-407 Principle of X-Nuclei MR imaging: what the radiologist Learning Objectives:
should know 1. To understand the role of medical physicists
L.R. Schad; Mannheim/DE in medical radiation protection.
2. To learn more about the added value medical physicists provide
in radiology departments.
14:00–15:30 Room MB 2 15:00
EuroSafe Imaging Session A-413 New European approaches to medical low-dose research
J. Repussard; Paris/FR
EuroSafe 2 EuroSafe imaging call for action Learning Objectives:
1. To raise awareness about existing knowledge gaps,
14:00 and related research programs.
2. To learn about the opportunities for participation
A-408 Chairman’s introduction to research project with field.
G. Frija; Paris/FR
Session Objectives: Panel discussion:
1. To learn more about the ESR’s strategy to establish a new quality 15:15 EuroSafe Imaging - feedback, contributions,
and safety culture across Europe through the EuroSafe Imaging future activities, endorsement
campaign. N. Bedlington; Vienna/AT (European Patients Forum)
2. To learn about CT practices in Europe based on the results N. Denjoy; Brussels/BE (COCIR)
of an ESR data collection survey. G. Simeonov; Luxembourg/LU (European Commission)
3. To learn more about EuroSafe Imaging’s training and education M. Perez; Geneva/CH (WHO)
activities in the area of radiation protection. O. Holmberg; Vienna/AT (IAEA)
4. To understand that medical radiation protection is
a multi-disciplinary team effort.
Friday
Session Objectives: 16:20
1. To understand therapeutic decision-making from the urologist’s A-422 B. Perianal fistula disease: the basics
point of view. S. Halligan; London/UK
2. To understand the role of imaging in the early detection Learning Objectives:
of prostate cancer. 1. To understand the pathophysiology and classification
3. To learn about the new role of imaging in active surveillance. of perianal fistula disease.
16:05 2. To become familiar with the role of US and MRI in assessing
fistula disease.
A-417 PSA screening: the EAU view 3. To learn about the basic reporting of non-complex fistula disease.
P.-A. Abrahamsson; Malmö/SE
Learning Objectives: 16:40
1. To be aware of the limitations of PSA. A-423 C. Perianal fistula disease: advanced
2. To understand how to personalise prostate cancer screening. F. Maccioni; Rome/IT
3. To understand the indications for prostate MRI from the urological Learning Objectives:
point of view. 1. To learn about complex perianal fistula disease, notably extensions
16:23 and abscesses.
2. To understand the role of imaging in patient follow-up and
A-418 Role of a multiparametric MRI in early detection treatment monitoring.
G.M. Villeirs; Gent/BE
3. To learn about benign inflammatory conditions which may affect
Learning Objectives: the anal canal, including hydradenitis and pilonidal disease and
1. To understand the basic principles of mpMRI. how they are differentiated from perianal fistulae.
2. To be aware of the advantages and limitations of each MR technique.
3. To understand the PIRADS classification system. 17:00
16:41 A-424 D. Interactive case discussion
D. Weishaupt; Zurich/CH
A-419 Active surveillance strategies in prostate cancer Learning Objectives:
A. Villers; Lille/FR
1. To become familiar with typical cases demonstrating
Learning Objectives: the crucial role of imaging perianal fistula disease.
1. To understand the paradigm shift from invasive treatment 2. To learn about typical imaging findings.
to active surveillance (rationale for active surveillance). 3. To be aware of potential pitfalls in imaging perianal fistula disease.
2. To learn how to select patients for active surveillance
(comparison between the different available criteria).
3. To identify triggers for active treatment (tumour progression).
17:01 16:05
A-436 C. Update on irreversible electroporation A-444 Current endovascular treatment in iliofemoral DVT
A. Nilsson; Uppsala/SE R. Uberoi; Oxford/UK
Learning Objectives: Learning Objectives:
1. To understand the physical and technical basics of irreversible 1. To learn about the typical clinical and imaging features of acute
electroporation (IRE). and chronic iliofemoral DVT.
2. To become familiar with the current indications in oncology. 2. To become familiar with common interventional techniques
3. To consolidate knowledge of results from personal experience and in acute and chronic iliofemoral DVT.
from the literature. 3. To understand current evidence and management recommendations
based on this evidence.
Friday
corner injuries.
1. To understand the principles of endovenous thermal ablation.
17:00 2. To become familiar with the procedural technique.
A-442 C. The patellofemoral joint and osteochondral injuries: 3. To learn how to build a dedicated service.
how do I assess and what do I report?
C. Schaeffeler; Chur/CH Panel discussion:
17:25 What does the interventional radiologist need
Learning Objectives: to know about modern anticoagulation treatment?
1. To improve the reporting of osteochondral injuries.
2. To improve the reporting of patellofemoral abnormalities.
16:00–17:30 Room F1
16:00–17:30 Room E2
State of the Art Symposium
Special Focus Session SA 12 Fleischner guidelines for nodules:
SF 12 Interventional radiology in venous theory and practice
thromboembolism and chronic 16:00
venous disease A-448 Chairman’s introduction
C.M. Schaefer-Prokop; Amersfoort/NL
16:00
Session Objectives:
A-443 Chairman’s introduction 1. To learn about the patho-radiological correlation during
D.K. Tsetis; Iraklion/GR the development of pulmonary adenocarcinomas.
Session Objectives: 2. To realise the value of CT as an imaging biomarker for the detection
1. To understand when the interventional radiologist should intervene of early lung cancer.
to treat venous thromboembolism and venous insufficiency. 3. To become familiar with the content of the Fleischner guidelines and
2. To learn about the principles and procedural challenges of the how to apply them in various clinical situations.
different endovascular techniques. 4. To learn about the options and limitations of using CT for growth
3. To appreciate the importance of building a dedicated interventional assessment and nodule character.
radiological service. 5. To learn about the fine line between estimation of risk, necessity
to control and performance of imaging features.
16:05 16:35
A-449 The 2011 classification of adenocarcinomas: A-455 Equipment age - COCIR
rationale and implications for nodule management N. Denjoy; Brussels/BE
A. Nicholson; London/UK Learning Objective:
Learning Objectives: 1. To provide information on the age of CT equipment across Europe.
1. To become familiar with the most recent pathological classification 16:50
of pulmonary adenocarcimomas and to understand the rationale
behind it. A-456 Training and certification
2. To understand how pathologists determine the histological B. Ertl-Wagner; Munich/DE
composition of a nodular lesion and its implication on nodule Learning Objective:
management, tumour staging and patient prognosis. 1. To provide information on the training and certification disparities in
Europe, and to present the ESR tools to support harmonisation
16:30 in this area.
A-450 The Fleischner guidelines for solid and subsolid nodules:
17:05
theory and practice
A.A. Bankier; Boston, MA/US A-457 Issues related to coding terminology and IT access
P. Mildenberger; Mainz/DE
Learning Objectives:
1. To illustrate the role of CT as an imaging biomarker with examples Learning Objective:
of patho-radiological correlation. 1. To highlight the current European disparities in coding and
2. To become familiar with and understand the rationale behind the to propose a unified approach for imaging.
content of the Fleischner guidelines for solid and subsolid nodules.
3. To realise the impact of applying the Fleischner guidelines in clinical Panel discussion:
practice. 17:20 A global plan for imaging
4. To learn how the Fleischner guidelines may have to be adapted J. Griebel; Neuherberg/DE
to incorporate the most recent knowledge about the biological (HERCA Chair of the Working Group on Medical Applications - BfS, Germany)
behaviour of pulmonary nodules. T. Peetso; Brussels/BE
(Policy Officer of Unit ‘Health and Wellbeing’ - DG CNECT, European Commission)
16:55 A. Rys; Brussels/BE
A-451 Estimating the risk for malignancy of pulmonary nodules (Director Health systems and products - DG SANCO, European Commission)
B. van Ginneken; Nijmegen/NL
G. Simeonov; Luxembourg/LU
Learning Objectives: (Policy Officer Radiation Protection Unit - DG ENER, European Commission)
1. To learn about 2. and 3. methods of assessing nodule growth
and their accuracy.
2. To understand the different demands of solid and subsolid nodules 16:00–17:30 Room D1
with respect to growth assessment.
3. To learn about the role of computers in assessing the risk Chest
of malignancy of pulmonary nodules.
16:00
16:00–17:30 Room F2 A-458 A. The crucial role of chest x-ray:
mediastinal lines and stripes
Professional Challenges Session J. Cáceres; Barcelona/ES
Learning Objectives:
PC 12a Harmonised approach for imaging 1. To become familiar with the signs that indicate
in Europe: myth or reality? mediastinal pathology.
2. To confidently identify and localise a mediastinal mass
16:00 on chest plain films.
A-452 Chairman’s introduction 16:30
L. Donoso; Barcelona/ES
A-459 B. Mediastinal masses: role of CT
Session Objectives: V.E. Sinitsyn; Moscow/RU
1. To present the basis for a Call for Action for medical imaging
Learning Objectives:
in Europe and beyond.
1. To learn the most common causes of mediastinal masses.
2. To highlight the current European disparities in terms of manpower,
2. To recognise signs which allow us to characterise mediastinal lesions.
education and training, and equipment.
16:05 17:00
A-453 Current heterogeneities in imaging in Europe A-460 C. A new look at the mediastinum: role of MRI and PET/CT
E.J.R. van Beek; Edinburgh/UK
G. Frija; Paris/FR
Learning Objectives:
Learning Objective:
1. To learn when and how to apply MR for mediastinal disease.
1. To provide information on the status of EU Member states regarding
2. To learn when and how to apply PET/CT for mediastinal masses.
key issues: equipment distribution, manpower, practices and
compliance with EURATOM Directives.
16:20
A-454 Imaging equipment: an ESR perspective
B. Brkljacic; Zagreb/HR
Learning Objective:
1. To present the ESR policy regarding the standards of equipment.
16:00
16:00–17:30 Room MB 1
A-461 A. Where are we in measuring kidney function
with imaging?
N. Grenier; Bordeaux/FR
E³ - ECR Master Classes
Learning Objectives: (Molecular Imaging)
1. To become familiar with the renal physiological parameters
to be quantified. E³ 1226d Chemical exchange saturation
2. To learn about the techniques available for evaluating the function.
3. To understand the limitations of each technique
transfer (CEST):
in clinical applications. a new toy for molecular imaging?
Moderator: O. Clément; Paris/FR
16:30
A-462 B. The added value of DWI in gynaecological malignancies: 16:00
the ADC and beyond A-467 A. Physical principle
A.G. Rockall; London/UK M. Bock; Freiburg/DE
Learning Objectives: Learning Objectives:
1. To describe the role of diffusion weighed MRI (DW-MRI) 1. To understand the physical principle of CEST imaging.
in lesion detection and characterisation. 2. To understand the requirements for a molecule to be suited
2. To review the added clinical value of DW-MRI in staging and for CEST imaging.
follow-up of patients with gynaecologic malignancies. 3. To learn about MR sequences used for CEST imaging.
3. To highlight technical and interpretation challenges of DW-MRI
in evaluation of gynaecologic malignancies. 16:30
A-468 B. Probes
17:00 S. Aime; Turin/IT
A-463 C. Will genomics change imaging? Learning Objectives:
Renal cancer as a case study 1. To learn about available endogenous and exogenous contrast agents
P.L. Choyke; Bethesda, MD/US and probes.
Learning Objectives: 2. To understand the advantages of para-CEST agents.
Friday
1. To identify the major genetic abnormalities associated 3. To discuss the potential of hyper-CEST.
with renal cancer.
2. To discuss how these genetic abnormalities affect the imaging
17:00
of renal cancer. A-469 C. Clinical applications
3. To describe how the interplay between genomics and S. Walker-Samuel; London/UK
imaging affects management of patients. Learning Objectives:
1. To understand the clinical potential of CEST.
2. To learn about gluco-CEST.
16:00–17:30 Room K 3. To discuss CEST applications in the orthopaedic and oncologic field.
E³ - ECR Academies:
16:00–17:30 Room MB 2
Hybrid Imaging (advanced)
E³ - ECR Master Classes (Cardiac)
E³ 1218 MR/PET - the future of hybrid imaging?
Moderator: R.A. Coulden; Edmonton, AB/CA E³ 1226c Cardiac MR imaging
Moderator: P. Croisille; Saint-Etienne/FR
16:00
A-464 A. For which indications is MR/PET better than PET/CT? 16:00
L. Umutlu; Essen/DE A-470 A. T1 and T2 mapping
Learning Objectives: C. Lücke; Leipzig/DE
1. To understand the advantage of using MRI instead of CT together Learning Objectives:
with PET. 1. To understand the principles of T1 and T2 mapping.
2. To become familiar with scanner technology. 2. To learn about the current insights and potential role
3. To consolidate the situation in advanced hybrid imaging. of T1 and T2 mapping.
16:30 16:30
A-465 B. MR/PET technology: state of the art A-471 B. Quantification of myocardial perfusion by MRI
A. Cuocolo, C. Nappi, R. Assante; Naples/IT K. Kitagawa; Mie/JP
Learning Objectives: Learning Objectives:
1. To understand the different demands of a PET System 1. To understand the different approaches to quantification
with MR instead of CT. of myocardial perfusion by MRI.
2. To become familiar with challenges in attenuation correction 2. To learn about the clinical potential of imaging
in PET/MR. perfusion quantification.
3. To consolidate knowledge of the new technique.
17:00 16:05
A-472 C. 4D MR perfusion imaging of the myocardium A-478 A. Gastrointestinal tract
R. Manka; Zurich/CH M.A. Patak; Zurich/CH
Learning Objectives: Learning Objectives:
1. To understand the disadvantages of standard approaches 1. To describe the main techniques for surgery and
to MR perfusion imaging. list their potential complications.
2. To learn about the clinical potential of 4. perfusion imaging. 2. To become familiar with imaging features of postoperative
complications.
16:00–17:30 Room MB 3 3. To understand the indications and contraindications
for interventional and surgical procedures.
Computer Applications 16:29
A-479 B. Liver and pancreas
RC 1205 Update on computer-aided S. Wirth, M. Rentsch; Munich/DE
diagnosis (CAD) Learning Objectives:
1. To be familiar with surgical procedures and
16:00 their common complications.
A-473 Chairman’s introduction 2. To learn typical imaging findings in patients
M. Langer; Freiburg/DE with postsurgical complications.
Session Objectives: 3. To learn the guidelines for interventional radiological procedures.
1. To give an overview of the most important clinical applications 16:53
of CAD.
2. To describe results of clinical trials that use CAD for lesion detection
A-480 C. Genitourinary tract
R.H. Oyen; Leuven/BE
and interpretation.
3. To summarise advantages and limitations of CAD technology. Learning Objectives:
1. To be familiar with surgical procedures often resulting
16:05 in clinical complications.
A-474 A. CT colonography and CAD 2. To learn how to choose the best imaging modality
S.A. Taylor; London/UK to diagnose these complications.
Learning Objectives: 3. To understand the impact of imaging findings
1. To describe the reading paradigms of CAD applied on further management of patients.
to CT colonography.
2. To present the results of clinical trials adopting CAD as Panel discussion:
an additional tool to report CT colonography. 17:17 Time is gold - where and when can we go faster?
3. To describe indications, advantages and pit-falls of using CAD
in clinical practice.
16:00–17:30 Room MB 5
16:28
A-475 B. CAD for lung nodules Paediatric
A.R. Larici; Rome/IT
Learning Objectives: RC 1212 Hepatobiliary imaging in children
1. To describe CAD algorithms for nodule detection and Moderator: D. Akinci; Ankara/TR
volume measurement.
2. To underline advantages and limitations of the use of CAD 16:00
for lung nodule detection. A-481 A. Imaging of liver masses
3. To review the importance of lung nodule volume measurements. D.J. Roebuck; London/UK
16:51 Learning Objectives:
A-476 C. CAD for breast cancer detection 1. To learn about imaging protocols.
U. Bick; Berlin/DE 2. To learn about common benign and malignant lesions and
differential diagnosis.
Learning Objectives:
3. To become familiar with the role of new imaging techniques and
1. To describe different types of CAD algorithms for detection and
hepatocytes-specific contrast agents.
characterisation of breast lesions.
2. To review the results of clinical trials that use CAD for detection 16:30
of breast lesions. A-482 B. Imaging of biliary disorders
3. To give an overview of the potential role of CAD applied S.G.F. Robben; Maastricht/NL
to new technologies.
Learning Objectives:
1. To become familiar with the roles of US, CT and MRI.
Panel discussion:
2. To learn about manifestations of common diseases.
17:14 Is CAD ready for prime time?
3. To discuss the role of hepatobiliary contrast agents.
Saturday
how we can differentiate both.
3. To understand the role of different imaging techniques in assessing A-492 D. Interactive case discussion
both diseases. A. Graser; Munich/DE
09:30
A-488 C. Paraduodenal and autoimmune pancreatitis 08:30–10:00 Room Z
S.A. Jackson; Plymouth/UK
Learning Objectives: Joint Session of the ESR and EORTC
1. To become familiar with the clinical presentation and the radiological
signs that may be observed in autoimmune pancreatitis. Imaging in multicentre clinical oncological trials
2. To become familiar with the diagnostic criteria for the disease. Moderators: L. Fournier; Paris/FR, Y. Liu; Brussels/BE
3. To learn strategies for managing doubtful clinical situations.
08:30
A-493 Imaging in clinical trials: the EORTC perspective
Y. Liu; Brussels/BE
Learning Objectives:
1. To become familiar with the importance of imaging
in oncologic trials.
2. To learn about the role of the EORTC Imaging Group.
3. To appreciate how standardisation enhances the role of imaging
in oncologic trials.
09:00 09:00
A-508 B. MRI of the spine and sacroiliac joints A-514 B. Imaging tumour heterogeneity and perfusion:
C. Schueller-Weidekamm; Vienna/AT predicting tumour behaviour
Learning Objectives: V.J. Goh; London/UK
1. To learn about standardised imaging. Learning Objectives:
2. To understand the MRI-specific findings that aid diagnosis. 1. To be familiar with the techniques for measuring tumour
3. To learn a structured approach to reporting. heterogeneity on imaging.
09:30 2. To know the main findings of perfusion imaging in predicting
tumour behaviour.
A-509 C. MRI of the hand 3. To be familiar with current research in this field.
M. Shahabpour, C. Boulet, M. De Maeseneer; Brussels/BE
Learning Objectives: 09:30
1. To learn about standardised imaging. A-515 C. Molecular imaging:
2. To understand the MRI-specific findings that aid diagnosis. visualising the characteristics of cancer cells
3. To learn a structured approach to reporting. G. Cook; London/UK
Learning Objectives:
1. To learn about important imaging targets in cancer cells.
08:30–10:00 Room E2 2. To be familiar with specific radiotracers currently in early phase
cancer imaging studies.
Neuro 3. To be familiar with the potential role of new tracers
in patient management.
RC 1311 Reporting spine imaging studies
Moderator: M.A. Papathanasiou; Athens/GR
08:30–10:00 Room F2
08:30
A-510 A. Disc nomenclature and treatment strategy Breast
M. Gallucci; L’Aquila/IT
Learning Objectives: RC 1302 Tailoring breast cancer screening
1. To become familiar with the different nomenclatures in degenerative to risk level
disk disease. Moderator: B. Brkljacic; Zagreb/HR
2. To learn how to differentiate between degenerative disease and
other pathologies. 08:30
3. To learn whether or not disc nomenclature influences
treatment strategy. A-516 A. Calculating, using and improving individual
risk estimates
09:00 S.W. Duffy; London/UK
A-511 B. What to say and not to say in your report Learning Objectives:
M.M. Thurnher; Vienna/AT 1. To know the different models for risk evaluation.
Learning Objectives: 2. To understand the limitations of risk modelling for predicting
1. To understand the legal value of a report. the individual risk.
2. To demonstrate how detailed a report should be. 3. To appreciate the potential applications of risk modelling for tailoring
3. To understand the importance of a clinical correlation and breast cancer screening.
previous exam correlation.
09:00
09:30 A-517 B. Intermediate risk: the grey zone
A-512 C. Introduction to structured reporting in the spine S.H. Heywang-Köbrunner; Munich/DE
J. Van Goethem1, L. van den Hauwe1, F. De Belder1, C. Venstermans1, F. Ramon2, Learning Objectives:
P.M. Parizel1; 1Antwerp/BE, 2Sint-Niklaas/BE
Saturday
1. To become familiar with the concept of increased breast cancer risk.
Learning Objectives: 2. To discuss the role of breast density in relation to cancer risk.
1. To understand if it is always helpful to have a structured report. 3. To evaluate the evidence in favour of intensive screening protocols
2. To learn what a structured report is. in women at intermediate risk.
3. To learn whether or not we can escape through structured reporting.
09:30
A-518 C. High risk: MRI alone?
08:30–10:00 Room F1 F. Sardanelli; San Donato Milanese/IT
Learning Objectives:
E³ - ECR Master Classes 1. To appreciate the evidence in favour of MRI for screening high-risk
women in terms of diagnostic performance and patient outcome.
(Oncologic Imaging) 2. To become aware of the value of MRI alone for screening women
with high-risk genes.
E³ 1326 Imaging tumour phenotype: 3. To become aware of the need for using mammography as an adjunct
the future is now to MRI when screening women who have had previous thoracic
radiation therapy.
Moderator: D. Regge; Turin/IT
08:30
A-513 A. Radiogenomics for cancer: phenotypic and genomic
heterogeneity
P.L. Choyke; Bethesda, MD/US
Learning Objectives:
1. To be familiar with the concept of radiogenomics.
2. To understand the potential role of radiogenomic studies
in evaluating cancer.
3. To be familiar with the research objectives in this field.
08:30 11:30
A-529 A. Neuroendocrine tumours A-535 D. Interactive case discussion
S. Fanti; Bologna/IT S.A. Taylor; London/UK
Learning Objectives:
1. To become familiar with PET imaging of neuroendocrine tumours
with PET. 10:30–12:00 Room B
2. To understand the biochemistry.
3. To learn about challenges in advanced imaging ESR meets the Republic of Korea
of neuroendocrine tumours.
09:00
EM 3 CT in lung cancer screening and
A-530 B. Prostate cancer
COPD evaluation
M.C. Roethke; Heidelberg/DE Welcome by the ESR President
L. Bonomo; Rome/IT
Learning Objectives:
Presiding
1. To learn about tracers for PET imaging of prostate cancer. B. Hamm; Berlin/DE
2. To learn about advanced MRI imaging of prostate cancer. T.-H. Lim; Seoul/KR
3. To consolidate knowledge in PET/MR imaging of prostate cancer.
09:30 10:30
A-531 C. Coronary atherosclerotic plaque A-536 Introduction: Korean Society of Radiology -
M.R. Dweck; Edinburgh/UK evolution and new challenges
T.-H. Lim; Seoul/KR
Learning Objectives:
1. To learn about tracers for PET imaging of atherosclerosis. Session Objectives:
2. To learn about advanced MRI imaging of atherosclerosis. 1. To learn about smoking-related pulmonary diseases.
3. To consolidate knowledge in PET/MR imaging of atheroscperosis. 2. To discuss the role of CT in lung cancer screening and COPD.
3. To learn about recent results of clinical trials in lung cancer screening
and COPD.
10:30–12:00 Room A 10:35
E³ - ECR Academies: A-537 Lung cancer screening in Korea
K.S. Lee; Seoul/KR
Modern Imaging of the GI Tract Learning Objectives:
1. To understand issues related to cancer screening.
E³ 1422 Inflammatory bowel disease 2. To learn about the results of recent clinical trials
of lung cancer screening.
Moderator: S.A. Taylor; London/UK
3. To present the situation and results of lung cancer screening in Korea.
10:30 10:55
Saturday
A-532 A. Cross-sectional imaging protocols A-538 Interlude: Republic of Korea (South Korea):
M.A. Patak; Zurich/CH
Korean people and culture
Learning Objectives: J. Hur; Seoul/KR
1. To understand state-of-the-art MRI, CT and US protocols
Learning Objectives:
for imaging IBD.
1. To briefly introduce Korean culture, food and people.
2. To appreciate the comparative advantages and disadvantages
2. To introduce unique tourist attractions in Korea.
of enterography and enteroclysis protocols.
3. To learn about protocol modifications when evaluating the colon. 11:00
10:50 A-539 Computer-aided nodule detection and volumetry:
A-533 B. Small bowel disease role in lung cancer screening
J. Stoker; Amsterdam/NL J.M. Goo; Seoul/KR
Learning Objectives: Learning Objectives:
1. To learn about the classifications of small bowel Crohn’s disease. 1. To understand basic ideas of computer-aided nodule detection
2. To become familiar with cross-sectional imaging signs of disease and volumetry.
activity and complications. 2. To learn the results of computer-aided nodule detection and
3. To understand a rational deployment of cross-sectional imaging volumetry in nodule management.
techniques according to clinical indication, highlighting the main 3. To discuss the measurement variability and related issues
advantages and disadvantages of CT, MRI and US. in nodule volumetry.
11:20
A-540 Interlude: Introduction of the Korean Society
of Thoracic Radiology (KSTR)
J. Hur; Seoul/KR
Learning Objectives:
1. To introduce the Korean Society of Thoracic Radiology (KSTR).
2. To introduce the “Weekly Chest Cases” website.
11:25 10:33
A-541 CT in COPD: now and future A-546 A. Hepatobiliary system
J.B. Seo; Seoul/KR Y. Menu; Paris/FR
Learning Objectives: Learning Objectives:
1. To know the current role of CT in clinical practice of COPD. 1. To differentiate the anatomy, normal variants and congenital
2. To know the early results of clinical researches in quantification disorders of the hepatobiliary system.
of emphysema and airway wall inflammation with CT of COPD. 2. To describe the primary and secondary imaging features of acute and
3. To know several new potential CT techniques in evaluating COPD, chronic diffuse liver diseases.
such as analysis of peripheral vascular changes, air trapping, 3. To differentiate the causes and imaging features of benign and
diaphragmatic morphology and so on. malignant focal liver lesions, including cysts, hemangiomas,
adenomas, focal nodular hyperplasia, hepatocellular carcinomas and
Panel discussion: metastases.
11:45 Is CT an effective tool for management 4. To differentiate the various causes and imaging features of benign
of lung cancer screening and COPD? and malignant diseases of the biliary tract and gallbladder.
11:02
10:30–12:00 Room M A-547 B. Pancreas and spleen
W. Schima; Vienna/AT
RTF - Radiology Trainees Forum Learning Objectives:
1. To describe the anatomy, normal variants and congenital disorders
TF 1 Highlighted Lectures of the pancreas.
2. To differentiate the causes and imaging features of benign and
Moderators: M. Basta-Nikolic; Novi Sad/RS, C.A. Minoiu; Bucharest/RO
malignant pancreatic tumours.
3. To understand the imaging features of acute and chronic pancreatitis
10:30 and its potential complications.
A-542 Ischemic cardiomyopathy - coronary arteries and 4. To list the causes and imaging features of focal and
myocardium: two sides of the same coin? diffuse splenic abnormalities.
R. Marano; Rome/IT
11:31
11:00 A-548 C. Imaging of the gastrointestinal tract
A-543 MRI appearances of incidental focal liver lesions: R.G.H. Beets-Tan; Maastricht/NL
role of hepatocyte-specific contrast agents and DWI Learning Objectives:
S. Gourtsoyianni; London/UK 1. To differentiate the anatomy, normal variants and congenital
Learning Objectives: disorders of the oesophagus, stomach, duodenum, small bowel,
1. To learn about typical MRI imaging characteristics of the most colon, rectum and anal canal.
commonly encountered focal liver lesions in non-cirrhotic patients. 2. To describe the imaging features of colonic diverticulosis,
2. To become familiar with different available MRI contrast diverticulitis, tumour stenosis, ileocolic intussusception, colonic
mechanisms; including hepatocyte-specific contrast agents and DWI fistula, paracolic abscess, epiploic appendagitis, intra-peritoneal fluid
acquisition protocols. collection, colonic pneumatosis and pneumoperitoneum.
3. To appreciate additional information that can be gained towards the 3. To understand radiological manifestations of inflammatory bowel
detection and characterisation of focal liver lesions when using the diseases, malabsorption syndromes, infection and bowel ischemia.
afforementioned contrast mechanisms. 4. To be familiar with the the staging of tumours of the gastrointestinal
tract, including features that indicate nonresectability.
11:30
A-544 Radiology and sports injuries:
10:30–12:00 Room L 1
more than reading the image!
M. Maas; Amsterdam/NL
ESR Patient Advisory Group (PAG)
10:30–12:00 Room N ESR-PAG 1 The challenges of providing true
patient-centred care:
E³ - European Diploma Prep Sessions moving forward together
E³ 1423 Gastrointestinal and abdominal 10:30
A-552 Chairmen’s introduction
10:30 N. Bedlington1, P. Cavanagh2; 1Vienna/AT, 2Taunton/UK
A-545 Chairman’s introduction Session Objectives:
C. Stoupis; Männedorf/CH 1. To introduce a framework for delivering patient-centred care
Session Objectives: in radiology.
1. To describe typical imaging features of benign and malignant lesions 2. To understand the need for balance between professional
of the heaptobiliary system. responsibility and patient autonomy.
2. To differentiate the imaging features of benign and malignant lesions 3. To understand the patient’s needs and concerns.
of the pancreas and spleen. 4. To become familiar with methods and examples of good practice
3. To be familiar with the methodological basis and to differentiate and how to improve the patient-doctor relationship.
typical features in imaging examinations of the gastrointestinal tract.
10:40
A-553 Ethics in patient-centred radiology
C.D. Claussen1, G. Marckmann2; 1Tübingen/DE, 2Munich/DE
Learning Objectives:
1. To learn about the basic ethical principles that guide patient-centred
medical practice.
2. To understand some of the more specific ethical issues that arise
in clinical radiology.
3. To develop perspectives of how to deal appropriately with these
ethical issues in daily practice.
Saturday
E³ - ECR Master Classes
12:30–13:30 Room B
(Abdominal and Gastrointestinal)
E³ - The Beauty of Basic Knowledge: E³ 1526 Advances in liver imaging
Breast Imaging Moderator: F. Caseiro Alves; Coimbra/PT
Saturday
standards directive.
3. To learn more about EuroSafe Imaging’s activities in relation
14:00–15:30 Room N to the legal and regulatory environment.
E³ - European Diploma Prep Sessions 14:20
A-582 Implementing a dose management solution in your
E³ 1523 Musculoskeletal department: where to start and what to expect?
D. Weishaupt; Zurich/CH
14:00 Learning Objectives:
A-576 Chairman’s introduction 1. To understand the challenges of implementing dose management
F.M.H.M. Vanhoenacker; Antwerp/BE in radiology departments.
Session Objectives: 2. To learn from practical examples of dose management
1. To understand typical and atpyical imaging features of traumatic implementation.
disorders of the musculoskeletal system.
2. To differentiate imaging features of benign and malignant bone
14:35
tumours. A-583 Developing a multi-disciplinary team
3. To describe the imaging appearance of degenerative and in dose management (CT example)
inflammatory disorders of the musculoskeletal system. L. Martí-Bonmatí; Valencia/ES
14:03 Learning Objectives:
1. To understand which disciplines are required
A-577 A. Traumatic disorders of the musculoskeletal system on a CT dose management team.
M. Maas; Amsterdam/NL 2. To learn more about the advantages of multi-disciplinary
Learning Objectives: collaboration.
1. To describe the anatomy and normal variants of the musculoskeletal
system.
2. To understand common imaging presentations of acute and chronic
trauma involving the skeleton and soft tissue.
3. To understand common pitfalls in trauma imaging of the
musculoskeletal system.
14:50 14:05
A-584 PiDRL - European Commission Tender Project A-590 Reporter gene imaging
on diagnostic reference levels in paediatric imaging C.W.G.M. Löwik, E.L. Kaijzel, L. Mezzanotte; Leiden/NL
J. Damilakis; Iraklion/GR Learning Objectives:
Learning Objectives: 1. To learn about the methodology of creating reporter genes.
1. To understand the methodology for establishing and using DRLs 2. To understand the differences between reporter gene imaging
for paediatric imaging. and other methods of labeling used in optical imaging.
2. To learn about the specific requirements for paediatric DRLs 3. To become familiar with successful examples
(in comparison to DRLs for adults). of reporter gene imaging.
15:05 14:30
A-585 Deploying a dose management strategy across A-591 Cerenkov - faster than the speed of light
J. Grimm; New York, NY/US
multiple sites
K. Katsari; Athens/GR Learning Objectives:
1. To understand the method of Cerenkov imaging.
Learning Objectives:
2. To become familiar with representative applications
1. To understand the challenges of implementing a dose management
of Cerenkov imaging.
strategy in different locations.
3. To appreciate strength and limitations of this approach compared
2. To learn more about practical examples of dose management
to other methods of molecular imaging.
strategies implemented across multiple sites.
14:55
15:20 Panel discussion
A-592 The kiss of light and sound - optoacoustics
V. Ntziachristos; Munich/DE
14:00–15:30 Room E1 Learning Objectives:
1. To understand the method of optoacoustics.
Musculoskeletal 2. To become familiar with representative applications
of optoacoustic imaging.
3. To appreciate the strengths and limitations of this approach
RC 1510 The hand and wrist compared to other methods of molecular imaging.
Moderator: A. Plagou; Athens/GR
Panel discussion:
14:00 15:20 Potential of optical imaging for translation
A-586 A. Patterns of injury to human applications
A. Navas Canete; Leiden/NL
Learning Objectives:
1. To learn more about the imaging appearances of soft tissue and 14:00–15:30 Room F1
osteoarticular injury.
2. To become familiar with the patterns of bone and soft tissue injury Special Focus Session
in the hand and wrist.
14:30 SF 15 Cardiac CT: cutting-edge techniques
A-587 B. Inflammatory disorders 14:00
H. Guerini; Paris/FR
A-593 Chairman’s introduction:
Learning Objectives:
1. To learn more about the imaging appearances of soft tissue overview of the cutting-edge techniques
R. Salgado; Antwerp/BE
and osteoarticular inflammation.
2. To become familiar with imaging findings Session Objectives:
of specific inflammatory conditions. 1. To learn about new developing technologies in cardiac-CT.
2. To understand their potential benefits and limitations
15:00 in clinical practice.
A-588 C. Tumours and tumour-like lesions 3. To learn about their current state of scientific evidence.
E. Llopis; Valencia/ES
14:05
Learning Objectives:
1. To learn more about the spectrum of intra and para-articular soft A-594 Estimation of coronary flow reserve by CT: a new arrival
G. Bastarrika; Pamplona/ES
tissue tumours, and soft tissue tumour-like lesions.
2. To become familiar with US and MRI findings Learning Objectives:
of specific soft tissue lesions. 1. To understand the principles and clinical significance of fractional
flow reserve (FFR).
2. To describe the rationale of CT-derived FFR (CT-FFR).
14:00–15:30 Room E2 3. To provide insights into the usefulness of CT-FFR to assess ischemia-
causing coronary lesions.
New Horizons Session 14:30
A-595 Myocardial perfusion imaging in clinical routine: ready for
NH 15 Optical molecular imaging: a new prime time?
dimension for radiology K. Kitagawa; Mie/JP
Learning Objectives:
14:00 1. To learn about state-of-the-art imaging techniques for myocardial
A-589 Chairman’s introduction perfusion and viability.
C.-C. Glüer; Kiel/DE 2. To appreciate clinical usefulness of comprehensive cardiac CT
Session Objectives: protocol.
1. To appreciate the versatility and power of optical imaging methods. 3. To get informed about current limitations of myocardial perfusion
2. To appreciate the difference in strengths and limitations of these imaging by CT.
methods.
3. To become familiar with state-of-the-art preclinical imaging
concepts.
14:55 15:00
A-596 Plaque imaging with cardiac CT: coming of age? A-602 C. MRI in pulmonary artery hypertension
J. Hoe; Singapore/SG J. Biederer; Groß-Gerau/DE
Learning Objectives: Learning Objectives:
1. To understand pathophysiology of coronary plaque and clinical effect 1. To learn about the MRI diagnosis of pulmonary artery hypertension.
of plaque rupture. 2. To appreciate the role of MRI in the assessment of pulmonary
2. To learn how CT can be used to detect, quantify and characterise artery hypertension.
coronary plaque. 3. To become familiar with MRI techniques in the assessment
3. To become informed about clinical value and outcomes of plaque of pulmonary artery hypertension.
detected by CT.
Saturday
their clinical application. use of contrast media.
14:51
14:00–15:30 Room D1 A-606 C. Tips and tricks for CT optimisation
R. Booij; Rotterdam/NL
Chest Learning Objectives:
1. To learn how to effectively use scan parameters and innovative
RC 1504 Pulmonary arterial hypertension technologies to optimise CT protocols.
Moderator: R. Cesar; Golnik/SI 2. To appreciate the need for well-educated and -trained radiographers
for optimal use of CT innovations.
14:00 3. To learn about iterative reconstruction processes and
their quality impact.
A-600 A. An overview of pulmonary artery hypertension 4. To recognise CT artefacts and learn how to deal with them.
N.J. Screaton; Cambridge/UK
Learning Objectives: Panel discussion:
1. To learn about the epidemiology of pulmonary artery hypertension. 15:14 How should a radiographer develop the interface
2. To become familiar with the clinical symptoms, signs and causes of between patient and technology?
pulmonary artery hypertension.
3. To appreciate the importance and difficulties of treating pulmonary
artery hypertension.
14:30
A-601 B. CT in pulmonary artery hypertension
M.-P. Revel; Paris/FR
Learning Objectives:
1. To learn about the CT diagnosis of pulmonary artery hypertension.
2. To become familiar with the causes of pulmonary artery
hypertension on CT.
14:30 16:45
A-608 B. How can I improve my reporting A-614 B. Cardiomyopathies: from diagnosis to prognosis
A. Jacquier; Marseille/FR
of T2-hyperintense lesions? Learning Objectives:
A. Rovira-Cañellas; Barcelona/ES
1. To understand the diagnostic work-up of cardiomyopathies.
Learning Objectives: 2. To review the association between diagnostic findings
1. To understand if it is possible to use a structured report and clinical outcome.
with white brain abnormality.
2. To learn how to define a comprehensive imaging protocol
for those patients. 16:00–17:30 Room B
3. To appreciate the role of modern imaging techniques
for defining white brain hyperintense T2 lesions.
GI Tract
15:00
A-609 C. Is there a need for quantitative reporting RC 1601 From my workstation:
of white matter lesions? difficult cases on review
F. Barkhof; Amsterdam/NL
Learning Objectives: 16:00
1. To understand the importance of quantitative analysis A-615 Chairman’s introduction
in white matter lesions. A. Maier; Vienna/AT
2. To show how to perform the quantitative analysis.
3. To understand the importance of follow-up in in patients 16:05
with white matter lesions. A-616 A. Pancreas
C. Triantopoulou; Athens/GR
Learning Objectives:
14:00–15:30 Room K 1. To appreciate the challenging variants in pancreatic anatomy.
2. To learn about the most important pitfalls in pancreatic imaging.
E³ - ECR Academies: 3. To understand the management of these challenging cases.
Hybrid Imaging (advanced) 16:28
A-617 B. Small bowel
E³ 1518 Advanced hybrid imaging of brain E. Biscaldi; Genoa/IT
Moderator: G. Morana; Genoa/IT Learning Objectives:
1. To learn about the normal anatomy and normal variants.
14:00 2. To learn about the most important pitfalls in imaging assessment
A-610 A. Memory decline of small bowel lesions.
L. Nyberg; Umea/SE 3. To understand the management of these challenging cases.
Learning Objectives: 16:51
1. To learn about PET imaging in cognition.
2. To learn about advanced MRI in cognition.
A-618 C. Rectum
D.M.J. Lambregts; Maastricht/NL
3. To understand PET/MRI in cognition.
Learning Objectives:
14:30 1. To learn about normal rectal anatomy and normal variants.
A-611 B. Minimal cognitive impairment and dementia 2. To learn about the most important pitfalls in imaging assessment
J.O. Rinne; Turku/FI of rectal cancer or rare tumours of the rectum.
Learning Objectives: 3. To understand the management of these challenging cases.
1. To learn about PET tracers in minimal cognitive impairment (MCI)
and dementia. Panel discussion:
2. To learn about MRI in MCI and dementia. 17:14 What can we learn from challenging cases?
3. To understand the role of advanced hybrid imaging in MCI
and dementia.
15:00
A-612 C. Brain tumours
P. Bartenstein, N. Jansen; Munich/DE
Learning Objectives:
1. To learn about PET tracers in brain tumours.
2. To learn about advanced MRI in brain tumours.
3. To understand the use of advanced hybrid imaging in brain tumours.
Saturday
C. McGrath; Belfast/UK
ESR/ESTRO 2 Radiology and radiation oncology: Learning Objectives:
new chances for a partnership 1. To re-familiarise the listener with the origin of signal in MRI.
2. To understand the concept of magnetic susceptibility and
Moderators: P.M.P. Poortmans; Nijmegen/NL, L. Bonomo; Rome/IT
how differences between magnetic susceptibilities determine
16:00 metal artefacts in MRI.
3. To understand the MRI physics of artefact reduction around
A-623 Introduction metal implants.
L. Bonomo; Rome/IT 4. To understand the parameters used in an optimised
Session Objectives: imaging protocol.
1. To understand how collaboration between radiology and radiation
oncology presents great opportunities to both the disciplines. 17:00
2. To learn how interventional radiology can achieve excellent clinical A-629 C. Artefacts in perfusion and diffusion MRI
results in oncologic patients. I. Tsougos; Larissa/GR
3. To understand how the partnership between radiology and radiation Learning Objectives:
oncology offers the best treatment to patients. 1. To review the artefacts and pitfalls of diffusion MRI on a qualitative
16:05 basis, especially in terms of eddy currents and sensitivity to motion.
2. To review and evaluate the possible issues that can affect the accuracy
A-624 Imaging in oncology: achievements and limitations of measurements regarding dynamic susceptibility contrast
V.J. Goh; London/UK (DSC)-MRI (measurements of cerebral blood flow (CBF),
Learning Objectives: cerebral blood volume (CBV), and mean transit time (MTT)).
1. To learn about the actual capabilities of imaging for the management 3. To introduce possible strategies that have been developed
of oncologic patients. to mitigate or overcome these artefacts and pitfalls.
2. To become familiar with functional techniques applied
to oncologic patients.
3. To understand how imaging can help radiation oncologists.
17:00 16:05
A-642 The European Radiation Protection Regulators’ A-648 Proteoglycan-specific quantitative imaging
perspective on audit in osteoarthritis and cartilage repair - part 1
S. Ebdon-Jackson; Didcot/UK E.H.G. Oei; Rotterdam/NL
Learning Objectives: Learning Objectives:
1. To understand the legal and regulatory environment 1. To learn about the basic principles of delayed gadolinium-enhanced
for clinical audits. MRI of cartilage (dGEMRIC).
2. To learn more about the role and expectations of radiation protection 2. To learn about imaging protocol issues and analysis methods
regulatory authorities in clinical audit. for dGEMRIC.
3. To understand the advantages and disadvantages of dGEMRIC
17:15 Panel Discussion for clinical research and patient care.
4. To appreciate the additional value of dGEMRIC for the follow-up
of cartilage repair procedures.
16:00–17:30 Room E1
16:28
E³ - ECR Master Classes (Head and Neck) A-649 Proteoglycan-specific quantitative imaging
in osteoarthritis and cartilage repair - part 2
E³ 1626a Cone-beam vs multi-detector CT M.-A. Weber, C. Rehnitz; Heidelberg/DE
in head and neck imaging Learning Objectives:
Moderator: A. Trojanowska; Lublin/PL 1. To understand basic principles of chemical exchange saturation
transfer (CEST) in cartilage imaging.
16:00 2. To become familiar with possible clinical applications of gagCEST.
3. To learn about the advantages and disadvantages of gagCEST
A-643 A. Understanding image quality and radiation dose compared to other compositional methods.
in MDCT and CBCT 4. To appreciate current challenges and future perspectives of CEST
M. Kachelrieß; Heidelberg/DE in comprehensive cartilage assessment.
Learning Objectives:
1. To review the working of multi-detector computed tomography
16:51
(MDCT). A-650 Degenerative joint disease: collagen-specific quantitative
2. To understand the basic principles of cone-beam CT (CBCT). imaging of menisci and tendons
3. To become familiar with strategies for dose optimisation in CT. K.M. Friedrich, V. Juras, P. Szomolanyi, S. Trattnig; Vienna/AT
16:35 Learning Objectives:
1. To understand the basic principles of T2. mapping and ultra-short
A-644 B. My finest cone-beam CT cases TE methods in MSK imaging.
J. Casselman1, B. De Foer2; 1Bruges/BE, 2Antwerp/BE
2. To become familiar with T2. mapping and ultra-short TE methods
Learning Objectives: in meniscal and tendon disease.
1. To describe the application of CBCT in head and neck imaging. 3. To understand the benefits of these quantitative MRI techniques
2. To present examples of the value of CBCT in head and neck compared to morphological MRI.
pathology. 4. To learn about the limitations and future applications of these
quantitative MRI techniques in MSK imaging.
16:55
A-645 C. What can be missed on cone-beam CT: Panel discussion:
pitfalls and challenges 17:14 What are the new imaging biomarkers
R. Maroldi; Brescia/IT in degenerative MSK disease?
Learning Objectives:
1. To discuss exclusion criteria for CBCT scanning.
2. To learn about pitfalls in CBCT imaging. 16:00–17:30 Room F1
Saturday
17:15 State of the Art Symposium
A-646 Panel discussion: Cone-beam vs multi-detector CT:
pros and cons SA 16 Controversies in comprehensive
A. Trojanowska; Lublin/PL
imaging of coronary artery disease
16:00
16:00–17:30 Room E2 A-651 Chairman’s introduction: what is the evidence?
M. Dewey; Berlin/DE
Special Focus Session Session Objectives:
1. To appreciate the different modalities used for coronary
SF 16 Imaging biomarkers in degenerative disease imaging.
joint disease 2. To understand the open research questions for coronary
disease imaging.
16:00 3. To learn what coronary disease imaging could look like in the future.
A-647 Chairman’s introduction 16:05
S. Trattnig; Vienna/AT
Session Objectives:
A-652 Computed tomography is all you need
H. Alkadhi; Zurich/CH
1. To provide an overview of possible quantitative imaging biomarkers
in the musculoskeletal system. Learning Objectives:
2. To discuss the requirements of imaging biomarkers in degenerative 1. To understand the high diagnostic accuracy of coronary CT
diseases of the musculoskeletal system. angiography.
3. To present the clinical impact of imaging biomarkers in degenerative 2. To learn about the great clinical potential of CT to rule out significant
diseases of the musculoskeletal system. coronary stenosis.
3. To appreciate in which patients CT may become the single test
needed for coronary disease imaging.
16:30
A-664 B. How to report MRI in patients with epilepsy
D. Zlatareva; Sofia/BG
Learning Objectives:
1. To understand if it is possible to use a structured report
in those patients.
2. To explain the medico-legal value of your report.
3. To demonstrate the importance of the report at follow-up.
17:00
A-665 C. MRI, electroclinical and neuropathological correlations
N. Colombo; Milan/IT
Learning Objectives:
1. To understand the importance of a multimodality approach in
patients with epilepsy.
2. To show the importance of high field MR in those patients.
3. To show MR and neuropathological correlation.
16:00–17:30 Room K
E³ - ECR Academies:
Hybrid Imaging (advanced)
E³ 1618 Advanced hybrid imaging in oncology
Moderator: K. Ahlström Riklund; Umea/SE
16:00
A-666 A. In female pelvis
P.R. Ros; Cleveland, OH/US
Learning Objectives:
1. To learn about indications for PET/CT and PET/MR in female pelvis.
2. To become familiar with evaluation.
3. To understand where MR/PET may be advantageous over PET/CT.
16:30
A-667 B. In head neck cancer
M. Becker; Geneva/CH
Learning Objectives:
1. To learn about indications for PET/CT and PET/MR
in head-neck cancer.
2. To become familiar with evaluation of head-neck imaging data.
3. To understand where PET/MR may be beneficial over other imaging
of head-neck cancer.
17:00
A-668 C. Modern planning of radiation treatment
Saturday
U. Nestle; Freiburg/DE
Learning Objectives:
1. To learn about dose painting in radiation treatment.
2. To understand the role of hybrid imaging in radiation
treatment planning.
3. To understand potential strength of hybrid imaging
in radiation treatment.
Learning Objectives:
1. To understand the different functional imaging techniques
that can be used to monitor response to therapy including perfusion,
diffusion MRI and PET/CT.
2. To learn about efficient algorithms for assessing therapeutic response
of liver metastases that influence prognosis.
3. To understand how functional biomarkers are incorporated
into multicentric trials.
Panel discussion:
09:44 The “vanishing” lesions: what should you do?
09:00 09:29
A-696 B. MRI features and their differential diagnosis A-702 Early detection for cardiothoracic disease in smokers
S.J. Ostlere; Oxford/UK M. Rémy-Jardin; Lille/FR
Learning Objectives: Learning Objectives:
1. To learn more about the appearance of gout using MRI. 1. To become familiar with the broad spectrum of smoking-related
2. To become familiar with differential diagnosis in acute settings. diseases in the chest.
2. To learn about comprehensive imaging protocols for diagnoses
09:30 of all smoking-related diseases of lung, heart and vessels.
A-697 C. Ultrasound and DECT features in gout 3. To appreciate the necessity of software tools for computer-assisted
A. Klauser; Innsbruck/AT detection and quantitation: opportunities and limitations.
Learning Objectives:
1. To review the appearance of gouty changes in DECT. Panel discussion:
2. To understand strengths and weakness of US. 09:47 Comprehensive imaging and education
in cardiothoracic diseases
08:30–10:00 Room E2
08:30–10:00 Room F1
New Horizons Session
Special Focus Session
NH 17 Comprehensive personalised imaging
of cardiothoracic diseases SF 17b Congenital heart disease:
from infancy to adulthood
08:30
A-698 Chairman’s introduction: how to prepare for the future? 08:30
T. Benedek; Targu-Mures/RO A-703 Chairman’s introduction
Session Objectives: M. Haliloglu; Ankara/TR
1. To understand the unique potential of radiologists Session Objectives:
to comprehensively assess cardiothoracic diseases. 1. To recognise the role of multimodality imaging
2. To learn about the diversity of etiologies that can be addressed in congenital heart disease.
by radiology. 2. To become familiar with the common features
3. To appreciate the comprehensive approach needed for having clinical of congenital heart disease.
utility by imaging cardiothoracic diseases. 3. To understand how to evaluate postoperative patients
with congenital heart disease.
08:35
A-699 Patients with acute and chronic chest pain 08:35
C. Loewe; Vienna/AT A-704 Cardiac CT: challenges in congenital heart diseases
Learning Objectives: M. Kantarci; Erzurum/TR
1. To understand the clinical utility of CT and MRI in acute chest pain. Learning Objectives:
2. To understand the clinical utility of CT and MRI in chronic 1. To become familiar with new cardiac CT techniques.
chest pain. 2. To understand benefits and limitations of the cardiac CT applications.
3. To appreciate comprehensive assessment of anatomy and 3. To understand cardiac CT characteristics.
function feasible in chest pain patients.
09:00
08:53 A-705 Segmental approach to MR imaging
A-700 Patients with acute shortness of breath of congenital heart disease
J. Bremerich; Basle/CH A.M. Taylor; London/UK
Learning Objectives: Learning Objectives:
1. To understand the high diagnostic accuracy of CT and MRI 1. To learn about MR techniques.
for assessing acute pulmonary embolism. 2. To become familiar with the benefits and limitations of MR imaging.
2. To learn about comprehensive approaches for assessing acute 3. To understand MR imaging features.
lung injury.
3. To appreciate the strengths of comprehensive cardiothoracic imaging 09:25
for diagnosis of the most common diseases leading to acute shortness A-706 Imaging of congenital heart disease in adults
of breath. S. Leschka; St. Gallen/CH
09:11 Learning Objectives:
1. To become familiar with imaging features of adult patients.
A-701 Patients with chronic shortness of breath 2. To understand imaging characteristics of postoperative patients.
E.J.R. van Beek; Edinburgh/UK
3. To learn about management in terms of diagnostic approaches
Learning Objectives:
Sunday
10:35 11:02
A-728 Liver hydatid cysts: percutaneous treatment A-735 B. Neurovascular disorders and trauma of the brain
O. Akhan; Ankara/TR M. Forsting; Essen/DE
Learning Objectives: Learning Objectives:
1. To learn about the epidemiology and some structural characteristics 1. To describe the normal anatomy and normal variants
of the disease. of the craniocervical arterial and venous system and its relevance
2. To appreciate the importance of imaging, classifications and to interventional neuroradiology.
stage-specific approach. 2. To understand the causes and imaging features of stroke,
3. To become familiar with the indications and techniques haemorrhage and other common vascular lesions of the brain.
for the percutaneous treatment. 3. To differentiate the imaging features of traumatic injury
4. To learn about the results of percutaneous treatment in comparison to the brain and spine.
with surgical results.
5. To understand complications of percutaneous treatment and 11:31
their management. A-736 C. Tumours of the brain and spine
M.M. Thurnher; Vienna/AT
10:55 Learning Objectives:
A-729 Interlude I: Music show 1. To describe the normal anatomy and normal variants of the spine,
I. Barutçu, M. Burçin Derçin; Trabzon/TR spinal cord and nerve roots.
2. To understand imaging features of benign and malignant tumours
11:00 of the neurocranium.
A-730 fMRI of the brain: beyond expectations? 3. To differentiate imaging features of benign and malignant tumours
C. Calli; Izmir/TR of the spine.
Learning Objectives:
1. To give an introduction to the fMRI techniques.
2. To discuss the limitations and advantages of fMRI. 10:30–12:00 Room L 1
3. To give some interesting examples of fMRI studies.
4. To discuss the future projects of fMRI. ESR Patient Advisory Group (PAG)
11:20
A-731 Interlude II: Music show
ESR-PAG 2 Communicating the results of
I. Barutçu, M. Burçin Derçin; Trabzon/TR radiological studies to patients:
from high-tech to human
11:25 touch imaging
A-732 Advanced hepatopancreaticobiliary imaging
S.M. Ertürk; Istanbul/TR 10:30
Learning Objectives: A-737 Chairmen’s introduction
1. To understand novel imaging approaches that are used N. Bedlington1, B. Brkljacic2; 1Vienna/AT, 2Zagreb/HR
in the diagnostic work-up of pathologies of the liver, pancreas Session Objectives:
and biliary system. 1. To understand the importance of patient-doctor communication.
2. To understand state-of-the-art imaging algorithms regarding 2. To learn how the patient wants to be informed by the radiologist
the pathologies of liver, pancreas, and biliary system. about the relevant findings.
3. To learn pearls and pitfalls regarding the imaging 3. To learn strategies on how to facilitate communication between
of the hepatopancreaticobiliary system. patients and radiologists.
11:45 Panel Discussion 10:40
A-738 Who is the patient of the radiologist?
L.E. Derchi; Genoa/IT
10:30–12:00 Room N
Learning Objectives:
E³ - European Diploma Prep Sessions 1. To comprehend existing good practice regarding patient-doctor
communication models in radiology.
2. To understand the importance of informed consent.
E³ 1823 Neuro 3. To become familiar with techniques/methods to deliver news
to a patient.
10:30
A-733 Chairman’s introduction 11:00
B. Ertl-Wagner; Munich/DE A-739 Communicating results of radiological studies
Session Objectives: to the patient with breast cancer:
1. To describe relevant imaging and interventional algorithms and view of the patient who is also a physician
important imaging features of neurovascular disorders of the brain A. Balenovic; Zagreb/HR
and spine.
Learning Objectives:
2. To understand imaging features and prognostic implications
1. To present a personal experience regarding communication
of tumours of the brain and spine.
by a radiologist at the time diagnosis was established and during
10:33 follow-up examinations.
2. To present the need for radiological presentation of mammographic
A-734 A. Congenital and white matter disorders of the brain findings, communication during ultrasound examinations, core
A. Rossi; Genoa/IT
biopsy of the breast, and breast MRI from the patient’s point of view.
Learning Objectives: 3. To present the need for psychological support for women treated for
1. To describe the development, normal anatomy and normal variants breast cancer and to discuss the position of the radiologist from the
of the brain. point of view of the chair of the patient group dedicated to providing
2. To differentiate common congenital disorders of the brain and psychological support to women with breast cancer.
neurocutaneous syndromes.
3. To understand imaging features and differential diagnoses
of white matter disease, inflammation and neurodegeneration.
241
Scientific Sessions
10:30
B-0002 Hepatic lipid assessment: 10:30–12:00 Room C
Multi echo Dixon technique versus MR spectroscopy
at 3T scanner
Breast
1 1 1 2 3
M. Abd Ellah , B. Henninger , C. Kremser , S. Kannengießer , X. Zhong ,
W.R. Jaschke1; 1Innsbruck / AT, 2Erlangen / DE, 3Malvern, PA / US SS 202a Imaging for neoadjuvant chemotherapy
Moderators: P. Martínez-Miravete; Zaragoza/ES, F. Thibault; Paris/FR
10:38
B-0001 Diagnostic accuracy of a three-step magnetic 10:30
resonance imaging approach for the assessment B-0012 Predictability of complete response through apparent
of hepatic steatosis in a healthy general population diffusion coefficient measured before neoadjuvant
H. Hetterich1, C. Bayerl1, A. Peters2, C. Meisinger2, H. Kramer1, B. Ertl-Wagner1, chemotherapy in breast cancer depends on tumour
M.F. Reiser1, F. Bamberg1; 1Munich / DE, 2Neuherberg / DE
phenotype
E. Bufi, P. Belli, M. Costantini, A. Cipriani, A. Bonatesta, G. Franceschini,
10:46 D. Terribile, L. Bonomo; Rome / IT
B-0003 Does hepatic steatosis influence the detection rate
of metastases in hepatobiliary phase of Gd-EOB-DTPA 10:38
enhanced MRI with conventional 3D-T1-weighted B-0013 Shrinkage patterns of tumour regression aer
fat-saturated sequences? neoadjuvant chemotherapy on magnetic resonance
J.H. Rothe, T. Denecke, T. Weissmann, C. Grieser, B. Hamm, W. Brenner, imaging: correlation with tumour biological subtypes
I.G. Steffen; Berlin / DE
and pathological response aer therapy
S. Gigli, L. Ballesio, F. Di Pastena, C. Petriglia, C. Catalano; Rome / IT
10:54
B-0004 Gd-EOB-DTPA-enhanced liver MRI for prediction of 10:46
liver growth aer portal vein occlusion B-0014 What happens to the DCIS in HER 2 positive cancers
B.K. Barth, M.A. Fischer, C.S. Reiner; Zurich / CH
treated with NACT and trastuzumab?
R. Millican-Slater, K. Horgan, M. McMahon, D. Dodwell, B. Dall, N. Sharma;
11:02 Leeds / UK
B-0005 T1 segmental hyperintensity in liver cholestasis
on MRI: in vitro explanation 10:54
I.L. Gubskiy, O.N. Sergeeva, V. Panov, I.E. Tyurin, B. Dolgushin; Moscow / RU B-0015 Breast MRI in the evaluation of patients undergoing
neoadjuvant chemotherapy: assessment of tumour
11:10
features and predictive markers of response according
B-0006 Quantitative analysis of diffusion-weighted MRI
to histopathology
at 3T: which parameter is more useful in differential E. Schiani, C. Losio, F. Ballati, M. Panzeri, G. Cristel, M. Rodighiero, F. De Cobelli,
diagnosis of focal solid liver lesions? A. Del Maschio; Milan / IT
K.K. Lomovtseva , N.A. Karelskaya , G.G. Karmazanovsky ; Vidnoe / RU,
1 2 2 1
2
Moscow / RU 11:02
B-0016 Before the tumour shrinks: apparent diffusion
11:18
coefficient in early assessment of breast cancer
B-0007 Image quality of the hepatic arterial phase
response to neoadjuvant chemotherapy
in gadoxetic acid-enhanced liver MRI: M. Nadrljanski, R. Maksimovic, V. Plesinac-Karapandzic, M. Nikitovic,
analysis of respiratory pattern and image quality Z. Milosevic; Belgrade / RS
Y. Park, C. Lee, J. Lee, J. Choi, K. Kim, C. Park; Seoul / KR
11:10
11:26 B-0017 Apparent diffusion coefficient and fractional
B-0008 Performance of magnetic resonance elastography anisotropy values as biomarkers for treatment
for the staging of liver fibrosis: in terms of comparison response in breast cancer
between patients with chronic hepatitis B and those E.A. Joyce, A.J. Fagan, J.P. McMorrow, D. Byrne, M.J. Kennedy, J.F. Meaney,
with other etiologies S.A. O’Keeffe; Dublin / IE
W. Chang, J. Lee, J. Han, B. Choi; Seoul / KR
11:18
11:34 B-0018 A new parameter to assess response to neoadjuvant
B-0009 Characterisation and evaluation of longitudinal extent chemotherapy by quantitative vascular mapping in
of perihilar biliary strictures: does diffusion-weighted patients with locally advanced breast cancer
MRI provide additional value? C. Rebellato, G. Gennaro, L. Evangelista, E. Bezzon, I. Polico, L. Pescarini;
K. Choi, J. Lee, I. Joo, J. Han, B. Choi; Seoul / KR Padova / IT
11:42 11:26
B-0010 MR evaluation of biliary-enteric anastomoses B-0019 MRI parameters as imaging biomarker for prediction
with Gd-EOB-DTPA-enhanced MR cholangiography: of response in patients with breast cancer receiving
comparison with conventional T2-weighted MR neoadjuvant therapy
S. Viganò1, A.J. Patterson2, M.A. McLean2, H. Earl2, R. Bedair2, W.G. Matthew2,
cholangiography M.J. Graves2, E. Provenzano2, F.J. Gilbert2; 1Milan / IT, 2Cambridge / UK
P. Boraschi, F. Donati, F. Pacciardi, G. Gherarducci, R. Gigoni, F. Falaschi,
C. Bartolozzi; Pisa / IT
11:34 11:18
B-0020 Factors influencing the accuracy of magnetic B-0029 Simultaneous PET/MRI for primary staging of patients
resonance imaging in the assessment of disease with cervical cancer: preliminary results
response following neoadjuvant chemotherapy in J. Grueneisen1, B.M. Schaarschmidt2, M. Heubner1, V. Ruhlmann1,
T.C. Lauenstein1, M. Forsting1, L. Umutlu1; 1Essen / DE, 2Düsseldorf / DE
early and locally advanced breast cancer
J. Murphy, K. James, P. Nicholson, L. Duddy, N. Marshall, M.F. Ryan, J. Barry; 11:26
Cork / IE
B-0030 Translational imaging in diagnostic workup
11:42 of neurodegenerative parkinsonian syndrome
B-0021 The value of multi-parameter strategy of ultrasound C. Paschetta, F. Buttari, D. Gned, M. Iudicello, A. Skanjeti, A. Veltri, V. Podio;
Orbassano / IT
in the assessment of neoadjuvant chemotherapy for
breast cancer 11:34
Y. Jin, L.Y. Peng, Y.B. Ma; Chengdu / CN
B-0031 Implementation of a fast-protocol for simultaneous
Wednesday
11:50 PET/MR imaging for whole-body staging of female
B-0022 Evaluation with digital breast tomosynthesis of the patients with recurrent pelvic malignancies:
pathological response to neoadjuvant chemotherapy a comparison to the PET/CT
J. Grueneisen1, B.M. Schaarschmidt2, M. Heubner1, S. Kinner1, V. Ruhlmann1,
in locally advanced breast cancer T.C. Lauenstein1, M. Forsting1, L. Umutlu1; 1Essen / DE, 2Düsseldorf / DE
G. Mariscotti, M. Durando, E. Sardo, E. Regini, P. Campanino, G. Donato,
C. Bogetti, P. Fonio, G. Gandini; Turin / IT 11:42
B-0032 Blood oxygen level-dependent magnetic resonance
10:30–12:00 Room Z imaging (BOLD-MRI) evaluating human visceral
adipose tissue (AT) oxygenation induced by salt
Molecular Imaging loading/depletion: feasibility study
L. Zheng1, Z. Zhang2; 1Shanghai / CN, 2Chicago, IL / US
SS 206 Clinical molecular imaging 11:50
Moderators: M. Eisenblaetter; Münster/DE, F.A. Gallagher; Cambridge/UK
B-0033 The hybrid tracer ICG-99mTc-nanocolloid for combined
10:30 radio- and fluorescence-guidance to the sentinel node
B-0023 SECURE study: observational post-marketing study in the groin
N.S. van den Berg1, G.H. KleinJan1, O.R. Brouwer2, S. Horenblas2, R.A. Valdés
on the safety profile of gadoterate meglumine: Olmos2, H.G. van der Poel2, F.W.B. van Leeuwen1; 1Leiden / NL, 2Amsterdam / NL
final results in 35,499 patients
R. Souillard-Scemama, C. Mellerio, C. Oppenheim, J.-F. Meder, P. Soyer;
Paris / FR
10:30–12:00 Room M
10:38
B-0024 68Ga-labelled PSMA- versus 11C-Choline PET/CT GI Tract
in the detection of recurrent prostate cancer
H. Rempp, J. Schwenck, G. Reischl, K. Nikolaou, C. La Fougère, C. Pfannenberg; SS 201b Improving abdominopelvic imaging:
Tübingen / DE technical aspects
Moderators: D. Breen; Southampton/UK, R. Malago; Verona/IT
10:46
B-0025 Navigation in an intraoperatively acquired freehand 10:30
SPECT scan has the potential to improve lesion B-0034 Does abdominal ultrasound show equivalence to
identification computed tomography and magnetic resonance
N.S. van den Berg1, T. Engelen1, G.H. KleinJan1, R.A. Valdés Olmos2, W.M.C. Klop2,
F.W.B. van Leeuwen1; 1Leiden / NL, 2Amsterdam / NL enterography in predicting disease severity and
complications?
10:54 A. Wadhwani, S. Batool, K. Novak, S. Wilson; Calgary, AB / CA
B-0026 Diagnosing relapse in brain tumours utilising 10:38
integrated [11C]-methionin PET/MRI B-0035 Reduction of contrast and radiation dose in
1 1 1 1 1 2
L. Umutlu , T. Pöppel , K. Wrede , O. Müller , C. Pöttgen , P. Heusch ,
T.C. Lauenstein1, M. Forsting1, M. Schlamann1; 1Essen / DE, 2Düsseldorf / DE multidetector computed tomography (MDCT)
using individualised tailored protocols
11:02 A. Vanzulli1, L. Romano2, N. Flor1, A. Carriero3, T. Albrecht4, M. Prokop5;
B-0027 Role of 11C-methionine PET as a prognostic factor
1
Milan / IT, 2Naples / IT, 3Novara / IT, 4Berlin / DE, 5Nijmegen / NL
in patients with primary brain gliomas eligible 10:46
for surgery B-0036 Low-dose fluoroscopic examinations of the upper
E. Lopci, L. Bello, L. Olivari, M. Riva, M. Simonelli, F. Raneri, A. Chiti; Rozzano / IT
gastrointestinal tract: assessment of image quality
11:10 and radiation levels
B-0028 Impact of attenuation correction on quantification J. Weiß1, A. Pomschar2, K. Neumaier2, W. Flatz2, B. Ertl-Wagner2, M. Li2,
M. Notohamiprodjo2; 1Tübingen / DE, 2Munich / DE
of tracer uptake in a fully integrated PET/MR system:
comparison between MR- and CT-based attenuation 10:54
correction B-0037 Clinical impact of double reading of abdominal
F. Seith, S. Gatidis, H. Schmidt, I. Bezrukov, C. La Fougère, K. Nikolaou,
C. Pfannenberg, N. Schwenzer; Tübingen / DE CT scans of surgical patients
P.M. Lauritzen1, J. Andersen2, M. Stokke3, A. Tennstrand4, T. Heggelund1,
R. Aamodt1, P. Hurlen1, G. Sandbæk2, P. Gulbrandsen5; 1Lørenskog / NO,
2
Oslo / NO, 3Drammen / NO, 4Bærum / NO, 5Nordbyhagen / NO
11:02 11:02
B-0038 Diagnostic efficacy of a low-radiation B-0049 Myocardial extracellular volume fraction quantified
high-contrast dose protocol in single-pass abdominal by cardiovascular magnetic resonance compared with
multi-detector CT (MDCT): a prospective comparison histological and organic blood markers
with a standard protocol J. Izaaryene, A. Jacquier; Marseille / FR
L. Camera, I. Liccardo, F. Romano, S. De Fronzo, A. Rispo, R. Liuzzi, M. Imbriaco,
F. Castiglione, M. Salvatore; Naples / IT 11:10
B-0050 Automatic soware for extracellular volume (ECV)
11:10 fraction map generation of the myocardium
B-0039 Comparison of water and mannitol as negative N. Galea, L. Altabella, C. Borrazzo, E. Di Castro, M. Francone, C. Catalano,
contrast agents in abdominal staging CT I. Carbone; Rome / IT
T. Kaireit, C. Lutat, M.J. Peperhove, F. Wacker, K.I. Ringe; Hannover / DE
11:18
11:18 B-0051 Accuracy and reproducibility of native myocardial
B-0041 Comparison between two different techniques for T1 mapping using 9, 10, and 11 heartbeat MOLLI
dynamic magnetic resonance imaging of the pelvic acquisition schemes
floor, one with gel rectal filling and the other with air S. Mangold1, A. Varga-Szemes1, C.N. De Cecco1, G. Muscogiuri1, P.M. Cannaò1,
J.L. Wichmann1, P. Suranyi1, W.G. Rehwald2, U.J. Schoepf1; 1Charleston, SC / US,
balloon rectal distention in the evaluation of pelvic 2
Durham, NC / US
floor disorders
N. Al Ansari, F. Maccioni, V. Buonocore, F. Mazzamurro, C. Catalano; Rome / IT 11:26
B-0052 Le ventricular myocardial remodeling in pulmonary
11:26
hypertension: a non-contrast magnetic resonance T1
B-0042 Radiation dose of 3rd generation CT colonography
D. Skripkin; Omsk / RU mapping study
U. Reiter1, G. Reiter1, G. Kovacs1, G. Adelsmayr1, A. Greiser2, H. Olschewski1,
M.H. Fuchsjäger1; 1Graz / AT, 2Erlangen / DE
11:34
B-0043 Pelvic static MR vs MR-defecography in the study of 11:34
woman’s pelvic floor disorders B-0053 Native T1-mapping for visualisation of septal le
A. Ambrosi, G. De Franco, F. Lorusso, M. Cascarano, A. Scardapane, G. Angelelli;
Bari / IT ventricular fibrosis in chronic thromboembolic
pulmonary hypertension (CTEPH)
11:42 F.C. Roller, C. Schneider, G.A. Krombach; Giessen / DE
B-0044 Semi-automatic computed tomography volumetry 11:42
of esophageal cancer: a reproducible method for B-0054 Early non-invasive detection of microvascular
assessment of primary tumour size insensitive to disfunction and myocardial damage in systemic
radiologist experience
Y.-H. Zhang, M. Fisher, A. Tomson, H. Lehmann, G. Herlin, I. Rouvelas, L. Lundell, sclerosis (SSc): a cardiovascular magnetic resonance
T.B. Brismar; Stockholm / SE N. Galea, G. Barchetti, A. Fiorelli, M. Francone, E. Rosato, C. Catalano, I. Carbone;
Rome / IT
11:50
10:30–12:00 Room N B-0055 Quantification and optimisation of computed
Cardiac tomography myocardial late enhancement imaging
with correlation to magnetic resonance imaging
M.C. Williams, N. Weir, C. Gray, T. MacGillivray, E.J.R. van Beek, D.E. Newby,
SS 203a Tissue characterisation S. Mirsadraee; Edinburgh / UK
Moderators: N. Kawel-Böhm; Chur/CH, B.K. Velthuis; Utrecht/NL
10:55 10:46
B-0058 Type III endoleak aer endovascular aortic repair: B-0068 Symptomatic Osteoartrhitis (OA) of the knee:
incidence, etiology and management treatment with platelet rich plasma in comparison
L. Poorteman1, B. Saint-Lèbes2, S. Heye1, S. Houthoofd1, H. Rousseau2, with hialuronic acid group control
G. Maleux1; 1Leuven / BE, 2Toulouse / FR A. La Marra, F. Arrigoni, S. Mariani, L.M. Gregori, A. Mancini, L. Zugaro, A. Barile,
C. Masciocchi; L’Aquila / IT
11:03
B-0059 Post-EVAR split-bolus CT-angiography using 10:54
dual-energy CT: all you need in a single scan! B-0069 Targeted ultrasound-guided hydrodilatation via the
R. Iezzi, M. Nestola, G. Coppola, A. Contegiacomo, F. Snider, L. Bonomo; rotator interval for adhesive capsulitis
Rome / IT D. McKean1, P. Yoong2, S.W. Duffy3, N.P. Hujairi4, R. Mansour1, J. Teh1;
1
Oxford / UK, 2Reading / UK, 3Norwich / UK, 4London / UK
11:11
B-0060 Dual-energy computed tomography (DECT): 11:02
Wednesday
hard plaque imaging for endoleak detection B-0070 Morphometric analysis of radiation dose and
R. Müller-Wille, T. Borgmann, C. Stroszczynski, C. Dornia; Regensburg / DE procedure time during percutaneous radiofrequency
11:19 ablation of osteoid osteomas
P. Magyar, P.N. Kaposi, D. Kozics, B. Kovács, J. Kiss, I. Kalina, K. Karlinger,
B-0061 Long-term results aer EVAR: aorto-monoiliac M. Szendrői, V. Bérczi; Budapest / HU
configuration increases the risk of complications and
aneurysm-related death 11:10
A.M. Morales Vargas, G. Garzón Moll, M. Martí de Gracia; Madrid / ES B-0072 Four years of clinical and MRI follow-up aer
intratendinous US-guided platelet rich plasma (PRP)
11:27 injection in patients with degenerative tendinopathy
B-0062 Accuracy of MDCT angiography of the anterior of rotator cuff tendons of the shoulder
abdominal wall in the planning of the mammary F. Arrigoni, A. La Marra, S. Mariani, L.M. Gregori, L. Zugaro, A. Barile,
reconstruction with DIEP-flap in mastectomised C. Masciocchi; L’Aquila / IT
patients 11:18
F. Carbonetti, A. Cremona, P. Aloisio, N. Maltzeff, G. Argento, C. Capotondi,
V. David; Rome / IT B-0073 Comparison of ultrasound guided collagenase
clostridium histolyticum injections and blinded
11:35 injections in treatment of Dupuytren’s contracture
B-0063 Intra-arterial ultra low-iodine volume CT of renal V. Higueras, E. Llopis, L. Aguillella, R. Perez, E. Belloch; Alzira-Valencia / ES
transplant arteries
C.E. Althoff, R.W. Günther, B. Hamm, M. Rief; Berlin / DE 11:26
B-0074 Prognostic factors in needle aspiration of calcific
11:43 deposits (NACD) for calcific tendinitis of the rotator
B-0064 Effect of TIPS on splanchnic arterial and portal venous cuff
blood flow in 4D flow MRI measurement at 3Tesla B.W. Oudelaar1, S.B.A. van der Valk2, A.J.H. Vochteloo1, R. Huis in t Veld1,
Z. Stankovic1, M. Roessle2, W. Euringer2, M. Schultheiss2, R. Salem1, A. Barker1, E.M. Ooms1, R. Schepers-Bok2; 1Hengelo / NL, 2Almelo / NL
M. Langer2, M. Markl1, J. Collins1; 1Chicago, IL / US, 2Freiburg / DE
11:34
11:51 B-0075 Can PRP US-guided injection accelerate healing and be
B-0065 Evaluation of cranial DAVF: alternative to surgery for patients with Achilles and
use of 4D CTA before and aer embolisation patellar tendinopathy?
B. Tian, J. Lu, B. Xu, M. Wang, Q. Liu; Shanghai / CN A. La Marra, S. Mariani, F. Arrigoni, L.M. Gregori, L. Zugaro, A. Barile,
C. Masciocchi; L’Aquila / IT
10:38
B-0067 Ultrasound / MRI fusion imaging guided lumbar nerve
root blocks; preliminary experience
D.J. Wilson, G.M. Allen; Oxford / UK
10:39
SS 216 Thoracic oncology
Moderators: I.E. Tyurin; Moscow/RU, A. Vilaplana; Seville/ES
B-0077 Improved Alzheimer’s disease diagnostic
performance using structural MRI: 10:30
validation of the MRI combination biomarker B-0087 CT perfusion of lung tumour: do morphological and
that won the CADDementia challenge functional heterogeneity correlate?
L. Sørensen1, M. Lillholm1, A. Pai1, I. Balas1, C. Anker2, C. Igel1, M. Nielsen1; D. Barone1, A. Bevilacqua2, S. Baiocco2, G. Gavelli1; 1Meldola / IT, 2Bologna / IT
1
Copenhagen / DK, 2Kgs. Lyngby / DK
10:38
10:47 B-0088 Virtual monoenergetic dual-energy CT:
B-0078 MRI-based automated hippocampal volumetry as a optimisation of keV-settings in lung cancer
screening tool for Alzheimer’s disease in subjects with M. Kaup, J.-E. Scholtz, A. Engler, R.W. Bauer, M. Kerl, T.J. Vogl, J.L. Wichmann;
memory complaints supplemented by FDG-PET/CT Frankfurt a. Main / DE
I. Sacarea1, P. Suppa2, L. Spies3, M. Pixberg1, J. Müller-Hübenthal1; 1Cologne / DE,
2
Berlin / DE, 3Hamburg / DE 10:46
B-0089 Potential influence of automated volumetry on
10:55 treatment response classifications in lung cancer
B-0079 Association of MR features, clinical presentation lesions
and levels of glutathione and glutatione peroxidase K. Akbari; Linz / AT
in erythrocytes of patients with clinically isolated
syndrome and relapsing remiting multiple sclerosis 10:54
D. Stojanov, S. Ljubisavljevic, I. Stojanovic, S. Vojinovic; Nis / RS B-0090 Prognostic value of additional findings in CT scans
of patients with cancer-related pulmonary embolism:
11:03 data from 208 consecutive cases from
B-0080 Disrupted small-world networks in never treated the EPIPHANY study
schizophrenia patients with long illness duration D. Calvo-Temprano1, J. Plasencia2, P. Jiménez-Fonseca1, M. Solis1, M. Benegas3,
L. Yao1, W. Deng1, W. Liao2, F. Li1, Y. Xiao1, W. Zhang1, J. Sweeney3, Q. Gong1, M. Sanchez3, S. Hernandez4, D. Martinez de la Haza3, A. Carmona-Bayonas2;
S. Lui1; 1Chengdu / CN, 2Hangzhou / CN, 3Dallas, TX / US 1
Oviedo / ES, 2Murcia / ES, 3Barcelona / ES, 4Madrid / ES
11:11 11:02
B-0081 The different pattern of functional and structural B-0091 High diagnostic performance for MRI-based regional
changes depending on the rate of cognitive decline in lymph node staging in NSCLC:
Parkinson’s disease with mild cognitive impairment results from a meta-analysis
I. Kim1, J. Kwon2, N.-Y. Shin1; 1Seoul / KR, 2Gongju / KR J. Peerlings, E.G.C. Troost, P.J. Nelemans, A.L. Hoffmann, R.G.H. Beets-Tan;
Maastricht / NL
11:19
B-0082 Comparison of 3T and 7T susceptibility weighted 11:10
angiography of the substantia Nigra in diagnosing B-0092 Diagnostic accuracy of different MRI pulse sequences
Parkinson’s disease in non-small cell lung cancer in a dedicated, thoracic
M. Cosottini, D. Frosini, I. Pesaresi, G. Donatelli, P. Cecchi, M. Costagli, L. Biagi, 18F-FDG PET/MRI protocol
R. Ceravolo, M. Tosetti; Pisa / IT B.M. Schaarschmidt1, C. Buchbender1, C. Rubbert1, F. Hild2, V. Ruhlmann3,
V. Ruhlmann3, H.H. Quick3, G. Antoch1, P. Heusch1; 1Dusseldorf / DE, 2Hamm / DE,
11:27 3
Essen / DE
B-0083 Pattern of spontaneus neuronal activity within default
11:18
mode network in patients with Parkinson’s disease
E. Seliverstova, Y. Seliverstov, R. Konovalov, M. Krotenkova, S. Illarioshkin; B-0093 Multi-parametric PET-CT correlates with hypoxia,
Moscow / RU angiogenesis and ALK expression in non-small cell
lung cancer
11:35 D. Neriman, B. Ganeshan, A. Groves; London / UK
B-0084 Estimating the need for MRI conditionally safe deep
brain stimulation systems in Parkinson’s disease 11:26
patients: a European perspective B-0094 Correlation between CT features and KRAS mutation in
C. Gunnarsson1, G. Barnett2, S. Autiero Walleser3, J. Hinnenthal4, Y. Safriel5, patients with stage I lung adenocarcinoma and their
M. Ryan1; 1Cincinnati, OH / US, 2Dunganaghy / IE, 3Tolochenaz / CH, 4Minneapolis,
MN / US, 5Clearwater, FL / US prognostic value
H. Wang1, Y. Liu2, O. Grove2, Y. Balagurunathan2, J. Heine2, S. Eschrich2, Z. Ye1,
R. Gillies2; 1Tianjin / CN, 2Tampa, FL / US
11:43
B-0085 Susceptibility weighted imaging improves
the diagnostic accuracy of brain MRI in the work-up
of parkinsonism
F.J.A. Meijer, B.A.C.M. Fasen, A. van Rumund, B.R. Bloem, B. Goraj; Nijmegen / NL
11:34 11:26
B-0095 CT of the lung: distinct features of NSCLC harbouring B-0105 Attenuation values in virtual non-contrast
the EML4-ALK translocation dual-energy CT: effect of acquisition protocol,
U.G. Mueller-Lisse, A. Tufman, H.A. Zimmermann, C. Reiners, A. Borgmeier, phantom size and contrast agent concentration
F. Gamarra, S. Reu, M.F. Reiser, R.M. Huber; Munich / DE K. Matsubara, K. Sakuda, H. Kawashima, T. Takata, K. Ichikawa, K. Koshida,
T. Gabata; Kanazawa / JP
11:42
B-0096 Epidermal growth factor receptor mutation in lung 11:34
adenocarcinomas: comparing CT characteristics with B-0106 Model-based iterative reconstruction in CT thorax:
and without activating EGFR mutation first quantitative clinical results
J. Zhao, C. Heußel, J. Dinkel, H.-U. Kauczor, H.-P. Schlemmer, a. Warth, C.C. Brussaard1, B. Ilsen1, J. Milles2, W. Giepmans2, J. de Mey1; 1Brussels / BE,
P. Schnabel, T. Muley, M. Steins; Heidelberg / DE 2
Eindhoven / NL
11:50 11:42
Wednesday
B-0097 NSCLC with EGFR and KRAS positive genes mutations. B-0107 Advanced modelled iterative reconstruction for
Do CT findings help in differentiating these from other abdominal CT: qualitative and quantitative evaluation
forms of NSCLC? S. Gordic1, L. Desbiolles2, P. Stolzmann1, L. Gantner1, S. Leschka2, D.B. Husarik1,
A. Sabri, M. Batool, Z. Xu, D. Bethune, D. Manos; Halifax, NS / CA H. Alkadhi1; 1Zurich / CH, 2St. Gallen / CH
11:50
10:30–12:00 Room F2 B-0108 Adaptative statistical iterative reconstruction
and model based iterative reconstuction in liver
Physics in Radiology multiphase CT: quality image impact
E. Hérin1, M. Chiaradia1, F. Gardavaud1, L. Baranes1, P. Richard2, F. Legou1,
J.-F. Deux1, A. Rahmouni1, A. Luciani1; 1Créteil / FR, 2Buc / FR
SS 213 Advances in CT imaging
Moderators: J. Geleijns; Leiden/NL, A. Stratis; Leuven/BE
11:10 11:02
B-0115 The diagnostic performance of dedicated axillary B-0125 Interventional radiology service provision:
T2- and diffusion-weighted MRI for nodal staging can we treat safely peripheral vascular disease
in breast cancer in a day unit setting?
R. Schipper1, M. Lobbes1, R.G.H. Beets-Tan1, P. Nelemans1, B. de Vries1, A. Cannavale, S. Ilyas, N. Shaida, C. Cousins, M. Krokidis; Cambridge / UK
E. Heuts1, K. van de Vijver2, K. Keymeulen1, M. Smidt1; 1Maastricht / NL,
2
Amsterdam / NL 11:10
11:18 B-0126 Analysis of outcome aer PTA in patients with
B-0116 Potential role of Dixon sequences on predicting infrainguinal TASC A and TASC B arterial lesions
D. Ilic, T. Kokovic, V. Vucaj-Cirilovic, V. Till, S. Stojanovic; Novi Sad / RS
metastatic axillary lymph nodes in patients with
breast cancer: preliminary results 11:18
M. Marcon, V. Bertani, P. Clauser, A. Linda, C. Zuiani, M. Bazzocchi; Udine / IT B-0127 Recanalisation of femoro-popliteal chronic total
11:26 occlusions: no fancy devices, just a crossing catheter
A. Cannavale, M. Krokidis; Cambridge / UK
B-0117 Role of DWI assessing nodal involvement and
response to neoadjuvant chemotherapy in advanced 11:26
breast cancer B-0128 Peripherally inserted central venous catheter-related
C. Buccheri, E. Bufi, A. Bonatesta, R. Fubelli, M. Tumino, F. Padovano, infections in a large cohort of hospitalised adult
F. Patrolecco, P. Belli, L. Bonomo; Rome / IT
patients
C. Bouzad1, S. Duron2, A. Bousquet3, L. Valbousquet3, G. Weber-Donat1,
11:34 J. Baccialone1, J. Potet1; 1Clamart / FR, 2Marseille / FR, 3Saint-Mandé / FR
B-0118 The diagnostic performance of
gadofosveset-enhanced axillary MRI for nodal 11:34
(re-)staging in breast cancer patients: B-0129 Endovenous laser ablation of symptomatic varicose
can the initial promising results be reproduced? veins: experience of a tertiary health care center
R. Schipper, M. Smidt, L. van Roozendaal, P. Nelemans, B. Brans, K. Keymeulen, in India
J.E. Wildberger, R.G.H. Beets-Tan, M. Lobbes; Maastricht / NL P. Jagia, S. Sharma, G. Gulati; New Delhi / IN
11:42 11:42
B-0119 Correlation between enlarged axillary lymph nodes B-0130 A comparative study of RFA and EVLT in treatment
to breast silicone implants tears seen on MRI of symptomatic varicose veins patients
E. Klang, O. Helshtok, A. Rundstein, A. Shalmon, Y. Servadio, M. Gotlieb, K.B. Taori; Nagpur / IN
M. Sklair-Levy; Ramat Gan / IL
10:30–12:00 Room G
10:30–12:00 Room D2
11:11 11:02
B-0135 Differentiation of tuberculous peritonitis, and B-0145 Air gap in hip joint axiolateral projection
peritoneal carcinomatosis in normal-sized ovarian S.H. Kivistö, A. Henner, U. Kuismin, M. Jaakkola, A. Kotiaho; Oulu / FI
carcinoma in female patients on CT 11:10
S. Shim, J. Lee, Y. Jeong; Ulsan / KR
B-0146 Balancing image quality and effective radiation dose
11:19 in orbital X-ray screening for ferromagnetic IOFBs:
B-0136 Haemodynamic evaluation of normal ovaries and a pilot study
different ovarian tumours: 3.0T DCE-MRI study S.A. Jessop1, G. Hart1, A.R. Santiago2, J. Guerreiro2, Y. Cottier3, B. Markali4,
Q. Ji; Tianjin / CN E.N. Andersen4, J. Jorge3, A.E. England1; 1Manchester / UK, 2Lisbon / PT,
3
Lausanne / CH, 4Oslo / NO
11:27 11:18
B-0137 Value of DWI sequences in cervical cancer recurrence: B-0147 Orthopaedic surgery occupational exposure using
Wednesday
can we skip contrast?
R.N. Lucas, J. Lopes Dias, T. Cunha; Lisbon / PT active dosimeters
J. Francisco, N. Lopes, R. Ferreira, J. Santos, G. Paulo; Coimbra / PT
11:35 11:26
B-0138 Diffusion-weighted MRI of endometrial cavity B-0148 Pelvic radiography: patient orientation
pathologies: differentiation of benign and L. Khaledian, J. Ebadi; Tehran / IR
malign lesions and preoperative assessment
of myometrial invasion 11:34
M. Cavusoglu, D. Sözmen Cılız, A. Özsoy, S. Duran, E. Elverici, C. Atalay, B-0149 Does using a lower kVp offer a greater potential
B. Sakman; Ankara / TR
for fracture detection in hip radiography?
H. Milne, A.E. England; Manchester / UK
11:43
B-0139 Utility of MRI findings in differentiation of type I 11:42
and type II endometrial cancer: B-0150 The effect of patient shielding in intraoral
comparison of MRI and endometrial biopsy dental imaging
T. Manabe, H. Yoshida, M. Yoshida, T. Kato, M. Ishikawa, S. Ikeda, Y. Arai; T. Klemenčič, N. Mekiš; Ljubljana / SI
Tokyo / JP
11:50
11:51 B-0151 Musculotendinous structure changes evaluated
B-0140 Comparison of DWI and T2 TSE with gadolinium by ultrasound in elderly population submitted to
ehanced sequences for the staging of the uterine a physical activity programme
cervical cancer R. Santos, A. Amaral; Coimbra / PT
V. Vinci, S. Bernardo, M. Saldari, L. Manganaro; Rome / IT
10:30–12:00 Room MB 1
10:30–12:00 Room K
10:54 10:47
B-0155 Role of perfusion computed tomography B-0164 CT angiography findings of cardiovascular anomalies
in assessing submandibular gland in aortopulmonary window:
radiochemotherapy-induced injury a rare congenital heart disease
U. Lamot, K. Šurlan Popovič, M. Harej, T. Furlan, P. Popovič, P. Strojan; A. Bhatia, K.S. Sodhi, A.K. Saxena, M. Singhal, M.K. Rohit, N. Khandelwal;
Ljubljana / SI Chandigarh / IN
11:02 10:55
B-0156 Comparison of fine needle aspiration and core needle B-0165 Detection of pulmonary nodules in children with a free
biopsy under ultrasonography guidance for detecting breathing MRI technique compared to CT scans
malignancy and for the tissue-specific diagnosis of H.P. Schemuth, S. Sirin, B. Schweiger, J. Schelhorn, S. Kinner; Essen / DE
salivary gland tumours 11:03
H.-J. Eom, J. Lee, J. Baek, Y. Choi, M.-S. Ko, K. Cho, S. Nam, R. Yoon; Seoul / KR
B-0166 Coronary assessment in young children with
11:10 congenital heart disease:
B-0157 A study on serum antithyroglobulin antibodies comparing a novel spiral acquisition technique
interference in thyroglobulin measurement in to the standard sequential one in coronary CT
fine-needle aspirationin diagnosing lymph node angiography with dual-source CT
metastasis in postoperative patients A. Secinaro, T. Santangelo, C. Napolitano, B. Leonardi, M. Chinali, G. Rinelli,
J. Lee, J. Kwak, H. Shin, E.-K. Kim; Seoul / KR P. Tomà; Rome / IT
11:18 11:11
B-0158 ShearWave elastography in lymph nodes B-0167 Image quality criteria for paediatric CT thorax -
F. Houari, O. Lucidarme, J. Gabarre, F. Charlotte, C. Pellot-Barakat, M. Lefort, a useful tool?
L. Chami; Paris / FR L. Heiberg, S. Flatabo, A. Aarsnes, H. Olerud, C. de Lange; Oslo / NO
11:26 11:19
B-0159 ‘Illusion of blue’; role of ultrasound elastography in B-0168 Assessment of bronchiectasis in children with cystic
cervical lymph nodes fibrosis by comparing airway and artery dimensions
R. Arkar, V. Kasi Arunachalam, R. Renganathan, M. Cherian; Coimbatore / IN to normal controls on inspiratory and expiratory
11:34 spirometer guided chest computed tomography
W. Kuo1, M. de Bruijne1, K. Nasserinejad1, H. Ozturk1, Y. Chen2, A. Perez-Rovira1,
B-0160 Role of ultrasonographic elastography H.A.W.M. Tiddens1; 1Rotterdam / NL, 2Ningxia / CN
in differentiating benign and malignant
cervical lymph nodes 11:27
P.A.R.P. Sathiadoss, S. Narayanasamy, S. Wahab, E. Ullah, I. Ahmad; Aligarh / IN B-0169 Paediatric fluoroscopic imaging - comparison
of simulation results using an anthropomorphic
11:42 phantom representing a 1-year old child examined
B-0161 Elastography and histogram of Kikuchi disease: on an image-intensifier and a flat-panel detector
the comparison with reactive hyperplasia of cervical based system
lymph nodes M. Weidner1, A.A. Schegerer2, T. Diehm1, U. Lechel2, S.O. Schoenberg1, G. Brix2,
K. Lee, J. Ryu; Busan / KR K.W. Neff1; 1Mannheim / DE, 2Neuherberg / DE
11:50 11:35
B-0162 Real-time ultrasound elastographic features of B-0170 Dosimetric study of varicocele embolisation
primary open angle glaucoma in paediatric patients
Ö. Ünal, N. Cay, M. Gumus, F. Yulek; Ankara / TR A. Gioppo, F. Melchiorre, R. Azzeroni, C. Khouri Chalouhi, G. Cornalba; Milan / IT
11:43
10:30–12:00 Room MB 2 B-0171 CT dose monitoring and optimisation in paediatric CT
using radiation dose tracking Soware
Paediatric M. Twomey, F. Moloney, C. Bogue, M. Sheehy, O.J. O’ Connor, M.M. Maher;
Cork / IE
SS 212 Chest imaging and dosimetry 11:51
Moderators: L.-S. Ording Müller; Oslo/NO, C. Owens; London/UK
B-0172 Comparison of radiation dose between an image
10:30 intensifier system and a flat-panel detector system
K-04 Keynote lecture - evaluation of clinical imaging in a paediatric
C. Owens; London / UK population
M. Weidner, C. Hagelstein, T. Diehm, S.O. Schoenberg, K.W. Neff; Mannheim / DE
10:39
B-0163 Real-time ultrasound-guided pigtail catheter
placement in supine position for drainage of
symptomatic pleural effusions in paediatric patients
who underwent liver transplantation
M. D’Amico, R. Miraglia, L. Maruzzelli, G. Gallo, A. Luca; Palermo / IT
Wednesday
10:38
B-0174 Coronary CT angiography on 128-slice dual-source CT: 11:50
comparison of incidence and location of artefacts B-0183 Effect of a novel motion correction algorithm on the
in high-pitch spiral and prospectively ECG-gated image quality of low-dose coronary CTA
M. Komarova, V. Sinitsyn, E.A. Mershina; Moscow / RU
sequential acquisitions
F. Laffranchi, D. Farina, E. Gavazzi, A. Borghesi, M. Ravanelli, R. Maroldi;
Brescia / IT
10:30–12:00 Room MB 4
10:46
B-0175 Comparison of coronary CT angiography (CCTA) for Emergency Radiology
patients with high heart rates using a 512-slice
new-generation MDCT and a 128-slice CT: SS 217 Emergency imaging:
image quality and radiation dose how to be more precise
L. Macron, J.-L. Sablayrolles, J. Feignoux; Saint Denis / FR Moderators: K.H. Nieboer; Brussels/BE, G. Schueller; Opfikon/CH
10:54 10:30
B-0176 Coronary angiography by 320-row CT in patients with B-0184 Simple CBF grading based on MR perfusion to
atrial fibrillation: prospective intention-to-diagnose anticipate long-term clinical outcome in severe stroke
comparison with conventional coronary angiography patients due to the carotid artery occlusion
E. Zimmermann1, S. Feger1, M. Rief1, P. Schlattmann2, M. Laule1, M. Dewey1; T. Mori, T. Iwata, Y. Tanno, S. Kasakura, Y. Aoyagi, K. Yoshioka; Kamakura / JP
1
Berlin / DE, 2Jena / DE
10:38
11:02 B-0185 Prevalence of pulmonary embolism during pregnancy
B-0177 Influence of iodinated contrast agents on heart S. Schmidt, V. Dunet, R. Meuli, O. Hugli, V. Ilic; Lausanne / CH
rate variation during CT angiography of the
10:46
coronary arteries aer intravenous administration
of beta blocker B-0186 Intensive care patients with elevated laboratory
C. Loewe, L. Reider, A. Wielandner, V. Schoepf, S. Unterhumer, D. Beitzke, inflammatory parameters: indications to perform
F. Wolf; Vienna / AT a CT examination of the head, chest and abdomen
to search for the focus of infection
11:10 N.N.N. Naguib, B. Dana, N.-E.A. Nour-eldin, M. Albrecht, T. Gruber-rouh, V. Jacobi,
B-0178 Influence of atrial fibrillation on le atrial appendage T.J. Vogl; Frankfurt a. Main / DE
movement and sizing evaluated with cardiac
10:54
computed tomography angiography
F. Avogliero, A. Clemente, T. Liguori, A. Monteleone, D. Della Latta, D. Chiappino; B-0187 The emerging role of contrast-enhanced CT to assess
Massa / IT esophageal necrosis aer corrosive ingestion
D. Bouda, A.-M. Zagdanski, F. Sabatier, P. Bourrier, C. De Margerie, E. De
11:18 Kerviler, M. Chirica, P. Cattan; Paris / FR
B-0179 Cardiac CT vs cardiac MRI for characterisation
11:02
of le atrium anatomy before radiofrequency
catheter ablation of atrial fibrillation: B-0188 Patients with acute pancreatitis:
impact on radiation exposure and outcome is computed tomography always necessary?
M. Karul, M. Avanesov, T. Kraus, K. Bachmann, T. Derlin, G. Adam, J. Yamamura;
E. Bertella, D. Andreini, M. Petullà, E. Russo, E. Innocenti, A. Baggiano, Hamburg / DE
S. Mushtaq, V. Beltrama, G. Pontone; Milan / IT
11:26 11:10
B-0180 Point-by-point correlation between electroanatomic B-0189 The CT “capsular sign”:
mapping (EAM) and 3D-model from a specific finding of acute adrenal ischemia
M. Moschetta, M. Telegrafo, A. Pignatelli, A. Stabile Ianora, G. Angelelli; Bari / IT
multidectector-computed tomography (3D-CT-model)
in patients affected by ventricular tachycardia (VT) 11:18
C. Colantoni, A. Esposito, A. Palmisano, S. Antunes, F. De Cobelli, G. Maccabelli, B-0190 Acute appendicitis - CT or ultrasound in patients
P. Della Bella, G. Rizzo, A. Del Maschio; Milan / IT
with differing body mass indices:
a comparative assessment
M. Khanna, S. Abusamaan, S. Ramanathan, H. Hena, D. Panwar, B. Rao;
Doha / QA
11:26 11:18
B-0191 Is CT transrectal enema useful in staging acute B-0201 Comparison of image quality and radiation dose:
colonic diverticulitis? cerebral CT angiography (CTA) using 120 kVP vs 100
M. Gentiluomo, D. Artioli, G. Chirico, A. Mariani, L. Ponzini, O. Chiara, S. Sironi, kVP protocols in patients with clipped aneurysm
A. Vanzulli; Milan / IT H. Park, H. Choi, B.-M. Gil, J. Jang, S. Jung, K.-J. Ahn, B.-S. Kim; Seoul / KR
11:34 11:26
B-0192 Utilising contrast-enhanced CT for detecting B-0202 Final report of the Polish multicentre study
post-traumatic placental abruption: for evaluation of CT angiography in the diagnosis
assessing accuracy and comparison with ultrasound of brain death
P. Jha1, G. Melendres2, B. Bijan2; 1San Francisco, CA / US, 2Sacramento, CA / US M. Sawicki1, R. Bohatyrewicz1, A. Walecka1, J. Walecki2, O. Rowiński2,
J. Sołek-Pastuszka1, Z. Czajkowski1, P. Skrzywanek3, M. Guziński4; 1Szczecin / PL,
11:42 2
Warsaw / PL, 3Poznań / PL, 4Wrocław / PL
B-0193 High-pitch low-dose paranasal sinus CT
in drunken emergency room patients aer assault: 11:34
initial results on image quality and dose with B-0203 Postmortem interval estimation:
third-generation dual-source CT value of postmortem cerebral CT
C. Frellesen, P. Dewes, B. Schulz, J.-E. Scholtz, M. Kerl, T.J. Vogl, R. Bauer; D.H.J.L. Koopmanschap, A.R. Bayat, D. Bosboom, K. Kamphuis-Van Ulzen,
Frankfurt a. Main / DE W.M. Prokop, W.M. Klein; Nijmegen / NL
11:50 11:42
B-0194 Intravenous and oral contrast vs intravenous contrast B-0204 Evaluation of the degree of arteriovenous shunting
alone CT for the visualisation of appendix and in intracranial arteriovenous malformations using
diagnosis of appendicitis in adult ED patients pseudo-continuous arterial spin labeling MRI
A. Wadhwani, L. Guo, E. Saude, H. Els, E. Lang, A. MacRae, D. Bhayana; Calgary, L. Sunwoo, C.-H. Sohn; Seoul / KR
AB / CA
11:50
B-0205 Evaluation of contrast-enhanced MR angiography and
10:30–12:00 Room MB 5 time of flight MR angiography at 3 Tesla in previously
coiled intracranial aneurysms
Neuro N. Khandelwal, A. Mahajan, V. Gupta, A. Kumar, S. Mathuriya, S. Gupta;
Chandigarh / IN
SS 211b Vascular disorders, diagnosis and
treatment 14:00–15:30 Room A
Moderators: K.D. Kurz; Stavanger/NO, Z. Merhemic; Sarajevo/BA
10:30 Breast
B-0195 Feasibility and validity of monitoring subarachnoid SS 302a Breast density and imaging biomarkers
haemorrhage by a noninvasive MRI imaging perfusion Moderators: L.A. Carbonaro; San Donato Milanese/IT, C. Colin; Lyon/FR
technique: pulsed arterial spin labelling (PASL)
M. Labriffe, A. Ter Minassian, A. Pasco-Papon, S. N’Guyen, C. Aubé; Angers / FR 14:00
10:38 B-0206 Mammographic density is the main correlate
B-0196 Intra-arterial infusion of milrinone in the treatment of tumours detected on ultrasound but not on
of severe symptomatic cerebral vasospasm in patients mammography
P.A. Fasching, B. Brehm, L. Haeberle, S.M. Jud, A. Hartmann, M. Meier-Meitinger,
with aneurysmal subarachnoid haemorrhage: M. Uder, M.W. Beckmann, R. Schulz-Wendtland; Erlangen / DE
first experience
F. Thaher, N. Hopf, P. Kurucz, A.-K. Hickmann, M. Aguilar Pérez, W. Kurre, 14:08
O. Ganslandt, H. Henkes; Stuttgart / DE B-0207 A preliminary retrospective study to determine early
10:46 mammographic breast density reduction following
B-0197 Safety and efficacy of a new device for the treatment treatment
L. Metaxa1, L. Leong2, S. W Duffy1, T. Suaris1; 1London / UK, 2Singapore / SG
of wide neck bifurcation aneurysms (pCONus):
initial results and long-term follow-up 14:16
M. Aguilar Pérez, W. Kurre, E. Henkes, O. Ganslandt, H. Bäzner, H. Henkes; B-0208 Inter-rater variability for breast density classification
Stuttgart / DE
between American and British radiologists
10:54 W. Alomaim1, S. Foley1, J. Ryan1, M. Evanoff2, L.A. Rainford1, D. O’Leary3;
1
Dublin / IE, 2Tucson, AZ / US, 3Hatfield / UK
B-0198 Flow diverters: a curative endovascular treatment
for ruptured intracranial blister-like aneurysms 14:24
S. Deepalam, S. Joseph, N. Mulimani; Chennai / IN B-0209 Comparison of two soware-based methods for
11:02 volumetric breast composition analysis
F. Engelken, C. Schmachtenberg, U. Bick; Berlin / DE
B-0199 Basilar tip aneurysms and fetal PCAs:
do they really coexist? 14:32
M.C. Diogo1, I. Fragata1, J. Nunes2, J. Pamplona1, J. Reis1; 1Lisbon / PT, 2Gaia / PT B-0210 Low mammographic breast density and other
11:10 mammographic characteristics are linked to
B-0200 Optimising the resting state fMRI processing pipeline Hyaluronan and HAS1-3 staining and survival in
using a data-driven approach patients with early breast cancer
A.N.J. Masarwah, M. Sudah, A. Sutela, S. Oikari, M. Tammi, R. Vanninen,
L.R. Kozák, G. Dávid, Á. Szabó, G. Rudas, S. Dávid; Budapest / HU P. Auvinen; Kuopio / FI
14:40 14:32
B-0211 Does the synthesised digital mammography (3D-DM) B-0221 Can ultrasound imaging predict the outcomes of an
change the ACR density pattern? experimental steatofibrosis model?
P. Martínez-Miravete1, M. Millor Muruzábal2, P. García-Barquín2, A. Elizalde2, R. Turkay, F.A. Aydin, E. Inci, B. Bakir, E. Hocaoglu, I. Dogan-Ekici, I. Bingul,
L. Pina2, J. Etxano2, P. Bartolomé2; 1Zaragoza / ES, 2Pamplona / ES C. Kucukgergin, M. Uysal; Istanbul / TR
14:48 14:40
B-0212 Automated texture scoring for assessing breast B-0222 Value of gadoxetate disodium enhanced MRI in
cancer masking risk in full field digital mammography patients with primary sclerosing cholangitis (PSC) for
M.G. Kallenberg1, K. Petersen1, M. Lilholm1, D.R. Jørgensen1, P. Diao1, assessment of hepatic function
K. Holland2, N. Karssemeijer2, C. Igel1, M. Nielsen1; 1Copenhagen / DK, J. Hinrichs, T. Kaireit, H. Lenzen, F. Wacker, K.I. Ringe; Hannover / DE
2
Nijmegen / NL
14:48
14:56
B-0223 Correlation between MRI examination and biopsy
Wednesday
B-0213 Association of ultrasound features of invasive ductal
of the liver in patients with primary sclerosing
mammary carcinoma with tumour grade and hormone
cholangitis: a retrospective study
receptor status J. Yamamura, C. Schramm, H. Ittrich, G. Adam, S. Keller; Hamburg / DE
I. Rehman, I.K. Niazi, A. Murtaza; Lahore / PK
14:56
15:04
B-0224 Pancreatic volume, iron and fat assessment
B-0214 Fully automated measurement of background
by MRI-T2* in B-Thalassemia major patients.
parenchymal enhancement using open source
Predictive value in development of diabetes:
soware
J.D. Balkman; Lebanon, NH / US a retrospective study
P. Arcuri1, M. Galati1, G. Raiola1, S. Roccia2, M. Cadioli3, G. Fodero1;
15:12
1
Catanzaro / IT, 2Lamezia Terme / IT, 3Monza / IT
B-0215 Triple negative breast cancer: 15:04
MRI features in comparison to other breast B-0225 Pancreatic iron assessment by MRI-R2* in patients
cancer subtypes with correlation to prognostic with transfusional siderosis and haemochromatosis
pathologic factors J. Yamamura1, S. Keller1, C. Pfeifer1, B. Schönnagel1, R. Grosse1, G. Adam1,
N.A.M. Chalabi, N. Osman, N. Abdraboh; Cairo / EG J. Wang2, R. Fischer1; 1Hamburg / DE, 2Dallas, TX / US
15:20 15:12
B-0216 Is choline concentration measured by MR B-0226 Application of fat suppression in T2* relaxometry for
Spectroscopy at 3.0T correlated to the outcome the quantification of pancreatic iron overload
of breast cancer prognostic indicators? F. Terrazzino1, A. Meloni2, G. Restaino3, T. Casini4, D. Messana1, A. Pepe2;
L. Camera, I. Baglio, F. Caumo, G. Meliadò, C. Cavedon, S. Montemezzi;
1
Palermo / IT, 2Pisa / IT, 3Campobasso / IT, 4Florence / IT
Verona / IT
15:20
B-0227 Comparison of spleen stiffness in HCV-positive
14:00–15:30 Room B and healthy/non-HCV patients using Shear wave
elastography (SWE): the pilot study
Abdominal Viscera A. Pawluś, M. Inglot, D. Hołownia, K. Szymańska, K. Kaczorowski, A. Szymczak,
J. Gąsiorowski, M. Inglot, U. Zaleska-Dorobisz; Wrocław / PL
SS 301a Diffuse liver and pancreatic diseases
Moderators: M.A. Bali; Brussel/BE, L. Cevasco; Genoa/IT
14:00–15:30 Room C
14:00
B-0217 Noninvasive liver iron content determination by Breast
dual-source dual-energy CT: initial results in patients
suspected of liver iron-overload
SS 302b Risk imaging and stratification
X. Luo, J. Yan, W. Chai, H. Zhang, F. Yan; Shanghai / CN Moderators: E. Azavedo; Stockholm/SE, P.A.T. Baltzer; Vienna/AT
14:08 14:00
B-0218 Multivariable analysis of clinical influence factors on B-0228 A prospective evaluation of a multimodal screening
liver enhancement of Gd-EOB-DTPA-enhanced 3T MRI regimen in BRCA carriers
N. Verloh, M. Haimerl, C. Stroszczynski, C. Fellner, P. Wiggermann; J.C.M. van Zelst1, R.M. Mann1, G.H. Woldringh1, R.D.M. Mus1, P. Bult1,
Regensburg / DE M.J.C.M. Rutten2, N. Hoogerbrugge1, N. Karssemeijer1; 1Nijmegen / NL,
2
’s-Hertogenbosch / NL
14:16 14:08
B-0219 Obliterative portal venopathy (OPV) vs. liver cirrhosis: B-0229 Breast cancer in women previously exposed to chest
appraisal of vascular changes on CT
A. Arora, S. Rajesh, S.K. Sarin; New Delhi / IN radiation therapy: single centre experience
L. Bonello, G. Trecate, F. Cartia, A. Vella, S. Viganò, G. Scaperotta, P. Panizza;
Milan / IT
14:24
B-0220 Acute extrahepatic infectious or inflammatory 14:16
diseases are a cause of transient sinusoidal dilatation B-0230 Foci on breast magnetic resonance imaging (MRI)
1 1 1 2 1 1
M. Ronot , P.-E. Rautou , A. Kerbaol , G. Brancatelli , P. Bodossa , D. Valla ,
V. Vilgrain1; 1Clichy / FR, 2Palermo / IT in high-risk women: cancer or not?
P. Clauser1, A. De Nicolò1, A. Rotili2, B. Bonanni2, C. Zuiani1, M. Bazzocchi1,
E. Cassano2; 1Udine / IT, 2Milan / IT
14:24 14:16
B-0231 Determination of recall rates in women B-0242 Impact of post-processing algorithms on the
undergoing annual surveillance breast MRI: reproducibility of apparent diffusion coefficient (ADC):
is a rate of less than 10% achievable? is it really quantitative?
N.A. Healy, K. Holohan, S. Cosgrove, T. Kwa, F. O’ Driscoll, G. Offiah, Y. Roden, M. Zeilinger1, M. Lell1, P.A.T. Baltzer2, M. Uder1, M. Dietzel1; 1Erlangen / DE,
S. Seboui, S.A. O’Keeffe; Dublin / IE 2
Vienna / AT
14:32 14:24
B-0232 Automated detection of breast cancer as an aid B-0243 Implementation of a phase detection algorithm for
in the interpretation of screening MRI dynamic cardiac computed tomography analysis based
A. Gubern Mérida1, S. Vreemann1, R. Martí2, J. Melendez1, S. Lardenoije1, on time dependent contrast agent distribution
R.M. Mann1, B. Platel1, N. Karssemeijer1; 1Nijmegen / NL, 2Girona / ES C. Kendziorra, H. Meyer, M. Dewey; Berlin / DE
14:40 14:32
B-0233 A critical audit of a breast MRI screening B-0244 Large-scale objective comparison of 29 novel
programme for intermediate and high risk patients algorithms for computer-aided diagnosis of dementia
in clinical practice based on structural MRI
S. Vreemann, A. Gubern Mérida, S. Lardenoije, B. Platel, N. Karssemeijer, E.E. Bron1, M. Smits1, F. Barkhof2, A.J. Bastos-Leite3, J.C. van Swieten1,
R.M. Mann; Nijmegen / NL W.J. Niessen1, S. Klein1; 1Rotterdam / NL, 2Amsterdam / NL, 3Porto / PT
14:48 14:40
B-0234 Can biannual ultrasound surveillance detect cancers B-0245 Volume measurement by using super-resolution MRI:
earlier in patients with breast cancer history? application to prostate volumetry
M. Kim, E.-K. Kim; Seoul / KR E. Oubel1, H. Beaumont1, A. Iannessi2; 1Valbonne / FR, 2Nice / FR
14:56 14:48
B-0235 A history of breast cancer and older age may warrant B-0246 CT perfusion studies of lung cancer: automatic
upgrade into BI-RADS 4 among patients assigned detection of misleading structures and artefacts
mammographic BI-RADS 3 in the diagnostic setting D. Barone1, A. Bevilacqua2, S. Malavasi2, G. Gavelli1; 1Meldola / IT, 2Bologna / IT
M. Benndorf1, Y. Wu2, E. Burnside2; 1Freiburg / DE, 2Madison, WI / US
14:56
15:04 B-0247 Water content calculation in cartilage through
B-0236 Towards personalised breast screening protocols: MR estimation: design and validation
validation of mammographic density estimation from of a mathematical model
full-field digital mammograms J.M. Shiguetomi-Medina1, J.L. Ramirez-GarciaLuna2, H. Stødkilde-Jørgensen3,
M. Abdolell, K.M. Tsuruda, E.E. McDougall, S. Iles, C.B. Lightfoot, J. Caines; B. Møller-Madsen1; 1Aarhus / DK, 2San Luis Potosi / MX, 3Skejby / DK
Halifax, NS / CA
15:04
15:12 B-0248 A novel approach for estimating fracture risk
B-0237 Tabár parenchymal patterns and breast cancer risk: by computerised processing of routine proximal
a case-control study adjusting for percent area femur radiographs
mammographic density and standard risk factors I. Leichter, B. Fargun, O. Rozengarten, O. Safran, M. Liebergall; Jerusalem / IL
M. Abdolell, S. Iles, K.M. Tsuruda, J. Payne, C.B. Lightfoot, J. Caines; Halifax,
NS / CA 15:12
15:20 B-0249 Clinical applicability of advanced trabecular
microarchitecture assessment using multi-detector
B-0238 Should volumetric breast density be included in breast
computed tomography
cancer prediction models? Proposal of an integrated A. Valentinitsch1, L. Fischer2, J.M. Patsch2, J.S. Bauer1, F. Kainberger2, G. Langs2,
quantitative and reproducible approach M. DiFranco2; 1Munich / DE, 2Vienna / AT
S. Ciatti1, G. Gennaro2, V. Mungai1, G. Nannini1; 1Prato / IT, 2Padova / IT
14:00–15:30 Room M
14:00–15:30 Room Z
GI Tract
Computer Applications
SS 301b Gastro-oesophageal and small bowel
SS 305 Imaging biomarkers imaging
Moderators: A. Alberich-Bayarri; Valencia/ES, M. de Bruijne; Rotterdam/NL
Moderators: D. Akata; Ankara / TR, S. Bickelhaupt; Heidelberg / DE
14:00 14:00
B-0239 Choice of deconvolution algorithm: B-0250 Metabolic volumetric parameters assessed with
impact on the perfusion analysis of human gliomas 18F-FDG PET/CT are superior to SUVmax and CT
1 2 1 1 3 1
M. Dietzel , N. Thanh , M. Schmidt , S. Kloska , M. Essig , A. Dörfler ;
1
Erlangen / DE, 2Ottawa, ON / CA, 3Winnipeg, MB / CA volumetry for predicting long-term outcome in
patients with esophageal cancer aer neoadjuvant
14:08 chemotherapy and resection
B-0241 Accurate and reproducible splenic volume estimation D. Tamandl, B. Fueger, M. Paireder, A. Haug, S. Schoppmann, A. Ba-Ssalamah;
in patients with splenomegaly from multidetector-row Vienna / AT
CT data using a quick stereological method
M. Mazonakis, J. Stratakis, J. Damilakis; Iraklion / GR
Wednesday
B-0253 Application of spectral CT on T staging of gastric image reconstruction (AIDR 3D) at 120, 100 and 80
carcinoma: evaluation of iodine concentration kVp instead of the standard reference protocol (FBP
of perigastric fat tissue adjacent to tumour at 120 kVp)
for diagnosing serosal invasion compared with J. Blobel, J. Mews, J.D. Schuijf, W. Overlaet; Zoetermeer / NL
pathological T staging 14:17
J. Xing, H.H. Limbu, J.B. Gao; Zhengzhou / CN
B-0262 Coronary calcium scoring at low radiation dose
14:32 using iterative reconstruction:
B-0254 Role of diffusion-weighted imaging and apparent intraindividual comparison with standard dose
diffusion coefficient in prediction of metastatic scanning using filtered back projection
regional lymph nodes in gastric cancer: A. Lembcke1, R. Luhur1, J. Mews2, B. Hamm1, J. Blobel2; 1Berlin / DE,
2
Zoetermeer / NL
comparison with morphological criteria
Y. Mao, F. Lv, Z. Wang; Chongqing / CN 14:25
14:40 B-0263 Detectability of small calcifications in patients
B-0255 PET/MR enterography for the assessment of different sizes: a stationary phantom study
M. Vonder1, G. Pelgrim1, S.E.M. Huijsse1, M.J.W. Greuter1, J.C. Gratama2,
of the small bowel: first experience M. Oudkerk1, R. Vliegenthart1; 1Groningen / NL, 2Apeldoorn / NL
1 1 1 2 1 1
K. Beiderwellen , S. Kinner , B. Gomez , P. Heusch , L. Umutlu , A. Bockisch ,
T.C. Lauenstein1; 1Essen / DE, 2Düsseldorf / DE 14:33
14:48 B-0264 The impact of Sn-filter on detection and quantification
B-0256 Clinical significance of pneumatosis of the bowel wall: of coronary calcification using third generation
correlation of MDCT findings with patients’ dual-source CT at ultra-low dose: a phantom study
M. Vonder1, G. Pelgrim1, S.E.M. Huijsse1, M. Meyer2, M.J.W. Greuter1, M. Oudkerk1,
management and outcome T. Henzler2, R. Vliegenthart1; 1Groningen / NL, 2Mannheim / DE
S. Schmidt, J.-F. Knebel, A. Denys, R. Meuli, M.-O. Treyvaud; Lausanne / CH
14:41
14:56
B-0265 Approaches to ultra-low radiation dose coronary
B-0257 Differentiate intestinal tuberculosis and Crohn’s artery calcium scoring using 3rd generation
disease on CT Enterography: an initial experience dual-source CT: a phantom study
S.R. Agrawal; New Delhi / IN
G. Muscogiuri, C.N. De Cecco, A. McQuiston, F.G. Meinel, J.L. Wichmann,
A. Varga-Szemes, P.M. Cannaò, U.J. Schoepf; Charleston, SC / US
15:04
B-0258 Redefining the mesenteric swirl sign (MSS) in the 14:49
diagnosis of internal herniation (IH) aer Roux-Y B-0266 Impact of iterative reconstruction algorithms
gastric bypass (RYGBP) on calcified plaque quantification with coronary
J. Maier, A. Floyd; Køge / DK
computed tomography angiography
M. Károlyi1, B. Szilveszter1, M. Kolossváry1, R. Raaijmakers2, W. Giepmans2,
15:12 P. Kitslaar3, T. Horváth1, B. Merkely1, P. Maurovich-Horvat1; 1Budapest / HU,
B-0259 Mesenteric panniculitis: review of abdominal MDCT 2
Best / NL, 3Leiden / HU
examinations with a matched-pair analysis
L. Protin-Catteau1, G. Thiefin1, P. Soyer2, M. Belkebir1, S. Deguelte1, C. Hoeffel1; 14:57
1
Reims / FR, 2Paris / FR B-0268 Optimising radiation dose by using advanced iterative
15:20 reconstruction in high-pitch coronary CT angiography
S. Gordic1, D.B. Husarik1, S. Wildermuth2, H. Alkadhi1, S. Leschka2; 1Zurich / CH,
B-0260 Lower stage migration rate of early gastric cancer 2
St.Gallen / CH
with a new reconstruction algorithm of images in dual
energy CT: preliminary study 15:05
C. Shi, H. Zhang, J. Yan; Shanghai / CN B-0269 CT coronary angiography with iterative image
reconstruction and low iodine (270mgI/mL)
concentration: comparison of image quality and
injection pressure with standard (320mgI/mL) iodine
concentration
L. Faggioni, M. Gabelloni, E. Galati, M. Bianchi, P. Marraccini, E. Neri,
C. Bartolozzi; Pisa / IT
15:13 15:04
B-0270 Dose reduction with iterative reconstruction B-0280 Efficacy of knowledge-based iterative reconstruction
for cardiac computed tomography angiography: on CT abdominal angiography
a systematic review and meta-analysis K.K.P. Lau, A. Kuganesan, K. Buchan, T. Lau; Melbourne / AU
A.M. den Harder1, M.J. Willemink1, Q.M.B. de Ruiter1, P.A. de Jong1,
A.M.R. Schilham1, T. Leiner1, R.P.J. Budde2; 1Utrecht / NL, 2Rotterdam / NL 15:12
B-0281 Nephrogenic systemic fibrosis in patients with chronic
kidney disease undergoing MRI with the injection of
14:00–15:30 Room L 1 gadobenate dimeglumine or gadoteridol:
findings from prospective cohort studies
Vascular G. Soulez1, D.C. Bloomgarden2, N.M. Rofsky3, M. Smith4, H.H. Abujudeh4,
D. Morgan5, M.A. Kirchin6, G. Pirovano7, A. Spinazzi7; 1Montreal, QC / CA,
SS 315 Innovations in vascular imaging 2
Milwaukee, WI / US, 3Dallas, TX / US, 4Boston, MA / US, 5Birmingham, AL / US,
6
Milan / IT, 7Monroe, NJ / US
Moderators: D. Brisbois; Liège/BE, H. Hoppe; Berne/CH
14:00
B-0272 Non-contrast 3D and QISS magnetic resonance 14:00–15:30 Room E1
angiography for pre-operative TAVR evaluation Musculoskeletal
P.M. Cannaò1, A. Varga-Szemes1, G. Muscogiuri1, C.N. De Cecco1, M. Renker1,
S. Mangold1, D. Piccini2, S. Giri3, U.J. Schoepf1; 1Charleston, SC / US,
2
Lausanne / CH, 3Chicago, IL / US SS 310 Fractures, spinal injuries and spine
Moderators: M. Muto; Naples/IT, G. Scheurecker; Linz/AT
14:08
B-0273 Free breathing navigated 3D T1w black-blood MRI at 14:00
3T for the diagnosis of thoracic large vessel vasculitis B-0282 Extremity CT and ultrasound in the assessment of
T. Saam1, S. Maurus1, N.N. Kammer1, H. Kooijman2, M. Treitl1, E. Coppenrath1, ankle injuries - occult fractures
M.F. Reiser1, K.M. Treitl1; 1Munich / DE, 2Hamburg / DE D.J. Wilson, G.M. Allen, S. Bullock; Oxford / UK
14:16 14:08
B-0274 Diagnostic accuracy of contrast-enhanced T1 B-0283 Diagnostic value of DW-SSFP and DW-EPI sequences
free-breathing GE sequences in the assessment in differential diagnosis of vertebral osteoporotic
of aortic disease: comparison with standard T1 fractures from the pathological neoplastic fractures
breath-hold GE 3D angiographic sequences J.H. Shin, J. Lim, J. Park; Seoul / KR
C.R.G.L. Talei Franzesi, D. Ippolito, P.A. Bonaffini, D. Fior, M. Colombo, S. Sironi;
Monza / IT 14:16
14:24 B-0284 Assessing the performances of the trabecular bone
score (TBS) on EOS images for the discrimination of
B-0275 3D black-blood T1-weightet turbo spin-echo
osteoporotic fractures
technique for the diagnosis of deep vein thrombosis: A. Feydy, K. Briot, N.-E. Regnard, A. Etcheto, S. Kolta, C. Roux; Paris / FR
a viable alternative to contrast-enhanced MRI
K.M. Treitl1, M. Treitl1, N.N. Kammer1, E. Coppenrath1, H. Kooijman-Kurfuerst2, 14:24
M.F. Reiser1, T. Saam1; 1Munich / DE, 2Hamburg / DE
B-0285 Trabecular bone microstructure assessed by low-dose
14:32 MDCT and iterative reconstruction predicts vertebral
B-0276 Aortic haemodynamics aer valve-sparing aortic root bone strength
T. Baum, F. Kopp, R.A. Nasirudin, E. Grande Garcia, R. Burgkart, E.J. Rummeny,
replacement with a physiologically shaped sinus J.S. Bauer, P.B. Noël; Munich / DE
prosthesis analysed by 4D Flow MRI
T.H. Oechtering1, J. Haegele1, P. Hunold1, C. Schmidtke2, H.-H. Sievers1, 14:32
J. Barkhausen1, A. Frydrychowicz1; 1Lübeck / DE, 2Bad Segeberg / DE
B-0286 Effect of ROI size and positioning on interobserver
14:40 variability, sensitivity and specificity in the
B-0277 New ECG-gated CTA technique coupled with differentiation of acute benign and malignant
computational flow analysis in ascending thoracic vertebral body fractures with quantitative
aortic aneurysm diffusion-weighted MRI
A. Pasta, C. Parisi, S. Maggio, A. Luca; Palermo / IT T. Geith1, B. Margarita1, M. Notohamiprodjo1, A. Biffar1, G. Schmidt1, H. Duerr1,
S. Sourbron2, M.F. Reiser1, A. Baur-Melnyk1; 1Munich / DE, 2Leeds / UK
14:48
14:40
B-0278 Assessment of wall shear stress in patients without
B-0287 ‘The value of DEXA assessment in patients with
aortic disease, with aortic aneurysms and with
a possible osteoporotic vertebral fracture’ - a
penetrating aortic ulcers using velocity encoding 4D
retrospective analysis
MRI O. Azmat1, N. Lee1, C. Groves2; 1Leeds / UK, 2Bradford / UK
M. Rasper, J. Rudolph, B.M. Gramer, C. Maegerlein, C. Reeps, B. Lutz,
H.-H. Eckstein, E.J. Rummeny, A. Huber; Munich / DE
14:48
14:56 B-0288 DECT evaluation of acute bone marrow contusion in
B-0279 Transcranial doppler ultrasonography in the spine with MRI correlation
D. Na1, S.-J. Hong1, C. Kang1, B. Kim2, K.-S. Ahn1, S. Lee2, Y. Jang1; 1Seoul / KR,
Beta-thalassemia major patients without and with 2
Gyeonggi-do / KR
thrombocytosis
A. Shariat, M. Nazeri, A. Abolhasani Foroughi, M. Karimi; Shiraz / IR
14:56 14:48
B-0289 MRI following whiplash injury is improved by routine B-0299 Use of MR tractography and T2* perfusion for
imaging of the cranio-cervical junction in addition to differentiating neoplastic and inflammatory cervical
the cervical spine cord lesions
F.W. Smith1, S. Morgan2; 1Aberdeen / UK, 2Bristol / UK M.S. Abdelgawad1, M.S.R. Reda2, N.A.M. Abdelmonsef2; 1Menofyia / EG,
2
Alexandria / EG
15:04
B-0290 Percutaneous vertebroplasty for single or multiple 14:56
thoracolumbar compression fractures B-0300 Natalizumab related PML:
A.R. Shah, A.M. Highland; Sheffield / UK atypical neuroradiological findings
S. Gerevini1, G. Caliendo1, M. Cava1, R. Capra2, N. De Rossi2, A. Falini1,
15:12 M. Cosottini3; 1Milan / IT, 2Brescia / IT, 3Pisa / IT
B-0291 Moiré fringe technique and bi-planar radiography of 15:04
Wednesday
the spine: accuracy to detect vertebral rotation of B-0301 Cortical gray matter localisation of initially
mild scoliotic patients
A. Hocquelet, F. Cornelis, L. Castaings, F. Petitpierre, C. Fournier, O. Hauger; diffusion-positive lesions is associated with no
Bordeaux / FR MRI-visible 8-week scar in a cohort of transitory
cerebral ischemic attack patients
15:20 I. Havsteen, C. Ovesen, J. Damm Nybing, J. Marstrand, A. Christensen,
B-0292 Clinical correlation of a new and practical magnetic H. Christensen; Copenhagen / DK
resonance grading system for cervical foraminal 15:12
stenosis assessment
H.J. Park, C.H. Han; Seoul / KR B-0302 Stress MRI for the assessment of lumbar canal
stenosis in degenerative disc disease:
comparison with routine MRI
14:00–15:30 Room E2 S. Goel; Delhi / IN
Neuro 15:20
B-0303 Dynamic lumbosacral MRI compared to upright
SS 311a Brain trauma, degenerative and spine myelography: comparison in the detection
diseases of segmental dural compression
S. Leschka1, M. Benndorf1, M. Vicari2, S. Meckel1, M. Schumacher1, M. Weigel3,
Moderators: P. Barsi; Budapest/HU, J. Hodel; Lille/FR C. Taschner1; 1Freiburg / DE, 2Bremen / DE, 3Basle / CH
14:00
B-0293 Cerebral perfusion disturbances in traumatic brain 14:00–15:30 Room F1
injury: direct and indirect effects on memory and
psychoemotional outcome Oncologic Imaging
E. Papadaki, S. Demetriou, E. Kavroulakis, S. Papadopoulou, P. Simos,
A. Karantanas; Iraklion / GR
SS 316 Molecular imaging and new agents
14:08 Moderators: A. Pomoni; Lausanne/CH, A.E. Sundin; Stockholm/SE
B-0294 Development of a common MRI protocol for the 14:00
collaborative European neuro trauma effectiveness B-0304 Diagnostic performance of 68Ga-PSMA-PET/MRI
research in TBI study versus 68Ga-PSMA-PET/CT in the evaluation of lymph
P. Pullens , J. Verheyden , W. van Hecke , A. Maas , P.M. Parizel ; Antwerp / BE,
1 2 2 1 1 1
2
Leuven / BE node metastases of metastatic prostate cancer
M.T. Freitag, J. Radtke, B. Hadaschik, H.-P. Schlemmer, U. Haberkorn,
14:16 M.C. Roethke, A. Afshar-Oromieh; Heidelberg / DE
B-0295 Prognostic value of DWI and DTI in severe traumatic 14:08
brain injury: a prospective cohort of 56 patients B-0305 Diagnostic performance of 68Ga PSMA-ligand PET/CT
H. Derbel, S. Haddar, A. Maalej, A. Chaari, H. Chelly, K. Ben Mahfoudh,
M. Bouaziz; Sfax / TN in prostate cancer patients with biochemical relapse
C. Uprimny, A. Kroiss, C. Decristoforo, L. Geraldo Roig, D. Kendler, D. Putzer,
14:24 W. Horninger, W.R. Jaschke, I.J. Virgolini; Innsbruck / AT
B-0296 Prognostic correlation of MRI findings with levels of 14:16
parasitemia in cerebral malaria B-0306 18F-FLT PET in the assessment of chemotherapy in
A.K. Udiya1, A. Jha1, U. Chauhan2, S. Singhal2; 1Lucknow / IN, 2New Delhi / IN
locally advanced breast cancer: a new approach
14:32 B. Malkowski1, E. Chmielowska1, E. Srutek1, P. Szlezak1, T. Gorycki2,
K. Gwozdziewicz2, M. Czarnowska-Cubala2, A. Szymanska-Dubowik2,
B-0297 “Power button sign”: a new typical MR imaging M. Studniarek3; 1Bydgoszcz / PL, 2Gdansk / PL, 3Warsaw / PL
pattern of focal cortical dysplasia in the central region
C. Melleiro, P. Roca, F. Chassoux, J. Meder, C. Oppenheim; Paris / FR 14:24
B-0307 Diagnostic accuracy of 11C-Choline PET/CT in
14:40
hepatocellular carcinoma (HCC)
B-0298 Apparent diffusion coefficient map can help E. Lopci, D. Poretti, A. Palmisano, E. Lanza, L. Rimassa, G. Torzilli, A. Chiti;
the voxel-based morphometric diagnosis Rozzano / IT
of Alzheimer’s disease
H. Takahashi1, K. Ishii2, Y. Watanabe1, H. Tanaka1, T. Murakami2, N. Tomiyama1;
1
Suita / JP, 2Osaka-Sayama / JP
14:32 14:24
B-0308 Diagnostic value of quantitative perfusion map, with B-0318 Proton-density fat fraction in an ultra-high-field MR
CT-perfusion technique in monitoring of tumour scanner: a feasibility study
response to sorafenib treatment in patients with J.-P. Kühn, B. Mensel, K. Kindermann, S. Hadlich, S. Otto, N. Hosten;
Greifswald / DE
advanced HCC lesions: preliminary results
D. Ippolito, G. Querques, C. Talei Franzesi, P.A. Bonaffini, S. Sironi; Monza / IT 14:32
14:40 B-0319 Simultaneous reconstruction of attenuation and
B-0309 Diagnostic value of first-pass CT-perfusion study in activity distributions in PET/MRI from PET emission
the quantitative vascular assessment of primary and data using MR prior information
T. Heußer1, C. Rank1, T. Beyer2, M. Kachelrieß1; 1Heidelberg / DE, 2Vienna / AT
metastatic liver lesion: preliminary results
O. Minutolo, D. Ippolito, C. Talei Franzesi, M. Mumoli, P.A. Bonaffini, S. Sironi; 14:40
Monza / IT
B-0320 Quality control for quantitative multi-center
14:48 whole-body PET/MRI studies
B-0310 Feasibility of 10-min delayed hepatocyte phase R. Boellaard1, I. Rausch2, T. Beyer2, G. Delso3, S. Ziegler4, M. Yaqub1, H.H. Quick5,
B. Sattler6; 1Amsterdam / NL, 2Vienna / AT, 3Zurich / CH, 4Erlangen / DE,
imaging with 30° flip angle in Gd-EOB-DTPA-enhanced 5
Duisburg-Essen / DE, 6Leipzig / DE
MR imaging for the detection of liver metastases,
compared with 20-min delayed imaging with 14:48
10° flip angle B-0321 Do we need MRI quality assurance: experience from
D. Lee, E.-S. Cho, I. Jeon; Seoul / KR a multi-unit imaging center with 14 MRI systems
L.J. Kuusela, M. Timonen, T. Mäkelä, J. Peltonen, T. Ihalainen, J. Uusi-Simola,
14:56 T. Kaasalainen, S. Savolainen, O. Sipilä; Helsinki / FI
B-0311 Reproducibility of dynamic contrast-enhanced MRI
14:56
in oncology: 2D vs 3D approach
S. Hibat Allah, M. Wagner, S. Raslan, O. Lucidarme; Paris / FR B-0322 Does MRI influence blood coagulation?
P. Seyfer, V. Klingmüller, M. Voelker, A.H. Mahnken, T. Stief; Marburg / DE
15:04
15:04
B-0312 HANP/PTX treatment
L. Zhu, L. Zhang, J. Wang; Xiamen / CN B-0323 Parallel-transmit-accelerated spatially-selective
excitation MRI for reduced-FOV diffusion-weighted
15:12 imaging of the pancreas
B-0313 Theranostic application of a cyanine-based linker K.M. Thierfelder1, W.H. Sommer1, O. Dietrich1, F.G. Meinel1, P.M. Paprottka1,
M.F. Reiser1, K. Nikolaou2; 1Munich / DE, 2Tübingen / DE
functionalised with temozolomide using solid phase
chemistry 15:12
D. Komljenovic, M. Wiessler, R. Pipkorn, W. Waldeck, K. Braun; Heidelberg / DE
B-0324 Method to determine dynamic in vivo material
15:20 properties of the achilles tendon using ultrafast MRI
B-0314 CT perfusion imaging in the evaluation of response to sequence
T.J. Vogl, M. Kardeh, G. Silber; Frankfurt a. Main / DE
treatment of radiofrequency thermal ablation (RFA),
in patients with lung cancer 15:20
A. Infante, A. Contegiacomo, A. del Ciello, A.R. Larici, R. Iezzi, L. Bonomo;
Rome / IT B-0325 Texture analysis of R2 map in the assessment of renal
function: is this a promising tool?
L. Pelliccia, S. Carbone, L. Mazzoni, L. Volterrani; Siena / IT
14:00–15:30 Room F2
14:16 14:16
B-0329 Complications of transthoracic CT-guided lung B-0339 Vertebral augmentation in extreme vertebral
biopsies: a systematic review and meta-analysis fractures: comparison between standard and
W.J. Heerink, G. de Jonge, R. Vliegenthart, M. Oudkerk; Groningen / NL augmented vertebroplasty
M. Tsitskari, D.K. Filippiadis, G. Velonakis, L. Reppas, E. Brountzos, N. Kelekis,
14:24 A.D. Kelekis; Athens / GR
B-0330 In CT-guided transthoracic lung biopsy the
contribution of FDG PET/CT in biopsy planning and 14:24
diagnostic accuracy B-0340 Cone-beam computed tomography guided unipedicular
Y. Dadali1, O. Ozmen2, U. Calıkoglu2, &. Bursali2, F. Demirag2; 1Kirsehir / TR, central stentoplasty of the thoracolumbar spine:
2
Ankara / TR early experience and results
K. Huang, U. Pua; Singapore / SG
14:32
B-0331 Radiofrequency ablation of malignant pleural 14:32
Wednesday
mesothelioma plaque B-0341 The use of cone-beam CT in achieving unipedicular
G.G. Taverna, F. Brucculeri, E. Oppezzo, G. Gola, C.M.S.O. Tappero, S. Barbero; spinal cement augmentation
Casale Monferrato / IT T.C. Hui, G. Tan, U. Pua; Singapore / SG
14:40 14:40
B-0332 The diagnostic value of chest MRI in the follow up B-0342 Percutaneous vertebroplasty in malignant spinal
of lung cancer patients treated with radio frequency fractures with posterior vertebral column and/or
ablation epidural involvement. Feasibility and results:
E. Skondras1, A. Fusco2, J. Beeson1, P. Dalal1; 1London / UK, 2Rome / IT
a review of 63 cases
14:48 A. Pellegrin1, G. Gallo1, A. Caudal1, P. Foti1, O. Hauger2, N. Amoretti1; 1Nice / FR,
2
Bordeaux / FR
B-0333 Percutaneous treatment of parapneumonic effusions
and complex empyemas with drainage and fibrinolytic 14:48
therapy B-0343 Preliminary study for analysis of modification of disk
S. Roy-Choudhury, G. Gupta, S. Roy Choudhury, R. Dhar; Kolkata / IN volume and disk fragment in patients with lumbar
14:56 contained disk herniation treated with CT-guided
B-0334 CT assessment of fissure completeness in target lobe ozone-oxygen injection
M. Federici, A. Maira, M. Marconi, I. Iacucci, P. Mancini, M. Polito, C. Simonetti,
selection for endobronchial volume reduction therapy G.R. Ferreri, A. Bellelli; Rome / IT
in COPD
J.B. Seo, S. Shin, S. Lee, S. Lee, S. Oh, N. Kim, Y.-M. Oh; Seoul / KR 14:56
B-0344 Combined microwave ablation and cementoplasty in
15:04 patients with painful bone metastases at high risk of
B-0335 Anatomical and functional lung changes aer fracture
endobronchial lung volume reduction therapy: C. Pusceddu, R. Fele, B. Sotgia, N. Ballicu, L. Melis; Cagliari / IT
evaluation with combined xenon ventilation and
iodine contrast perfusion dual energy CT 15:04
J.B. Seo, S. Shin, S. Lee, S. Oh, N. Kim, S. Lee, Y.-M. Oh; Seoul / KR B-0345 Role of CT guided spinal injections in management
of chronic low back pain
15:12 S.A.Z. Khodair, E. Mashaly, H. Sameer; Qwuesna / EG
B-0336 Metal artifact reduction on chest CT examinations:
comparison of the IMAR (iterative metallic artefact 15:12
reduction) algorithm and monoenergetic approach B-0346 Safety of cervical transforaminal steroid injections
J. Pagniez, L. Legrand, J.-B. Faivre, S. Khung, J. Remy, M. Remy-Jardin; Lille / FR under CT guidance:
a five-year experience in 248 cases
D. Krause, P. Pottecher, P.-Y. Genson, L. Estivalet, S. Favelier, R. Loffroy;
14:00–15:30 Room D2 Dijon / FR
14:08
B-0338 MR guided focused ultrasound surgery (MRgFUS)
vs radiofrequency thermoablation (RFA) in the
imaging-guided treatment of osteoid osteoma:
clinical and imaging results
F. Arrigoni, S. Mariani, A. La Marra, L.M. Gregori, L. Zugaro, A. Barile,
C. Masciocchi; L’Aquila / IT
14:08 14:08
B-0380 Dynamic contrast-enhanced MR imaging for the
Wednesday
B-0369 Recurrent vertigo: is MRI useful for diagnosis of
endolymphatic hydrops in clinical practice? evaluation of so tissue tumours of trunk and limbs in
A. Attye, G. Dumas, I. Tropres, M. Roustit, A. Karkas, E. Banciu, J. Pietras, the children
S. Schmerber, A. Krainik; Grenoble / FR A. Barbashova; Moscow / RU
14:16 14:16
B-0370 CT pre-operative planning of Bonebridge™: B-0381 Simultaneous whole-body PET/MR Imaging in
a new semi-implantable bone conduction paediatric sarcomas and malignant so tissue
hearing device tumours: preliminary results
E.K.C. Law, W.S.S. Tsang, M.C.F. Tong, S. Lin, K.S.S. Bhatia; Shatin / HK J.F. Schäfer, S. Gatidis, I. Tsiflikas, G. Seitz, M. Ebinger, M. Reimold, C. La
Fougère, N. Schwenzer, K. Nikolaou; Tübingen / DE
14:24
B-0371 Auditory brainstem implant: computed tomography 14:32
assessment of electrods dislocation B-0383 When to make a postmortem babygram and when not
F. Spagnolli, N. Cardobi, R. Cerini, M. Barillari, V. Colletti, R. Pozzi Mucelli; K. Kamphuis-van Ulzen, D.H.J.L. Koopmanschap, W.M. Klein; Nijmegen / NL
Verona / IT
14:40
14:32 B-0384 Fetal short femurs: interest of three-dimensional
B-0372 Value of MRI in patients with temporomandibular joint computed tomography in prenatal management
dysfunction: correlation of MRI and clinical findings M. Blouet, F. Belloy, G. Benoist, J.-P. Pelage; Caen / FR
T.J. Vogl1, H.C. Lauer1, T. Lehnert1, N.N.N. Naguib1, H. Soekamto1, N. Fillmann1,
P. Ottl2; 1Frankfurt a. Main / DE, 2Rostock / DE 14:48
B-0385 Dynamic contrast-enhanced MRI of the wrist
14:40
in patients with juvenile idiopathic arthritis:
B-0373 Comparison of a 32-channel head coil and a 2-channel a feasibility study
surface coil for MR imaging of the temporomandibular C.M. Nusman, C. Lavini, R. Hemke, M.W.A. Caan, D. Schonenberg, K.M. Dolman,
joint at 3.0 Tesla J.M. van den Berg, T.W. Kuijpers, M. Maas; Amsterdam / NL
1 1 1 1 1 2 1
A. Manoliu , G. Spinner , M. Wyss , S. Erni , D. Ettlin , D. Nanz , E.J. Ulbrich ,
L.M. Gallo1, G. Andreisek1; 1Zurich / CH 14:56
B-0386 Single radiograph of the pelvis for non traumatic hip
14:48
pathology: what do we miss?
B-0374 MR imaging of the temporomandibular joint at 7.0 S. McGurk, E. Lindell, D. Broomfield; Edinburgh / UK
Tesla: a feasibility study using novel high-permittivity
dielectric pads 15:04
A. Manoliu, G. Spinner, M. Wyss, S. Erni, D. Ettlin, D. Nanz, E.J. Ulbrich, L.M. Gallo, B-0387 Tibial bowing in children:
G. Andreisek; Zurich / CH
what is normal? A radiographic study
I. Zbinden1, E. Rutz1, J.A. Jacobson2, O. Magerkurth1; 1Basle / CH, 2Ann Arbor,
14:56 MI / US
B-0376 Automatic segmentation of head and neck deep
spaces using morphing techniques 15:12
S. Boussouar1, O. Bouhelal1, B. Gilles2, F. Faure2, C. Vaniet1, P. Halimi1, B-0388 Hand bone age determination: quantitative
C.-A. Cuenod1; 1Paris / FR, 2Montpellier / FR
radiographical evaluation method for in 0-59
15:04 months aged children
V. Taravari, I. Özyavuz, E. Yilmaz, O.B. Erol, F. Ertem, R. Sarifov, M. Bulakçi,
B-0377 Volumetric quantification of cervical adiposity: B. Bulakçi, E. Yekeler; Istanbul / TR
a novel anthropometric tool
H.S. Maresky, Z. Sharfman, P. Gottlieb, S. Tal; Zeriffin / IL 15:20
B-0389 Ultrasound evaluation of thyroid gland pathologies
15:12
aer radio- and/or chemotherapy during childhood
B-0378 Does MRI help to distinguish between odontogenic A. Lollert, C. Gies, K. Laudemann, J. Faber, D. Jacob-Heutmann, C. Düber,
cysts and keratocystic odontogenic tumours? G. Staatz; Mainz / DE
U.G. Mueller-Lisse, F.A. Probst, M. Probst, E. Kaltsi, S. Otto, S. Schiel,
M. Troeltzsch, M. Ehrenfeld, P.C. Cornelius; Munich / DE
14:48 14:32
B-0396 Quality improvement using educational intervention: B-0405 Whole body computed tomography for trauma
improving accuracy of cardiac CT function reporting in patients in the Nordic countries 2014. Survey shows
triple-rule-out patients with acute chest pain significant differences and a need for guidelines
H. Eklöf1, E. Wiklund1, F. Linder1, S. Koskinen2; 1Uppsala / SE, 2Stockholm / SE
P. Suranyi, L. Hewett; Charleston, SC / US
14:56 14:40
B-0397 Evaluation of aortic strain with MR imaging in B-0406 Patients subject to high energy trauma without signs
different pathologic conditions: a retrospective study of injury do not benefit from whole-body CT imaging
F. Linder, H. Eklöf; Uppsala / SE
F. Secchi, M. Scarabello, F. Damiani, M. Petrini, G. Di Leo, F. Sardanelli; Milan / IT
15:04 14:48
B-0398 Intra- and interobserver agreement of noninvasive B-0407 Watch and wait or irradiate
M. Kakollu, N. Jones, L.-G. Baca, S. Pillai, S. Kumar; Cardiff / UK
pressure difference measurements derived from 4D
flow MRI in patients with repaired aortic coarctation 14:56
and healthy volunteers B-0408 Scanning and war: utility of FAST and CT in the
F. Rengier1, M. Delles2, J. Eichhorn1, Y.-J. Azad2, H. von Tengg-Kobligk3, assessment of battlefield abdominal trauma
R. Unterhinninghofen2, H.-U. Kauczor1, R. Dillmann2, S. Ley1; 1Heidelberg / DE, I.M. Smith, D.N. Naumann, M.E.R. Marsden, M. Ballard, D.M. Bowley;
2
Karlsruhe / DE, 3Berne / CH Birmingham / UK
15:04 14:56
B-0409 CT in trauma patients: automatic dose monitoring for B-0420 To compare post contrast 3D T2 FLAIR, T1-SPACE and
demonstrating the effect of iterative reconstructions MP-RAGE sequences to select the ideal sequence for
K. Higashigaito, A. Becker, K. Sprengel, G. Wanner, H. Alkadhi; Zurich / CH leptomeningeal abnormalities at 3 T MRI
B. Jeevanandham; Coimbatore / IN
15:12
B-0410 Is whole-body CT accurate in management of 15:04
brain-dead patients before organ harvesting? B-0421 Impact of image denoising on image quality,
C. Ridereau-Zins, E. Berthier, L. Dube, C. Nedelcu, C. Aube; Angers / FR quantitative parameters, and sensitivity of
15:20 ultra-low-dose volume perfusion CT imaging
A. Othman1, C. Brockmann1, Z. Yang2, M.A. Brockmann1, M. Wiesmann1, J. Kim2;
B-0411 Comparisons of liver CT perfusion of blunt liver 1
Aachen / DE, 2Seoul / KR
injuries between patients treated with intervention
15:12
Wednesday
and conservative management
Y.-C. Wong, L.-J. Wang, C.-H. Wu; Taoyuan, Taiwan / TW B-0422 Quantitative comparison of Gadoterate and Gadobutrol
for the MR-angiographic (MRA) evaluation of
neurovascular disease
14:00–15:30 Room MB 5 M. Dietzel1, P. Hölter1, S. Lang1, T. Struffert1, M. Essig2, A. Dörfler1;
1
Erlangen / DE, 2Winnipeg, MB / CA
Neuro
SS 311b Hypertension and stenosis
Moderators: T.A.. Yousry; London/UK, D. Gürbüz; Istanbul/TR
14:00
B-0412 Endovascular treatment in idiopathic intracranial
hypertension, clinical result and long-term follow-up
M. Aguilar Pérez1, W. Kurre1, D. Horvath-Rizea1, R. Unsöld2, H. Bäzner1,
H. Henkes1; 1Stuttgart / DE, 2Düsseldorf / DE
14:08
B-0413 Leptomeningeal collateral vessels are a major risk
factor for intracranial hemorrhage aer carotid
stenting in patients with carotid atherosclerotic
plaque
K. Lee, H. Kwak, G. Chung, J. Song; Jeonju / KR
14:16
B-0415 Phase contrast and arterial spin labelling magnetic
resonance imaging shows improved cerebral blood
flow aer cardioversion of atrial fibrillation
M. Gardarsdottir1, S. Sigurdsson2, T. Aspelund2, V.A. Gardarsdottir1,
V. Gudnason2, D.O. Arnar1; 1Reykjavik / IS, 2Kopavogur / IS
14:24
B-0416 Contribution of susceptibility weighted imaging in
differentiating acute from chronic internal carotid
occlusion
I. Yoon1, Y. Kim1, Y. Kim1, Y. Won1, H. Song2; 1Uijeongbu / KR, 2Jeju / KR
14:32
B-0417 Intracranial arterial calcifications as a prognostic
factor for the subsequent occurrence of mixed
adverse cardiovascular events (MACE)
F.F. Strobl, B. Kuhlin, F. Bamberg, M.F. Reiser, T. Saam; Munich / DE
14:40
B-0418 Normal ranges and test-retest repeatability of velocity
parameters in intracranial arteries measured with
phase contrast magnetic resonance imaging (PC-MRI)
M. Correia de Verdier, J. Wikström; Uppsala / SE
14:48
B-0419 Endovascular reconstruction of extra- and intracranial
vessels aer subacute or chronic occlusion:
indications, techniques, merits and failures
M. Aguilar Pérez, W. Kurre, E. Henkes, A. Lindner, O. Ganslandt, H. Bäzner,
H. Henkes; Stuttgart / DE
11:10 11:02
B-0428 Impact of observer experience on diagnostic B-0438 Background parenchymal enhancement (BPE) in
performance in reporting CT and MRI examinations contrast-enhanced spectral mammography (CESM):
of histopathologically proven non-colorectal liver classification and evaluation of impact on diagnostic
metastases performance
M.H. Albrecht, L. Umutyan, M. Hart, C. Polkowski, J.L. Wichmann, T. Lehnert, M. Sklair-Levy, A. Shalmon, Y. Servadio, A. Rundstein, O. Halshtok, M. Gotlieb,
R.W. Bauer, H. Ackermann, T.J. Vogl; Frankfurt a. Main / DE Y. Yagil; Ramat Gan / IL
11:18 11:10
B-0429 Application of dual-energy CT in hypervascular B-0439 Comparison of the accuracy of US-guided biopsy of
neoplstic lesions of liver: subjective and objective breast masses performed with 18-gauge, 16-gauge
analysis in 64 lesions and 14-gauge automated cutting needle biopsy
M.D. Mahajan1, R. Kakkar2, S. Soneji3, S.B. Desai2; 1Bangalore / IN, 2Mumbai / IN, devices
3
Montreal, QC / CA M.L. Huang, K. Hess, R.P. Candelaria, M. Eghtedari, B.E. Adrada, N. Sneige,
B.D. Fornage; Houston, TX / US
11:26
B-0430 Intermediate-stage HCC treated with TACE: 11:18
proposal for a new scoring system B-0440 Modern management of acute breast abscesses:
B. Ginanni, A. Scionti, F. Calcagni, P. Scalise, I. Bargellini, C. Bartolozzi; Pisa / IT radiological interventions replacing surgical incisions?
N.A. Healy, P. Hughes, M. Stenson, S. Harte; Dublin / IE
11:34
B-0431 Significance of gadoxetic acid-enhanced MR imaging 11:26
signal intensity for predicting the efficacy of hepatic B-0441 Clinical and sonographic predictors of complete
arterial infusion chemotherapy in hepatocellular resection for percutaneous excision of benign
carcinoma symptomatic breast lesions using US-guided
N. Fujita, A. Nishie, Y. Asayama, K. Ishigami, Y. Ushijima, Y. Takayama, vacuum-assisted breast biopsy system
D. Okamoto, K. Morita, H. Honda; Fukuoka / JP J.P. Salazar, I. Miranda, Y.K. Ng Wong, C. Avella-García, I. Rubio, R. Salvador;
Barcelona / ES
11:34 11:26
B-0442 Papillary lesions of the breast: B-0452 CAD soware for assessment of pulmonary nodules
is ultrasound-guided VAB useful in their management? with 100kV/Tin-filtered input data comparing iterative
V. Bertani1, P. Clauser1, A. De Nicolò1, M. Pizzamiglio2, C. Zuiani1, M. Bazzocchi1, to filtered back projection reconstructions:
E. Cassano2; 1Udine / IT, 2Milan / IT
a third-generation dual-source CT phantom study
11:42 S. Sudarski1, V. Steck1, M. Meyer1, H. Haubenreisser1, S.O. Schönberg1,
R. Vliegenthart2, T. Henzler1; 1Mannheim / DE, 2Groningen / NL
B-0443 Non-surgical complete excision of small suspicious
breast lesions using the breast lesion excision biopsy 11:34
system (BLES) B-0453 The visibility of lesions around hip prosthesis in
N.M. Abdel Razek; Giza / EG gemstone spectral imaging dual energy CT:
11:50 with or without metal artifact reduction soware
J. Jeong1, H.-J. Kim1, J. Cha2, H. Lim1, S. Hong1, J. Hwang1; 1Seoul / KR,
B-0444 Can the breast lesion excision system (BLES) under 2
Bucheon / KR
stereotactic guidance be used as a therapeutic tool in
the assessment of small areas of microcalcifications 11:42
of the breast? B-0454 Adaptive statistical iterative reconstruction technique
R.-I. Milos, M. Bernathova, P.A.T. Baltzer, K. Pinker-Domenig, P. Kapetas, to reduce radiation dose of brain CT in children
M. Rudas, T.H. Helbich; Vienna / AT P. Lupo1, F.A. Lupo2, G. De Matteis1, G. Sticchi1; 1Foggia / IT, 2Lecce / IT
11:50
10:30–12:00 Room Z B-0455 Use of dose tracking soware for assessment of
patient positioning in CT
Computer Applications M. Twomey, K. Murphy, K. Carey, P. Nicholson, M. Sheehy, O. O’ Connor,
M.M. Maher; Cork / IE
Thursday
SS 605 Dose tracking:
assessment and reduction of artefacts 10:30–12:00 Room M
Moderators: N. Kachenoura; Paris/FR, J. Thrall; Boston, MA/US
10:30 GI Tract
B-0445 Impact of automated attenuation-based tube voltage SS 601b Inflammatory bowel disease
selection on radiation dose at CT: Moderators: R. Del Vescovo; Rome/IT, C. Hohl; Siegen/DE
an observational big data analysis on a global scale
J.V. Spearman1, J.L. Wichmann1, F.G. Meinel1, I. Driesser2, C. Canstein2, 10:30
R.R. Bayer1, S. Mangold1, C.N. De Cecco1, U.J. Schoepf1; 1Charleston, SC / US,
2
Forchheim / DE K-08 Keynote lecture
S. Romano; Naples / IT
10:38
10:39
B-0446 Lessons learned from developing and establishing a
national web-based MDCT DRL survey program B-0456 The impact of Gadolinium-based contrast agent
A.B. Wallace, A. Hayton; Yallambie / AU in the assessment of Crohn’s disease activity:
Is it contrast agent injection necessary?
10:46 E. Quaia, M. Pontello, R. Angileri, M. Cova; Trieste / IT
B-0447 Adult CT dose monitoring using web based radiation
10:47
dose tracking soware
M. Twomey, J. Ryan, K. Murphy, M. Sheehy, M.M. Maher, O.J. O’ Connor; Cork / IE B-0457 Diagnostic value of CEUS to detect acute phase of
Crohn’s disease: systematic review and meta-analysis
10:54 M. Białecki, A. Białecka, Z. Serafin; Bydgoszcz / PL
B-0448 Accuracy of SSDE calculation using radiation dose
10:55
tracking soware (RDTS)
M. Twomey, K. Murphy, C. Sullivan, K. Carey, N. Moore, O.J. O’Connor, B-0458 Comparison of the impact of MRI and colonoscopy
M.M. Maher; Cork / IE on management of Crohn’s disease
J. Rimola, S. Rodríguez, I. Ordás, A. Lopez, E. Ricart, J. Panes; Barcelona / ES
11:02
B-0449 Automatic cloud-based monitoring and analysis of 11:03
computed tomography (CT) dose exposure using B-0459 Diffusion-weighted MRI for prediction of long-term
DICOM-structured report (DICOM-SR) outcomes in patients with perianal fistulas in Crohn’s
J. Boos, A. Meineke, R.S. Lanzman, C. Schleich, O.T. Bethge, G. Antoch, P. Kröpil; disease treated with anti-tumour necrosis factor
Düsseldorf / DE
antibodies
K. Katulska, M. Wykrętowicz, P. Eder, P. Stajgis, K. Linke, M. Stajgis; Poznan / PL
11:10
B-0450 Simulation study about the accuracy of advanced 11:11
airway geometry determination on MDCT using a B-0460 Multicentre prospective evaluation of soware
computer-generated phantom quantified small bowel motility as a biomarker of
O. Weinheimer, C.P. Heußel, H.-U. Kauczor, M.O. Wielpütz; Heidelberg / DE
inflammatory activity in Crohn’s disease
E.F.W. Gryspeerdt1, A. Menys1, D. Atkinson1, J. Makanyanga1, G. Bhatnagar1,
11:18 C. Tuteinnolthenius2, S.A. Taylor1; 1London / UK, 2Amsterdam / NL
B-0451 Lobewise registration of the lungs in computed
tomography improves anatomically correct
voxel-to-voxel mapping of inspiration and expiration
data
T. Kaireit, S. Dettmer, O. Solyanik, W. Frank, H.-o. Shin; Hannover / DE
11:19 11:03
B-0461 Is plain MRI feasible to evaluate inflammation and B-0469 Serial native T1- and T2-mapping to quantitatively
bowel damage in IBD? A prospective comparison with monitor resorption of myocardial edema following
conventional MR enterography acute myocardial infarction
K. Nielsen1, V. Løgager1, B. Rezanavaz-Gheshlagh1, P. Munkholm2, E. Tahir, M. Sinn, U. Radunski, D. Saering, K. Muellerleile, C. Stehning, G. Adam,
H.S. Thomsen1; 1Herlev / DK, 2Rungsted Kyst / DK L. Gunnar; Hamburg / DE
11:27 11:11
B-0462 MR enterography including diffusion weighted imaging B-0470 Assessment of intramyocardial haemorrhage
compared to capsule endoscopy in patients with in acute reperfused myocardial infarction using
suscpected or known inflammatory bowel disease 7.oT CMR T2 mapping
S. Kinner, S. Sirin, S. Kathemann, T.C. Lauenstein, M.L. Hahnemann; Essen / DE W. Chen1, B. Zhang1, F. Gao1, J. Zheng2, C. Wang1; 1Chengdu / CN, 2St. Louis,
MO / US
11:35
B-0463 Monitoring response to infliximab monotherapy in 11:19
Crohn’s disease with interval ultrasound: B-0471 Incidence and role of intramyocardial haemorrage
a safe and objective option (IMH) in the assessment of STEMI pts through
A. Wadhwani, P. Patel, K. Novak, R. Wilkens, S. Wilson; Calgary, AB / CA the use of T2 STAR (T2*) and T2 STIR sequences
G. Benedetti, F. De Cobelli, A. Damascelli, M. Cava, A. Esposito, A. Del Maschio;
11:43 Milan / IT
B-0464 CT-enterography: diagnostic value of 4th generation 11:27
iterative reconstruction algorithm in low-dose B-0472 Infarct evolution patterns following a revascularised
protocol in comparison with standard dose CT protocol acute myocardial infarction:
for clinical follow-up of patients with Crohn’s disease
S. Lombardi, D. Ippolito, A. Casiraghi, C. Talei Franzesi, P. Bonaffini, S. Sironi; a multilayer model for LGE analysis
Monza / IT L. Zhang, F. Odille, O. Huttin, N. Girerd, J. Felblinger, P.-Y. Marie, C. De Chillou,
D. Mandry; Nancy / FR
11:51 11:35
B-0465 MR features of anoperineal involvement B-0473 Delayed dual-energy CT (DECT) and conventional
in hidradenitis suppurativa: cardiac CT angiography (CCTA) in detection
comparison with Crohn’s disease
L. Monnier1, A. Dohan2, N. Amara1, L. Vandromme1, A.-M. Zagdanski2, C. Hoeffel1; of chronic myocardial scar tissue:
1
Reims / FR, 2Paris / FR do we need delayed acquisition? Comparison with MRI
E. Pershina, V. Sinitsyn, E.A. Mershina; Moscow / RU
10:54 10:30
B-0479 Follow-up of atheroma burden with sequential whole B-0487 Biceps pulley and rotator interval of the shoulder in
body contrast enhanced MR angiography: athletes: MR-arthrography dynamic evaluation
a longitudinal cohort study S. Mariani, A. La Marra, F. Arrigoni, L.M. Gregori, L. Patriarca, A. Barile,
J.R. Weir-McCall1, R.D. White2, P. Gutur Ramkumar1, J.J.F. Belch1, A.D. Struthers1, C. Masciocchi; L’Aquila / IT
G. Houston1; 1Dundee / UK, 2Cardiff / UK
10:38
11:02 B-0488 Evaluation of rotator cuff tears by MR arthrography
B-0480 Prediction of recurrent adverse events and organ using the Snyder’s arthroscopic classification and
specific risk in diabetic patients by contrast-enhanced arthroscopy as reference standard
whole body MRI C. Mattiuz, A. Aliprandi, N. Verardi; San Donato Milanese / IT
R.C. Bertheau1, C.L. Schlett1, F. Bamberg2, K. Parhofer3, H. Findeisen4,
H.-U. Kauczor1, S.O. Schönberg5, M.F. Reiser3, S. Weckbach1; 1Heidelberg / DE, 10:46
2
Tübingen / DE, 3Munich / DE, 4Aachen / DE, 5Mannheim / DE B-0489 High-frequency ultrasonography in penetrating tendon
11:10 and nerve injuries of the upper extremity
M. Haroon, I. Ahmad, I. Ahmad, M. Azfar Siddiqui, S. Narayanasamy; Aligarh / IN
B-0481 Screening for asymptomatic cardiovascular disease
with contrast enhanced MRI: association of le 10:54
Thursday
ventricular mass with whole body atheroma burden, B-0491 Quantitative shear wave ultrasound elastography
cardiovascular risk and B type natriuretic peptide of the supraspinatus muscle in relation to tendon
M.A. Lambert1, J.J.F. Belch1, J. Weir-McCall1, S.J. Gandy1, R. Littleford1, integrity and muscle quality
A.D. Struthers1, F. Sullivan2, G. Houston1; 1Dundee / UK, 2Toronto, ON / CA A.B. Rosskopf, C. Ehrmann, F.M. Buck, C. Gerber, C.W.A. Pfirrmann; Zurich / CH
11:18 11:02
B-0482 Reproducibility of manual measurement of B-0492 The effect of percutaneous ultrasound-guided
intima-media thickness at distal common carotid subacromial bursography using microbubbles in
artery under a strict measurement protocol by carotid assessment of subacromial impingement syndrome:
ultrasound in 242 subjects initial experience
J. Plasencia Martínez, J. García Santos; Murcia / ES M. Lu; Chengdu / CN
11:26 11:10
B-0483 Classification of coronary and carotid atherosclerotic B-0493 Evaluation of recurrent rotator cuff tendon tears:
plaque by grating-based phase-contrast computed comparison of MRI, MR arthrography and ultrasound
tomography B. He1, Q. Dong2; 1Kunming / CN, 2Ann Arbor, MI / US
H. Hetterich1, N. Webber1, M. Willner2, J. Herzen2, L. Birnbacher2, A. Hipp2,
F. Bamberg1, F. Pfeiffer2, T. Saam1; 1Munich / DE, 2Garching / DE 11:18
B-0494 Quantification of early fatty infiltration of the rotator
11:34
cuff muscles: comparison of multi-echo Dixon with
B-0484 Simultaneous PET-MR imaging with FDG for the single-voxel MR spectroscopy
evaluation of symptomatic patients with non-stenotic C.A. Agten, A.B. Rosskopf, C. Gerber, C.W.A. Pfirrmann; Zurich / CH
carotid atherosclerotic plaques
A. Schindler, F. Hyafil, D. Sepp, T. Obenhuber, A. Bayer-Karpinska, M. Schwaiger, 11:26
H. Poppert, S. Tobias; Munich / DE
B-0495 MR imaging aer supraspinatus tendon repair with
11:42 good clinical outcomes: morphology and signal
B-0485 Super micro-vascular imaging: a new technique alterations of the supraspinatus tendon
C.A. Agten, F.M. Buck, C.W.A. Pfirrmann; Zurich / CH
detecting neovascularisation in carotid plaque
Q. Yong, L. Zhang, J. Yuan, J. Mu; Beijing / CN 11:34
11:50 B-0496 Usefulness of IDEAL T2 imaging for homogeneous fat
B-0486 3D-black-blood 3T-MRI of the vessel wall and beyond: suppression and reducing susceptibility artifacts in
a clinical perspective brachial plexus MRI at 3T
T. Saam1, K.M. Treitl1, N.N. Kammer1, H. Kooijman2, M.F. Reiser1, E. Coppenrath1; B. Bignotti, S. Airaldi, F. Zaottini, G. Tagliafico, C. Martinoli, A. Tagliafico;
1
Munich / DE, 2Hamburg / DE Genoa / IT
11:42
B-0497 Comparison of 3T MR elastography and shear wave
US elastography measuring normal skeletal muscle
stiffness: a pilot study
D. Na1, S.-J. Hong1, C. Kang1, B. Kim2, K.-S. Ahn1, S. Lee2; 1Seoul / KR,
2
Gyeonggi-do / KR
11:50 11:35
B-0498 Three-dimensional glenohumeral relationship of B-0507 Peritumoural perfusion and proton spectroscopic MR
different surgical glenoid planes: a three-dimensional imaging in the differentiation of gliomas and solitary
CT-scan study metastases
T.R.G.M. Verstraeten, L.F. De Wilde; Gent / BE G. Sparacia1, A. Iaia2, J. Gadde2, M. Midiri1; 1Palermo / IT, 2Newark, DE / US
11:58 11:43
B-0499 Preoperative guiding for the reconstruction of the B-0508 DWI and dynamic susceptibility contrast
native glenoid plane: an anatomical three-dimensional perfusion-weighted imaging of ganglioglioma in
CT-scan reconstruction study adults: comparision study with oligodendroglioma
T.R.G.M. Verstraeten, L.F. De Wilde; Gent / BE S. Lee, S. Choi; Seoul / KR
11:51
10:30–12:00 Room E2 B-0509 Recurrence of high-grade glioma and post-treatment
effects: differentiation by using perfusion and proton
Neuro spectroscopic MR imaging
C. Ho; Singapore / SG
SS 611 Brain tumour (1)
Moderators: N. Bargalló; Barcelona/ES, Y. Özsunar; Aydin/TR
10:30–12:00 Room F1
10:30
K-10 Keynote lecture Oncologic Imaging
I.M. Björkman-Burtscher; Lund / SE
10:39
SS 616 Whole-body imaging of systemic
B-0500 Perfusion and permeability MRI biomarkers for
tumour spreading
Moderators: K.N. De Paepe; Leuven/BE, C.J. Johnston; Dublin/IE
enhancing and nonenhancing components predict
patient survival in newly diagnosed glioblastoma 10:30
O. Solà1, J. Puig1, G. Blasco1, J. Daunis-i-Estadella1, M. Essig2, R. Jain3,
M. Puigdemont1, S. Pedraza1, J. Cambronero1; 1Girona / ES, 2Winnipeg, MB / CA, K-11 Keynote lecture
X. Montet; Geneva / CH
3
New York, NY / US
10:47 10:39
B-0501 Prognosis prediction of measurable enhancing lesion B-0510 Whole-body MRI with T1, STIR and DWI:
aer completion of standard CCRT and adjuvant first non-invasive step to rule out bone marrow
temozolomide in glioblastoma patients: application of involvement in aggressive lymphoma -
dynamic susceptibility contrast perfusion and DWI feasibility study
A. Balbo-Mussetto, A. Fornari, C. Lario, M. Petracchini, C. Saviolo, R. Bruna,
J. Kim, S. Choi, T. Yun, J.-H. Kim, C.-H. Sohn; Seoul / KR C. Tarella, S. Cirillo; Turin / IT
10:55 10:47
B-0502 The functional language connectome in frontal and B-0511 Whole-body DW-MRI in staging of indolent
temporal gliomas lymphomas: comparison with FDG-PET/CT
K.-H. Nenning, A. Müller, D. Prayer, G. Langs, G. Kasprian; Vienna / AT F. Buemi1, A. Stecco1, M. Quagliozzi1, M. Perchinunno1, A. Biacca1,
A. Santagostino2, M. Lombardi1, A. Carriero1; 1Novara / IT, 2Vercelli / IT
11:03
B-0503 Prognostic value of dynamic contrast-enhanced MRI 10:55
for therapeutic evaluation of brain metastases from B-0512 Surveillance of aggressive lymphoma recurrence aer
lung cancer therapy with whole body-MR-DWI:
G. Kuchcinski, C. Delmaire, E. Le Rhun, R. Duhal, M. Lalisse, R. Lópes, J.-P. Pruvo,
A. Cortot, X. Leclerc; Lille / FR report of a single-centre experience
A. Balbo-Mussetto, A. Fornari, C. Lario, M. Petracchini, C. Saviolo, A. Gueli, A. De
Crescenzo, C. Tarella, S. Cirillo; Turin / IT
11:11
B-0504 Tumour permeability pattern: a potential for new 11:03
prognostic factor in immunocompetent patients with B-0513 Diffusion-weighted MR at 3T for therapy response
primary CNS lymphoma assessment in Hodgkin`s lymphoma:
S. Chung, H. Kim, C. Choi, S. Kim; Seoul / KR
comparison with FDG PET
I. Platzek, B. Beuthien-Baumann, K. Zoephel, T. Brauer, J. Maus, R. Ordemann,
11:19 M. Laniado, J. Kotzerke, J. van den Hoff; Dresden / DE
B-0505 The value of serial MR imaging in the assessment of
brain metastases volume control during stereotactic 11:11
radiosurgery B-0514 Incremental value of diffusion-weighted whole-body
G. Sparacia1, A. Banco1, F. Bencivinni1, G. La Tona1, V. Robusto2, M. Midiri1; imaging with background body signal suppression
1
Palermo / IT, 2Messina / IT
coupled with multiparametric MR imaging for the
11:27 detection of skeletal metastasis in prostate cancer
C.J. Das, P. Chakraborty, A.K. Gupta, C.S. Bal; Dehli / IN
B-0506 Intracranial multi-echo MR perfusion measurements:
reproducibility and differential diagnostic value for
intra- and extraaxial tumours
A. Abramyuk, V. Hietschold, K. Sitoci-Ficici, R. von Kummer; Dresden / DE
11:19 11:02
B-0515 Comparison between whole-body MRI and PET/CT B-0524 Fractional anisotropy of the fetal midbrain is
in staging newly diagnosed FDG-avid lymphomas: specifically elevated in Chiari II malformations
our experience R. Woitek, M. Weber, R. Seidl, D. Bettelheim, V. Schöpf, G. Amann, P.C. Brugger,
D. Albano, F. Agnello, C. Patti, A. Mulè, L. La Grutta, F. Midiri, G. Franco, M. Midiri, D. Prayer, G. Kasprian; Vienna / AT
M. Galia; Palermo / IT
11:10
11:27 B-0525 Selected regional changes in brain diffusivity in fetal
B-0516 Comparison of diagnostic certainty for abdominal isolated mild ventriculomegaly
incidentalomas in 18F-FDG PET/MRI and R. Bercovitz1, G. Yaniv1, E. Katorza1, D. Bergman2, C. Hoffmann1, A. Biegon3;
1
Ramat Gan / IL, 2Jerusalem / IL, 3New York, NY / US
18F-FDG PET/CT
B.M. Schaarschmidt1, J. Grueneisen2, P. Heusch1, L. Umutlu2, V. Ruhlmann2, 11:18
S. Rosenbaum-Krumme2, G. Antoch1, C. Buchbender1; 1Düsseldorf / DE,
2
Essen / DE B-0526 Automatic white matter tract segmentation in the
neonatal brain
11:35 C.V. Pul1, L. Fonseca2, N. Lori3, J. Buijs1, P. Andriessen1, A. Vilanova4;
B-0517 ADC of normal abdominal organs and bone marrow
1
Veldhoven / NL, 2Eindhoven / NL, 3Coimbra / NL, 4Del / NL
from whole body DW-MRI at 1.5T: 11:26
the effect of sex and age B-0527 Association between retinoblastoma tumour size and
F. Castelli1, I. Lavdas2, A.G. Rockall2, R.S. Sandhu2, A. Papadaki2, L. Honeyfield2,
A.D. Waldman2, E.O. Aboagye2; 1Verona / IT, 2London / UK tumour extent
M.C. de Jong1, F. van der Meer1, S. Göricke2, H.J. Brisse3, P. Galluzzi4, P. Maeder5,
11:43 A. Moll1, J. Castelijns1, P. de Graaf1; 1Amsterdam / NL, 2Essen / DE, 3Paris / FR,
4
Siena / IT, 5Lausanne / CH
B-0518 Achieving lower radiation dose in follow-up of
oncologic patients: comparison of whole-body CT with 11:34
Thursday
4th generation iterative reconstruction algorithm and B-0528 DTI and MR spectroscopy study in the auditory neural
standard dose examination pathway of paediatric congenital sensorineural
A. Casiraghi, D. Ippolito, P. Bonaffini, C. Talei Franzesi, D. Fior, S. Sironi;
Monza / IT hearing loss patients
C.X. Wu, W.B. Zheng; Shantou / CN
11:51 11:42
B-0519 Image based body surface area evaluation: B-0529 Neonatal lumbar puncture: are traditional clinical
quantitative radiology vs anthropomorphic evaluation landmarks of lumbar anatomy accurate when
A. Iannessi , H. Beaumont , C. Bastiani ; Nice / FR, Valbonne / FR
1 2 1 1 2
10:46 10:39
B-0522 Disrupted developmental organisation of brain B-0531 Ultralow-dose CT with tin-filtration for detection of
connectivity in fetuses with corpus callosum agenesis: solid and sub-solid pulmonary nodules:
an in utero study a phantom study
A. Jakab1, G. Kasprian1, E. Schwartz1, G.M. Gruber1, D. Prayer1, G. Langs1, K. Martini, K. Higashigaito, B.K. Barth, S. Baumüller, T. Frauenfelder; Zurich / CH
V. Schöpf2; 1Vienna / AT, 2Graz / AT
10:47
10:54 B-0532 Comparison of model-based iterative reconstruction
B-0523 Fetal MRI in the evaluation of facial anomalies: with iDose4 and filtered back projection
is there a role? for the analysis of ground-glass opacity nodule
M. Saldari, S. Bernardo, V. Vinci, A. Giancotti, L. Manganaro, C. Catalano; in the chest phantom
Rome / IT J. Nam, S. Choi, S. Shim, J. Lee, K. Bae, J. Park, W. Kwon; Ulsan / KR
10:55 10:38
B-0533 Agreement of pulmonary nodule management based B-0542 Radiation dose reduction in CT fluoroscopy-guided
on diameter- and volume measurements in CT lung cervical transforaminal epidural steroid injection by
cancer screening minimising preliminary planning step
M.A. Heuvelmans1, R. Vliegenthart1, P.M.A. Van Ooijen1, W.P.T.M. Mali2, H.J. De N. Paik; Ulsan / KR
Koning3, M. Oudkerk1; 1Groningen / NL, 2Utrecht / NL, 3Rotterdam / NL
10:46
11:03 B-0543 Reducing the dose in CT-fluroscopy-guided epidural/
B-0534 CT screening for lung cancer: part-solid nodules in perineural injections-how low remains safe?
baseline and annual repeat rounds on behalf of the S.M. Niehues, M. Haas, J. Vahldiek, K. Erb-Eigner, B. Hamm; Berlin / DE
I-ELCAP investigators
C.I. Henschke, R. Yip, A. Wolf, R. Flores, M. Salvatore, D. Yankelevitz; New York, 10:54
NY, NY / US B-0544 Preoperative embolisation of meningiomas:
11:11 analysis of a single-centre experience
A. Pedicelli, L. Danieli, M. Iacobucci, E. Visconti, F. D’ Argento, C. Colosimo;
B-0535 ACR lung-RADS guidelines for pure ground-glass Rome / IT
nodules: is a threshold of 20mm adequate?
S.J. van Riel1, K. Chung1, E.T. Scholten1, P.A. de Jong2, C.M. Schaefer-Prokop3, 11:02
B. van Ginneken1; 1Nijmegen / NL, 2Utrecht / NL, 3Amersfoort / NL B-0545 New single-layer WEBs intrasaccular flow
11:19 disrupters for intracranial aneurysm treatment:
preliminary results of a European multicenter study
B-0536 Automated CT densitometry in characterizing solitary J. Caroff1, C. Strasilla2, A. Berlis3, T. Patankar4, D. Behme5, E. Jacobsen6, T. Liebig7,
pulmonary nodule enhancement S. Prothmann8, L. Spelle1; 1Clichy / FR, 2Erfurt / DE, 3Augsburg / DE, 4Leeds / UK,
Y. Choi, M. Chung, H. Kim; Bucheon / KR 5
Bochum / DE, 6Oslo / NO, 7Cologne / DE, 8Munich / DE
11:27 11:10
B-0537 Differentiation of persistent and transient subsolid B-0546 Endovascular treatment of ruptured blister-like
nodules: does morphology help? aneursyms with special reference to
K. Chung1, E.T. Scholten1, S.J. van Riel1, F. Ciompi1, P.A. de Jong2, M.M. Wille3, the flow-diverting strategies
M. Prokop1, B. van Ginneken1, C.M. Schaefer-Prokop1; 1Nijmegen / NL, M. Gök1, C. Çinar2, H. Bozkaya2, I. Oran2; 1Kars / TR, 2Izmir / TR
2
Utrecht / NL, 3Hellerup / DK
11:18
11:35
B-0548 Complete recanalization aer mechanical
B-0538 Differentiating pre- and minimally invasive from
thrombectomy with stent retrievers:
invasive adenocarcinoma using CT features in
comparison between balloon guide catheter (BCG) and
persistent pulmonary part-solid nodules
J.G. Cohen1, E. Reymond1, M. Lederlin2, M. Medici1, S. Lantuejoul1, F. Laurent2, distal access catheter (DAC) in acute ischemic stroke
F. Arbib1, A. Jankowski1, G.R. Ferretti1; 1Grenoble / FR, 2Bordeaux / FR A. Velasco1, T. Zoubi1, W. Kurre2, M. Aguilar Perez2, S. Berkemeyer1,
T. Niederstadt1, H. Henkes2, R. Chapot3, W. Heindel4; 1Muenster / DE,
11:43
2
Stuttgart / DE, 3Essen / DE, 4Münster / DE
B-0539 Pulmonary nodules: a comparative evaluation of 11:26
unenhanced CAIPIRINHA- volumetric interpolated B-0549 Detection of residual clots aer endovascular stroke
breath-hold examination (VIBE)- 3-TMRI and multislice therapy with dual energy CT
computed tomography A.E. Grams, M. Knoflach, J. Willeit, M. Sojer, E.R. Gizewski, B. Glodny;
P. Dewes, C. Frellesen, F. Al-Butmeh, J.L. Wichmann, M. Albrecht, T.J. Vogl; Innsbruck / AT
Frankfurt / DE
11:34
11:51 B-0550 Does the therapist’s attitude affect the clinical
B-0540 Detection and quantification of the solid component outcome of lumbar facet joint intra-articular
in pulmonary subsolid nodules by semiautomatic injections?
segmentation A. Maataoui1, K. Kollias2, A. Splettstößer3, T.J. Vogl1, M. Khan1, M. Middendorp1;
E. Scholten1, C. Jacobs2, B. van Ginneken2, S. van Riel2, R. Vliegenthart3, 1
Frankfurt / DE, 2Düsseldorf / DE, 3Hilden / DE
M. Oudkerk3, M. Prokop2, H.A. Gietema1, P.A. de Jong1; 1Utrecht / NL,
2
Nijmegen / NL, 3Groningen / NL
10:30–12:00 Room G
10:30–12:00 Room D2 Genitourinary
Interventional Radiology SS 607a DWI in prostate cancer
Moderators: T. Durmus; Berlin/DE, G. Villeirs; Gent/BE
SS 609 Neuro interventions
Moderators: N. Amoretti; Nice/FR, A. Ringelstein; Essen/DE 10:30
10:30 B-0552 The role of ultra-high b-value diffusion-weighted MRI
for detection of the index tumour in patients with
B-0541 Novel x-ray shielding device for reducing the lens
prostate cancer
exposure during endovascular treatment for brain E. Rud, E. Baco, H.B. Eggesbø; Oslo / NO
diseases
1 2 3 4 5 1
L. Sun , T. Totsuka , K. Akahane , M. Hayakawa , Y. Matsumaru , K. Tsuboi ,
T. Moritake6; 1Tsukuba / JP, 2Higashi Ibaraki Chiou / JP, 3Chiba / JP, 4Osaka / JP,
5
Tokyo / JP, 6Kitakyushu / JP
10:46 10:30
B-0554 Small field-of-view single-shot EPI-DWI of B-0565 MRI of muscle strains of the thigh in professional
the prostate: evaluation of spatially-tailored soccer players:
two-dimensional radiofrequency excitation pulses correlation of imaging findings with the duration of
D. Hausmann1, N. Rathmann1, M. Sertdemir1, P. Riffel1, A. Weidner1, convalescence and presentation at return to play
S. Kannengiesser2, J.N. Morelli3, S.O. Schönberg1, U.I. Attenberger1; M. Regier, C. Behzadi, F.O.O. Henes, G. Adam, P. Catala-Lehnen; Hamburg / DE
1
Mannheim / DE, 2Erlangen / DE, 3Tulsa, OK / US
10:38
10:54 B-0563 Delayed gadolinium enhanced MRI of cartilage
B-0555 Assessment of prostate cancer aggressiveness using of the hip at 7 Tesla
the combination of quantitative diffusion-weighted A. Lazik, J.M. Theysohn, S. Orzada, H.H. Quick, O. Kraff; Essen / DE
and dynamic contrast-enhanced MRI
A.M. Hötker, Y. Mazaheri, Ö. Aras, J. Zheng, C.S. Moskowitz, T. Gondo, 10:46
K. Matsumoto, H. Hricak, O. Akin; New York, NY / US B-0564 Analysis of remodeling processes in patients
11:02 with avascular necrosis of the femoral head aer
advanced core decompression using 3T MRI
B-0556 Advantages of zoomed EPI with A. Lazik, O. Kraff, T. Claßen, S. Landgraeber, T.C. Lauenstein, J.M. Theysohn;
Essen / DE
Thursday
parallel-transmit-accelerated 2D-selective excitation
imaging in diffusion-weighted MRI of the prostate
K.M. Thierfelder1, M. Notohamiprodjo2, J. Weiß2, O. Dietrich1, U.G. Mueller-Lisse1, 10:54
M.F. Reiser1, K. Nikolaou2, D. Theisen1; 1Munich / DE, 2Tübingen / DE B-0566 T2- and T2*-mapping of hip cartilage at 7 Tesla:
11:10 initial results in healthy volunteers
A. Lazik, J.M. Theysohn, S. Orzada, H.H. Quick, O. Kraff; Essen / DE
B-0557 Comparison of field-of-view (FOV) optimised and
constrained undistorted single-shot (FOCUS) with 11:02
conventional DWI for the evaluation of prostate B-0567 CT-imaging of a hip prosthesis using model-based
cancer iterative reconstruction and its influence on metal
Z. Feng; Wuhan / CN artefact reduction: a quantitative analysis
R.H.H. Wellenberg1, M.F. Boomsma1, J.A.C. van Osch1, A. Vlassenbroek2, J. Milles3,
11:18 D. Mueller4, M. Maas5; 1Zwolle / NL, 2Best / NL, 3Eindhoven / NL, 4Hamburg / DE,
B-0559 Diffusion-weighted imaging of the prostate:
5
Amsterdam / NL
comparison of readout-segmented DWI and 11:10
parallel-transmit-accelerated selective excitation DWI B-0568 Various factors contribute to gra extrusion in lateral
regarding image quality and distortion meniscus allogra transplantation:
B.K. Barth , A. Cornelius , D. Nanz , D. Eberli , O.F. Donati ; Zurich / CH,
1 2 1 1 1 1
2
Aarau / CH MRI evaluation of 87 knees
J. Yoon, S. Lee, Y. Cho, R. Son, S. Kim, S. Ahn, H.-K. Lee; Sungnam / KR
11:26
B-0560 Added value of multiparametric MRI to clinical 11:18
parameters for characterising prostate cancer: B-0569 Oedema of the cartilage in the lateral facet of the
a histology validated study patella: does it predict patellar instability?
A. Falkowski1, C. Camathias1, J.A. Jacobson2, O. Magerkurth1; 1Basle / CH, 2Ann
P. Pricolo, S. Alessi, O. De Cobelli, G. Renne, B. Jereczek-Fossa, S. Raimondi, Arbor, MI / US
P. Summers, G. Petralia; Milan / IT
11:34 11:26
B-0561 MR-guided biopsy for prostate cancer: B-0570 Characterisation of achilles tendons in familial
the role of DWI at 3 Tesla in the decision making hypercholesterolemia patients using ultrasound
of index lesion imaging and shear wave elastography: a pilot study
L. Zhang, J. Lin, S. Zhang, Q. Yong; Beijing / CN
V. Panebianco, F. Vasselli, V. Forte, G. Manenti, G. Simonetti, C. Catalano;
Rome / IT
11:34
11:42 B-0571 Neurogenic myositis ossificans of the hip:
B-0562 Diffusion parameters (DTI and DWI) are superior correlation between enhanced CT and surgical findings
C. Hangard, R. Carlier; Garches / FR
to DCE-MRI in differentiation of BPH nodule from
prostate cancer: quantitative comparison 11:42
M. Kekelidze, G. Müller, M. Weigel, T. Haas, M. Pradella, G. Bongartz; Basle / CH
B-0572 Navicular bone position determined by weight bearing
11:50 MRI: interobserver and between day reliability
P. Hansen, S. Hangaard, F.E. Johannsen, S. Stallknecht, M. Henriksen, R. Bouert,
B-0558 Intravoxel incoherent motion (IVIM) MRI J.D. Nybing, B.B. Hansen, M. Boesen; Copenhagen / DK
for the interpretation of pelvic lymph nodes
in prostate cancer:
can we discriminate benign from malignant nodes?
M. Regier, C. Schmitt, C. Seiwerts, C. Behzadi, F.O.O. Henes, M. Kaul, G. Adam,
L. Budaeus; Hamburg / DE
11:50 11:35
B-0573 Role of the weight-bearing MRI in the evaluation of B-0581 The evaluation of residual bone marrow signal
traumatic and overload pathologies of the midtalar changes in nasopharyngeal carcinoma patients
and subtalar joints treated with radiation therapy
S. Mariani, A. La Marra, F. Arrigoni, L.M. Gregori, L. Patriarca, A. Barile, S. Parlak, B. Ozgen Mocan, G. Yazici, A. Dolgun Barak; Ankara / TR
C. Masciocchi; L’Aquila / IT
11:43
B-0582 CT scan in preservation protocols of laryngeal
10:30–12:00 Room MB 1 carcinomas: choice of response criterions and impact
of on disease free survival
Head and Neck J. Valcke; Marseille / FR
10:39
10:30–12:00 Room MB 2
B-0574 Detection of locoregional tumour recurrence
in post treatment head and neck malignancies: Genitourinary
a comparative evaluation of dynamic perfusion CT
with F-18 FDG PET/CT SS 607b Benign gynaecological pathology
N.M. Mulimani, N. Khandelwal, P. Ssingh, V. Gupta, S. Ghoshal, B.R. Mittal; Moderators: J. Arnáiz; Doha/QA, R.N. Lucas; Lisbon/PT
Chandigargh / IN
10:30
10:47
B-0586 Uterine fibroids treatment selection using MRI:
B-0575 FDG PET/CT and DWI of head and neck squamous cell
MR-guided high-intensity focused ultrasound
carcinoma: prognostic value of standardised uptake
(MRgFUS), uterine artery embolisation (UAE)
value and apparent diffusion coefficient
G. Conte, F. Ruju, M. Moscatelli, L. Bonello, L.L. Travaini, S. Raimondi, M. Ansarin, and surgery: a per group analysis of outcomes
L. Preda; Milan / IT F. Ciolina, C. Palla, F. Zaccagna, F. Sandolo, A. Napoli, C. Catalano; Rome / IT
10:55 10:38
B-0576 Combined PET/CT and DWI by rigid image B-0587 Transvaginal sonography vs uro-colon-CT
coregistration increases diagnostic accuracy in the diagnosis of deep infiltrating endometriosis
in head and neck tumours of the anterior and posterior compartment
A. Stecco, M. Perchinunno, S. Ciolfi, I. Divenuto, M. Lombardi, A. Carriero; D. Papadopoulos, F. Coppola, D. Valerio, C. Balacchi, L. Zannoni, S. Del Forno,
Novara / IT R. Seracchioli, R. Golfieri; Bologna / IT
11:03 10:46
B-0577 Oropharyngeal squamous cell carcinoma: B-0589 Role of virtual hysterosalpingography
morphological and functional MRI differences between in the diagnosis the causes of infertility
A. Dmitriev, A. Karpenko, E. Bogdanova; St. Petersburg / RU
human papilloma virus positive and negative tumours.
Preliminary results 10:54
S. Sdao, G. Calareso, L. Bonello, H. Kule, E. Orlandi, N.A. Iacovelli, E. Casiraghi,
P. Panizza; Milan / IT B-0590 The diagnostic accuracy of multidetector CT
in the evaluation of ovarian torsion:
11:11 compared with mis-read cases
B-0578 Evaluation of the feasibility of MRI volumetry J. Kim1, Y.-M. Ku2, S.-L. Lee2; 1Seoul / KR, 2Uijeongbu / KR
in staging of oral carcinoma 11:02
R.S.S. Al Umairi, J. Hallinan, K. Al-Macki, E. Ting, T. Loh, N. Leehy, S. Liang;
Singapore / SG B-0591 Diagnostic performance of diffusion-weighted MRI
in the diagnosis of ovarian torsion: comparison with
11:19 conventional MRI and surgical findings
B-0579 DWI and T2-W MRI for the evaluation of residual T. Bekci, A.V. Polat, K. Aslan, M. Ceyhan Bilgici, M. Danaci; Samsun / TR
lymph nodes in patients affected by squamous
cell carcinoma of the head and neck, treated with 11:10
chemo-radiotherapy B-0592 Ultrasound guided therapeutic aspiration of simple
E. Gangemi, F. Piludu, V. Manciocco, A. Guerrisi, R. Covello, S. Marzi, A. Vidiri; ovarian cysts with tetracycline sclerotherapy
Rome / IT V. Patre, V. Dutt, S.B. Netam, R. Gahine, A. Singh, T. Nagaria; Raipur / IN
11:27 11:18
B-0580 MDCT and MRI evaluation of mandibular invasion by B-0593 Benign enhancing solid component of mature ovarian
squamous cell carcinoma of the oral cavity teratoma: MR imaging features
S. Agarwal; Guwahati / IN H. Shin, K. Kim, C. Lee, J. Choi, J. Lee, Y. Park, C. Park; Seoul / KR
11:26
B-0594 Clinical utility of pelvic magnetic resonance imaging
(MRI) in patients with suspected ectopic pregnancy
Y. Ragab1, M. Edris2; 1Cairo / EG, 2Jeddal / SA
Thursday
10:55 14:17
B-0597 Assessment of the regurgitant orifice area in aortic B-0606 Use of dual-energy virtual non-contrast CT for
regurgitation with dual-source CT: comparison with quantitative assessment of hepatic steatosis with
cardiovascular MR dual-source CT scanner: a preliminary study
T. Kim, S. Ko, J. Park, J. Shin, J. Kim; Seoul / KR X. Wang, S.-t. Wang, H.-d. Xue, Z.-Y. Jin; Beijng / CN
11:03 14:25
B-0598 CT planning of aortic valve replacement: B-0607 Heritability of abdominal adipose tissue
evaluation of virtually reconstructed ultra low keV compartments and hepatic lipid accumulation:
monoenergetic reconstructions based a classical twin study
on 3rd generation dual-energy CT Z.D. Drobni1, A.L. Jermendy1, T. Horvath1, A. Bartykowszki1, A.D. Tarnoki1,
H. Haubenreisser, M. Meyer, S.O. Schönberg, T. Henzler; Mannheim / DE S. Voros2, B. Merkely1, P. Maurovich-Horvat1, G. Jermendy1; 1Budapest / HU,
2
Richmond, VA / US
11:11
B-0599 Multimodality imaging evaluation before TAVI: 14:33
incidence of CI-AKI in relation to known risk factors B-0608 The role of MR in the diagnosis of non-alcoholic
C. Schneider, A. Brumberg, F.C. Roller, J. Rixe, P. Roth, G.A. Krombach; fatty liver disease:
Giessen / DE correlation with liver biopsy and insulin resistance
C. Berzovini, R. Faletti, C. Arese, F. Barisone, D. Righi, P. Fonio, G. Gandini;
11:19 Turin / IT
B-0600 Pre-TAVI evaluation: dynamic assessment
of circumference-derived diameter and its influence 14:41
on prosthesis selection B-0609 Association between T2, T2* and indicators of hepatic
J. Turek, M. Kok, C. Mihl, B.L.J.H. Kietselaer, V.V.A. van Ommen, E.C. Nijssen, inflammation as an early sign of non-alcoholic fatty
J.E. Wildberger, M. Das; Maastricht / NL liver disease in asymptomatic high-risk subjects
M.N. Bongers, C. Schabel, F. Bamberg, A. Fritsche, H.-U. Häring, K. Nikolaou,
11:27 F. Schick, J. Machann; Tübingen / DE
B-0601 Valve-in-valve transcatheter implantation work-up:
CT can accurately determine the implanted 14:49
bioprosthesis size B-0610 Grading of steatosis and liver-fibrosis using phase
D. Suchá1, C.G. Daans1, P. Symersky2, R.N. Planken2, W.P.T.M. Mali1, L.A. van contrast imaging
Herwerden1, R.P.J. Budde3; 1Utrecht / NL, 2Amsterdam / NL, 3Rotterdam / NL M. Armbruster1, B. Zupanc1, E. Brun2, A. Bravin2, W.H. Sommer1, R. Reimar1,
W. Thasler1, M.F. Reiser1, P. Coan2; 1Munich / DE, 2Grenoble / FR
11:35
B-0602 Medium-term biventricular heart remodeling 14:57
aer percutaneous and surgical pulmonary valve B-0611 Diagnostic accuracy of real-time ShearWave
implantation evaluated with cardiac magnetic elastography for the noninvasive assessment of liver
resonance fibrosis
F. Secchi, F. Pluchinotta, E. Resta, P. Cannaò, M. Carminati, F. Sardanelli; N. Huet, I. Bricault, A. Martino, M. Medici, E. Chipon, N. Sturm, J.-P. Zarski,
Milan / IT A. Moreau-Gaudry, V. Leroy; Grenoble / FR
11:43 15:05
B-0603 Assessment of pulmonary insufficiency by cardiac B-0612 Diagnostic value of Real-Time elastography (RTE)
magnetic resonance using regurgitation fraction or compared to biopsy in the assessment of liver
absolute value of reverse volume stiffness in patients with chronic viral hepatitis
M. Petrini, F. Secchi, F.R. Pluchinotta, M. Carminati, M. Chessa, F. Sardanelli; San M. Schiavone, D. Ippolito, P.A. Bonaffini, C.R.G.L. Talei Franzesi, D. Fior, S. Sironi;
Donato Milanese / IT Monza / IT
15:13 15:04
B-0613 Estimation of extracellular volume fraction using B-0623 Unenhanced breast magnetic resonance imaging:
routine four-phase liver CT for grading hepatic fibrosis detection of breast cancer
J.-H. Yoon1, J. Lee1, E. Klotz2, J. Han1, B. Choi1; 1Seoul / KR, 2Forchheim / DE A. Bonatesta, P. Belli, E. Bufi, M. Tumino, C. Buccheri, L. Bonomo; Rome / IT
15:21 15:12
B-0614 Assessment of fibrotic tissue and microvascular B-0624 Breast lesion differentiation by 3-parameter
architecture by in-line phase-contrast imaging in IVIM analysis
mouse model of liver fibrosis H. Dijkstra, M.D. Dorrius, M. Wielema, M. Oudkerk, P.E. Sijens; Groningen / NL
Y. Fu, W.-j. Peng, X. Zhang; Shanghai / CN
15:20
B-0625 Correlation of intravoxel incoherent motion
14:00–15:30 Room C diffusion-weighted imaging with immunohistochemical
index in breast ductal carcinoma
Breast L. Cai, Y. Chen, X. Liu, Y. Chen, Y. Xiao; Fujian / CN
SS 702 Breast:
diffusion-weighted MR imaging (DWI) 14:00–15:30 Room Z
Moderators: G. Forrai; Budapest/HU, C. Iacconi; Carrara/IT
Vascular
14:00
B-0615 Is there a systematic bias of apparent diffusion SS 715 Arteries and veins
Moderators: A. Capelastegui; Galdakao/ES, L. Mailli; London/UK
coefficient (ADC) measurements of the breast if
measured on different workstations? An inter- and 14:00
intra-reader agreement study B-0626 Overall evaluability of 80-kV multi-detector CTA of the
P. Clauser1, M. Maieron1, M. Marcon1, C. Zuiani1, M. Bazzocchi1, P.A.T. Baltzer2;
1
Udine / IT, 2Vienna / AT thoracic aorta using a not-tailored injection protocol
with low concentration iso-osmolar iodinated contrast
14:08 medium
B-0616 Diffusion-weighted imaging with background body A.D. Annoni, A. Formenti, G. Pontone, S. Mushtaq, M. Petullà, E. Bertella,
E. Nobili, M. Pepi, D. Andreini; Milan / IT
signal suppression (DWIBS) imaging of breast lesions
before and aer gadolinium injection 14:08
M. Telegrafo, M. Moschetta, A. Stabile Ianora, G. Angelelli; Bari / IT
B-0627 CTA of the aorta using 80kVp in combination
14:16 with iterative reconstruction:
B-0617 The influence of size and position of the region of evaluation of image quality and dose reduction
J. Boos, J. Aissa, R.S. Lanzman, P. Heusch, L. Schimmöller, G. Antoch, P. Kröpil;
interest on the apparent diffusion coefficient values in Düsseldorf / DE
discriminating between benign and malignant breast
lesions in diffusion weighted imaging 14:16
M. Wielema, M.D. Dorrius, H. Dijkstra, M. Oudkerk, P.E. Sijens; Groningen / NL B-0628 CT dose reduction using sequential or fast pitch spiral
14:24 technique employed in CTA of the aorta:
B-0618 Sensitivity of dynamic contrast-enhanced and results from the CT dose study
A.M. Bucher1, M. Renker2, F.G. Meinel3, T.J. Vogl1, K.M. Chinnaiyan4, G.L. Raff4,
diffusion-weighted MRI in the detection of ductal U.J. Schoepf5; 1Frankfurt a. Main / DE, 2Giessen / DE, 3Munich / DE, 4Royal Oak,
carcinoma in situ and correlation with nuclear grade MI / US, 5Charleston, SC / US
C. Borelli, G.K. Parapatt, R. Fubelli, C. Buccheri, M. Giuliani, P. Rinaldi, P. Belli,
L. Bonomo; Rome / IT 14:24
B-0629 Lower limbs low voltage (80kV) CTA:
14:32 lower radiation dose delivered and less contrast
B-0619 Traffic light labelling of the apparent diffusion medium with preservation of image quality
coefficient improves specificity of breast MRI M. Belgrano, C. Cercato, W. Toscano, A. Rossi, M.A. Cova, M. Cazzagon;
M. Dietzel1, A. Baltzer2, P.A.T. Baltzer2; 1Erlangen / DE, 2Vienna / AT Trieste / IT
14:40 14:32
B-0620 Are morphologic descriptors of MR BIRADS lexicon B-0630 Low-dose runoff CTA in overweight and obese
applicable to breast DWI? patients: effect of hybrid iterative reconstruction
V. Piccione, L. Martincich, S. Carabalona, M. Eandi, S. Osano, F. Astegiano,
D. Regge; Candiolo / IT technique on image quality
V. Aznaurov, E.V. Kondratyev, V. Shirokov, P. Davydenko, G.G. Karmazanovsky;
Moscow / RU
14:48
B-0621 Diffusion-weighted imaging at 3T: 14:40
correlation of the apparent diffusion coefficient B-0631 Location and severity of aortic valve calcium in
value with breast cancer biomarkers patients undergoing transcatheter aortic valve
M. Telesca, F. Pediconi, S. Ursu, M. Luciani, C. De Felice, V. Cipolla, C. Catalano;
Rome / IT implantation
P. Apfaltrer1, T. Henzler1, S. Wolke1, H. Schroefel2, S. Schoenberg1, G. Schymik2;
1
Mannheim / DE, 2Karlsruhe / DE
14:56
B-0622 Role of unenhanced breast MRI for detecting and
differentiating breast lesions
M. Moschetta, M. Telegrafo, E. Tricarico, L. Rella, A. Stabile Ianora, G. Angelelli;
Bari / IT
14:48 14:40
B-0632 Accuracy and time-efficiency of multi-path curved B-0642 Ultrasound versus magnetic resonance imaging
planar reformations in the evaluation of low-dose CT for Morton neuroma: systematic review and
angiography of the peripheral arteries meta-analysis
M.M. Schreiner, C. Loewe, S. Unterhumer, M. Weber, G. Mistelbauer, M. Sramek, B. Bignotti, A. Signori, M. Sormani, L. Molfetta, S. Airaldi, F. Zaottini,
E. Gröller, R.E. Schernthaner; Vienna / AT G. Tagliafico, C. Martinoli, A. Tagliafico; Genoa / IT
14:56 14:48
B-0633 3D DCE-MRA in evaluation of blood-flow in diabetic B-0643 Fascicular involvement in common peroneal
foot neuropathy: evaluation with ultrasound
M. Zamyshevskaya, V. Zavadovskaya, M. Zorkaltsev, V. Udodov, E. Grigoriev; S. Airaldi, B. Bignotti, F. Zaottini, G. Tagliafico, A. Tagliafico, C. Martinoli;
Tomsk / RU Genoa / IT
15:04 14:56
B-0634 Differential diagnosis of chronic total occlusive and B-0644 Ultrasound versus magnetic resonance imaging
subtotal occlusive disease of the lower extremity in common peroneal neuropathy
arteries using reverse attenuation gradient sign on S. Airaldi, B. Bignotti, F. Zaottini, G. Tagliafico, A. Tagliafico, C. Martinoli;
Genoa / IT
CTA
H.J. Park; Seoul / KR 15:04
15:12 B-0645 The quantitative MRI evaluation of repair tissue aer
B-0635 Dynamic assessment of deep vein thrombosis: microfracture treatment for ankle osteochondritis
CE MR venography with a bloodpool agent vs duplex dissecans (OCD)
H. Tao, Y. Qiao, S. Chen; Shanghai / CN
ultrasound and contrast venography
Thursday
C.W.K.P. Arnoldussen1, R. Strijkers2, R. de Graaf2, C.H.A. Wittens3, 15:12
J.E. Wildberger2; 1Maastricht / NL, Venlo / NL, 2Maastricht / NL, 3Aachen / DE,
Maastricht / NL B-0646 Knee joint subchondral bone structure is altered in
active athletes
15:20 F.W. Roemer1, M. Jarraya2, J. Niu2, J. Duryea2, J. Lynch3, A. Guermazi1; 1Doha / QA,
B-0636 Thrombus dissolution using contrast enhanced
2
Boston, MA / US, 3San Francisco, CA / US
ultrasound in an in-vitro model of acute deep vein 15:20
thrombosis B-0647 Efficacy of computed tomography (CT) guided
1 1 2 2 1 1
B. Dharmarajah , T. McKinnon , C. Keravnou , M. Averkiou , A. Davies , E. Leen ;
1
London / UK, 2Nicosia / CY radiofrequency ablation (RFA) for osteoid osteomas in
31 patients
J. Kim, E. Lee; Seongnam-si / KR
14:00–15:30 Room E1
14:40 14:40
B-0653 Dynamic T1 contrast-enhanced MRI of peritumoural B-0664 Accuracy of retrospective PET and MRI-DWI (PET/
white matter in differentiation between glioblastoma MRI-DWI) image fusion in detection of cervical and
multiforme and metastatic tumour endometrial cancer lymph node metastases:
R. Tupý, J. Ferda, J. Kastner, O. Hes, V. Přibáň; Plzen / CZ comparison with PET/CT and MRI-DWI
F. Buemi, A. Stecco, A. Cassarà, G. Sacchetti, R. Matheoud, M. Brambilla,
14:56 A. Arnulfo, A. Carriero; Novara / IT
B-0655 DWI and histological parameters in meningioma
A. Surov1, S. Gottschling2, A. Wienke2, C. Mawrin3, R. Spielmann2, J. Prell2, 14:48
E. Fiedler2; 1Leipzig / DE, 2Halle / DE, 3Magdeburg / DE B-0665 Role of DWI in cervical cancer for prediction and
15:04 monitoring of chemoradiotherapy response
P. Kala, V. BharGavi, R. Avantsa, G. Narayan; Bangalore / IN
B-0656 MRS in differentiating low-grade from high-grade
astrocytoma in children 14:56
M. Dziubinska-Basiak, M. Konopka, M. Basiak, M. Wicher, B-0666 CT performance for the pre-operative quantification
M. Machnikowska-Sokolowska, J. Walecki; Katowice / PL
of peritoneal carcinomatosis in ovarian cancer
15:12 S. Bennani, A.-S. Bats, F. Chamming’s, C. Bensaid, C. Bourillon, C. Couvidat,
F. Lecuru, L. Fournier; Paris / FR
B-0657 fMRI signal changes in the central nervous system
aer 3D based radiotherapy 15:04
A. Kovacs1, M. Emri2, C. Vandulek1, C. Glavak1, Z. Szalai1, G. Biro1, G. Bajzik1, B-0667 Accuracy of MDCT in preoperative definition of
I. Repa1; 1Kaposvár / HU, 2Debrecen / HU
peritoneal carcinomatosis of bowel loops in patients
15:20 with advanced ovarian cancer who underwent
B-0658 Diffusion Kurtosis imaging in diagnosis of malignancy peritonectomy and hyperthermic intraperitoneal
and proliferative activity of brain gliomas chemotherapy
A.S. Tonoyan1, I. Pronin1, F. Grinberg2, E. Farrher2, D. Pitskhelauri1, L. Fadeeva1, S. Guerrini, M.A. Mazzei, A. Cirigliano, N. Cioffi Squitieri, G. Bettini, F.G. Mazzei,
E. Pogosbekyan1, A. Potapov1, V. Kornienko1; 1Moscow / RU, 2Juelich / DE D. Marrelli, L. Volterrani; Siena / IT
15:12
14:00–15:30 Room F1 B-0668 Agreement in identification of tumour recurrence,
peritoneal deposits or distant metastasis in patients
Oncologic Imaging treated with ovarian cancer using MRI
K. Skrobisz-Balandowska, L. Klasa, M. Liro, D. Wydra, M. Studniarek,
SS 716 Urogenital oncology A. Bianek-Bodzak; Gdansk / PL
Moderators: R.A. Kubik-Huch; Baden/CH, I. Thomassin-Naggara; Paris/FR 15:20
14:00 B-0669 Prediction of 5-year survival with texture analysis in
B-0659 Prediction of response of primary tumours patients with ovarian cancer
I. Radlgruber, M.E. Mayerhoefer, S. Aust, S. Polterauer, M. Weber, S. Polterauer,
to neoadjuvant sunitinib using perfusion (DCE) CT T. Knogler; Vienna / AT
in metastatic renal cell carcinoma (mRCC) patients
(PREINSUT trial)
M. Bouaboula, Y. Vano, L. Mauge, H. Pereira, D. Helley, A. Mejean, C.-A. Cuenod, 14:00–15:30 Room F2
S. Oudard, L. Fournier; Paris / FR
14:32 14:41
B-0675 Empirical dual-energy beam hardening correction in B-0686 Comparison of diagnostic capability for N-stage in
dual-energy CT non-small cell lung cancer patients with DWI using EPI
S. Schüller1, S. Sawall1, M. Lell2, M. Kachelrieß1; 1Heidelberg / DE, 2Erlangen / DE sequence at 3T and FDG-PET/CT
Y. Ohno1, S. Seki1, H. Koyama1, Y. Kassai2, M. Yui2, T. Yoshikawa1, S. Matsumoto1,
14:40 K. Sugimura1; 1Kobe / JP, 2Otawara / JP
B-0676 Dual source dual energy CT for kidney stones:
impact of patient motion 14:49
B. Krauss, B. Schmidt, T. Allmendinger, T. Flohr; Forchheim / DE B-0687 Multifunctional assessment of NSCLC using
whole-body MRI with DWI and 18F-FDG-PET/CT:
14:48 correlation between ADC and metabolic volumetric
B-0677 A comparison of image quality between fine focal spot and non-volumetric parameters
and standard focal spot CT of the abdomen and pelvis L. Calandriello, A. Larici, M. Ciliberto, A. del Ciello, L. Leccisotti, A. Giordano,
Y.P. Goh, K.K. Lau, K.Y. Low, C.W. Oh, M. Huynh, K. Buchan, A. Kuganesan; L. Bonomo; Rome / IT
Melbourne / AU
14:57
14:56 B-0688 Sequential dynamic PET and dynamic MR imaging
B-0678 Alpha-image reconstruction: a novel iterative image in N-staging of lung cancer patients
reconstruction algorithm with well-defined image P. Flechsig, H. Zabeck, C.-P. Heußel, H.-U. Kauczor, U. Haberkorn, F. Giesel;
quality metrics applied to clinical CT data Heidelberg / DE
S. Lebedev, S. Sawall, M. Knaup, M. Kachelrieß; Heidelberg / DE
15:05
15:04 B-0689 Dynamic contrast-enhanced perfusion area-detector
B-0679 Iterative model reconstruction and hybrid iterative CT in non-small cell lung cancer patients with
reconstruction techniques in liver CT for evaluation
Thursday
chemoradiotherapy: influence of mathematical model
of hepatocellular carcinoma: to early prediction of recurrence
comparison of image quality in the detection of Y. Ohno1, S. Seki1, H. Koyama1, T. Yoshikawa1, S. Matsumoto1, Y. Fujisawa2,
N. Sugihara2, K. Sugimura1; 1Kobe / JP, 2Otawara / JP
hypervascular hepatocellular carcinoma
H. Park, J. Lee, S. Park, J. Lee, Y.-K. Jeong; Seoul / KR
15:13
15:12 B-0690 Value of computerised 3D shape analysis in
B-0680 The influence of the orbital bone density differentiating encapsulated from invasive thymomas
J. Lee, C. Park, S. Park, J. Bae, S. Lee, J. Goo; Seoul / KR
on the eye-lens dose in dental CBCT
A. Stratis, G. Zhang, R. Jacobs, R. Bogaerts, H. Bosmans; Leuven / BE
14:00–15:30 Room D2
14:00–15:30 Room D1
Interventional Radiology
Chest SS 709a TIPS and portal vein intervention
SS 704 Lung cancer: screening and staging Moderators: A. Krajina; Hradec Králové/CZ, A. Massmann; Homburg/DE
Moderators: F. Gleeson; Oxford/UK, T. Henzler; Mannheim/DE
14:00
14:00 B-0691 Comparison of hepatic venous pressure gradient and
K-16 Keynote lecture endoscopic grading of oesophageal varix
P.A. Grenier; Paris / FR E. Lee1, Y. Kim1, S. Yang2, D. Goo1, J. Hwang1, S. Hong1, J. Hwang1, H.-J. Kim1;
1
Seoul / KR, 2Gumi / KR
14:09
14:08
B-0681 Diagnostic performance of ultra-low-dose computed
B-0692 Towards a turning point in gastric varices treatment:
tomography for detecting asbestos-related
modified balloon-occluded retrograde transvenous
pleuropulmonary diseases:
obliteration
prospective study in a screening setting M.-Y. Chang, M. Kim, S. Lee, G. Kim, J. Won, S. Park, D. Lee; Seoul / KR
M. Schaal, F. Severac, A. Labani, M.-Y. Jeung, C. Roy, M. Ohana; Strasbourg / FR
14:16
14:17
B-0693 Fast balloon-occluded retrograde transvenous
B-0682 Pleural abnormalities in lung cancer screening trial:
obliteration using n- butyl cyanoacrylate aer foam
prevalence, features, and relation with cancer
M. Silva1, N. Sverzellati1, D. Colombi1, C. La Vecchia2, C. Galeone2, A. Marchiano2, sclerosants for gastric varices
U. Pastorino2; 1Parma / IT, 2Milan / IT J. Koizumi, C. Itou, T. Hara, T. Sekiguchi, N. Mori, S. Ono, T. Ichikawa, C. Tanaka,
Y. Imai; Isehara / JP
14:25
14:24
B-0683 Parametric response mapping in lung cancer screening
B-0695 Long-term outcome of expandable-polytetraethylene
subjects with and without COPD
E. Pompe1, E.M. van Rikxoort2, L. Gallardo Estrella2, M. Oudkerk3, H.J. de (e-PTFE) covered stents for transjugular intrahepatic
Koning4, J.-W.J. Lammers1, B. van Ginneken2, P.A. de Jong1, F.A.A. Mohamed portosystemic shunts (TIPS)
Hoesein1; 1Utrecht / NL, 2Nijmegen / NL, 3Groningen / NL, 4Rotterdam / NL B. Geeroms, W. Laleman, S. Heye, C. Verslype, F. Nevens, G. Maleux; Leuven / BE
14:33
B-0685 Screening for lung cancer using ultra-low dose
computed tomography with Iterative model
reconstruction algorithm
M. Zhang, Y. Sun, W. Qi, Y. Jiang, Y. Liu, N. Hong; Beijing / CN
14:32 14:32
B-0696 Digital subtraction angiography during TIPS creation or B-0706 Feasibility of a pneumatically actuated MR-compatible
revision: data on radiation exposure and image quality second generation robot for transrectal prostate
obtained using a standard and a low-dose acquisition biopsy guidance by using the PIRADS classification
protocol in a flat-panel detector-based system D. Yakar, J. Bomers, D. Bosboom, J.J. Fütterer; Nijmegen / NL
M. D’Amico, R. Miraglia, L. Maruzzelli, C. Tafaro, R. Gerasia, A. Luca; Palermo / IT
14:40
14:40 B-0707 Angio-uro dynamic functional MRI: difference between
B-0697 A real-time three-dimensional ultrasound user this new technique and the traditional investigations
interface for TIPS: preliminary results in patients with pathology of the urinary tract (work
C. Klink1, C.F. Cuijpers2, E. Varga2, J. Banerjee1, P. Stappers2, A. Moelker1, T. van in progress)
Walsum1, A. Freudenthal2; 1Rotterdam / NL, 2Del / NL A. Viviani, L. Moreschi, E. Ricci, C. Guerra; Pescia / IT
14:48 14:48
B-0698 Clinical outcomes of selective variceal coil B-0708 Reproducibility and agreement in quantification of
embolisation during PTFE-covered transjugular renal function using 1.5-T DCE-MRI
intrahepatic portosystemic shunt (TIPS) placement for E. Eikeord, E. Andersen, A. Lundervold, E. Hodneland, J. Monssen, E. Hanson,
variceal hemorrhage J. Rørvik; Bergen / NO
C.N. Weber, B.H. Ge, T.W.I. Clark, M.C. Soulen, G.J. Nadolski; Philadelphia, PA / US
14:56
14:56 B-0709 Arterial spin labeling and T1-mapping allow
B-0700 Benefit and safety of combined partial splenic detection of acute kidney injury in patients aer lung
artery embolisation to transjugular intrahepatic transplantation
portosystemic shunt for the treatment of portal M.J. Peperhove, D. Hartung, S. Tewes, M.-S. Jang, B. Jüttner, R. Lichtinghagen,
G. Warnecke, F. Gueler, K. Hueper; Hannover / DE
hypertension: a pilot study
A. Geffray, J. Pucheux, L. d’Alteroche, M. Sainz Barriga, D. Alison, J.-M. Perarnau; 15:04
Chambray-Lès-Tours / FR
B-0710 Distribution profile of gadolinium (Gd) in gadolinium
15:04 chelate-treated renally impaired rats:
B-0701 Portal vein embolisation with histoacryl via an role of pharmaceutical formulation
ipsilateral approach is safe and effective N. Fretellier1, M. Salhi1, J. Schroeder2, T. Chevalier1, G. Jestin-Mayer1, J.-F. Mayer1,
C. Loberg, M. Schmeding, C.K. Kuhl, P. Bruners; Aachen / DE B. Bonnemain1, J.-M. Idée1, C. Corot1; 1Roissy / FR, 2Regensburg / DE
15:12
14:00–15:30 Room G B-0711 Nonionic iodinated contrast medium (CM) and
risk of nephrotoxicity: results of a prospective study
Genitourinary G.M. Giuseppetti, G. Polonara, S. Galassi, G.M. Frascà, F.P. Gentile, L. Ferrante,
E. Skrami, S. Amoroso; Ancona / IT
SS 707 New frontiers and contrast agents in 15:20
GU imaging B-0712 NSsaFe study: determining the incidence
Moderators: S. Dudea; Cluj-Napoca/RO, M. Onur; Elazig/TR of nephrogenic systemic fibrosis aer administration
of Dotarem in patients with renal impairment
14:00 R.G. McWilliams; Liverpool / UK
B-0702 Magnetisation transfer MR imaging of normal and
abnormal testis: initial experience
A. Tsili, A. Ntorkou, D. Baltogiannis, S. Stavrou, V. Maliakas, N. Sofikitis, 14:00–15:30 Room K
M. Argyropoulou; Ioannina / GR
14:24 14:08
B-0705 Computer-assistant histoscanning-targeted prostate B-0714 Robot-assisted navigation system for CT-guided
biopsies in diagnosis of PCa: a pilot study percutaneous lung lesions procedures:
A. Fedorova, S. Salnikova, A. Pavlovichev, N. Sokolova, G. Varlamov, A. Zubarev; our experience in Hong Kong
Moscow / RU C. Chu, S.C. Yu; Shatin / HK
14:16
B-0715 Value of contrast-enhanced ultrasound guided
percutaneous biopsy in peripheral pulmonary lesions
Y. Dong, W.-P. Wang, F. Mao, B. Huang; Shanghai / CN
14:24 14:08
B-0716 CT-fluoroscopy guidance for lung biopsies performed B-0725 Diagnostic performance of cone beam computed
by clinical fellows without prior training: tomography and MDCT in diagnostic imaging of the
radiation dose and workflow midface: a comparative study on phantoms and
A. Ghali, P. Rogalla, S. Kandel; Toronto, ON / CA cadaver head scans
S. Veldhoen1, M. Schöllchen2, H. Hanken2, C. Precht1, F.O.O. Henes2, G. Schön2,
14:32 M. Heiland2, G. Adam2, M. Regier2; 1Würzburg / DE, 2Hamburg / DE
B-0717 Cone-beam CT vs CT in lung ablation procedure:
which is faster? 14:16
R. Cazzato1, J. Battistuzzi2, R. Grasso1, X. Buy2, J. Palussiere2; 1Rome / IT, B-0726 Pre- and postoperative head radiography and MSCT
2
Bordeaux / FR imaging in patients with zygomatico-orbital trauma
O.Y. Pavlova, N.S. Serova; Moscow / RU
14:40
B-0718 Percutaneous thermal ablation of breast cancer 14:24
metastases in oligometastatic patients: B-0727 Clinical aspects of imaging quality in visualisation
local control and disease-free survival of anterior and lateral skull base
M. Barral1, A. Auperin1, A. Hakime1, S. Delaloge1, V. Cartier1, V. Tacher1, C. Gueldner, J. Voigt, R. Leppek, J. Werner; Marburg / DE
Y. Otmezguine2, T. de Baere1, F. Deschamps1; 1Villejuif / FR, 2Boulogne
Billancourt / FR 14:32
14:48 B-0728 Reducing the dose of CT of paranasal sinuses:
possibilities using an iteractive reconstruction
B-0719 Pancreatic lesions core biopsy -
algorithm
analysis of efficacy and complications S.M. Niehues, L.-A. Schaafs, B. Hamm; Berlin / DE
M. Studniarek1, K. Gwozdziewicz1, M. Czarnowska-Cubala1, T. Gorycki1,
P. Szlezak2; 1Gdansk / PL, 2Bydgoszcz / PL
14:40
Thursday
14:56 B-0729 80-kVp neck computed tomography in patients
B-0720 Percutaneous microwave ablation (MWA) of renal with suspected peritonsillar abscess:
tumours: intermediate-term results and usefulness evaluation of objective and subjective image quality,
of R.E.N.A.L. scoring for predicting outcomes and and reduction of radiation exposure
J.-E. Scholtz, K. Hüsers, M.H. Albrecht, M. Beeres, M. Kaup, B. Schulz,
complications R.W. Bauer, T.J. Vogl, J.L. Wichmann; Frankfurt a. Main / DE
C. Floridi, L. Nocchi, F. Fontana, A. Ierardi, G. De Marchi, C. Fugazzola,
G. Carrafiello; Varese (VA) / IT
14:48
15:04 B-0730 Assessment of an advanced monoenergetic
B-0721 Retrospective comparison between renal reconstruction technique in dual-energy computed
tumours treated with RFA and laparoscopic tomography of head and neck cancer
M.H. Albrecht, J.-E. Scholtz, R.W. Bauer, M. Kaup, I. Burck, J. Wagenblast,
partial nephrectomy T. Lehnert, T.J. Vogl, J.L. Wichmann; Frankfurt a. Main / DE
V. Acosta Ruiz, P. Dahlman, E. Brekkan, A. Magnusson, M. Häggman,
S. Ladjevardi, M. Lönnemark; Uppsala / SE
14:56
15:12 B-0731 Non-linear image blending for dual energy
B-0722 Radiofrequency ablation of prevertebral sympathetic CT improves visualisation of head and neck
ganglia in patients with essential arterial primary squamous cell carcinoma compared
hypertension for lowering blood pressure to linear blending technique
G. Knyshov, B. Batsak; Kiev / UA J.-E. Scholtz, K. Hüsers, M. Kaup, M. Albrecht, C. Frellesen, R.W. Bauer, J.M. Kerl,
T.J. Vogl, J.L. Wichmann; Frankfurt / DE
15:20
15:04
B-0723 Laser and radiofrequency ablation in the treatment of
B-0732 Direct and indirect organ dose distribution
benign thyroid nodules
G. Mauri, L. Cova, T. Ierace, A. Baroli, L. Solbiati; Busto Arsizio / IT measurements in fluoroscopic swallow examinations
with a modern flat detector system and dose
reduction techniques -a phantom study
14:00–15:30 Room MB 1 A. Pomschar1, J. Weiß2, K. Neumaier1, M. Li1, W. Flatz1, B. Ertl-Wagner1,
M. Peller1, M.F. Reiser1, M. Notohamiprodjo2; 1Munich / DE, 2Tübingen / DE
Head and Neck 15:12
SS 708 CT including cone beam CT: B-0733 Quantitative analyses of 3-D volumetry and histogram
image quality, dosimetry and of thyroid gland on CT: can thyroid CT reflect thyroid
function in the patients with hypothyroidism?
clinical applications K. Lee, J. Ryu; Busan / KR
Moderators: B. Gómez-Ansón; Barcelona/ES,
D.-A. Varoquaux; Marseille/FR 15:20
B-0734 Comparison of incidental findings between normal and
14:00
obstructive sleep apnea patients using cone beam
B-0724 A dentalscan or a multi-layer digital
computed tomography scans
ortopantomography in the study of the jaws? K. Orhan1, U. Oz2, M. Misirli3, S. Aksoy3, F. Rasmussen3; 1Ankara / TR, 2Lefkosa,
A dosimetric evaluation on a CBCT device Mersin 10 / TR, 3Lefkosa, Mersin 10, / TR
F. Testa1, E. Fumero1, E. Roberto2, S. Chauvie2, R. Olivero1, M. Lo Bello1,
D. Fraire1; 1Bra / IT, 2Cuneo / IT
14:56 14:48
B-0742 Image quality assessment of ultra low-dose CT B-0752 Evaluation of diagnostic value of a novel non-invasive
colonography using sinogram-affirmed iterative coronary computed tomography angiography
reconstruction algorithm versus standard coronary angiography for
A. Delli Pizzi, R. Cianci, A. Filippone, M. Timpani, A. Tavoletta, G. Esposito, assessing fractional flow reserve
P. Pulsone, A.R. Cotroneo; Chieti / IT S. Mangold, M. Renker, S. Baumann, R. Wang, F.G. Meinel, J.L. Wichmann,
R.R. Bayer, D.H. Steinberg, U.J. Schoepf; Charleston, SC / US
15:04
B-0743 Anatomic variability of the colon: 14:56
a study with CT-colonography B-0753 The effect of coronary calcium deposits and
M. Pancot, R. Girometti, C. Zuiani, M. Bazzocchi; Udine / IT CT acquisition artifacts on coronary CT
angiography derived fractional flow reserve,
15:12 validated by invasive FFR
B-0744 Treatment of perityphlitic abscess: comparison A. Coenen, M.M. Lubbers, A. Kurata, A. Kono, A. Dedic, R.G. Chelu,
of interventional and surgical management M.L. Dijkshoorn, R.-J. van Geuns, K. Nieman; Rotterdam / NL
B. Mensel, L.I. Partecke, J.-P. Kühn, W. Keßler, M. Patrzyk; Greifswald / DE
15:04
B-0754 Dynamic first pass CT perfusion imaging
of the myocardium vs. intracoronary transluminal
attenuation gradient in coronary CT angiography
for the assessment of coronary artery stenosis
B.M. Gramer1, I. Baur1, M. Rasper1, V. Leber1, A. Leber1, M. Vembar2,
E.J. Rummeny1, A.M. Huber1; 1Munich / DE, 2Cleveland, OH / US
15:12
B-0755 Incremental diagnostic value of functional CT
for the assessment of hemodynamically significant
coronary artery disease: a meta-analysis
R.A.P. Takx1, T. Leiner2, U. Hoffmann1; 1Boston, MA / US, 2Utrecht / NL
15:20
B-0756 Regadenoson-stress dynamic myocardial
perfusion with computed tomography -
diagnostic performance and contribution
in patients prior major vascular surgery
J. Baxa, J. Ferda, M. Hromadka, J. Sedivy, T. Matouskova, B. Kreuzberg; Pilsen / CZ
Thursday
10:30 10:30
K-17 Keynote lecture B-0789 The pattern of myocardial perfusion in patients with
A. Del Guerra; Pisa / IT intermediate and significant coronary artery stenosis
K.W. Zavadovsky, M.O. Gulya, Y.B. Lishmanov, L.N. Maslov, V.V. Saushkin;
10:39 Tomsk / RU
B-0779 Virtual unenhanced images of the abdomen with
third-generation dual-source dual-energy CT and 10:38
advanced modeled iterative reconstruction: B-0790 Usefulness of resting myocardial perfusion imaging
image quality, attenuation and radiation dose of coronary CT angiography in patients with acute
C.N. De Cecco, A.D. Hardie, G. Muscogiuri, J.L. Wichmann, C. Canstein, symptom in the emergency department:
P. Costello, U.J. Schoepf; Charleston, SC / US perfusion analysis of color-coded three-dimensional
10:47 volume rendering
S. Kim, D. Cha, Y. Choe; Seoul / KR
B-0780 Diagnostic ultra-low dose CT with a novel ultrafast
compressed sensing algorithm 10:46
S. Hashemi Amroabadi, S. Homampour, N.S. Paul; Toronto, ON / CA B-0791 Four-dimensional whole-heart computed tomography
10:55 perfusion of the myocardium with visual analysis
B-0781 Size-specific dose estimate can be used to calculate using temporal averaging of three-dimensional
patient-specific blood dose from paediatric CT datasets: feasibility study
C. Kendziorra, A. Shaban, M. Rief, P.D. Bady, S. Feger, M. Dewey; Berlin / DE
examinations
C. Franck, C. Vandevoorde, P. Smeets, R. Achten, K. Verstraete, H. Thierens, 10:54
K. Bacher; Ghent / BE
B-0792 Quantitative analysis of myocardial perfusion using
11:03 a Langendorff pig heart model: concept and results
G. Pelgrim1, M. Das2, U. Haberland3, S. Van Tuijl4, M. Stijnen4, E. Klotz3,
B-0782 Assessment of high cumulative patient doses of M. Oudkerk1, J.E. Wildberger2, R. Vliegenthart1; 1Groningen / NL, 2Maastricht / NL,
repetitive CT examinations 3
Forchheim / DE, 4Eindhoven / NL
M. Das, C.R.L.P. Jeukens, R.S. Schnerr, S. Niesen, J.E. Wildberger; Maastricht / NL
11:02
Friday
11:11 B-0793 Semi-automated global quantification of le
B-0783 Data distributions and the impact of iterative ventricular myocardial perfusion at stress dynamic CT:
reconstruction algorithms from the first three years diagnostic performance for detection of territorial
of the Australian MDCT DRL project (2011-2014) perfusion deficits
A.B. Wallace, P. Thomas, A. Hayton; Yallambie / AU J.L. Wichmann1, F.G. Meinel1, C.N. De Cecco1, A. Varga-Szemes1, G. Muscogiuri1,
P.M. Cannaò1, Y.H. Choe2, Y. Wang3, U.J. Schoepf1; 1Charleston, SC / US,
11:19 2
Seoul / KR, 3Beijing / CN
B-0784 Patient doses in standard CT examinations:
results of a nationwide survey in Germany 11:10
A.A. Schegerer1, H.-D. Nagel2, G. Stamm3, G. Brix1; 1Neuherberg / DE, B-0794 Le ventricular myocardial perfusion at stress
2
Buchholz / DE, 3Hannover / DE dynamic CT: multi-center evaluation of relative and
11:27 absolute territorial myocardial blood flow in patients
B-0785 Intra-institution CT dose surveys in adults: with coronary artery stenosis
J.L. Wichmann1, C.N. De Cecco1, F.G. Meinel1, A. Varga-Szemes1, G. Muscogiuri1,
what sample size for what precision? P.M. Cannaò1, Y.H. Choe2, Y. Wang3, U.J. Schoepf1; 1Charleston, SC / US,
S. Taylor1, A. Van Muylem2, P.A. Gevenois2, D. Tack3; 1Mons / BE, 2Brussels / BE, 2
Seoul / KR, 3Beijing / CN
3
Baudour / BE
11:18
11:35
B-0795 Cardiac dual-energy computed tomography reduces
B-0786 How much is the effective dose varying between beam-hardening artefacts in a phantom study
follow-up examinations performed on the same CT J. Choe, J. Kang, D.H. Yang, T.-H. Lim; Seoul / KR
scanner, when using the same imaging protocol?
S. Suntharalingam, F.F. Stecker, N. Guberina, M. Forsting, J.M. Theysohn, 11:26
A. Ringelstein, T. Schlosser, K. Nassenstein; Essen / DE B-0796 Quantitative myocardial perfusion with dual-energy
11:43 CT: iodine concentration differences between normal
B-0787 Estimation of organ dose from tube current modulated and ischemic myocardium
R. Oca Pernas, C. Delgado, C. Trinidad, D. Mera, A. Bustos, M. Vázquez; Vigo / ES
CT of the torso: SSDE vs MC simulation
X. Lopez Rendon1, G. Zhang1, H. Bosmans1, R.H. Oyen1, F. Zanca2; 1Leuven / BE, 11:34
2
Diegem / BE
B-0797 Myocardium: dynamic CT perfusion imaging:
11:51 a comparison to coronary angiography/FFR and
B-0788 Quantitative comparison of single-acquisition to MR first pass perfusion imaging
dual-energy iodine maps as a reduced dose A.M. Huber1, B.M. Gramer1, V. Leber1, M. Rasper1, D. Münzel1, A. Leber1,
E. Hoffmann1, M. Vembar2, E.J. Rummeny1; 1Munich / DE, 2Cleveland, OH / US
alternative to abdominal CT-perfusion measurements
S. Skornitzke, F. Fritz, M. Klauß, J. Hansen, G. Pahn, L. Grenacher, H.-U. Kauczor,
W. Stiller; Heidelberg / DE
11:42 11:34
B-0798 Impact of iterative reconstruction on objective and B-0808 Useful tool in virtopsy: postmortal 31P magnetic
subjective image quality parameters in 256-slice resonance spectroscopy of the skeletal muscle:
MDCT dynamic myocardial perfusion imaging α-ATP/Pi ratio
B.M. Gramer, M. Rasper, V. Leber, A. Leber, E.J. Rummeny, A.M. Huber; J. Yamamura1, T. Schmidt1, S. Keller1, J. Wang2, G. Adam1, R. Fischer1;
Munich / DE 1
Hamburg / DE, 2Hamburg, TX / US
11:50 11:42
B-0799 Relationship among stenosis severity and CT-derived B-0809 Multiparamentric MRI at 7 T for the non invasive
myocardial blood flow in patients with coronary artery assessment of acute ischemic and non-ischemic
disease muscle damage
A. Rossi1, A. Wragg1, E. Klotz2, F. Pugliese1; 1London / UK, 2Forchheim / DE A. Palmisano, A. Esposito, T. Canu, F. Lo Russo, F. De Cobelli, A. Del Maschio;
Milan / IT
11:18 11:11
B-0817 Is Alberta stroke program early CT score B-0826 Impact of the patient age on flip-flop phenomenon in
(ASPECTS) a useful tool in the assessment lung metastasis from thyroid cancer
of acute stroke patients? T. Isoda, S. Baba, Y. Maruoka, Y. Kitamura, M. Sasaki, H. Honda; Fukuoka / JP
J.E.T. Alves, T. Rodrigues, A.L. Sousa, Â. Carneiro, R. Felgueiras, J. Xavier;
Porto / PT 11:19
B-0827 Accuracy of [18F]-FDG PET/MRI for the detection of
11:26 liver metastases
B-0818 Imaging related predictors of favorable outcome K. Beiderwellen1, L. Geraldo2, V. Ruhlmann1, P. Heusch3, B. Gomez1, F. Nensa1,
in acute ischemic stroke treated by thrombectomy L. Umutlu1, T.C. Lauenstein1; 1Essen / DE, 2Barcelona / ES, 3Düsseldorf / DE
A. Balodis, M. Radzina, K. Kupcs, E. Miglāne, J. Savlovskis; Riga / LV
11:27
11:34 B-0828 Diagnostic accuracy of imaging methods
B-0819 Effects of radiation dose reduction in volume for the diagnosis of skeletal malignancies:
perfusion CT imaging of acute ischaemic stroke retrospective analysis against
A. Othman1, C. Brockmann1, M.A. Brockmann1, Z. Yang2, J. Kim2, M. Wiesmann1; pathology-proven reference
1
Aachen / DE, 2Seoul / KR B. Lange1, M. Nielsen2, J. Andersen2, H. Lilholt2, M. Vyberg2, L. Petersen2;
1
Hilleroed / DK, 2Aalborg / DK
11:42
B-0820 Improved prediction of ischaemic stroke outcome 11:35
using combined ASPECTS and the NIHSS B-0829 Dynamic contrast-enhanced magnetic
K.W. Wanambiro1, J. Jowi2, S.W. Ponda1; 1Nairobi / KE, 2Kisumu / KE resonance imaging in benign and malignant
11:50 sclerotic bone lesions
P. Kosucu, S. Süleyman, H. Kavgaci, A. Karacin, A. Küpeli; Trabzon / TR
B-0821 Leptomeningeal score (LMs) on computed tomography
angiography can predict clinical outcome in patients 11:43
with acute ischaemic stroke (AIS) B-0830 Detection of distant metastases in patients
E. Puglielli1, R. Lattanzi1, M. Fuschi1, V. Di Mizio1, V. Di Egidio2; 1Teramo / IT, with primary breast cancer: is 18FDG-PET/CT
2
Pescrara / IT
better than conventional imaging?
A.G.V. Bitencourt, R.R. Cunha, J.F.A. Conrado, W.P. Andrade, E.N.P. Lima,
R. Chojniak; Sao Paulo / BR
10:30–12:00 Room F1
11:51
Oncologic Imaging B-0831 Palliation of painful bone metastases:
the “Rizzoli” experience
SS 1016 Advances in imaging A. Bazzocchi1, G. Facchini1, P. Spinnato1, E. Rimondi1, M. Battaglia1,
Friday
metastatic disease S. Donatiello2, G. Filonzi1, U. Albisinni1; 1Bologna / IT, 2Modena / IT
Moderators: D. Filippiadis; Athens/GR,
M. Müller-Schimpfle; Frankfurt a. Main/DE
10:30–12:00 Room F2
10:30
K-18 Keynote lecture GI Tract
M. Müller-Schimpfle; Frankfurt a. Main /DE
SS 1001 Rectal cancer and anorectal imaging
10:39 Moderators: L. Curvo-Semedo; Coimbra/PT, F. Maccioni; Rome/IT
B-0822 Whole brain 3D T1w-VISTA for the diagnosis
of small brain metastases at 3.0 Tesla 10:30
N.N. Kammer1, E. Coppenrath1, K.M. Treitl1, H. Kooijman2, M.F. Reiser1, T. Saam1; K-19 Keynote lecture
1
Munich / DE, 2Hamburg / DE L. Blomqvist; Stockholm / SE
10:47 10:39
B-0823 Differentiation of primary brain tumours B-0832 Magnetisation transfer (MT) Imaging as a tool to
from metastases: quantitative evaluation of quantify post-chemoradiation fibrosis in rectal cancer:
multi-parameters from diffusion and DCE-MR perfusion does it help in the assessment of tumour response?
in tumour parenchyma and peritumoural area M.H. Martens1, D.M. Lambregts1, N. Papanikolaou2, S. Alefantinou2, M. Maas1,
J. Zhao, J. Chu, J. Yang, Z. Yang, B. Luo; Guangzhou / CN G.C. Manikis2, K. Marias2, G.L. Beets1, R.G.H. Beets-Tan1; 1Maastricht / NL,
2
Iraklion / GR
10:55
B-0824 Volumetric dynamic contrast enhanced computed 10:47
tomography (DCE-CT) for preoperative assessment of B-0833 Performance of texture analysis, diffusion-weighted
the vascularity of spinal metastases imaging and perfusion imaging in predicting tumoural
C. Lauridsen1, C. Clausen2, M. Lundsgaard2, B. Dahl1, M. Bachman1, S. Frevert1, response to neoadjuvant chemoradiotherapy in rectal
L. Lonn1; 1Copenhagen / DK, 2Herlev / DK cancer patients studied with 3-T MR
M. Ciolina1, C. De Cecco2, B. Ganeshan3, M. Rengo2, D. Bellini2, A. Laghi1;
11:03 1
Rome / IT, 2Latina / IT, 3London / UK
B-0825 Superb microvascular imaging (SMI): applying a new
contrast-free ultrasound technique for the analysis of 10:55
the microvascular structure in suspect lymph nodes B-0834 Follow-up with MRI of rectal cancer treated by TEM:
T. Diekhoff, T. Fischer; Berlin / DE recurrence detection and inter-observer
reproducibility
M. Maas1, M. Martens1, C. van Berlo1, W. Deserno2, J. Leijtens2, G.L. Beets1,
R.G.H. Beets-Tan1; 1Maastricht / NL, 2Roermond / NL
11:03 10:46
B-0835 Added value of diffusion-weighted MRI for early B-0845 Does accuracy of MSCT signs of right ventricular
detection of tumour response to preoperative dysfunction depend on the time since the onset
chemoradiation therapy, in locally advanced rectal of symptoms in patients with acute pulmonary
cancer: correlation with histopathologic analysis embolism?
M. Mumoli, D. Ippolito, C. Talei Franzesi, O. Minutolo, P.A. Bonaffini, S. Sironi; G. Staskiewicz, E. Czekajska-Chehab, S. Uhlig, E. Siek, A. Tomaszewski,
Monza / IT J. Przegalinski, A. Drop; Lublin / PL
11:11 10:54
B-0836 Reproducibility of evaluation of invasion depth B-0846 Can coronary artery calcifications on CT pulmonary
of rectal cancer into the mesorectal fat: angiography predict right heart strain?
can we reliably discern T3ab from T3cd tumours? M.C. Williams1, N. Morley1, K. Muir1, E.J.R. van Beek1, J.H. Reid2, J. Murchison1;
M. Maas1, G.L. Beets1, M. Ageitos Casais2, X. Li3, S.-X. Rao4, M.M. van Heeswijk1,
1
Edinburgh / UK, 2Melrose / UK
R. Beckers1, R.G.H. Beets-Tan1; 1Maastricht / NL, 2Santiago de Compostela / ES,
3
Beijing / CN, 4Shanghai / CN 11:02
B-0847 Dual-energy CT pulmonary perfusion maps improve
11:19 the detection of small pulmonary embolism:
B-0837 DWI for assessment of rectal cancer nodes aer a multi-rater study
chemoradiotherapy: does the absence of nodes S. Fischer, N. Schultheis, C. Frellesen, M. Kaup, W. Kromen, P. Dewes,
on DWI predict a ypN0 status? J.E. Scholtz, T.J. Vogl, R.W. Bauer; Frankfurt a. Main / DE
M.M. van Heeswijk, D.M. Lambregts, W.M. Palm, B.M.F. Hendriks, G.L. Beets,
R.G.H. Beets-Tan; Maastricht / NL 11:10
B-0848 Evaluation of multi-phase post-mortem
11:27 CT-angiography for the investigation
B-0838 Comparison between MRI and water soluble contrast of pulmonary embolism
enema in evaluating complications aer colorectal A. Perini1, J. Grimm2, C. Egger2, C. Bruguier2, E. Silingardi1, S. Grabherr2;
anastomosis and protective ileostomy in patient with
1
Modena / IT, 2Lausanne / CH
rectal cancer 11:18
E. Raimondi, M. Bassi, V. Pollastri, R. Rizzati, M. Giganti, G. Benea; Ferrara / IT
B-0849 A nomogram based on CT pulmonary angiography
11:35 for prediction of pulmonary hypertension
B-0839 Primary cystic lesions of the retrorectal space: in patients without pulmonary embolism
MRI evaluation, histopathology confirmation and A. Bendet, H. Shmueli, S.Z. Adam, T. Ziv-Baran, S. Berliner, Y. Topilsky,
G. Aviram; Tel Aviv / IL
clinical assessment
R.S. Dwarkasing, S. Verschuuren, G. van Leenders, L. Braun, W. Schouten, 11:26
G. Krestin; Rotterdam / NL
B-0850 Angio-CT in the evaluation of patients with
11:43 chronic thromboembolic pulmonary hypertension
B-0840 Rectal MRI of fistula-in-ano: diagnostic values undergoing pulmonary endarterectomy:
of diffusion-weighted imaging (DWI) radiological and hemodynamic assessment
S. Ahn, J. Park, S. Moon, D. Lee, S. Park, J. Lim; Seoul / KR S. Porelli, M. Giannotta, M.B. Leone, M. Cefarelli, S. Martin Suarez, N. Galié,
M. Zompatori; Bologna / IT
11:51
B-0841 Local staging of rectal cancer: 11:34
performance comparison between 3D transrectal B-0851 Comparison of diagnostic performance of pulmonary
ultrasound and 3-Tesla magnetic resonance imaging MRA and CTA in patients with chronic thromboembolic
E. Guidi1, L. Faggioni1, R. Scandiffio1, R. Balestri1, G. D’Ippolito2, E. Neri1, pulmonary hypertension
P. Buccianti1, C. Bartolozzi1; 1PISA / IT, 2São Paulo / BR E.A. Mershina, V. Sinitsyn, M. Komarova, K. Mershin, N. Danilov; Moscow / RU
11:42
10:30–12:00 Room D1 B-0852 Lung perfusion characteristics in pulmonary arterial
hypertension and peripheral forms of chronic
Chest thromboembolic pulmonary hypertension:
dual-energy CT
SS 1004 Pulmonary hypertension and J. Giordano, N. Tacelli, C. Hossein-Foucher, A. Duhamel, J. Remy, M. Remy-Jardin;
thromboembolic disease Lille / FR
Moderators: E.E.J.G. Coche; Brussels/BE, B. Graca; Coimbra/PT
10:30
B-0842 Are we overcalling pulmonary embolism and why?
Discordance in interpretation of CTPA between general
and chest radiologists
B. Hutchinson1, P. Navin1, E. Marom2, M. Truong2, J. Bruzzi1; 1Galway / IE,
2
Houston, TX / US
10:38
B-0844 Pulmonary infarction in CT pulmonary angiography:
correlation with thrombus distribution and signs of
right heart strain for risk stratification
L.F.M. Beenen, C.M. Schaefer-Prokop, J. Stoker, P. Gerrits, H.R. Buller,
S. Middeldorp; Amsterdam / NL
Friday
J. Banerjee, C. Klink, E.D. Peters, W.J. Niessen, A. Moelker, T.v. Walsum;
Rotterdam / NL B-0865 The influence of isocenter gantry patient positioning
for paediatric head CT examinations in eye lens dose,
11:11 using in-plane vinyl bismuth and barium shielding
B-0857 Comparison between radiofrequency ablation and F. Pereira, F. Carvalho, M. Malva, G. Paulo, J. Santos; Coimbra / PT
surgical resection by using propensity score matching 10:54
for hepatocellular carcinoma within Milan criteria
A. Hocquelet, N. Frulio, C. Salut, C. Cassinotto, m. Bouzgarrou, H. Trillaud, B-0866 Phantom study: the impact of obesity on abdominal
P. Balageas; Bordeaux / FR CT radiation dose and image quality
A.A. Qurashi, L.A. Rainford, S. Foley; Dublin / IE
11:19
B-0858 Microwave ablation (MWA) in malignant liver tumours: 11:02
comparative evaluation of local tumour control B-0867 Cardiac computed tomography dose levels:
and survival rates using two different microwave a national approach and comparison with other
generator systems cardiac radiation procedures
T.J. Vogl, A. Hagar, N.N.N. Naguib, N.-E.A. Nour Eldin, W.O. Bechstein, S. Zeuzem; D. Vicente1, V. Dessandier1, A. Pimenta2, C. Almeida3, D. Silva4, R. Gaspar1,
Frankfurt a. Main / DE G. Paulo1, J. Santos1; 1Coimbra / PT, 2Porto / PT, 3Lisbon / PT, 4Algarve / PT
11:27 11:10
B-0859 New concept in microwave ablation (MWA) B-0868 Is iterative reconstruction for CT worth the
of liver and lung malignancies: investment? A retrospective study of dose
does MWA with thermosphere technology reproduce reduction and image quality
L.V. Magee, P. Ball; Dundonald / UK
a predictable spheric ablation zone?
T.J. Vogl, L. Basten, B. Panahi, N.-E.A. Nour-Eldin, N.N.N. Naguib; 11:18
Frankfurt a. Main / DE
B-0869 Radioprotection in CT scans: use of bismuth, barium
11:35 and lead shields
B-0860 Local ablation of unresectable liver malignancies R. Pescada, P. Sousa, A.F.C.L. Abrantes, L.P. Ribeiro, R.P.P. Almeida,
S. Rodrigues, K.B. Azevedo, J.P. Pinheiro; Faro / PT
using CT-guided high-dose rate brachytherapy or
CT-guided radiofrequency ablation: a cost comparison 11:26
D. Schnapauff1, F. Collettin1, B. Gebauer1, B. Hamm1, M.H. Maurer2; 1Berlin / DE,
2
Berne / CH B-0871 Development of a soware application
for the registration and monitoring of diagnostic
reference levels
A.F.C.L. Abrantes, B. Braga, L.P. Ribeiro, P. Sousa, R.P.P. Almeida, S. Rodrigues,
S. Rodrigues, J.P. Pinheiro, N.F. Pinto; Faro / PT
11:34 11:42
B-0872 Design of an ultra-low dose non-contrast kidney stone B-0884 The role of MR in the preoperative management
CT protocol with a radiation dose ≤ 1mSv of primary hyperparathyroidism in clinical practice:
S. Moerup1, D. Skov- Hansen2, O. Graumann3; 1Odense / DK, 2Kolding / DK, single-center experience with a 3T MR
3
Aarhus / DK B. Sacconi, R. Argirò, A. Iannarelli, C. Cipriani, S. Minisola, C. Catalano, M. Bezzi,
D. Diacinti; Rome / IT
11:42
B-0873 CT dose optimisation soware synergy:
a clinical perspective 10:30–12:00 Room MB 2
L.R. O’Hora; Dublin / IE
Paediatric
10:30–12:00 Room MB 1 SS 1012 Abdominal imaging
Moderators: M. Haliloglu; Ankara/TR, A.S. Littooij; Leiden/NL
Head and Neck
10:30
SS 1008 Thyroid and parathyroid imaging B-0885 Re-appraising ultrasonography as the first line
Moderators: A. Lévai; Budapest/HU, J. Olliff; Birmingham/UK diagnostic modality in surgical causes of paediatric
10:30 acute abdomen
I. Goel, R. Anand, M. Narula, S. Choudhury; New Delhi / IN
B-0874 Role of quantitative diffusion-weighted MRI and 1H
MR spectroscopy in distinguishing between benign 10:38
and malignant thyroid nodules B-0886 Comparison of axial T2-weighted BLADE and
R.A. Elshafey, A. Elattar, M. Melees, N. Esheba; Tanta / EG respiratory triggering turbo spin-echo sequences in
10:38 the paediatric abdomen
J. Lee, Y. Choi, J.-E. Cheon, S. Lee, H.-H. Cho, S.-M. Shin, W. Kim, I.-O. Kim;
B-0875 The role of magnetic resonance spectroscopyas a Seoul / KR
pre-surgical diagnostic modality in thyroid nodules
L. Aghaghazvini, P. Pirouzi, H. Sharifian, N. Yazdani, S. Kooraki, A. Ghadiri; 10:46
Tehran / IR B-0887 Fibrosing liver diseases in paediatric age:
10:46 MRI investigation by diagnostic maps of slow diffusion
B-0876 Comparison between two thyroid ultrasound and fast diffusion generated from a multiple b values
classification systems for characterisation of thyroid DWI sequence through IVIM model
P. Gulino, A. Ciccarone, D. Cozzi, D. Salpietro, C. Defilippi; Florence / IT
nodules
G.A. Ashamallah, M.A. El-Adalany; Mansoura / EG 10:54
10:54 B-0888 Quantification of liver steatosis in paediatric
B-0877 Role of ARFI in risk stratification of thyroid nodules by population: comparison of ¹H MRS and Triple-echo GRE
TIRADS sequence with liver biopsy as reference standard
M. Di Martino, L. Pacifico, M. Bezzi, F. Zaccagna, B. Sacconi, C. Chiesa,
B. Raghavan, D. Sundaram; Chennai / IN C. Catalano; Rome / IT
11:02 11:02
B-0879 Preoperative ultrasound of papillary thyroid B-0889 Imaging approach in infantile cholestasis evaluation:
carcinoma (PTC): evaluation of predictive factors for utility and efficacy of US signs in biliary atresia
extrathyroidal extension L. Monti, M. Salsano, G. Soglia, M. Colella Bisogno, A. Simonetti, G. Torre,
H.-S. Ahn, S. Park, S. Kim, M. Seo, B. Chung; Seoul / KR P. Rossi, L. Bonomo, P. Tomà; Rome / IT
11:10 11:10
B-0880 Comparison of clinical and sonographic characteristics B-0890 Impact of hepatic arterial haemodynamics in
for distinguishing follicular adenoma and carcinoma predicting early hepatic arterial thrombosis
and the predictive factors of malignancy in thyroid in paediatric recipients aer living donor liver
follicular neoplasm transplantation
S. Park, S. Kim, H.-S. Ahn, M. Seo, J. Yoo, J. Choi; Seoul / KR L..-H. Gu, H. Fang, F. Li, S. Zhang, C. Shen, L. Han; Shanghai / CN
11:18 11:18
B-0881 Evaluation of underlying lymphocytic thyroiditis with B-0891 The role of magnetic resonance enterography in the
histogram analysis using gray scale ultrasound images evaluation of activity of paediatric Crohn‘s disease
J. Seo, G. Kim, E.-K. Kim, J. Kwak; Seoul / KR F. Al Bunni, M. Zuliani, F. Pomerri; Padua / IT
11:26 11:26
B-0882 Can ARFI elastography be used to differentiate B-0892 Radiation reduction in the follow-up of abdominal
parathyroid from thyroid lesions? trauma imaging using contrast-enhanced ultrasound
A. Chandramohan, D. Abraham, M.T. Manipadam, T.V. Paul; Vellore / IN A.-M. Deganello, E. Konstantatou, O. Romanos, M. Sellars, P. Sidhu; London / UK
11:34 11:34
B-0883 MR appearance of parathyroid adenomas at 3T in B-0893 High-resolution MRI for preoperative workup of
patients with primary hyperparathyroidism: neonates with an anorectal malformation:
the value of imaging for pre-operative localisation a direct comparison with rectofistulography using
A. Iannarelli, B. Sacconi, R. Argirò, C. Cipriani, S. Minisola, C. Catalano, M. Bezzi, surgical findings as reference standard
D. Diacinti; Rome / IT M.G. Thomeer, A. Devos, M. Lequin, N. De Graaf, M. Meradji, I. De Blaauw,
C. Sloots; Rotterdam / NL
11:42 11:26
B-0894 The role of functional MR urography (fMRU) in the B-0903 Cardiac diffusion-weighted MR imaging in acute
evaluation of unilateral hydronephrosis in children myocarditis: initial experience
A. Ntoulia, L. LeCompte, M. Adeb, D. Khrichenko, S. Lambert, P. Casale, J.-P. Laissy, V. Gaxotte, A. BenDriss, J.-M. Serfaty; Paris / FR
K. Darge; Philadelphia, PA / US
11:34
11:50 B-0904 Prognostic value of different cardiac magnetic
B-0895 Contrast-enhanced voiding urosonography with resonance (CMR) patterns in patients with acute
a second-generation ultrasound contrast agent myocarditis
for diagnosis of vesicoureteric reflux in 1350 children: M. Cava, G. Benedetti, D. Palumbo, G. Fragasso, A. Esposito, A. Del Maschio,
the experience of a single center F. De Cobelli; Milan / IT
F. Papadopoulou1, A. Ntoulia2, K. Darge2; 1Thessaloniki / GR, 2Philadelphia,
PA / US 11:42
B-0905 Multi-parametric myocardial mapping of patients
with Anderson Fabry disease: regional distribution of
10:30–12:00 Room MB 3 changes in T1, T2 relaxation and ECV
T.C. Walter1, G. Knobloch1, A. Sandek1, V. Ding-Reinelt1, P. Freyhardt1, A. Krebs2,
Cardiac T. Denecke1, B. Hamm1, M. Makowski1; 1Berlin / DE, 2Prague / CZ
10:30 Musculoskeletal
B-0896 Late gadolinium enhancement in MRI
for cardiomyopathies: SS 1010b Hand, upper extremity
a quantitative comparison of 2D and 3D acquisition Moderators: I. Beggs; Edinburgh/UK, E. Drakonaki; Iraklion/GR
F. Morsbach, S. Gordic, M. Niemann, H. Alkadhi, R. Goetti, R. Manka; Zurich / CH
10:30
10:38 B-0907 Diagnostic work-up of scapholunate dissociation:
B-0897 Prognostic value of late enhancement in cardiac cine-MR imaging as a new approach
magnetic resonance in patients with dilated E. Rathmann, I. Langner, K. Rebecca, S. Langner, N. Hosten; Greifswald / DE
cardiomyopathy: systematic review and meta-analysis 10:38
F. Secchi, E. Resta, P. Cannaò, M. Petrini, G. Di Leo, F. Sardanelli; Milan / IT
B-0908 Ultra-high field MR-microscopy of fetal forearm -
10:46 ex vivo assessment of the ossification patterns
P.-C. Krüger1, I. Langner1, T. Stahnke2, O. Stachs2, S. Langner1, N. Hosten1;
Friday
B-0898 Extent of myocardial fibrosis by LGE, pre- and 1
Greifswald / DE, 2Rostock / DE
post-contrast T1 and ECV in patients with hypertrophic
cardiomyopathy referenced to normal appearing 10:46
myocardium or healthy volunteers B-0909 Accelerated diffusion tensor imaging of the median
M. Avanesov, D. Säring, M. Patten, U.K. Radunski, K. Muellerleile, C. Stehning,
E. Tahir, G. Adam, G. Lund; Hamburg / DE nerve using simultaneous multi-slice echo planar
imaging with blipped CAIPIRINHA
10:54 L. Filli, M. Piccirelli, D. Kenkel, A. Boss, G. Andreisek, V.M. Runge,
R. Guggenberger; Zurich / CH
B-0899 Prognostic CMR parameters for heart failure
and arrhythmias in large cohort of well treated 10:54
thalassemia major patients B-0910 Evaluation of lesions of the internal ligaments of the
C. Tudisca1, A. Meloni2, E. Grassedonio1, M. Restaino3, F. Terrazzino1,
C. Argento4, N. Vallone5, M. Midiri1, A. Pepe2; 1Palermo / IT, 2Pisa / IT, 3Taranto / IT, wrist: conventional magnetic resonance imaging vs
4
Agrigento / IT, 5Catania / IT MR arthrography
H.A. Kamal; Cairo / EG
11:02
B-0900 Isolated le ventricular non-compaction (LVNC) 11:02
in patients with b-thalassemia: B-0911 Development of a statistical 3D modell of the intact
41 months follow-up with cardiac magnetic resonance distal radius: preliminary results
M. Gatti, R. Faletti, A. Veltri, A. Piga, F. Longo, G. Gandini, R. Bonamini; Turin / IT J. Binder1, S.F. Baumbach1, F. Mück1, A. Synek1, Y. Chevalier1, G. Langs2,
L. Fischer2; 1Munich / DE, 2Vienna / AT
11:10 11:10
B-0901 Isolated non-compaction of the le ventricle: B-0912 Can ultrasound replace MRI in assessment
correlation between clinical and genetic of nerve entrapment in osteofibrous tunnels in the
manifestations of the disease and cardiac upper extremity
MR parameters A.M. Abdel Magied, Y.M. Tohamy, T. Taymour, L. Adel; Cairo / EG
E.A. Mershina, O. Larina, V. Sinitsyn, R. Myasnikov, M. Kharlap, O. Kulikova,
S. Boytsov; Moscow / RU 11:18
11:18 B-0913 Possibilities of magnetic resonance imaging
B-0902 Semiquantitative assessment of low and in diagnosis of shoulder joint instability
A. Filimonova, I. Lisachenko, I. Znamenskiy, A. Uchevatkin; Moscow / RU
high b value DWI for detecting myocardial edema
in acute myocarditis
J. Broncano1, A. Luna2, T. Martin Noguerol2, J. Sanchez-Gonzalez3; 1Córdoba / ES,
2
Jaen / ES, 3Madrid / ES
11:26
B-0914 High resolution ultrasound in evaluation
of bifid median nerve in carpal tunnel syndrome
in Indian population
S. Sripathi, D. Bansal, A. Ayachit, R. Kadavigere; Manipal / IN
11:34
B-0915 Prospective comparative analysis of ultrasound vs
arthroscopy in evaluation of impingement syndrome
and supraspinatus tear
N. Shetty1, P.E. Chandy1, M.D. Mahajan1, G. K2, N.P. Hegde2, M. Shetty1,
A. Shetty1, V. Ruprela1; 1Bangalore / IN, 2Mangalore / IN
11:42
B-0916 A radiographic union score to assess healing in
surgically treated long bone fractures:
a feasibility study
V. Perlepe1, P. Omoumi2, A. Larbi1, D. Putineanu1, J.-E. Dubuc1, T. Schubert1,
B. Vande Berg1; 1Brussels / BE, 2Lausanne / CH
11:50
B-0917 Novel features of metabolic bone diseases
in high-resolution imaging: reproducibility and
validity of radiologic reading
S. Fussenegger, L. Fischer, M. Weber, F. Kainberger, M. DiFranco, G. Langs,
J.M. Patsch; Vienna / AT
Friday
11:19 11:10
B-0923 Is synthetised Digital Mammography (3D-DM) superior B-0935 Treatment response and hypoxia monitoring assessed
to conventional Digital Mammography (2D-DM)? A by molecular imaging of tumour microenvironment
retrospective study of 210 patients using multiparametric 3T-MRI and 18F-FMISO
P. Martinez-Miravete1, P. Garcia Barquin2, M. Millor2, J. Etxano2, A. Elizalde2, P. Georg1, P. Andrzejewski2, W. Wadsak2, A. Sturdza2, G. Karanikas2, R. Pötter2,
L. Pina2, R. Zalazar2; 1Zaragoza / ES, 2Pamplona / ES T.H. Helbich2, D. Georg2, K. Pinker-Domenig2; 1Wiener Neustadt / AT, 2Vienna / AT
11:27 11:18
B-0924 Can digital breast tomosynthesis predict the benignity B-0936 Glycosaminoglycan chemical exchange saturation
or malignancy of circumscribed masses? transfer magnetic resonance imaging of knee joint
J. Morel, R. Wasan, A. Iqbal, D.R. Evans, C. Peacock, R. Rahim, J. Goligher, cartilage at 3 Tesla: baseline values in asymptomatic
K. Satchithananda, M.J. Michell; London / UK young adult volunteers
C. Schleich1, F. Miese1, C. Zilkens1, B. Schmitt2, A. Müller-Lutz1, M. Sondern1,
11:35 G. Antoch1, R. Krauspe1, B. Bittersohl1; 1Düsseldorf / DE, 2Macquarie Park
B-0925 Invasive Breast Carcinomas (IBCs) that do not look NSW / AU
suspicious on Digital Breast Tomosynthesis (DBT): 11:26
important considerations when integrating DBT
B-0937 Chemical exchange saturation transfer imaging:
into clinical practice
O. Abeyakoon, R. Rahim, J. Morel, R. Wasan, D. Evans, K. Satchithananda, preliminary experience for characterisation
J. Goligher, C. Peacock, M.J. Michell; London / UK of thoracic nodule and mass based on MR-based
molecular information
11:43 Y. Ohno1, M. Yui2, C. Ouyang3, M. Miyazaki3, S. Seki1, H. Koyama1, T. Yoshikawa1,
B-0926 Additional US or DBT aer digital mammography: S. Matsumoto1, K. Sugimura1; 1Kobe / JP, 2Otawara / JP, 3Vernon Hills, IL / US
which one is the best combination?
A. Elizalde, P. Garcia Barquin, M. Millor, J. Etxano, P. Martinez-Miravete, L. Pina,
M. Páramo; Pamplona / ES
11:34 11:35
B-0938 Apoptosis-targeted optical fluorescence imaging B-0946 Differences between supine and orthostatic positions
for characterisation of regorafenib effects on in facet joint (FJ) fluid and spondylolisthesis
experimental colon carcinomas validated by perfusion at lumbar-spine MRI
MRI and multiparametric immunohistochemistry C. Ottonello1, A. Giardino1, P. Giuliani1, C. Messina2, G. Di Leo3, F. Sardanelli3;
P.M. Kazmierczak, E. Burian, R. Eschbach, M. Moser, L. Havla, H. Hirner,
1
Rome / IT, 2Milan / IT, 3San Donato Milanese / IT
M.F. Reiser, K. Nikolaou, C.C. Cyran; Munich / DE
11:43
B-0947 Feasibility and reproducibility of T2 mapping
10:30–12:00 Room E1 of the sacroiliac joints at 3T
G. Lefebvre, A. Bergère, E. Dodré, V. Pansini, X. Demondion, A. Cotten; Lille / FR
Musculoskeletal 11:51
SS 1410 Spine B-0948 The effect of low back pain on positional changes
Moderators: M.A. Cova; Trieste/IT, C. Giraudo; Vienna/AT in the lumbar lordosis:
a cross-sectional comparison with healthy controls
10:30 B. Hansen, T. Bendix, J. Grindsted, H. Bliddal, P. Hansen, R. Christensen, R. Riis,
M. Boesen; Copenhagen / DK
K-22 Keynote lecture
I.W. McCall; Devon / UK
Saturday
time predict future low back pain? L. Hu, N. Hong; Beijing / CN
M. Raudner, D. Stelzeneder, C. Kronnerwetter, R. Windhager, S. Trattnig;
Vienna / AT 10:54
B-0953 Diagnostic improvement from average intensity
11:11 projection in acute ischemic stroke
B-0943 Fat suppression in MRI of the spine at 3T using a fast N. Magne, B. Dubourg, E. Tollard, O. Ozkul Wermester, V. Macaigne, J.-N. Dacher,
T2-weighted two-point mDixon TSE technique: E. Gerardin; Rouen / FR
initial clinical experience 11:02
P.A. Kupczyk, M. Marinova, J. Gieseke, H.H. Schild, G.M. Kukuk, D.R. Hadizadeh;
Bonn / DE B-0954 Dual-energy CT brain in the evaluation
of cerebral infarction
11:19 H.S. Teh, M.M.L. Tan, S. Srinivasan, T.W. Choy, K.K. Yeow; Singapore / SG
B-0944 Evaluation of artifacts reducing effect of orthopedic
metal artifact reduction technique in patients aer 11:10
pedicle screw placement B-0955 Endovascular treatment of acute ischemic
Y. Wang, Y. Xiao, Y. Jiang, H. Li, S. Liu; Shanghai / CN stroke. Evolution among 100 consecutive patients
in the last 10 years
11:27 E. Fandiño, J.C. Méndez, D. Lourido, J. García Poza, J. Sanmillán; Madrid / ES
B-0945 Impact of patient positioning during MRI of the
Lumbar Spine in patients with stenosis: 11:18
changes in lordosis and canal dimensions B-0956 Perfusion CT (pCT) in acute stroke:
N. Martins, R.G. Nunes, H. Ferreira, J.P. Figueiredo, L. Barroso, J.D. Mineiro; value of automatically generated colour map
Lisbon / PT in the evaluation of patients with acute stroke
M. Ukmar, R. Pozzi Mucelli, F. Degrassi, F. Neri, F. Pozzi Mucelli, M. Cova;
Trieste / IT
11:26 11:26
B-0957 False penumbra on CT perfusion studies in acute B-0967 MRI findings in men on active surveillance for prostate
ischaemic stroke (AIS) cancer: does dutasteride make MRI visible lesions
E. Puglielli1, R. Lattanzi1, M. Fuschi1, V. Di Mizio1, V. Di Egidio2; 1Teramo / IT, less conspicuous? Results from a pilot randomised
2
Pescara / IT
controlled trial
11:34 F. Giganti1, C.M. Moore1, N.L. Robertson1, A. Freeman1, F. De Cobelli2,
M. Emberton1, C. Allen1, A. Kirkham1; 1London / UK, 2Milan / IT
B-0958 Clinical predictors of diffusion-weighted MR-imaging
(DWI) abnormalities in transient ischaemic attack 11:34
(TIA) B-0968 Prostate cancer staging with extracapsular
M. Mahmoud, A.F. Christensen, I. Havsteen, H. Christensen; Copenhagen / DK extension risk scoring using multiparametric MRI:
11:42 a correlation with histopathology
L. Boesen, E. Chabanova, V. Loegager, I. Balslev, K. Mikines, H.S. Thomsen;
B-0959 Benefits and harms of endovascular devices for acute Herlev / DK
ischaemic stroke in accordance with the cochrane
collaboration recommendations 11:42
J. Kristensen, C. Gluud, A.F. Christensen, H. Christensen; Copenhagen / DK B-0969 MR-guided prostatic biopsy at 3T: the role of
PI-RADS-score: a histopahologic-radiologic correlation
A. Malich; Nordhausen / DE
10:30–12:00 Room F1
11:50
Oncologic Imaging B-0970 Role of 3T MRI in radiotherapy planning
for stereotactic treatment of the prostate
SS 1416 Prostate cancer imaging with helical tomotherapy
Moderators: E.C. Pereira Mendes Serrao; Cambridge/UK, G. Petralia; Milan/ G. Timon, S. Agostinelli, G. Blandino, G. Vidano, S. Barra, R. Corvò; Genoa / IT
IT
11:34 11:26
B-0979 CT in peritoneal tuberculosis revisited: B-0989 MR diagnosis of diaphragmatic endometriosis
mystery, myth and reality P. Rousset1, C. Bordonne2, C. Rousset-Jablonski1, F. Golfier1, J. Hugon-Rodin2,
M. Khanna, S. Ramanathan, A.M. Abualruz, D. Kumar, S.R. Buddhavarapu, M. Alifano2, M.-P. Revel2; 1Pierre Bénite / FR, 2Paris / FR
A. Darweesh, J. Khanna; Doha / QA
11:34
11:42 B-0990 Magnetic resonance imaging versus chest radiography
B-0980 Fast MRI-based quantification of visceral adipose in the study of lung parenchyma: preliminary results
tissue in morbidly obese I. Merli, C. Messina, M. Petrini, F. Secchi, L.M. Sconfienza, F. Sardanelli; San
N. Linder, A. Schaudinn, N. Garnov, M. Blüher, T. Schütz, T. Karlas, A. Dietrich, Donato Milanese / IT
T. Kahn, H. Busse; Leipzig / DE
11:42
11:50 B-0991 T2 relaxation and proton density characterisation
B-0981 Real-time splenic elastography as a tool for detection of pathologically proved nonspecific interstitial
and grading of oesophago-gastric varices pneumonia and usual interstitial pneumonia
V. Venugopal, S.K. Arjun; New Delhi / IN M.T.A. Buzan1, M. Eichinger2, C. Heussel2, H.-U. Kauczor2, M. Kreuter2,
U. Oltmanns2, A. Warth2, C.M. Pop1, J. Dinkel2; 1Cluj-Napoca / RO, 2Heidelberg / DE
10:38 10:30
B-0983 Ultra-low dose CT pulmonary angiography for imaging K-23 Keynote lecture
pregnant women: can dose reduction be achieved P. Haage; Wuppertal / DE
without affecting image quality? 10:39
D. Halpenny, B. Park, J. Alpert, L. Latson, J. Babb, J. Ko; New York, NY / US
B-0993 Post-SIRT survival in a tertiary referall centre for HCC
10:46 P. Lucatelli, G. Vallati, G. Pizzi, F. Portieri, F. Rosella, F. Paradiso; Rome / IT
B-0984 Reducing the radiation dose of CT scans to exclude 10:47
pulmonary embolism by using protocols adapted to
B-0994 Transarterial chemoembolisation (TACE) in primary
patient weight
T. De Bondt, R. Salgado, M. Geldof, F. Deferme, P.M. Parizel; Antwerp / BE liver malignancies: Intraprocedural blood volume
measurement using fast C-arm-CT for monitoring
10:54
Saturday
response
B-0985 Low-kilovoltage and low-mAs MDCT chest T.J. Vogl, S. Tietz, S. Zangos, S. Zeuzem; Frankfurt a. Main / DE
examinations in adults: assessment in terms of 10:55
feasibility, image quality and radiation dose
A.A. Patil; Kochi / IN B-0996 Utility of intra-procedural cone-beam CT in predicting
treatment outcome for drug-eluting bead (DEB)
11:02 transarterial chemoembolisation (TACE)
B-0986 Quantitative measurements in low-dose chest CT with B.H. Ge, C.N. Weber, M.M. Watts; Philadelphia, PA / US
hybrid iterative reconstruction technique 11:03
S. Kawanami, T. Kamitani, T. Yamanouchi, Y. Yamasaki, M. Jinnouchi,
M. Yonezawa, M. Nagao, H. Yabuuchi, H. Honda; Fukuoka / JP B-0997 Conventional transarterial chemoembolisation versus
drug-eluting bead transarterial chemoembolisation for
11:10 the treatment of hepatocellular carcinoma
B-0987 Chest CT radiation dose optimisation: comparison of R. Kloeckner, F. Prinz, C. Ruckes, A. Weinmann, C. Dueber, M.B. Pitton;
automatic exposure control strength curves Mainz / DE
E. Gyssels1, P. Bohy2, A. Cornil3, A. Van Muylen4, P.A.A. Gevenois4, D. Tack2;
1
Sirault / BE, 2Baudour / BE, 3Ath / BE, 4Brussels / BE 11:11
B-0999 Parametric response mapping of dynamic CT for
11:18 longitudinal quantitative assessment of regional
B-0988 Ultra-reduced dose chest CT: comparison between tumour vascularisation in TACE treatment for
iterative model reconstruction, iDose4 and hepatocellular carcinoma
filtered-back projection T. Rodt, D. Kaercher, D.B. Hasdemir, T. Kaireit, C. Lutat, A. Vogel, B. Meyer,
C. de Margerie-Mellon1, C. de Bazelaire1, J. Lambert1, C. Montlahuc1, F. Wacker, H.-O. Shin; Hannover / DE
A. Martineau1, E. de Kerviler1, C. Beigelman2; 1Paris / FR, 2Lausanne / CH
11:19 11:34
B-1000 Can cone-beam CT-assisted chemoembolisation B-1012 X-ray phase-contrast CT:
improve survival of patients with single nodular a novel method for differentiation of low-fat
hepatocellular carcinoma? angiomyolipomas from renal cell carcinomas
J. Lee, J. Choi, H.-C. Kim; Seoul / KR M. Braunagel1, L. Birnbacher2, M. Willner2, J. Herzen2, S. Notohamiprodjo1,
T. Saam1, F. Pfeiffer2, M.F. Reiser1, M. Notohamiprodjo3; 1Munich / DE,
11:27 2
Garching / DE, 3Tübingen / DE
B-1001 Evaluation of quality of life aer initial TACE for 11:42
treatment of HCC B-1013 CT perfusion parameters to determine
D.B. Hasdemir, M. Nordlohne, K.J. Hartrumpf, N. Schweitzer, A. Vogel, F. Wacker,
B.C. Meyer, T. Rodt; Hannover / DE split renal function
M. El-Diasty, G. Gaballa, H. Gad, M.A. Borg, M. Abou El-Ghar, K. Sheir,
T.A.E. El-Diasty; Mansoura / EG
10:30–12:00 Room G
10:46 10:46
B-1005 Acute pyelonephritis in kidney transplant patients: B-1016 Paediatric chest digital radiography optimisation
P. Freitas, F. Lopes, D. Costa, J. Santos, G. Paulo; Coimbra / PT
role of diffusion-weighted MR imaging
J. Giglio, R. Faletti, C. Guarnaccia, M. Messina, P. Fonio, G. Gandini; Turin / IT 10:54
10:54 B-1017 An investigation into cardiologists’ opinion/awareness
B-1006 Evaluation of chronic kidney disease using blood of radiation risk as part of routine patient consent for
oxygenation-level dependent magnetic resonance cardiac interventional procedures
I. Banerjee1, J. McNulty1, D. Catania2, D. Maccagni2, L. Masterson1, J.L. Portelli3,
imaging at 3T L.A. Rainford1; 1Dublin / IE, 2Milan / IT, 3Malta / MT
J. Bae, C. Kim, J. Park, B. Park, S. Park; Seoul / KR
11:02
11:02
B-1018 Dose evaluation releted image quality on paediatric
B-1007 Assessment of intravoxel incoherent motion MR chest examination with dedicated flat-panel
imaging for the differentiation of renal benign tumour C. Dionisi1, E. Stefani1, S. Barbera2; 1Treviso / IT, 2Biella / IT
and renal malignant tumour
L. Li, H. Ye, H. Wang, Y. Tang, D. Zheng; Beijing / CN 11:10
B-1019 AP vs PA positioning in lumbar spine computed
11:10
radiography: image quality and individual organ doses
B-1009 Clear cell renal cell carcinoma: associations between E. Davey, A.E. England; Manchester / UK
CT imaging features and patient survival
A.M. Hötker, C.A. Karlo, J. Zheng, C.S. Moskowitz, P. Russo, H. Hricak, O. Akin; 11:18
New York, NY / US
B-1021 Uniformisation of the anode heel effect and
11:18 image quality
A.F.C.L. Abrantes, J. Aleixo, L.P. Ribeiro, S. Rodrigues, P. Sousa, J.P. Pinheiro,
B-1010 Differentiation of clear cell renal cell carcinoma from R.P.P. Almeida, O. Lesyuk; Faro / PT
other renal cortical tumours using a quantitative
multi-parametric MRI Approach 11:26
A.M. Hötker, Y. Mazaheri, A. Wibmer, C.A. Karlo, J. Zheng, C.S. Moskowitz, B-1022 The effect of lead shielding in pelvis radiography
P. Russo, H. Hricak, O. Akin; New York, NY / US N. Mekiš, J. Zibert, D. Zontar; Ljubljana / SI
11:26 11:34
B-1011 Tubulocystic renal cell carcinomas: B-1023 Optimising pelvis images of a paediatric phantom by
a new radiological entity using additional filtration and different combinations
F. Cornelis1, O. Hélénon2, J.-M. Correas2, L. Lemaitre3, M. André4, J.-Y. Meuwly5,
C. Sengel6, L.E. Derchi7, N. Grenier1; 1Bordeaux / FR, 2Paris / FR, 3Lille / FR, of kVp and mAs
4
Marseille / FR, 5Lausanne / CH, 6Grenoble / FR, 7Genoa / IT V. Harsaker1, W. Schaake2, R. Visser2, C. Bloomfield3, F. Boavida4, D. Chabloz5,
E. Crausaz5, E. Huizinga2, H. Hustveit1, H. Knight3, A. Pereira4, P.H. Hogg3;
1
Oslo / NO, 2Groningen / NL, 3Salford / UK, 4Lisbon / PT, 5Lausanne / CH
11:42
B-1024 A European collaborative research study investigating
paediatric cardiac interventional radiation dose levels
L.A. Rainford1, D. Catania2, M. Pasquato2, L. Masterson1, C. McLaren3, S. Foley1;
1
Dublin / IE, 2Milan / IT, 3London / UK
Saturday
11:11 10:54
B-1029 Well-defined mass lesions in mammographic B-1038 Development of a shared multisite virtual PACS
P. Rowlands, S. Dyce, N. Pfirsch, S. Lomax; Liverpool / UK
screening: determining the rate of cysts and
solid lesions 11:02
F. Kilburn-Toppin, M. Wallis; Cambridge / UK B-1039 VISCERAL - visual concept extraction challenge
11:19 in radiology: segmentation challenge -
B-1030 Comparison of the diagnostic workup of women overview, insights and preliminary results
K.M. Grünberg1, M.-A. Weber1, O.A. Jimenez del Toro2, O. Goksel3, H. Müller2,
referred at non-blinded or blinded double reading G. Langs4, M. Krenn4, M. Winterstein1, A. Hanbury4; 1Heidelberg / DE, 2Sierre / CH,
in a population-based screening mammography
3
Zurich / CH, 4Vienna / AT
programme in the south of the Netherlands 11:10
E.G. Klompenhouwer1, R.J.P. Weber1, A.C. Voogd1, L.J.A. Strobbe2,
M.J.M. Broeders1, L.E.M. Duijm2; 1Eindhoven / NL, 2Nijmegen / NL B-1040 Automated liver lesions classification using dictionary
Bag-of-Visual-Words (BoVW) model
11:27 N. Rozendorn1, M.M. Amitai2, E. Klang2, E. Konen2, A. Ben Cohen1, I. Diamant1,
B-1031 Characteristics and survival of interval breast cancer H. Greenspan1; 1Tel Aviv / IL, 2Ramat Gan / IL
subtypes at biennial screen-film and full-field digital 11:18
screening mammography B-1041 Evaluation of a computer algorithm for automated
R.J.P. Weber1, E.G. Klompenhouwer1, J. Nederend1, M.W. Louwman1, A.C. Voogd2,
L.J.A. Strobbe3, F.H. Jansen1, L.E.M. Duijm3; 1Eindhoven / NL, 2Maastricht / NL, detection and measurement of liver metastases
3
Nijmegen / NL E. Klang1, A. Ben Cohen2, I. Diamant2, N. Rozendorn2, E. Konen1, H. Greenspan2,
M.M. Amitai1; 1Ramat Gan / IL, 2Tel Aviv / IL
11:35
B-1032 Screening outcome and surgical treatment during 11:26
and aer the transition from screen-film to digital B-1042 A breast cancer digital repository for assessing CADx
screening mammography in the south of the methods on mammography
M. Guevara Lopez1, N. Gonzalez de Posada2, D. Cardoso Moura2, P. Cunha2,
Netherlands I. Ramos2, J. Pinheiro Loureiro2, I. C. Moreira2, B. Ferreira de Araújo2; 1Aveiro / PT,
R.J.P. Weber1, E.G. Klompenhouwer1, J. Nederend1, A.C. Voogd2, L.J.A. Strobbe3, 2
Porto / PT
L.E.M. Duijm3; 1Eindhoven / NL, 2Maastricht / NL, 3Nijmegen / NL
11:34 11:27
B-1043 Real world application of new technologies enhancing B-1053 Added value of functional dynamic CT-perfusion
teleradiology services in the Waldviertel healthcare in assessment of neoangiogenesis tumour-related
region, Austria phenomenon in diagnosis and treatment evaluation of
A. Bernegger; Horn / AT HCC patients
D. Ippolito, D. Fior, P.A. Bonaffini, C. Talei Franzesi, R. Corso, S. Sironi; Monza / IT
11:42
B-1044 Teleradiology in Italy: results of an online survey 11:35
F. Coppola1, E. Neri2, D. Regge3; 1Bologna / IT, 2Pisa / IT, 3Turin / IT B-1054 Radiological response of hepatocellular carcinoma
11:50 (HCC) treated with transarterial chemoembolisation
B-1045 French and Italian residents’ expectations concerning (TACE) before liver transplant (LT): correlation with
teleradiology: a comparative study histopathology and recurrence free survival
A. Agostini, D. Nicolini, C. Mincarelli, G. Svegliati Baroni, A. Mandolesi,
N. Pyatigorskaya1, F. Coppola2, D. Regge3, E. Neri4; 1Paris / FR, 2Bologna / IT, A. Lorenzoni, R. Candelari, M. Vivarelli, A. Giovagnoni; Ancona / IT
3
Turin / IT, 4Pisa / IT
11:43
10:30–12:00 Room M
B-1055 The impact of transarterial chemoembolisation (TACE)
on uninvolved liver parenchymal perfusion in patients
Abdominal Viscera with hepatocellular carcinoma undergoing TACE
M. Horger, K. Nikolaou, S. Kaufmann; Tübingen / DE
SS 1801 HCC diagnosis and treatment
Moderators: C. Ayuso Colella; Barcelona/ES, A. Furlan; Pittsburgh, PA/US
10:30–12:00 Studio 2015
10:30
K-25 Keynote lecture
Cardiac
C. Ayuso Colella; Barcelona / ES
SS 1803 Biomarkers in cardiac imaging
10:39 Moderators: A. Kallifatidis; Thessaloniki/GR, T. Leiner; Utrecht/NL
B-1046 Reporting of hepatocellular carcinoma:
comparison of interreader agreement between 10:30
LI-RADS and standard LIKERT-scale in patients B-1056 MRI-proven cardiac pathologies in female carriers of
at risk for hepatocellular carcinoma Duchenne muscular dystrophy
J. Schelhorn, A. Schoenecker, U. Neudorf, K. Nassenstein, U. Schara,
B.K. Barth, O.F. Donati, M.A. Fischer, E.J. Ulbrich, K.A. Christoph, C.S. Reiner; T. Schlosser; Essen / DE
Zurich / CH
10:47 10:38
B-1048 Clinical application of LI-RADS: B-1057 Correlation of thoracic aortic distensibility with aortic
preliminary evaluation with Gd-BOPTA MR Imaging and coronary atherosclerotic plaques
M.A. Karimi, A. Arjmand Shabestari, M. Shahnazi, T. Faghihi Langroudi,
M. Di Martino, M. Bezzi, C. Catalano; Rome / IT H. Pouraliakbar, M. Tehrai; Tehran / IR
10:55 10:46
B-1049 A prospective study to compare the diagnostic B-1058 Cardiac computed tomography is an accurate method
performance of gadoxetic acid-enhanced MRI and US to differentiate le atrial appendage thrombi from
for surveillance of HCC in high risk patients with liver spontaneous echo contrast in acute stroke patients
cirrhosis M. Taina, R. Vanninen, P. Sipola, A. Muuronen, P. Jäkälä, M. Hedman; Kuopio / FI
S. Kim, Y.-S. Lim, J. Byun, H. Won, S. Lee, S. Han, J. An, H. Lee, Y. Lee; Seoul / KR
10:54
11:03 B-1059 Impact of implementing cardiac CT in evaluating
B-1050 Hypointense nodules on hepatobiliary phase Gadoxetic patients suspected of cardioembolic stroke
acid-enhanced MR images: imaging features, evolution A.M. Ajlan, R.R. Bagdadi; Jeddah / SA
and the role of diffusion-weighted imaging
C. Briani, M. Di Pietropaolo, G.F. Federici, F. Carbonetti, M. Marignani, P. Begini, 11:02
E. Iannicelli; Rome / IT B-1060 Geometrical differences of the coronary arteries
11:11 during the cardiac cycle on 4D CT angiography
J.K. van Zandwijk1, V. Tuncay1, C.H. Slump2, M. Oudkerk1, R. Vliegenthart1,
Sunday
B-1051 Non-hypervascular hepatobiliary phase hypointense P.M.A. van Ooijen1; 1Groningen / NL, 2Enschede / NL
nodules on gadoxetic acid-enhanced MRI:
risk of HCC recurrence aer radiofrequency ablation 11:10
D. Lee, J. Lee; Seoul / KR B-1061 Heritability of coronary geometry: initial experience
M. Kolossváry1, Z.D. Drobni1, G. Závodszky1, I. Kolossváry1, P. Kitslaar2,
11:19 B. Merkely1, P. Maurovich-Horvat1; 1Budapest / HU, 2Leiden / NL
B-1052 Role of DWI, ADC and correlation with hepatobiliary 11:18
phase (DPI, delayed phase imaging) findings in the
B-1062 Heritability of coronary calcification and plaque
differentiation of hepatocellular carcinoma (HCC) from
burden: a classical twin study
dysplastic nodules (DNs) in liver cirrhosis P. Maurovich-Horvat1, Z.D. Drobni1, T. Horvath1, A.L. Jermendy1, M. Karoly1,
D. Curione, R. Inchingolo, A. De Gaetano, M. Ciresa, L. Bonomo; Rome / IT M. Kolossvary1, A.D. Tarnoki1, S. Voros2, B. Merkely1; 1Budapest / HU, 2Richmond,
VA / US
11:26 11:19
B-1063 Measuring athlete’s risk of cardiovascular events B-1072 Use MRI T1rho monitor the curative effective
(MARC) study: the role of coronary CT in the treatment of epimedium on early osteoarthritis
cardiovascular evaluation of middle-aged sportsmen S. Liu, J. Zhang, S. Shen, F. Wang, L. Qiu, M. Chen, C. Zhang; Guangzhou / CN
T. Braber, B.K. Velthuis; Utrecht / NL
11:27
11:34 B-1073 Is it worth to include MRI of the spine in the ASAS
B-1064 Athletes’ normal le ventricular magnetic resonance classification criteria for axial spondyloarthritis:
parameters modified by trabeculae measurement data from the DESIR-cohort
H. Vago, A. Toth, C. Czimbalmos, F. Suhai, I. Csecs, K. Kecskes, B. Merkely; M. de Hooge, J.-B. Pialat, A. Feydy, M. Reijnierse, M. Dougados, D. van der
Budapest / HU Heijde; Paris / FR
11:42 11:35
B-1065 Cardiac MRI in athletes can be a final step in the B-1074 Gouty arthritis: effect of dual-energy CT on diagnostic
eligibility for competitive sport aer suspicious thinking and therapeutic decision making
ultrasonography or stress ECG? T. Finkenstaedt, A. Manoliou, M. Toniolo, T. Frauenfelder, G. Andreisek,
L. Patriarca, F. Bruno, A. Mancini, F. Smaldone, E. Di Cesare, C. Masciocchi; B. Michel, R. Guggenberger, H. Alkadhi; Zurich / CH
L’Aquila / IT
11:43
11:50 B-1075 Prevalence of MRI spinal lesions typical
B-1066 Can pericardial fat volume be a marker of metabolic for axial Spondyloarthritis in patients
syndrome in adult patients? A preliminary study with inflammatory back pain
H. Chen1, J. Yu1, X. Zhang2; 1Chengdu / CN, 2Shanghai / CN M. De Hooge1, J.-B. Pialat2, A. Feydy3, M. Reijnierse1, P. Claudepierre4,
A. Saraux5, M. Dougados3, D. van der Heijde1; 1Leiden / NL, 2Lyon / FR, 3Paris / FR,
4
Créteil / FR, 5Brest / FR
10:30–12:00 Room E1 11:51
Musculoskeletal B-1076 Scoring of spinal lesions compatible with axial
spondyloarthritis on MRI in clinical practice
SS 1810 Arthritis by local radiologist or rheumatologist in DESIR:
Moderators: A. Cotten; Lille/FR, S. Weckbach; Heidelberg/DE comparison with central reading
M. de Hooge1, J.-B. Pialat2, M. Reijnierse1, D. van der Heijde1, M. Dougados3,
10:30 A. Feydy3; 1Leiden / NL, 2Lyon / FR, 3Paris / FR
K-26 Keynote lecture
I. Boric; Zabok / HR
10:30–12:00 Room E2
10:39
B-1067 A comparison between x-ray, CT and DECT in detection Neuro
of tophi in gouty arthritis: first clinical experience with
single source DECT in volume scan mode
SS 1811 Brain epilepsy and inflammation
T. Diekhoff, T. Kiefer, K.-G.A. Hermann; Berlin / DE Moderators: T. Kau; Klagenfurt/AT, M. Mantatzis; Alexandroupolis/GR
10:47 10:30
B-1068 Evaluation of a simplified version of the rheumatoid B-1077 Widespread white matter maldevelopment in children
arthritis magnetic resonance imaging score (RAMRIS) with specific language impairment
I.L. Štepán-Buksakowska1, N. Szabó2, R. Vydrová1, T.Z. Kincses2, J. Šanda1,
comprising 5 joints (RAMRIS5) M. Kynčl1, D. Hořínek2, M. Roček1, V. Komárek1; 1Prague / CZ, 2Brno / CZ
C. Schleich, C. Buchbender, P. Sewerin, B. Ostendorf, C. Rubbert, G. Antoch,
F. Miese; Düsseldorf / DE
10:38
10:55 B-1078 Acute necrotising encephalopathy of childhood:
B-1069 Increased risk for incident radiographic osteoarthritis correlation of MRI findings and clinical outcome
M.D. Mahajan, V. Ruprela, B. Banerjee, P.E. Chandy, R. Ananthasivan, U. Patil,
and cartilage loss in knees undergoing meniscal S. Kumar GG, N. Shetty, P. Reddy; Bangalore / IN
surgery in the previous year
F.W. Roemer1, C. Kwoh2, M. Hannon3, J. Grago3, D.J. Hunter4, F. Eckstein5, 10:46
A. Guermazi6; 1Erlangen / DE, 2Tucson, AZ / US, 3Pittsburgh, PA / US, 4Sydney / AU,
5
Salzburg / AT, 6Boston, MA / US B-1079 Abnormal brain development in neonates with
congenital heart disease: evaluation with quantitative
11:03 magnetic resonance spectroscopy
B-1070 Comparison of optimised high-resolution MR imaging R.A. Elshafey, M. Awny, A. Elmashad, M. Nassar; Tanta / EG
of the temporomandibular joint at 1.5T and 3.0T using 10:54
an optimised high-resolution protocol
A. Manoliu, G. Spinner, M. Wyss, S. Erni, D. Ettlin, D. Nanz, E.J. Ulbrich, L.M. Gallo, B-1080 The value of resting-state fMRI for detecting
G. Andreisek; Zurich / CH epileptogenic zone in patients with focal epilepsy
J. Yin1, B. Zhao1, P. Zuo2, H. Ni1, W. Shen1; 1Tianjin / CN, 2Beijing / CN
11:11
B-1071 Increased risk for radiographic osteoarthritis 11:02
features in young active athletes: B-1081 fMRI resting-state in temporal lobe epilepsy
N. Ananyeva, L. Shmeleva, R. Ezhova; St. Petersburg / RU
a cross-sectional matched case-control study
F.W. Roemer1, M. Jarraya2, J. Niu2, J.-R. Silva Jr.2, R. Frobell3, A. Guermazi1;
1
Doha / QA, 2Boston, MA / US, 3Lund / SE
11:10 11:03
B-1082 Relative contributory role of Interictal/Ictal SPECT, B-1091 Prognostic value of dynamic contrast-enhanced CT
interictal PET, MR spectroscopy and T2 relaxometry with perfusion imaging in assessing the response to
in localisation of seizure focus in temporal lobe anti-angiogenic therapy in patients with advanced
epilepsies: a metaanalysis and systematic review hepatocellular carcinoma: preliminary results
V. Venugopal, I. Afshan, S.K. Arjun; New Delhi / IN G. Querques, D. Ippolito, P.A. Bonaffini, C. Talei Franzesi, A. Nasatti, S. Sironi;
Monza / IT
11:18
B-1083 Application of “Zero” Time-of-Echo (ZTE) MRI 11:11
sequence for “Silent” T1-weighted imaging B-1092 Prediction of tumouru response to neoadjuvant
at 7.0 Tesla concurrent chemoradiotherapy for borderline
M. Costagli1, M.R. Symms1, L. Angeli1, D.A.C. Kelley2, L. Biagi1, C.H.S. Rua1, resectable pancreatic cancer by diffusion-weighted
G. Tiberi1, M. Tosetti1, M. Cosottini1; 1Pisa / IT, 2San Francisco, CA / US MRI and 18F-FDG PET/CT
I. Joo, J. Lee, J. Han, B. Choi; Seoul / KR
11:26
B-1084 Globe flattening: conventional two-dimensional vs 11:19
three-dimensional T2-weighted imaging B-1093 DCE-MRI-derived parameters as predictors of response
J. Ann, E. Kim; Incheon / KR to neo-adjuvant chemoradiation treatment of rectal
11:34 carcinoma
S. Phongkitkarun, U. Tohmad, N. Larbcharoensub, K. Sumbunnanondha,
B-1085 Decreased auditory GABA+ concentrations in T. Sawangsilpa, E. Sirachainan; Bangkok / TH
presbycusis demonstrated by edited magnetic
resonance spectroscopy 11:27
F. Gao1, B. Zhao1, G. Wang1, F. Ren1, R.A.E. Edden2; 1Jinan / CN, 2Baltimore, B-1094 Automated and semi-automated diffusion-weighted
MD / US MRI volumetry to assess response aer neoadjuvant
11:42 therapy in rectal cancer
M.M. van Heeswijk1, D.M. Lambregts1, S. Oei1, N. Papanikolaou2, S.-X. Rao1,
B-1086 Diffusion tensor imaging of cervical spine in subjects G.L. Beets1, R.F.A. Vliegen3, R.G.H. Beets-Tan1; 1Maastricht / NL, 2Iraklion,
presenting successful aging: preliminary report Crete / GR, 3Heerlen / NL
J. Ciescinski, E. Zawada, B. Augustynska, K. Porzych, Z. Serafin; Bydgoszcz / PL
11:35
11:50 B-1095 Early monitoring of tumour response to photothermal/
B-1087 Multiple sclerosis deep grey matter: photodynamic therapy delivered by nano-graphene
the relation between demyelination, oxide using diffusion-weighted and BOLD-contrast MRI
neurodegeneration, inflammation and iron F. Zhang, J. Cao, G. Fu, G. Fu; Xiamen / CN
L. Haider1, C. Simeonidou2, G. Steinberger1, S. Hametner1, N. Grigoriadis2,
H. Lassmann1, J. Frischer1; 1Vienna / AT, 2Thessaloniki / GR 11:43
B-1096 Tumour volume as a quantitative imaging biomarker
on computed tomography: toward adaptive criteria
10:30–12:00 Room F1 H. Beaumont1, S. Egels2, S. Zaim1, A. Iannessi3, O. Lucidarme2; 1Valbonne / FR,
2
Paris / FR, 3Nice / FR
Oncologic Imaging 11:51
SS 1816 Response assessment: new concepts B-1097 Does DWI improve therapy response evaluation
Moderators: B. Banko; Belgrade/RS, A. Sohaib; London/UK by Gd-EOB-DTPA MRI in patients with HCC aer
radioembolisation?
10:30 J. Schelhorn1, J. Best1, M.P. Reinboldt1, G. Gerken1, M. Ruhlmann1,
T.C. Lauenstein1, G. Antoch2, S. Kinner1; 1Essen / DE, 2Düsseldorf / DE
K-27 Keynote lecture
H. Hricak; New York, NY / US
10:46 10:38
B-1100 A structured phantom for comparative detectability B-1110 The pulmonary vascular alteration in COPD as
evaluation in 2D digital mammography and breast determined by quantitative CT measurement:
tomosynthesis a two-year longitudinal study
L. Cockmartin, N.W. Marshall, G. Zhang, E. Shaheen, H. Bosmans; Leuven / BE N. Yu, C. Jin, Y. Li, J. Ma, Y. Guo; Xi‘an / CN
10:54 10:54
B-1101 In vivo proof of principle: x-ray dark-field radiography B-1112 Correlation study of emphysema based on each lobe
for diagnosis of lung fibrosis and small airway remodeling by using CT quantitative
K. Hellbach1, A. Yaroshenko2, O. Eickelberg3, F.G. Meinel1, M. Bech4, analysis in patients with chronic obstructive
T. Conlon3, M.F. Reiser1, A. Yildirim3, F. Pfeiffer2; 1Munich / DE, 2Garching / DE,
3
Neuherberg / DE, 4Lund / SE pulmonary disease
Y. Guan, Y. Xia, L. Fan, Y. Jiang, S. Liu; Shanghai / CN
11:02
10:46
B-1102 Improved imaging performance with Cs-halide needle
B-1111 Quantitative regional analysis of functional lung
phosphor based detectors over powder phosphor CR
imaging in chronic obstructive pulmonary disease
detectors: application in neonatal imaging
N. Marshall, M. Hofmans, M. Smet, H. Pauwels, H. Bosmans; Leuven / BE (COPD)
T.N.H. Matin, X. Xu, T. Doel, V. Grau, N. Rahman, A. Nickol, F.V. Gleeson;
11:10 Oxford / UK
B-1103 RIS-integrated dose monitoring systems: dose quality 11:02
ratio optimisation by iterative acquisition settings B-1113 Impact of HIV infection lenght on CT assessed
standardisation. First results for a large breast emphysema and respiratory bronchiolitis prevalence
screening programme and pattern
A. Nitrosi, M. Bertolini, A. Corazza, R. Sghedoni, C. Campari, P. Pattacini, C. Mori, R. Scaglioni1, G. Besutti1, G. Ligabue1, A. Santoro1, S. Zona1, J. Leipsic2,
P. Notari, M. Iori; Reggio Emilia / IT G. Guaraldi1, P. Torricelli1; 1Modena / IT, 2Vancouver, BC / CA
11:18 11:10
B-1104 Comparison of mDIXON and proton density liver fat B-1114 Incidentally detected lymphangioleiomyomatosis like
fraction maps in patients suspected of NAFLD/NASH lesions in male patients on thoracic MDCT
with ¹H-MRS as reference S. Malekzadeh, M. Christodoulou, T. Christoforidis, V. Soubeyran, C. Constantin,
J.H. Runge, A.J. Nederveen, J. Verheij, U.H. Beuers, J. Stoker; Amsterdam / NL M.-E. Kamel; Sion / CH
11:26 11:18
B-1106 In vivo study of microcirculation in a murine model of B-1115 CT airway morphology related to obesity:
pseudomyxoma peritonei using the IVIM method for evaluation pre- and post bariatric surgery
the assessment of antiangiogenic drugs with functional correlation
A. Dohan1, C. Eveno1, C. Pimpie1, F. Duchat2, P. Bonnin1, M. Pocard1, P. Soyer1; A.C. Carlton Jones1, N. Soneji1, J. Cousins1, A. Ahmed1, A. Edey2, A. Wells1,
1
Paris / FR, 2Dijon / FR S. Copley1; 1London / UK, 2Bristol / UK
11:34 11:26
B-1107 Improved receiver coil arrays for real-time B-1116 Correlation of radiological findings and
contrast-enhanced MRA of the peripheral vasculature immunological parameters in patients with allergic
S. Riederer, P.T. Weavers; Rochester, MN / US bronchopulmonary aspergillosis (ABPA) based on
11:42 high-attenuation mucus (HAM) impaction and
B-1108 Anatomical noise and impact on lung nodule mean CT density
S. Phuyal; Kathmandu / NP
conspicuity: comparing digital radiography,
dual-energy x-ray, and digital angular tomosynthesis 11:34
S. Richard1, S. Sajja2, X. Wang1, L. Vogelsang1, N.S. Paul2; 1Rochester, NY / US, B-1117 Automated quantification of bronchiectasis, airway
2
Toronto, ON / CA
wall thickening and lumen tapering in chest CT
A. Perez-Rovira1, W. Kuo1, J. Petersen2, H.A.W.M. Tiddens1, M. de Bruijne1;
1
Rotterdam / NL, 2Copenhagen / DK
10:30–12:00 Room D1
11:42
Chest B-1118 Feasibility study of low dose CT with a hybrid iterative
reconstruction technique for evaluation of airway
SS 1804 Obstructive pulmonary diseases and stents in patients with malignant tracheal stenosis
reduced lung function T. Li1, Y. Zhang1, J. Gao1, Y. Jiang2; 1Zhenzhou of Henan province / CN,
Moderators: G.R. Ferretti; Grenoble/FR, A.P. Parkar; Bergen/NO
2
Shanghai / CN
10:30 11:50
B-1109 Predictive value of CT-quantified emphysema and B-1119 Regional image-derived lung function and structure
airway wall thickness on all-cause mortality in in chronic obstructive pulmonary disease (COPD) and
current and former smokers with and without COPD non-small cell lung cancer (NSCLC)
F.A.A. Mohamed Hoesein1, E. Pompe1, M. Schmidt2, R. Vliegenthart3, E.M. Van T.N.H. Matin, X. Xu, D.R. McGowan, T. Doel, N. Rahman, V. Grau, A. Nickol,
Rikxoort4, H.J. De Koning5, J.-W.J. Lammers1, P.A. De Jong1; 1Utrecht / NL, F.V. Gleeson; Oxford / UK
2
Bremen / DE, 3Groningen / NL, 4Nijmegen / NL, 5Rotterdam / NL
10:30 10:30
B-1120 Fluoroscopic gastroduodenal stent placement vs B-1131 Scrotal ultrasonography in adult patients with cystic
surgical gastrojejunostomy: fibrosis
palliation for patients with gastric obstructions M. Buscaglia, L.E. Derchi, R. Casciaro, F. Cresta, L. Minicucci; Genoa / IT
due to unresectable gastric cancer 10:38
H.-Y. Song, J.-H. Park, J. Kim, M.-H. Ryu, M.-W. Yoo, J. Lee; Seoul / KR
B-1132 Can we investigate the patient with more than 70%
10:38 dose reduction CT urography without affecting the
B-1121 Efficacy of gastric balloon dilatation and/or diagnostic value?
retrievable stent insertion for pyloric spasm aer M. Al-Amin, I. Diakov; Sofia / BG
pylorus-preserving distal gastrectomy 10:46
J. Bae, S. Kim, C.-I. Shin, I. Joo, J. Yoon, J. Baek, J. Han, B. Choi; Seoul / KR
B-1133 Efficacy of bosentan, an endothelin receptor
10:46 antagonist, in preventing contrast-induced
B-1122 Incidence and management of esophageal perforation nephropathy
aer fluoroscopic balloon dilation in 820 adult A. Nawaz, H. Elzeawy, M. Salama, I. Mamoun, I. Junaid; Jeddah / SA
patients with esophageal strictures 10:54
H.-Y. Song1, W.-Z. Zhou2, J.-H. Park1, H.-Y. Jung1, Y. Kim1; 1Seoul / KR,
2
Nanjing / CN B-1134 Dynamic contrast-enhanced computed tomography:
a new diagnostic tool to assess renal perfusion aer
10:54 ischemia-reperfusion injury in mice
B-1123 Management of benign biliary strictures by M. Braunagel1, A. Helck1, M. Notohamiprodjo2, N. Schupp1, A. Wagner1,
percutaneous interventional techniques M.F. Reiser1, A. Habicht1; 1Munich / DE, 2Tübingen / DE
C.B. Kulkarni, S. Moorthy, S. Karumathil Pullara, N. Prabhu, R. Kannan, N. P.K;
Cochin / IN 11:02
B-1135 Arterial spin labeling and T1-mapping for assessment
11:02 of acute renal allogra rejection in mice
B-1124 Treatment of benign biliary strictures with K. Hueper1, B. Hensen1, S. Rong1, M. Gutberlet1, M. Meier1, M. Mengel2,
bioabsorbable biliary stent: F. Wacker1, D. Hartung1, F. Gueler1; 1Hannover / DE, 2Edmonton, AB / CA
preliminary results of a multicentric study 11:10
G. Mauri1, C. Michelozzi1, F. Melchiorre1, D. Poretti1, V. Pedicini2, G. Paone1,
M. Salvetti1, E. Criado3, J. Fages3, M. De Gregorio4, L. Monfardini1, M. Gimenez5; B-1136 Dual-phase triple-split-bolus protocol for
1
Milan / IT, 2Rozzano / IT, 3Sabadell / ES, 4Zaragoza / ES, 5Buenos Aires / AR pre-operative CT evaluation of laparoscopic donor
11:10 kidney anatomy: a way for dose reduction
A. Posa, R. Iezzi, M. Nestola, A. Contegiacomo, F. Citterio, L. Bonomo; Rome / IT
B-1125 Balloon dilatation biopsy of the Biliary stricture
through the PTBD tract: 11:18
feasibility and diagnostic accuracy B-1138 MR imaging in patients with stress urinary
H. Ryeom, J. Hong; Daegu / KR incontinenсe
A. Solopova, M. Barinova, N. Tupikina, S.K. Ternovoy; Moscow / RU
11:18
B-1126 Endoluminal radiofrequency ablation of malignant 11:26
biliary stenoses B-1139 Estimates of glomerular filtration rate by cystatin
T. Andrasina, J. Panek, J. Hlavsa, V. Bernard, V. Valek; Brno / CZ C formula by Larson to assess renal function in
11:26 outpatients undergoing injection of iodinated contrast
for CT
B-1127 Long-term outcomes of intraductal photodynamic J.I.F. Melo, R. Chojniak, A.G.V. Bitencourt, D.H.C. Silva, J.J. Oliveira, D.H. Silva; São
therapy in Klatskin tumour patients Paulo / BR
O.N. Sergeeva, A. Kukushkin, V. Panov, B. Dolgishin; Moscow / RU
Sunday
11:34
11:34 B-1140 MR-guided focal laser ablation for prostate cancer
B-1128 Percutaneous endoluminal RFA in biliary, Wirsung duct followed by radical prostatectomy:
and PV inoperable malignant block recanalisation validation of MR predicted ablation volume
M. Mizandari, N. Habib, A. Mtvaradze, T. Azrumelashvili; Tbilisi / GE J.G.R. Bomers1, E.B. Cornel2, S.F.M. Jenniskens1, C.A. Hulsbergen-van de Kaa1,
J.A. Witjes1, J.P.M. Sedelaar1, J.J. Fütterer1; 1Nijmegen / NL, 2Hengelo / NL
11:42
B-1130 In vitro effectiveness of vasodilators used in 11:42
intra-arterial infusion therapy of non-occlusive B-1141 Evaluation of periprostatic nerve fibers using diffusion
mesenteric ischemia tensor imaging tractography at 3T:
C. Mahlke, J.-P. Kühn, B. Mensel, A. Glitsch, A. Schreiber, N. Hosten, O. Grisk; correlation with radical prostatectomy specimens
Greiswald / DE C. Kim, B. Jeong, G. Kwon, J. Park, B. Park, S. Park; Seoul / KR
Radiographers Breast
SS 1814 Professional challenges for SS 1902a Multiparametric MRI and PET
radiographers Moderators: E.M. Fallenberg; Berlin/DE, V. Girardi; Brescia/IT
Moderators: S. Geers-van Gemeren; Utrecht/NL, C. Roche; Galway/IE
14:00
10:30 B-1153 Implementation of multiparametric MRI with
B-1142 An eye-tracking study investigating radiographers’ high-resolution DCE and DWI MRI at 7T of breast
visual search patterns whilst reviewing x-ray tumours: a feasibility study
K. Pinker-Domenig, P.A.T. Baltzer, W. Bogner, D. Leithner, S. Trattnig, O. Zaric,
examination request forms P. Dubsky, Z. Bago-Horvath, T.H. Helbich; Vienna / AT
E. Hendy, J. Grehan, T. Herlihy, L.A. Rainford; Dublin / IE
10:38 14:08
B-1143 Chest x-ray agreement: comparative analysis between B-1154 Quantitative assessment of primary breast cancer at
consultant radiologists, reporting radiographers and 3.0T MRI
R. Bedair, A.J. Patterson, M.A. McLean, R. Manavaki, S. Reid, M. Graves,
expert chest radiologists F.J. Gilbert; Cambridge / UK
N.H. Woznitza1, K. Piper2, S. Burke1, S. Ellis1, G. Bothamley1; 1London / UK,
2
Kent / UK 14:16
10:46 B-1155 Application of total choline compound integral in
B-1144 A self-test for screening radiographers in the diferentiating benign and malignant breast disease
R. Chen, W.-G. Zhang; Chongqing / CN
Netherlands, in signalling apparent abnormalities
C. van Landsveld-Verhoeven, J.M.H. Timmers, P. van de Looi, G.J. den Heeten, 14:24
M.J.M. Broeders; Nijmegen / NL
B-1156 Value of 1H spectroscopy 3T MR imaging in breast
10:54 lesions in addition to BIRADS MR findings and DWI:
B-1145 Comparative study of diagnostic accuracy between CT a preliminary report
R. Asadov, M.E. Aribal, A. Ramazan, M.U. Ugurlu, H. Kaya; Istanbul / TR
colonography and optical colonoscopy
N.F. Pinto, A.F.C.L. Abrantes, L.P. Ribeiro, S. Rodrigues, R.P.P. Almeida,
K.B. Azevedo, B. Tomás, J.P. Pinheiro; Faro / PT 14:32
B-1157 The role of high-field MR spectroscopy in the
11:02 multiparametric evaluation of breast lesions
B-1146 An investigation into the accuracy of computed C. Cavedon, I. Baglio, L. Camera, G. Meliadò, F. Caumo, S. Montemezzi;
Verona / IT
radiography in detecting ferromagnetic intra-ocular
foreign bodies 14:40
H. Momoniat, A. England; Manchester / UK
B-1158 Intraindividual assessment of tumour neovascularity,
11:10 microenvironment, glucose metabolism and hypoxia
B-1148 What is the minimum amount of simulated breast in breast cancer patients by multiparametric 18F-FDG/
movement required for visual detection of blurring? 18F-FMISO PET/MRI at 3T: a feasibility study
P.H. Hogg1, W. Ma1, R. Aspin1, D. Brettle2, S. Millington3, J. Kelly3; K. Pinker-Domenig, P. Andrzejewski, H. Magometschnigg, T.H. Helbich,
1
Manchester / UK, 2Leeds / UK, 3Chester / UK D. Georg, G. Karanikas, W. Wadsak, P. Kapetas, P.A.T. Baltzer; Vienna / AT
11:18 14:48
B-1149 An investigation into preliminary clinical evaluation in B-1159 Value of simultaneous PET MR mammography in
an Irish x-ray departmental setting patients with breast cancer undergoing neoadjuvant
R. Murphy, L.A. Rainford, T. Herlihy, J. Grehan, M. Lotter; Dublin / IE chemotherapy: preliminary results
S. Kinner, J. Nagarajah, J. Grüneisen, L. Umutlu, O. Hoffmann, A.-K. Bittner,
11:26 K. Nassenstein, T. Pöppel; Essen / DE
B-1150 Evaluation of the performance and efficiency of
technology and radiographer: the Italian model 14:56
D. Di Feo1, C. Dionisi2, S. Barbera3; 1Florence / IT, 2Treviso / IT, 3Biella / IT B-1160 Diagnostic accuracy of 18F-FDG PET/CT of the breast:
comparison to DCE MRI imaging at 3 Tesla
11:34 H. Magometschnigg, P.A.T. Baltzer, B. Fueger, T.H. Helbich, G. Karanikas,
B-1151 Adverse event reporting P. Dubsky, M. Rudas, M. Weber, K. Pinker-Domenig; Vienna / AT
S. Browne, L.A. Rainford, J. Grehan, T. Herlihy; Dublin / IE
15:04
11:42 B-1161 18F-FDG PET/CT for initial staging
B-1152 Endovascular treatment of ruptered abdominal aortic in breast cancer patients:
aneurysm (rAAA) is there a relevant impact on treatment planning
J. Jensen, H. Mogensen; Odense / DK compared to conventional staging modalities?
J. Krammer, C.G. Kaiser, A. Schnitzer, K.A. Buesing, S.O. Schoenberg, E. Sperk,
M. Suetterlin, K. Wasser; Mannheim / DE
15:12
B-1162 Feasibility of [F-18]FDG-PET/CT for clinicopathological
evaluation in patients with Ductal Carcinoma In-Situ
(DCIS) of the breast
T. Fujioka, K. Kubota, A. Toriihara, Y. Saida, U. Tateishi; Tokyo / JP
14:56 15:05
B-1183 PET/MR mammography for local tumour staging of B-1193 Development of a publicly accessible Bayesian CADx
patients with primary breast cancer: algorithm for mammographic mass lesions based
a comparison with PET/CT and MRI alone on the breast imaging:
J. Grueneisen1, J. Nagarajah1, C. Buchbender2, O. Hoffmann1, M. Forsting1, reporting and data system (BI-RADS) lexicon
L. Umutlu1, S. Kinner1; 1Essen / DE, 2Düsseldorf / DE M. Benndorf1, E. Kotter1, M. Langer1, C. Herda2, Y. Wu3, E. Burnside3;
1
Freiburg / DE, 2Graubünden / CH, 3Madison, WI / US
15:04
B-1184 Digital breast tomosynthesis for preoperative local 15:13
staging of breast cancer in dense breasts B-1194 Is PI-RADs-score more accurate versus DWI+T2w
J. Krammer, K. Stepniewski, C.G. Kaiser, A. Schnitzer, S.O. Schoenberg, at 3T MRI of the prostatic gland:
K. Wasser; Mannheim / DE
analysis according to 189 MR-guided prostate biopsies
A. Malich; Nordhausen / DE
14:00–15:30 Room Z 15:21
B-1195 The impact of peer-review introduction on the
Computer Applications subsequent publication rate and impact factor of
SS 1905 Methods for image interpretation and presentations at national radiology meetings
A.M. Cahalane, Y. Purcell, D.E. Malone, E.J. Heffernan; Dublin / IE
reporting
Moderators: M. Fatehi; Tehran/IR, W.J. Niessen; Rotterdam/NL
14:00–15:30 Room M
14:00
K-28 Keynote lecture
W.J. Niessen; Rotterdam / NL
Abdominal Viscera
14:09 SS 1901b Liver CT and ultrasound:
B-1186 IHE-compliant templates for structured reporting: new techniques
Moderators: M. Laniado; Dresden/DE, V. Vandecaveye; Leuven/BE
first implementations
D. Pinto dos Santos, G. Klos, P. Mildenberger; Mainz / DE
14:00
14:17 B-1196 Preoperative CT texture analysis predicts outcome
B-1187 Free text reporting vs structured reporting of MRI in patients with colorectal liver metastases post
of the pelvis in patients with rectal cancer: liver resection
A. Schulz1, K. Skogen1, A. Bethke1, K.J. Labori1, B. Ganeshan2, N.-E. Kløw1,
potential effects for surgical planning J.B. Dormagen1; 1Oslo / NO, 2London / UK
M. Armbruster, J. D‘Haese, M.F. Reiser, W.H. Sommer; Munich / DE
14:25 14:08
B-1188 Development of eye movement adaptation during B-1197 The optimal body size index for determining
the interpretation of CT studies from resident the iodine dose for hepatic dynamic CT:
to specialist radiologists: a potential new tool to a prospective multicenter study using hierarchical
measure resident training progress multivariate linear regression analysis
K. Awai1, M. Kanematsu2, K. Tonsok3, T. Ichikawa4, K. Yoshioka5, T. Mochizuki6,
F.V. Bensch1, J.K. Kaakinen2, R. Bertram2, L. Helle2, N. Lundbom1; 1Helsinki / FI, N. Matsunaga7, Y. Yamashita8; 1Hiroshima / JP, 2Gifu / JP, 3Osaka / JP, 4Chuo / JP,
2
Turku / FI 5
Morioka / JP, 6Matsuyama / JP, 7Ube / JP, 8Kumamoto / JP
14:33 14:16
B-1189 Difference in attitudes towards radiology video B-1198 Reproducibility and variability of very low-dose
reporting between inpatient/emergency medicine hepatic perfusion CT in metastatic liver disease
and subspecialty providers O. Topcuoglu, M. Ozmen, E. Topcuoglu, M. Karcaaltincaba, D. Akata; Ankara / TR
J.D. Balkman, T.L. Cooke, E.S. Cooke; Lebanon, NH / US
14:24
14:41 B-1199 Small-size low-contrast liver lesion detectability:
B-1190 Comparison of consumer grade, tablet and dual energy CT (DECT) versus conventional CT
6MP-displays: observer performance in detection G. Van Gompel, N. Buls, P. Covens, J. de Mey; Brussels / BE
of anatomical and pathological structures
in panoramic radiographs 14:32
S. Kallio-Pulkkinen1, M. Haapea1, E. Liukkonen1, S. Huumonen2, O. Tervonen1, B-1200 Performance of ultrasonic transient elastography for
M. Nieminen1; 1Oulu / FI, 2Turku / FI the noninvasive assessment of liver steatosis
M. Lupsor-Platon, D. Feier, H. Stefanescu, A. Tamas, E. Botan, R. Badea; Cluj
14:49 Napoca / RO
B-1191 Patient lifetime graphs as an aid to subsequent
image interpretations 14:40
D.J. Vining1, A. Pitici2, A. Prisacariu2, C. Popovici2; 1Houston, TX / US, 2Chapel Hill, B-1201 Acoustic radiation force impulse (ARFI) imaging in
NC / US the pre-operative liver function evaluation in patients
14:57 candidate to liver resection
S. Crosara, M. D’Onofrio, A. Ruzzenente, S. Valcanover, R. Pozzi Mucelli;
B-1192 Comparing the utility and usability of the Microso Verona / IT
Kinect and Leap Motion sensor devices in the
context of their application for gesture control 14:48
of biomedical images B-1202 Differential diagnosis of polypoid lesions of the
P. Hughes, N. Nestorov, N.A. Healy, N. Sheehy, N. O’Hare; Dublin / IE gallbladder using contrast-enhanced ultrasonography
X.-S. Liu, L.-H. Gu, J. Du, J.-G. Xia, F.-H. Li; Shanghai / CN
14:56 14:49
B-1203 Colour-coded perfusion imaging with CEUS for B-1212 Role of MDCT for evaluating prosthetic malrotation
evaluation of the post-interventional success in patients with painful knee prosthesis
following trans-arterial chemoembolisation (TACE) G. De Franco, G. Martino, C. Campagna, V. Favia, A. Spinarelli, G. Angelelli;
Bari / IT
and ablative techniques of liver lesions: first results
J. Rennert, C. Niessen, C. Stroszczynski, E.M. Jung; Regenbsurg / DE 14:57
15:04 B-1213 Anterolateral ligament of the knee:
B-1204 Liver stiffness evaluation aer radioembolisation correlation of MR imaging with anatomical findings
E. Tahir, C. Berliner, S. Yarar, G. Lüers, M. Karul, G. Adam, J. Yamamura;
by real-time Shear-wave elastography Hamburg / DE
A. Bas, C. Samanci, F. Gulsen, F. Ustabasioglu, M. Cantasdemir, L. Kabasakal,
F. Kantarci, F. Numan; Istanbul / TR 15:05
15:12 B-1214 Effects of extremity positioning on femoral tunnel
B-1205 Future liver remnant volume estimation aer portal localisation aer anatomic single bundle anterior
vein embolisation and contralateral application cruciate ligament reconstruction - evaluation by
of stem cells digitally reconstructed radiographs
J. Ludvík, J. Ferda, P. Duras, V. Třeka, J. Brůha, D. Lysák; Plzeň / CZ P.S. Mahajan, P. Chandra, N. Ahamad, S.A. Hussein; Doha / QA
15:20 15:13
B-1206 An experimental study on the relationship between B-1215 3-dimensional isotropic high spatial resolution
the haemodynamic changes and liver regeneration proton-density-weighted fat-suppressed and
based on a rat model of different degrees of portal T1-weighted imaging of the knee at 3.0 Tesla
R. Homsi1, G.M. Kukuk1, J. Gieseke2, H.H. Schild1, W.A. Willinek1, D.R. Hadizadeh1;
vein stenosis following 70% partial hepatectomy 1
Bonn / DE, 2Best / NL
L. Yang, Y. Luo; Chengdu / CN
15:21
B-1216 Clinical significance of dark cartilage lesions identified
14:00–15:30 Room E1 on MRI
R. Kijowski, B.K. Markhardt; Madison, WI / US
Musculoskeletal
SS 1910 Knee 14:00–15:30 Room E2
Moderators: L. Cerezal; Santander/ES,
L.M. Sconfienza; San Donato Milanese/IT Neuro
K-29 Keynote lecture
M. Mechl; Brno / CZ SS 1911 Advanced imaging
Moderators: M.T. Fernández Taranilla; Toledo/ES,
14:09 L. Pierot; Reims/FR
B-1207 Smaller volume of anterior cruciate ligament
increases the risk of anterior cruciate ligament injury: 14:00
a MRI based case-control study B-1218 Diagnostic performance of diffusion tensor imaging
P.S. Mahajan1, N.M. Al Moosawi2, Y.S. Al Nahedh2; 1Doha / QA, 2Kuwait City / KW in visual pathways of primary open angle glaucoma
patients
14:17 B. Özkul1, F. Yenihayat1, N. Yüksel1, A. Akça2, A. Arslan1; 1Kocaeli / TR,
B-1208 Lateral patellar tilt: the best measurement to unmask 2
İstanbul / TR
patellar maltracking with weight-bearing MRI 14:08
S. Mariani, F. Arrigoni, A. La Marra, L.M. Gregori, A. Barile, C. Masciocchi;
L’Aquila / IT B-1219 A first insight in regional brain changes aer parabolic
flight: a voxel-based morphometry study
14:25 A. Van Ombergen1, B. Jeurissen1, F. Vanhevel2, D. Loeckx3, V. Dousset4,
B-1209 Diagnostic value of the meniscal stability of the knee: S. Laureys5, P.H. Van de Heyning1, P.M. Parizel2, F.L. Wuyts1; 1Antwerp / BE,
2
Edegem / BE, 3Leuven / BE, 4Bordeaux / FR, 5Liege / BE
weight-bearing MRI vs arthroscopy
A. La Marra, S. Mariani, F. Arrigoni, L.M. Gregori, F. Smaldone, A. Barile,
C. Masciocchi; L’Aquila / IT 14:16
B-1220 Evaluating the intracranial perforating branches by
14:33 new x-ray system using a cerium anode
Sunday
14:41 14:32
B-1211 Postero-lateral instability of the knee in young B-1222 Usefulness of diffusion-weighted (DWI) magnetic
patients: association between postero-lateral corner resonance for distinguishing neuroborreliosis from
involvment and anterior cruciate ligament injury and acute disseminated encephalomyelitis
the role of the weight-bearing MRI A. Ivkovic, T. Milosavljevic; Niš / RS
S. Mariani, F. Arrigoni, A. La Marra, L.M. Gregori, A. Barile, C. Masciocchi;
L’Aquila / IT
14:40 14:48
B-1223 3D time-resolved vessel-selective angiography based B-1234 The possibility of MR dynamic contrast enhancement
on pseudo-continuous arterial spin labelling to separate groups of potentially good and bad
T. Lindner1, U. Jensen-Kondering1, M.J.P. van Osch2, M. Helle3, O. Jansen1; response aer preoperative chemoradiotherapy in
1
Kiel / DE, 2Leiden / NL, 3Hamburg / DE
patients with rectal cancer
14:48 K.B. Puzakov, N. Rubtsova, D. Sidorov, O. Mainovskaya, I. Droshneva;
Moscow / RU
B-1224 Dynamic CT angiography for the evaluation of
shunting vascular malformation of brain and spine 14:56
F. D’orazio, L.M. Gregori, A.V. Giordano, S. Carducci, A. Splendiani, M. Gallucci; B-1235 Modification in abdominal fat distribution in mCRC
L’Aquila / IT
patients aer Cetuximab
14:56 S. Battisti, F. Greco, A. Pallottino, B. Beomonte Zobel; Rome / IT
B-1225 The typical and atypical MR imaging appearances 15:04
of tuberculosis of the central nervous system. An B-1236 3.0-T magnetic resonance imaging in predicting
imaging based experience of 100 cases subtypes of IPMN and invasive IPMN
A. Banerjee; Ludhiana / IN R. Graziani, G. Lo Bue, L. Monti, C. Bonifacio, A. Zerbi, L. Balzarini; Rozzano / IT
15:04 15:12
B-1226 The additional value of neuroimaging combined B-1237 Gastrointestinal stromal tumours of the stomach:
with visual rating scales to the clinical diagnosis of CT percentage of tumour necrosis and prediction of
dementia malignancy
M.V. Verhagen, G.L. Guit, G.J. Hafkamp, C.J. Kalisvaart; Haarlem / NL N. Cioffi Squitieri, M.A. Mazzei, C. Vindigni, G. Sadotti, P. Mercuri, L. Righi,
S. Guerrini, F.G. Mazzei, L. Volterrani; Siena / IT
15:12
B-1227 Multimodal imaging of disorders of consciousness 15:20
L. Hermoye1, L. Tshibanda2, C. Di Perri2, V. Katsaros3, S. Laureys2; 1Brussels / BE, B-1238 Gastrointestinal stromal tumour xenogras:
2
Liège / BE, 3Athens / GR
therapeutic repose to treatment
with imatinib assessed by intravoxel incoherent
14:00–15:30 Room F1 motion diffusion-weighted MR imaging
with histopathological correlation
Oncologic Imaging F. Pan1, J. Deng2, Y. Wang1, H. Wang3, J. Cheng1, W. Wu1; 1Beijing / CN, 2Chicago,
IL / US, 3Shanghai / CN
SS 1916 Oncologic imaging of the GI tract
Moderators: G. Conte; Milan/IT, J. Sosna; Jerusalem/IL
14:00–15:30 Room F2
14:00
B-1228 Value of FDG PET/CT in the assessment of patients
Physics in Radiology
with colon cancer comparing to CT alone SS 1913 Patient and staff dose studies
K. Akbari; Linz / AT
Moderators: H. de las Heras Gala; Madrid/ES, G. Paulo; Coimbra/PT
14:08
B-1229 MR imaging for dedicated staging of colon cancer 14:00
patients: preliminary results K-30 Keynote lecture
C. Leidecker; Forchheim / DE
M.J. Lahaye1, D.M. Lambregts1, E. Nerad2, G.L. Beets1, R.G.H. Beets-Tan1;
1
Maastricht / NL, 2Eindhoven / NL
14:09
14:16 B-1239 Comparing CT dose performance to regional and
B-1230 Modified, high resolution pelvic MRI in rectal cancer: national benchmarks:
a comparison of field strengths - 7T vs. 1.5 T multicenter experience in Belgium
K. Beiderwellen, O. Kraff, A. Laader, S. Johst, S. Maderwald, M. Forsting, L. Pyfferoen1, T.H. Mulkens2, T. De Bondt3, J.W. Casselman1, P.M. Parizel3,
T.C. Lauenstein, L. Umutlu; Essen / DE F. Zanca4; 1Bruges / BE, 2Lier / BE, 3Antwerp / BE, 4Leuven / BE, Brussels / BE
14:24 14:17
B-1231 A novel T3 subgroup system based on MRI for B-1240 Effective dose in cardiac CT - evaluation
stratifying T3 rectal cancer into favorable and of a new dose monitoring soware (radimetrics™)
S. Suntharalingam, N. Guberina, F.F. Stecker, J.M. Theysohn, K. Nassenstein,
unfavorable subgroups M. Forsting, A. Ringelstein, T. Schlosser; Essen / DE
S. Moon, S. Cho, K.-M. Shin, H. Kim, G. Kim, Y.-J. Jang, H. Ryeom; Daegu / KR
14:32 14:25
B-1232 Does multiparametric MRI allow for response B-1241 Limits and strengths of novel dose monitoring
prediction of neoadjuvant chemoradiation in patients programme eXposure
N. Guberina, F.F. Stecker, S. Suntharalingam, M. Schlamann, M. Forsting,
with advanced rectal cancer? J.M. Theysohn, B. Mukherjee, U. Lechel, A. Ringelstein; Essen / DE
D. Hausmann, N. Rathmann, U.I. Attenberger, S.O. Schönberg, F. Doyon,
P. Kienle, R.D. Hofheinz; Mannheim / DE 14:33
14:40 B-1242 Implementation of a dose monitoring soware
B-1233 Evaluation of rectal cancer response to therapy: in clinical routine: first experiences
C. Heilmaier, N. Zuber, D. Weishaupt; Zurich / CH
role of MR tumour regression grade to predict
pathological complete response
M. Rengo, M. Ciolina, C.N. de Cecco, D. Caruso, C. Forina, S. Marzi, A. Laghi;
Rome / IT
14:41 14:32
B-1243 Comparison of iterative reconstruction techniques for B-1253 Comparison of chest-CT findings of influenza
reduced-dose liver computed tomography following virus-associated pneumonia in immunocompetent
transarterial chemoembolisation for hepatocellular vs. immunocompromised patients: patterns of
carcinoma involvement and interchangeability at time
W. Lee1, W. Jeong1, M. Cha1, Y. Kim1, S. Lim2, S.-Y. Choi2, D. Choi1; 1Seoul / KR, C. Kloth, K. Nikolaou, M. Horger; Tübingen / DE
2
Gyeonggi-do / KR
14:40
14:49 B-1254 Restrictive allogra syndrome aer lung
B-1244 Detection of midfacial and orbital fractures using transplantation: new radiological insights
ultralow dose CT and iterative reconstructions A. Dubbeldam, J. Coolen, J. Verschakelen, W. De Wever; Leuven / BE
G. Widmann, D. Dalla Torre, R. Hoermann, P. Schullian, E.-M. Gassner, R. Bale,
W. Puelacher; Innsbruck / AT 14:48
14:57 B-1255 Diagnostic accuracy of ultra-low-dose chest CT with
model-based iterative reconstruction (MBIR) in the
B-1245 CTPA bolus timing techniques in pregnancy:
detection of early pulmonary complications within the
an underappreciated contributor
first six months following lung transplantation
to breast radiation dose M.-P. Debray1, G. Dauriat1, A. Khalil1, S. Leygnac1, A. Grandjean2,
D.P. Mitchell, M. Rowan, M. Crockett, F. Ni Ainle, P. Mac Mahon; Dublin / IE E. Schouman-Claeys1, P. Ou1; 1Paris / FR, 2Buc / FR
15:05 14:56
B-1246 Clinical indications and radiation doses to the B-1256 Non-infectious panbronchiolitis in the setting
conceptus associated with CT scanning in pregnancy: of allogeneic stem cell transplantation:
a retrospective study a potential mimic of lower respiratory tract infection
S.E. Woussen, F. Zanca, H. Bosmans, D. Vanbeckevoort, R.H. Oyen; Leuven / BE C. Kloth, U. Grosse, S. Wirths, S. Gatidis, W. Bethge, K. Nikolaou, M. Horger;
Tübingen / DE
15:13
B-1247 Pregnant employee in the cardiac catheterisation lab: 15:04
data for estimation of conceptus dose B-1257 Does the use of a checklist help medical students in
K. Perisinakis, J. Stratakis, G. Solomou, J. Damilakis; Iraklion / GR the detection of abnormalities on a chest radiograph?
A. Abed, E.M. Kok, S.G.F. Robben; Maastricht / NL
15:21
B-1248 Personnel dose reduction for Y90 microspheres 15:12
liver-directed radioembolisation: B-1258 Using comparison films in education
from angiogram suite to patient ward E.M. Kok, A.B.H. de Bruin, J. Leppink, J.J.G. van Merriënboer, S.G.F. Robben;
M. Law, K. Wong, W. Tso, V. Lee, M. Luk; Hong Kong / HK Maastricht / NL
15:20
14:00–15:30 Room D1 B-1259 Clinical impact of double reading of thoracic CT
P.M. Lauritzen1, J. Andersen2, M. Stokke3, A. Tennstrand4, G. Bjerke1, K. Stavem1,
P. Hurlen1, G. Sandbæk2, P. Gulbrandsen5; 1Lørenskog / NO, 2Oslo / NO,
Chest 3
Drammen / NO, 4Bærum / NO, 5Nordbyhagen / NO
14:33 14:16
B-1263 Prostatic artery embolisation using B-1272 Dual energy CT classification of renal calculi using
the PerFectED technique in the treatment single energy scanners
of prostatic benign hyperplasia: V. Hietschold, F. Schaab, M. Laniado; Dresden / DE
results of a single-centre prospective study 14:24
G. Amouyal, O. Pellerin, N. Thiounn, M. Sapoval; Paris / FR
B-1273 Diagnostic value of B-TFE MR Urography and the
14:41 effect of additional factors on the diagnosis of urinary
B-1264 Functional and technical outcomes of patients stones
treated with selective microcoil embolisation due E. Cifci, G. Coban, T. Cicek, U. Gonulalan; Konya / TR
to pseaudoaneurysms or arteriovenous fistulas 14:32
aer partial nephrectomy B-1274 Renal stone composition in Vivo Determination:
F.F. Strobl, M. D’Anastasi, T. Waggershauser, C.G. Trumm, A. Graser, M.F. Reiser,
P.M. Paprottka; Munich / DE comparison between 100/140 kV Dual-energy CT
and 120 kV Single-energy CT
14:49 M. Bonatti, F. Ferro, P. Pernter, M. Senoner, G. Bonatti; Bolzano / IT
B-1265 Bariatric embolisation using non-spherical Polyvinyl
alcohol (PVA) for suppression of the ghrelin in swine 14:40
models B-1275 Effective z accuracy to determine stone composition
J. Kim, M.-D. Kim; Seoul / KR by single-source dual-energy computed tomography:
an in vivo study
14:57 A. Fekir, C. Werquin, R. Levy, C. Sanavi, V. Macaigne, G. Hue, M. Bubenheim,
B-1266 Selective arterial embolisation for hemangiomas A. Safsaf, J.-N. Dacher; Rouen / FR
G. Facchini, G. Rossi, E. Rimondi, P. Spinnato, G. Filonzi, T. Bartalena, C. Errani,
A. Bazzocchi; Bologna / IT 14:48
B-1276 Visceral obesity and urolithiasis - impact on disease
15:05 incidence, stone size and radiation dose
B-1267 Pre-delivery uterine arteries embolisation preventing J. Hansmann, S.O. Schönberg, A. Tran, T. Henzler, H. Haubenreisser;
peri-post-partum haemorrhage (PPH) in placenta Mannheim / DE
implant anomalies 14:56
R. Niola1, F. Giurazza2, M. Silvestre1, G. Nasti1, M. Di Pasquale1, F. Maglione1;
1
Naples / IT, 2Rome / IT B-1277 The role of multi-parametric MRI and the
supplemental worth of diffusion-weighted MRI on
15:13 bladder cancer before surgical operation
B-1268 Endovascular management of massive post-partum E. Hocaoglu, S. Aksoy, C. Colak, O. Kilickesmez, E. Inci; Istanbul / TR
hemorrhage in abnormal placental implantation
deliveries 15:04
A. Rebonato, S. Mosca, M. Fischer, D. Maiettini, L. Bellantonio, C. Fusco, B-1278 Role of diffusion-weighted (DW) MRI to evaluate upper
C. D’Elia, G. Crinò, M. Scialpi; Perugia / IT excreto urinary wall thickening
C. Roy, A. Labani, M. Ohana, G. Bierry, G. Aleman, H. Lang; Strasbourg / FR
15:21
B-1269 Fetal radiation dose during prophylactic balloon 15:12
occlusion for morbidly adherent placenta - a single B-1279 The value of diffusion-weighted MRI in the diagnosis
centre experience of muscle-invasive bladder cancer
V. Semeraro1, A. Susac1, A. Morasca2, F. D’Antonio1, A.-M. Belli1; 1London / UK, W. Xia, X. Chen, L. Wang, H. Li; Zhengzhou / CN
2
Rome / IT
15:20
B-1280 The dynamic MRI compared to conventional cystogram
14:00–15:30 Room G in evaluation of vesico-urethral anastomosis aer
laparoscopic radical prostatectomy
Genitourinary M. Danti, F. Forte, S. Sbarbati, G. Pagliarella, P. Nardis, S. Della Sala; Rome / IT
14:17
B-1282 Re-expansion of thoraco-abdominal and infrarenal
true lumen collapse by bare-metal stents in
complicated acute aortic dissection type B
A. Massmann, P. Fries, R. Seidel, G.K. Schneider, A. Buecker, H.-J. Schäfers;
Homburg a.d. Saar / DE
14:25
B-1283 Application of color-coded DSA technique in
intra-procedural assessment of thoracic endovascular
aortic repair combined with chimney stenting for le
subclavian artery
X. Guo, P. Li, W. Qiu, L. Ye, L.J. Huang; Beijing / CN
14:33
B-1284 Sandwich-technique for hypogastric artery
preservation by bilateral transfemoral access
A. Massmann1, A. Buecker1, N.J. Mosquera2; 1Homburg a.d. Saar / DE,
2
Ourense / ES
14:41
B-1285 Evaluation of aneurysm neck angle change aer
endovascular aortic aneurysm repair
Y.S. Jeon, T.B. Le, M.H. Moon, K.C. Hong, S.G. Cho, K.M. Park; Incheon / KR
14:49
B-1286 Non-invasive 4-dimensional wireless aneurysm
sac pressure monitoring aer endovascular aortic
aneurysm repair (EVAR): conceptional design of an
integrated stent-gra and first in vitro results
C. Spink1, B. John1, W. Krautschneider1, D. Schröder1, R. Fischbach2,
M. Braunschweig2, J.-H. Buhk1, G. Adam1, A. Koops1; 1Hamburg / DE,
2
Dresden / DE
14:57
B-1287 Ultra low profile polymer-filled stent gra for
abdominal aortic aneurysm treatment:
two-years follow up
E. Macchi, G. De Marchi, A. Ierardi, E. Duka, N. Lucchina, L. Nocchi Cardim,
F. Fontana, G. Carrafiello; Varese / IT
15:05
B-1288 First experience with a novel bioabsorbable and
non-synthetic vascular closure device:
FISHing in the angio-suite
M. Treitl, M.F. Reiser, K. Treitl; Munich / DE
15:13
B-1289 Treatment by embolisation
of type 1 endoleak aer EVAR
C. Marcelin, Y. Lebras, N. Grenier, A. Lasserre; Bordeaux / FR
15:21
B-1290 Hematrix® Active Patch for post-interventional
hemostasis in femoral artery access:
a study on efficacy and safety
Sunday
12:30–13:30 Room D2
12:30
Image-based structural and functional phenotyping of
the German COPD cohort (COSYCONET) using MRI and
CT
B. Jobst1, J. Biederer1, I. Fellhauer1, S. Triphan1, K. Burmester1, J. Schliebus1,
A. Karch2, C.-P. Heußel1, H.-U. Kauczor1; 1Heidelberg / DE, 2Hannover / DE
12:40
Wednesday
Presentation by discussant:
J.B. Seo; Seoul / KR
12:45
A pragmatic randomised controlled trial of the
comparative effectiveness of computed tomography
versus invasive coronary angiography for the
management of stable chest pain patients: Methods
of the multicentre DISCHARGE trial
R. Haase, M. Dewey, on behalf of the DISCHARGE Consortium (www.
dischargetrial.eu); Berlin / DE
12:55
Presentation by discussant:
K. Kitagawa; Mie / JP
13:00
Economic evaluation of gadoxetic acid-enhanced
magnetic resonance imaging (Gd-EOB-DTPA-MRI) in
the diagnosis of colorectal-cancer metastasis in the
liver: results from the VALUE trial
C.J. Zech1, N. Justo2, A. Lang2, A. Ba-Ssalamah3, M.-J. Kim4, H. Rinde5, E. Jonas2;
1
Basle / CH, 2Stockholm / SE, 3Vienna / AT, 4Seoul / KR, 5Binningen / CH
13:10
Presentation by discussant:
V. Vilgrain; Clichy / FR
13:15
Proteus trial: comparing neoplasia yield and
attendance of sigmoidoscopy and CT colonography in
a colorectal cancer screening setting
D. Regge1, C. Senore2, G. Iussich1, L. Correale2, C. Hassan3, S. Montemezzi4,
N. Segnan2; 1Candiolo / IT, 2Turin / IT, 3Rome / IT, 4Verona / IT
13:25
Presentation by discussant:
A. Laghi; Latina / IT
315
List of Authors & Co-Authors
A Aguilar Pérez M.: B-0196, B-0197, B-0412, B-0419, Almeida R.P.P.: B-0365, B-0869, B-0871, B-1021,
Aakil A.: B-0761 B-0548 B-1145
Aamodt R.: B-0037 Aguillar V.L.N.: B-0927 Aloisio P.: B-0062
Aarsnes A.: B-B-0167 Aguillella L.: B-0073 Alomaim W.: B-0208
Abd Ellah M.: B-0002, B-0071, B-0317 Ahamad N.: B-1214 Alpert J.: B-0983
Abd Ellah M.M.H.: B-0076 Åhlström Riklund K.: A-714 Altabella L.: B-0050
Abdel Magied A.M.: B-0912 Ahmad I.: B-0160, B-0489 Althoff C.E.: B-0063
Abdel Razek N.M.: B-0443 Ahmed A.: B-1115 Altintas S.: B-0775
Abdelgawad M.S.: B-0299 Ahmed H.U.: A-330 Alvarez-Linera J.: A-235
Abdelmonsef N.A.M.: B-0299 Ahn H.-S.: B-0879, B-0880 Alves J.E.T.: B-0817
Abdel-Rehim M.: B-1262 Ahn K.-J.: B-0201 Amann G.: B-0524
Abdolell M.: B-0236, B-0237 Ahn K.-S.: B-0288, B-0497 Amara N.: B-0465
Abdraboh N.: B-0215 Ahn S.E.: B-0840 Amaral A.P.: B-0151
Abdullah B.J.: B-0855 Ahn S.H.: B-0568 Ambrosi A.: B-0043
Abe H.: B-1177 Aime S.: A-468 Amer H.: B-0436
Abed A.: B-1257 Airaldi S.: B-0496, B-0642, B-0643, B-0644, B-0805 Amitai M.M.: B-1040, B-1041
Abela E.: B-0813 Aissa J.: B-0627 Ammari S.: A-270
Ajlan A.M.: B-1059 Amoretti N.: B-0342
Abeyakoon O.: B-0925
Akahane K.: B-0541 Amoroso S.: B-0711
Aboagye E.O.: B-0517
Akata D.: A-070, B-1198 Amouyal G.: B-1263
Aboian I.: B-0355
Akbari K.: B-0089, B-1228 Amzallag-Bellenger E.: A-085
Abolhasani Foroughi A.: B-0279
Akça A.: B-1218 An J.: B-1049
Abou El-Ghar M.: B-1013
Akhan O.: A-728 Anand R.: B-0885
Abraham D.: B-0882
Akhtar I.: B-0143 Ananthasivan R.: B-1078
Abrahamsson P.-A.: A-416, A-417
Akin O.: B-0348, B-0555, B-1009, B-1010 Ananyeva N.: B-1081
Abramyuk A.: B-0506
Akisue T.: B-0810 Anbar A.: B-0640
Abrantes A.F.C.L.: B-0365, B-0869, B-0871, B-1021,
Andersen E.: B-0708
B-1145 Aksoy S.: B-0734, B-1277
Andersen E.N.: B-0146
Abrantes C.M.L.: B-0365 Al Adwani N.: B-0530
Andersen J.D.: B-0828
Abrishami A.: B-0605 Al Ansari N.: B-0041
Andersen J.G.: B-0037, B-1259
Abualruz A.M.: B-0979 Al Bunni F.: B-0891
Andersen M.K.: A-524
Abujudeh H.H.: B-0281 Al Jubran S.: B-0530
Andersson I.: B-0921
Abusamaan S.: B-0190 Al Khuraish N.: B-0530
Andong A.-L.: B-0047
Accardi R.: B-0120 Al Moosawi N.M.: B-1207
Andrade W.P.: B-0830
Achenbach S.: B-0772 Al Nahedh Y.S.: B-1207
Andrasina T.: B-1126
Achten R.: B-0781 Al Umairi R.S.S.: B-0578
André M.: B-1011
Ackermann H.: B-0428 Al-Amin M.: B-1132
Andreini D.: B-0179, B-0467, B-0626, B-0777
Acosta Ruiz V.: B-0721 Albano D.: B-0515
Andreisek G.: A-440, B-0373, B-0374, B-0909,
Adam A.: K-20 Albarello L.: B-0251 B-1070, B-1074
Adam E.J.: A-156, A-426, A-638 Albers P.: B-0351, B-0357 Andriessen P.: B-0526
Adam G.: B-0188, B-0223, B-0225, B-0469, B-0558, Alberti N.: B-0800, B-0803 Andrzejewski P.: B-0132, B-0935, B-1158
B-0565, B-0725, B-0808, B-0898, B-0934, B-0974, Albisinni U.: B-0807, B-0831 Angelelli G.: B-0043, B-0189, B-0616, B-0622,
B-1213, B-1286 Albrecht M.: B-0186, B-0539, B-0731 B-1182, B-1212
Adam S.Z.: B-0849 Albrecht M.H.: B-0428, B-0729, B-0730, B-0770 Angeli L.: B-1083
Adamsbaum C.: A-064 Albrecht T.: B-0035 Angileri R.: B-0456
Addonisio G.: B-0366 Al-Butmeh F.: B-0539 Anile M.: B-0713
Adeb M.: B-0894 Alefantinou S.: B-0832 Anker C.: B-0077
Adel L.: B-0912 Aleixo J.: B-1021 Ann J.H.: B-1084
Adelsmayr G.: B-0052 Aleman G.: B-1278 Annoni A.D.: B-0626, B-0777
Adrada B.E.: B-0439 Alessi S.: B-0560 Ansarin M.: B-0575
Affifi L.: B-0530 Alexopoulou E.: A-063 Antoch G.: A-178, A-393, B-0092, B-0351, B-0357,
Afshan I.: B-1082 Alifano M.: B-0989 B-0449, B-0516, B-0627, B-0936, B-1004, B-1068,
Afshar-Oromieh A.: B-0304 Aliprandi A.: B-0488 B-1097
Afzal M.O.: B-0973 Alison D.: B-0700 Antonuccio E.G.M.: B-0121
Agadakos E.: A-603 Alison M.: A-359 Antunes S.: B-0180
Agarwal S.: B-0580 Alkadhi H.: A-123, A-652, B-0107, B-0268, B-0409, Anzidei M.: B-0713
Ageitos Casais M.: B-0836 B-0746, B-0896, B-1074 Aoyagi Y.: B-0184
Aghaghazvini L.: B-0875 Allegranza P.: B-1164, B-1166 Aparina O.: B-0181
Agnello F.: B-0515 Allen C.: B-0967 Apfaltrer P.: B-0631
Agostinelli S.: B-0970 Allen G.M.: B-0067, B-0282 Arablinskiy A.: B-1261
Agostini A.: B-1054 Allmendinger T.: B-0676 Arai Y.: B-0139
Agrawal S.R.: B-0257 Al-Macki K.: B-0578 Aras Ö.: B-0555
Agten C.A.: B-0494, B-0495, B-0641 Almeida C.: B-0362, B-0867 Arbib F.: B-0538
Aguiar P.: A-709 Almeida D.: B-0362 Arcuri P.P.: B-0224
Arenson R.: B-1036 Azfar Siddiqui M.: B-0489 Banerjee I.: B-1017
Arese C.: B-0608 Azmat O.: B-0287 Banerjee J.: B-0697, B-0856
Arfi-Rouche J.: A-389 Azmat Z.: B-0530 Bang M.S.: B-0977
Argento C.: B-0899 Aznaurov V.: B-0630 Bankier A.A.: A-037, A-450
Argento G.: B-0062 Azrumelashvili T.: B-1128 Bannas P.: B-0974
Argibay-Vazquez S.: A-709 Azzeroni R.: B-0170 Bansal D.: B-0914
Argirò R.: B-0713, B-0883, B-0884 Baranes L.: B-0108
Argyropoulou M.I.: A-046, A-686, B-0702 B Barbashova A.: B-0380
Aribal M.E.: B-1156 Baba S.: B-0826 Barbera S.: B-0364, B-0366, B-1018, B-1150
Arjmand Shabestari A.: B-1057 Babb J.: B-0983 Barbero S.: B-0331
Arjun S.K.: B-0981, B-1082 Baca L.-G.: B-0407 Barchetti G.: B-0054
Arkar R.: B-0159 Baccialone J.: B-0128 Barczyk-Kahlert K.: B-0931
Armbruster M.: B-0610, B-1187 Bacher K.: B-0781 Barentsz J.O.: A-437
Armocida A.: B-1033 Bachert P.: B-0103 Bargellini I.: A-198, B-0430
Armocida C.: B-1033 Bachman M.: B-0824 Barile A.: B-0066, B-0068, B-0072, B-0075, B-0338,
Arnar D.O.: B-0415 Bachmann K.: B-0188 B-0347, B-0487, B-0573, B-1208, B-1209, B-1211
Arnaud E.: A-685 Baco E.: B-0552 Barillari M.: B-0371
Arnoldussen C.W.K.P.: B-0635 Badea R.: B-1200 Barinova M.: B-1138
Arnulfo A.: B-0664 Bady P.D.: B-0791 Barisone F.: B-0608
Arora A.: B-0219 Bae J.: B-0133, B-1006, B-1121 Barker A.: B-0064
Arrigoni F.: B-0066, B-0068, B-0072, B-0075, B-0338, Bae J.S.: B-0690 Barkhausen J.: B-0276
B-0347, B-0487, B-0573, B-1208, B-1209, B-1211 Bae K.K.: B-0532 Barkhof F.: A-234, A-609, B-0244
Arslan A.S.: B-1218 Baek J.H.: B-0156, B-1121 Barnett G.: B-0084
Arsov C.: B-0351, B-0357 Bagdadi R.R.: B-1059 Baroli A.: B-0723
Artigas J.M.: B-0403 Baggiano A.: B-0179, B-0467 Baron R.L.: A-132
Artioli D.: B-0191 Baglio I.: B-0216, B-1157 Barone D.: B-0087, B-0246
Arya S.: B-0651 Bago-Horvath Z.: B-1153 Barra S.: B-0970
Asadov R.: B-1156 Baiocco S.: B-0087 Barral M.: B-0718
Asayama Y.: B-0252, B-0431 Bajzik G.: B-0657 Barron D.A.: A-343
Asbach P.: B-0356, B-0583 Bakir B.: B-0221 Barroso L.: B-0945
Aschoff A.: A-375 Bal C.S.: B-0514 Barry J.: B-0020
Ashamallah G.A.: B-0876 Balacchi C.: B-0587 Bartalena T.: B-1266
Aslan K.: B-0591 Balageas P.: B-0857 Bartenstein P.: A-612
Aslani Menareh Bazari R.: B-0476, B-1252 Balagurunathan Y.: B-0094 Barter S.: A-631, A-681
Aspelin P.: B-0100 Balaji R.: B-0965 Barth B.K.: B-0004, B-0531, B-0559, B-1046
Aspelund T.: B-0415 Balas I.: B-0077 Bartolomé P.: B-0211
Aspin R.: B-1148 Balbo-Mussetto A.: B-0510, B-0512 Bartolozzi C.: B-0010, B-0269, B-0430, B-0741,
Assante R.: A-465 Bale R.: A-057, A-364, B-1244 B-0841
Astegiano F.: B-0620 Balenovic A.: A-739 Bartykowszki A.: B-0607
Atalay C.R.: B-0138 Balestri R.: B-0841 Barwick T.: A-030
Atkinson D.: B-0460 Bali M.A.: A-005 Bas A.: B-1204
Attenberger U.I.: B-0554, B-1232 Balkman J.D.: B-0214, B-1189 Basiak M.: B-0656
Attye A.: B-0369 Ball P.: B-0868 Basilico R.: A-368
Aubé C.: B-0195, B-0410 Ballard M.: B-0408 Ba-Ssalamah A.: A-140, A-619, B-0250, B-1170, LBCT
Augustynska B.: B-1086 Ballati F.: B-0015 Bassi M.: B-0838
Auperin A.: B-0718 Ballesio L.: B-0013 Bastarrika G.: A-594
Aust S.: B-0669 Balleyguier C.S.: A-032, A-149, A-270, A-369, A-389 Basten L.: B-0859
Autiero Walleser S.: B-0084 Ballicu N.: B-0344 Bastiani C.: B-0519
Auvinen P.: B-0210 Ballinger J.R.: A-110 Bastos-Leite A.J.: B-0244
Auweter S.: B-0102 Balodis A.: B-0818 Batool M.: B-0097
Avanesov M.: B-0188, B-0898 Balslev I.: B-0960, B-0968 Batool S.: B-0034
Avantsa R.: B-0665 Baltogiannis D.: B-0702 Bats A.-S.: B-0666
Avella-García C.B.: B-0441 Baltzer A.: B-0619 Batsak B.: B-0722
Averkiou M.: B-0636 Baltzer P.A.T.: A-272, A-599, B-0242, B-0352, B-0444, Battaglia M.: B-0831
Aviram G.: B-0849 B-0615, B-0619, B-0759, B-0767, B-0920, B-1153, Battisti S.: B-1235
Avogliero F.: B-0178 B-1158, B-1160 Battistuzzi J.B.: B-0717
Avrin D.: B-1036 Balvay D.: B-0131 Bauer J.S.: A-713, B-0249, B-0285
Awai K.: B-1197 Balzarini L.: B-1236 Bauer R.W.: B-0088, B-0193, B-0428, B-0729,
Awny M.: B-1079 Bamberg F.: A-115, A-252, A-324, B-0001, B-0392, B-0730, B-0731, B-0770, B-0847, B-1270
Ayachit A.: B-0914 B-0417, B-0480, B-0483, B-0609 Bäuerle T.: A-280, A-724
Aydin F.A.: B-0221 Banciu E.: B-0369 Baum T.: B-0285
Ayuso Colella C.: K-25 Banco A.: B-0505 Baumann S.: B-0752
Azad Y.-J.: B-0398 Banerjee A.: B-1225 Baumbach S.F.: B-0911
Azevedo K.B.: B-0869, B-1145 Banerjee B.: B-1078 Baumüller S.: B-0531
de Baère T.: A-117, A-248, B-0718 Degrassi F.: B-0956 Di Paola V.: B-0354, B-1171
de Barros N.: B-0111 Deguelte S.: B-0259 Di Pasquale M.A.: B-1267
de Bazelaire C.: B-0988 Deiva K.: A-064 Di Pastena F.: B-0013
De Belder F.: A-177, A-183, A-512, A-719 del Ciello A.: B-0314, B-0687 Di Perri C.: B-1227
De Blaauw I.: B-0893 Del Forno S.: B-0587 Di Pietropaolo M.: B-0978, B-1050
De Bondt T.: A-580, B-0984, B-1239 Del Guerra A.: K-17 Di Rocco F.: A-685
de Bruijne M.: B-0168, B-1117 Del Maschio A.: B-0015, B-0180, B-0182, B-0251, Diacinti D.: B-0883, B-0884
de Bruin A.B.H.: B-1258 B-0468, B-0471, B-0809, B-0904, B-1172 Diakov I.: B-1132
de Bruin F.: B-0941 Delaloge S.: A-389, B-0718 Diamant I.: B-1040, B-1041
De Cecco C.N.: A-388, B-0051, B-0265, B-0272, Delemer B.: B-1003 Diamantopoulos A.: B-0124
B-0445, B-0474, B-0779, B-0793, B-0794, B-0833, Delgado C.: B-0796 Diao P.: B-0212
B-1233 D’Elia C.: B-1268 Diehl S.J.: A-405
De Chillou C.: B-0472 Della Bella P.: B-0180, B-0182 Diehl V.: A-401
De Cobelli F.: B-0015, B-0180, B-0182, B-0251, Della Latta D.: B-0178 Diehm T.: B-0169, B-0172
B-0471, B-0809, B-0904, B-0967, B-1172, K-14 Della Sala S.W.: B-1280 Diekhoff T.: B-0825, B-1067
De Cobelli O.: B-0560 Delles M.: B-0398 Diepstraten S.C.E.: A-033
De Crescenzo A.: B-0512 Delli Pizzi A.: B-0742 Dierks A.: B-1290
De Felice C.: B-0621 Dell’Oste G.: B-1033 Dietrich A.: B-0980
De Foer B.: A-644 Delmaire C.: B-0503 Dietrich O.: B-0323, B-0556, B-0814
De Franco G.: B-0043, B-1212 Delongchamps N.B.: A-106, A-329 Dietzel F.: B-0351, B-0357
De Fronzo S.: B-0038 Delso G.: B-0320 Dietzel M.: B-0239, B-0242, B-0422, B-0619
De Gaetano A.M.: B-1052 Demetriou S.: B-0293 DiFranco M.: B-0249, B-0917
De Graaf N.: B-0893 Demirag F.: B-0330 Dijkshoorn M.L.: B-0753
de Graaf P.: B-0527 Demondion X.: B-0947 Dijkstra H.: B-0617, B-0624
de Graaf R.: B-0635 den Harder A.M.: B-0270 Dillmann R.: B-0398
De Gregorio M.A.: B-1124 Den Heeten G.J.: B-1027, B-1144 Ding-Reinelt V.: B-0905
de Haan M.: B-0736 Denecke T.: B-0003, B-0011, B-0426, B-0436, B-0905 Dinkel J.: B-0096, B-0991
de Haan S.: B-0143 Deng J.: B-1238 Dinu L.E.: B-0403
de Hooge M.: B-1073, B-1075, B-1076 Deng W.: B-0080 Diogo I.: B-0368
De Jong H.W.: B-0815 Denjoy N.: A-455 Diogo M.C.: B-0199
de Jong M.C.: B-0527 Denton E.: A-748, A-756, B-1026 Dionisi C.: B-0364, B-0366, B-1018, B-1150
de Jong P.A.: B-0270, B-0535, B-0537, B-0540, Denys A.: A-146, B-0256 D’Ippolito G.: B-0841
B-0683, B-1109 Depeursinge A.: B-1088 Discalzi A.: B-0966
de Jonge G.: B-0329 Dequi C.B.: B-0927 Divenuto I.: B-0086, B-0576
De Kerviler E.: B-0187, B-0988 Derbel H.: B-0295 Dixon A.K.: A-314
De Koning H.J.: B-0533, B-0683, B-1109 Derchi L.E.: A-738, B-1011, B-1131 Dmitriev A.: B-0589
de Lange C.: B-0167 Derlin T.: B-0188, B-0974 Dodré E.: B-0947
de las Heras Gala H.: B-0103 Desai S.B.: B-0429 Dodwell D.: B-0014
de Linde D.: B-0143 Desai S.M.: B-0804 Doel T.: B-1111, B-1119
De Maeseneer M.: A-509 Desai S.R.: A-034 Dogan-Ekici I.: B-0221
de Man R.: B-0425 Desbiolles L.: B-0107 Dohan A.: B-0465, B-1106
De Marchi G.: B-0720, B-1287 Deschamps F.: A-248, B-0718 Dolgishin B.: B-1127
De Margerie C.: B-0187 Deserno W.: B-0834 Dolgun Barak A.: B-0581
de Margerie-Mellon C.: B-0988 deSouza N.M.: A-268, A-494 Dolgushin B.: B-0005
De Matteis G.: B-0454 Dessandier V.: B-0867 Dolman K.M.: B-0385
de Mey J.: A-626, B-0106, B-1199 Dettmer S.: B-0451 Dominguez A.: B-0966
De Nicolò A.: B-0230, B-0442 Deux J.-F.: B-0108 Dominguez A.D.: B-0141
De Ridder M.: A-626 Devaraj A.: A-170, K-12 Dominguez-Prado I.: A-709
de Rooy J.: B-0401 Devos A.: B-0893 Donaldson S.B.: B-0662
De Rossi N.: B-0300 Dewes P.: B-0193, B-0539, B-0847, B-1270 Donatelli G.: B-0082
de Ruiter Q.M.B.: B-0270 Dewey M.: A-651, B-0173, B-0176, B-0243, B-0791, Donati F.: B-0010
De Soccio V.: B-0337 LBCT Donati O.F.: B-0559, B-1046
de Vries B.: B-0115 D’Haese J.: B-1187 Donatiello S.: B-0831
De Wever W.: B-0326, B-1254 Dhar R.: B-0333 Donato G.: B-0022
De Wilde L.F.: B-0498, B-0499 Dharmarajah B.: B-0636 Donell S.: B-0637
Debray M.-P.: B-1255 Di Castro E.: B-0050 Dong Q.: B-0493
DeCobelli F.: B-0468 Di Cesare E.: B-1065 Dong Y.: B-0715
Decristoforo C.: B-0305 Di Egidio V.: B-0821, B-0951, B-0957 Donner R.: B-1037
Dedic A.: B-0753 Di Feo D.: B-1150 D’Onofrio M.: A-134, B-1201
Deepalam S.: B-0198 Di Leo G.: B-0397, B-0604, B-0757, B-0897, B-0919, Donoso L.: A-077, A-217, A-344, A-452
Deferme F.: A-580, B-0984 B-0946, B-1175 Dooms C.: B-0326
Defilippi C.: B-0887 Di Martino M.: B-0888, B-1048 Dora C.: B-0641
DeFriend D.: A-138 Di Miscio R.: B-0762, B-0764 D’orazio F.: B-1224
Deganello A.-M.: B-0892 Di Mizio V.: B-0821, B-0951, B-0957 Dörfler A.: A-175, B-0239, B-0422
Dormagen J.B.: B-1196 Edey A.: B-1115 Etxano J.: B-0211, B-0923, B-0926
Dornia C.: B-0060 Edris M.: B-0594 Etz C.: B-0595
Dorrius M.D.: B-0617, B-0624 Edwards M.: B-0401 Euringer W.: B-0064
dos Santos Silva I.: A-224 Egbers J.B.: B-0404 Evangelista L.: B-0018
Dösch C.: B-0391 Egels S.: B-1096 Evanoff M.: B-0208
Dougados M.: B-1073, B-1075, B-1076 Egger C.: B-0848 Evans A.: A-226, A-598
Dousset V.: B-1219 Eggesbø H.B.: B-0552 Evans D.: B-0925
Doyon F.: B-1232 Eghtedari M.: B-0439 Evans D.R.: B-0924
Draeger S.: B-0368 Ehrenfeld M.: B-0378 Evans J.: B-0529
Dratwa C.: B-0766 Ehrmann C.: B-0491 Eveno C.: B-1106
Drelich-Zbroja A.: B-0057 Eibofner F.: B-0854 Ewert P.: B-0596
Drevelegas A.: B-0649 Eichhorn J.: B-0398 Ewertsen C.: A-056
Drevelegas K.: B-0649 Eichinger M.: B-0991 Ezhova R.: B-1081
Dreyer K.J.: A-214, A-750 Eickelberg O.: B-1101
Driesser I.: B-0445 Eieland H.: B-0367 F
Drobni Z.D.: B-0607, B-1061, B-1062 Eikeord E.: B-0708 Faber J.: B-0389
Dromain C.: A-149, A-270, A-389 Eisenblatter M.: B-0931 Faby S.: B-0674
Drop A.: B-0845 Eklöf H.: B-0405, B-0406 Facchini G.: B-0807, B-0831, B-1266
Droshneva I.: B-1234 El Mahdy M.: B-0530 Fadeeva L.: B-0658
Du J.: B-1202 El-Adalany M.A.: B-0876 Fagan A.J.: B-0017
Dubbeldam A.: B-1254 Elattar A.: B-0874 Fagerli K.M.: B-0941
Dube L.: B-0410 El-Diasty M.: B-1013 Fages J.F.: B-1124
Düber C.: B-0389 El-Diasty T.A.E.: A-302, B-1013 Faggioni L.: A-749, B-0269, B-0841
Dubourg B.: B-0953 Elgeti T.: B-0394, B-1250 Faghihi Langroudi T.: B-1057
Dubrulle F.: A-560 Elizalde A.: B-0211, B-0923, B-0926 Faivre J.-B.: B-0336
Dubsky P.: B-1153, B-1160 Elliot T.: B-0662 Falaschi F.: B-0010
Dubuc J.-E.: B-0916 Ellis S.: B-1143 Faletti R.: B-0608, B-0900, B-0966, B-1005
Duchat F.: B-1106 Elmashad A.: B-1079 Falini A.: B-0300
Duddy L.: B-0020 Els H.: B-0194 Falkowski A.: B-0569
Dueber C.: B-0997 Elshafey R.A.: B-0874, B-1079 Fallenberg E.M.: B-0436, K-24
Duerr H.R.: B-0286 Elverici E.: B-0138 Fan L.: B-1112
Duffy S.W.: A-516, B-0069 Elzeawy H.: B-1133 Fandiño E.: B-0955
Dugnani E.: B-1172 Emad Y.: B-0477, B-0640 Fanelli F.: A-427
Duhal R.: B-0503 Emberton M.: B-0967 Fang H.: B-0890
Duhamel A.: B-0852 Emri M.: B-0657 Fanti S.: A-161, A-529
Duijm L.E.M.: B-1027, B-1030, B-1031, B-1032 Engelen T.: B-0025 Fantini C.: B-0978
Duka E.: B-1287 Engelhorn T.: A-175 Farghaly H.: B-0530
Dumas G.: B-0369 Engelken F.: B-0209 Fargun B.: B-0248
Dumpuri P.: B-0855 England A.E.: B-0141, B-0146, B-0149, B-1019, Farina D.: A-040, A-559, B-0174
Dunet V.: B-0185 B-1146 Farrher E.: B-0658
Duran S.: B-0138 Engler A.: B-0088 Farrugia Wismayer E.: B-0142
Durando M.: B-0022 Eom H.-J.: B-0156 Fasching P.A.: B-0206
Duras P.: B-1205 Erb-Eigner K.: B-0543, B-0583 Fasen B.A.C.M.: B-0085
Dürig E.: B-0353 Erickson B.J.: B-1036 Fatehi M.: A-756
Duron S.: B-0128 Erni S.: B-0373, B-0374, B-1070 Faure F.: B-0376
Duryea J.: B-0646 Erol O.B.: B-0388 Faustino M.D.A.F.: B-0360
Dutka I.: B-0660 Errani C.: B-1266 Fausto A.: B-1181
Dutt V.: B-0592 Ertem F.: B-0388 Favelier S.: B-0346
Dwarkasing R.S.: B-0425, B-0839 Ertl-Wagner B.: A-045, A-092, A-220, A-456, A-733, Favia V.: B-1212
Dweck M.R.: A-531 B-0001, B-0036, B-0732, B-0814 Federau C.: B-0940
Dyce S.: B-1038 Ertürk S.M.: A-732 Federici G.F.: B-0978, B-1050
Dziubinska-Basiak M.: B-0656 Eschbach R.: B-0938 Federici M.: B-0343
Eschrich S.: B-0094 Fedorova A.: B-0705
E Escourrou C.: A-106, A-329 Feger S.: B-0176, B-0791
Eandi M.C.: B-0620 Esfandiari E.: B-1252 Feier D.: B-1200
Earl H.: B-0019 Esheba N.: B-0874 Feignoux J.: B-0175
Ebadi J.: B-0148 Esposito A.: B-0180, B-0182, B-0468, B-0471, Fekir A.: B-1275
Ebdon-Jackson S.: A-642 B-0809, B-0904, B-1172 Felblinger J.: B-0472
Eberli D.: B-0559 Esposito G.: B-0742 Fele R.: B-0344
Ebinger M.: B-0381 Essig M.: B-0239, B-0422, B-0500 Felgueiras R.: B-0817
Eckstein F.: B-1069 Esteves B.: B-0362 Fellah L.: B-1088
Eckstein H.-H.: B-0278 Estivalet L.: B-0346 Fellhauer I.: LBCT
Edden R.A.E.: B-1085 Etcheto A.: B-0284 Fellner C.: B-0218
Eder P.: B-0459 Ettlin D.: B-0373, B-0374, B-1070 Feng S.S.J.: B-1098
Gazelle G.S.: B-0750, B-0751 Ginocchi V.: B-0437, B-0918 Grandjean A.: B-1255
Gazhonova V.E.: B-0134 Gioppo A.: B-0170 Granone P.: B-0328
Ge B.H.: B-0698, B-0853, B-0996 Giordano A.: B-0687 Graser A.: A-492, A-677, B-1264
Gebauer B.: A-145, B-0860 Giordano A.V.: B-1224 Grass M.: A-013
Geeroms B.: B-0695 Giordano J.: B-0852 Grassedonio E.: B-0393, B-0899
Geers-van Gemeren S.: A-640 Giovagnoni A.: B-1054 Grasso R.F.: A-247, B-0717
Geffray A.: B-0700 Girardi V.: A-031 Gratama J.W.C.: B-0263
Geissbühler A.: B-1088 Girerd N.: B-0472 Grau V.: B-1111, B-1119
Geith T.: B-0286 Giri S.: B-0272 Graumann O.: B-0872
Geldof M.: A-580, B-0984 Girometti R.: B-0350, B-0743 Graves M.: B-1154
Gellert M.: A-524 Giuliani M.: B-0618, B-1179 Graves M.J.: B-0019
Gemmel P.: B-0144 Giuliani P.: B-0946 Gray C.: B-0055
Gennaro G.: B-0018, B-0238 Giunta N.: B-0046 Graziani R.: B-1236
Genson P.-Y.: B-0346 Giurazza F.: B-1267 Greco F.: B-1235
Gentile F.P.: B-0711 Giuseppetti G.M.: B-0711 Greenspan H.: B-1040, B-1041
Gentiluomo M.: B-0191 Gizewski E.R.: B-0549 Gregori L.M.: B-0066, B-0068, B-0072, B-0075,
Georg D.: A-285, B-0132, B-0352, B-0935, B-1158 Glavak C.: B-0657 B-0338, B-0347, B-0487, B-0573, B-1208, B-1209,
Georg P.: B-0132, B-0935 Gleeson F.: A-689 B-1211, B-1224
Geraldo A.F.: B-0811 Gleeson F.V.: B-1111, B-1119 Grehan J.: B-1142, B-1149, B-1151
Geraldo L.: B-0827 Glitsch A.: B-1130 Greiser A.: B-0052
Geraldo Roig L.: B-0305 Glodny B.: B-0549 Grenacher L.: B-0099, B-0788
Gerami Seresht M.: B-0605 Glüer C.-C.: A-589 Grenier N.: A-139, A-316, A-461, B-1011, B-1289
Gerardin E.: B-0953 Gluud C.: B-0959 Grenier P.A.: A-168, K-16
Gerasia R.: B-0696 Gned D.: B-0030 Greuter M.J.W.: B-0263, B-0264
Gerber C.: B-0491, B-0494 Goehler A.: B-0750, B-0751 Griebel J.: A-581
Gerevini S.: B-0300 Goel I.: B-0885 Grieser C.: B-0003, B-0011, B-0426
Gerken G.: B-1097 Goel S.: B-0302 Grigoriadis N.: B-1087
Germano A.: B-0735 Goetti R.: B-0896 Grigoriev E.: B-0633
Germonpré S.: B-0144 Goh V.J.: A-514, A-624 Grimm J.: A-591, B-0848
Gerrits P.: B-0844 Goh Y.P.: B-0677 Grinberg F.: B-0658
Gevenois P.A.A.: B-0785, B-0987 Gök M.: B-0546 Grindsted J.: B-0948
Geyer C.: B-0931 Goksel O.: B-1039 Gripari P.: B-0467
Geyer L.L.: B-0748 Gola G.: B-0331 Grisk O.: B-1130
Ghadiri A.: B-0875 Goldberg S.N.: A-326 Gritzmann N.: A-276
Ghafoor U.: B-0529 Golfier F.: B-0989 Gröller E.: B-0632
Ghali A.: B-0716 Golfieri R.: B-0587 Grönberg F.: B-0671
Ghaye B.: A-129 Goligher J.: B-0924, B-0925 Grosse Hokamp N.: B-0931
Gherarducci G.: B-0010 Golitsyn S.P.: B-0181 Grosse R.: B-0225
Ghiddi L.: B-0918 Gomes A.: B-0735, B-0864 Grosse U.: B-1256
Ghoshal S.: B-0574 Gomez B.: B-0255, B-0827 Grothoff M.: B-0595
Giancotti A.: B-0520, B-0523 Gómez-Ansón B.: A-199 Grove O.: B-0094
Giannotta M.: B-0850 Gondo T.: B-0555 Groves A.: B-0093
Giardino A.: B-0946 Gong Q.: B-0080 Groves C.: B-0287
Gibaud B.: A-167 Gonulalan U.: B-1273 Gruber G.M.: B-0379, B-0522
Gielen G.: B-0648 Gonzalez de Posada N.: B-1042 Gruber-rouh T.: B-0186
Gielen J.L.M.A.: A-256 Goo D.E.: B-0691 Grueneisen J.: B-0029, B-0031, B-0516, B-0806,
Giepmans W.: B-0106, B-0266 Goo J.M.: A-539, B-0690 B-1183
Gies C.: B-0389 Goraj B.: B-0085 Grünberg K.M.: B-1039
Gieseke J.: B-0648, B-0943, B-1215 Gordic S.: B-0107, B-0268, B-0896 Grüneisen J.: B-1159
Giesel F.: A-466, B-0688 Göricke S.: B-0527 Gryspeerdt E.F.W.: B-0460
Gietema H.A.: B-0540 Gorycki T.: B-0306, B-0719 Gschwendtner A.: A-636
Giganti F.: B-0251, B-0967 Gotlieb M.: B-0119, B-0438 Gu L.-H.: B-0890, B-1202
Giganti M.: B-0838 Goto H.: B-0810 Guan Y.: B-1112
Gigli S.: B-0013 Gottlieb P.: B-0377 Guaraldi G.: B-0316, B-1113
Giglio J.: B-1005 Gottschling S.: B-0655 Guarnaccia C.: B-0966, B-1005
Gigoni R.: B-0010 Gourtsoyianni S.: A-543, A-564 Guarnieri G.: A-718
Gil B.-M.: B-0201 Gourtsoyiannis N.: A-219 Guberina N.: B-0786, B-1240, B-1241
Gilbert F.J.: A-093, A-148, B-0019, B-0757, B-1154, Grabherr S.: B-0848 Gubern Mérida A.: B-0232, B-0233, B-0758
B-1175 Grago J.: B-1069 Gubskiy I.L.: B-0005
Gilles B.: B-0376 Grainger A.J.: A-023 Gudnason V.: B-0415
Gillies R.: B-0094 Gralla J.: B-0813 Gueldner C.: B-0368, B-0727
Gilligan P.: A-430 Gramer B.M.: B-0278, B-0754, B-0797, B-0798 Gueler F.: B-0709, B-1135
Gimenez M.: B-1124 Grams A.E.: B-0549 Gueli A.: B-0512
Ginanni B.: B-0430 Grande Garcia E.: B-0285 Guenoun J.: B-0930
Hetterich H.: B-0001, B-0483 Hong N.: B-0685, B-0952 Hutchinson B.: B-0842
Heubner M.: B-0029, B-0031 Hong S.-J.: B-0288, B-0497 Huttin O.: B-0472
Heusch P.: B-0026, B-0045, B-0092, B-0255, B-0516, Hong S.S.: B-0453, B-0691 Huumonen S.: B-1190
B-0627, B-0806, B-0827, B-1004 Hoogerbrugge N.: B-0228 Huynh M.: B-0677
Heussel C.P.: A-128, A-637, B-0096, B-0450, B-0991 Hoogerwaard A.F.: B-0404 Huyskens J.: A-177
Heußel C.-P.: B-0688, LBCT Hopf N.J.: B-0196 Hwang I.: B-0423
Heußer T.: B-0103, B-0319 Hoppe H.: A-111 Hwang J.H.: B-0453, B-0691
Heuts E.: B-0115 Horenblas S.: B-0033 Hwang J.Y.: B-0691
Heuvelmans M.A.: B-0533 Horgan K.: B-0014 Hyafil F.: B-0484
Hewett L.: B-0396 Horger M.: B-1055, B-1253, B-1256 Hyun S.J.: B-0114
Heye S.: B-0058, B-0695 Hořínek D.: B-1077
Heywang-Köbrunner S.H.: A-517 Horninger W.: B-0305 I
Hibat Allah S.: B-0311 Hornung A.: B-0392 Iacobucci M.: B-0544
Hickmann A.-K.: B-0196 Horsch A.D.: B-0815 Iacovelli N.A.: B-0577
Hiester A.: B-0357 Horsthuis K.: A-421 Iacucci I.: B-0343
Hietschold V.: B-0506, B-1272 Horváth T.: B-0266, B-0607, B-1062 Iaia A.: B-0507
Higashigaito K.: B-0409, B-0531 Horvath-Rizea D.: B-0412 Iannarelli A.: B-0883, B-0884
Highland A.M.: B-0290 Hossein-Foucher C.: B-0852 Iannessi A.: B-0245, B-0519, B-1096
Higueras V.: B-0073 Hosten N.: A-101, A-250, A-374, B-0318, B-0907, Iannicelli E.: B-0978, B-1050
Hild F.: B-0092 B-0908, B-1130 Ichikawa K.: B-0105
Hildebrandt T.: B-0529 Hötker A.M.: B-0348, B-0555, B-1009, B-1010 Ichikawa T.: B-0693, B-1197
Hilton B.: B-1026 Houari F.: B-0158 Idée J.-M.: B-0710
Hinnenthal J.: B-0084 Houssami N.: A-242, A-656, B-0757, B-1175 Ierace T.: B-0723
Hinrichs J.: B-0222 Houston G.: B-0479, B-0481 Ierardi A.M.: B-0720, B-1287
Hipp A.: B-0483 Houston J.G.: B-0466 Iezzi R.: B-0059, B-0121, B-0314, B-1136
Hirner H.: B-0938 Houthoofd S.: B-0058 Igel C.: B-0077, B-0212
Hlavsa J.: B-1126 Howarth N.: A-503 Ihalainen T.: B-0321
Ho C.L.: B-0509 Hricak H.: B-0348, B-0555, B-1009, B-1010, K-27 IJzermans J.: B-0425
Hocaoglu E.: B-0221, B-1277 Hromadka M.: B-0756 Ikeda S.: B-0139
Hocquelet A.: B-0291, B-0857 Hu L.: B-0952 Ikejimba L.: B-1099
Hodler J.: A-312, A-317 Huang B.: B-0715 Iles S.: B-0236, B-0237
Hodneland E.: B-0708 Huang K.H.: B-0340 Ilic D.: B-0126
Hoe J.: A-596 Huang L.J.: B-1283 Ilic V.: B-0185
Hoeffel C.: A-676, B-0259, B-0465, B-1003 Huang M.L.: B-0439 Illarioshkin S.: B-0083
Hoermann R.: B-1244 Huber A.: B-0278, B-0813 Ilsen B.: B-0106
Hoffmann A.L.: B-0091 Huber A.M.: B-0754, B-0797, B-0798 Ilyas S.: B-0125
Hoffmann C.: B-0521, B-0525 Huber B.: B-0671 Imai Y.: B-0693
Hoffmann E.: B-0797 Huber R.M.: B-0095 Imbriaco M.: B-0038
Hoffmann O.: B-1159, B-1183 Huber S.: B-0750 Inchingolo R.: B-1052
Hoffmann R.: B-0854 Hue G.: B-1275 Inci E.: B-0221, B-1277
Hoffmann U.: B-0750, B-0751, B-0755 Hueper K.: B-0709, B-1135 Infante A.: B-0314
Hofheinz R.D.: B-1232 Huet N.: B-0611 Inglot M.: B-0227
Hofmans M.: B-1102 Hughes P.: B-0440, B-1192 Ingold-Heppner B.: A-096
Hofmeijer J.: B-0815 Hugli O.: B-0185 Innocenti E.: B-0179
Hogg P.H.: A-715, B-0141, B-0143, B-1023, B-1026, Hugon-Rodin J.: B-0989 Ioan I.: B-0757
B-1148 Hui T.C.H.: B-0341 Iori M.: B-0918, B-1103
Hohenhorst J.L.: B-0349 Huijsse S.E.M.: B-0263, B-0264 Iotti V.: B-0437, B-0922
Hohl M.: B-0478 Huis in t Veld R.: B-0074 Ipek-Ugay S.: B-0356
Holberg A.: B-0361 Huisman T.A.G.M.: A-239 Ippolito D.: B-0274, B-0308, B-0309, B-0464, B-0518,
Holla M.: B-0401 Huizinga E.: B-1023 B-0612, B-0774, B-0835, B-1053, B-1091, B-1164,
Holland K.: B-0212, B-1028 Hujairi N.P.: B-0069 B-1166
Holohan K.: B-0231 Hulsbergen-van de Kaa C.A.: B-1140 Iqbal A.: B-0924
Hołownia D.: B-0227 Hunink M.G.M.: A-215, A-522 Iranzo V.: A-683
Hölter P.: B-0422 Hunold P.: A-613, B-0276 Ishigami K.: B-0431
Holzer M.: B-1037 Hunt S.J.: B-0853 Ishii K.: B-0298
Homampour S.: B-0780 Hunter D.J.: B-1069 Ishikawa M.: B-0139
Homann G.: B-0402 Huppertz A.: B-0426 Isoda T.: B-0826
Homsi R.: B-1215 Hur J.: A-538, A-540 Itkin M.: B-0853
Honda H.: B-0252, B-0431, B-0826, B-0986 Hurlen P.: B-0037, B-1259 Itou C.: B-0693
Honeyfield L.: B-0517 Husarik D.B.: B-0107, B-0268 Ittrich H.: B-0223
Hong E.A.: B-0763 Hüsers K.: B-0729, B-0731, B-0770 Iudicello M.: B-0030
Hong G.: B-0152 Hussein S.A.: B-1214 Iussich G.: LBCT
Hong J.: B-1125 Husson B.: A-064 Ivkovic A.: B-0992, B-1222
Hong K.C.: B-1285 Hustveit H.: B-1023 Iwata T.: B-0184
Izaaryene J.: B-0049, B-1260 Jha A.: B-0296 Kalidos K.: B-0962
Jha P.: B-0192 Kalina I.: B-0070
J Ji Q.: B-0136 Kalisvaart C.J.: B-1226
Jaakkola M.: B-0145 Jiang Y.: B-0685, B-0944, B-1112, B-1118 Kallenberg M.G.: B-0212
Jackson A.: A-166 Jimenez del Toro O.A.: B-1039 Kallio-Pulkkinen S.: B-1190
Jackson S.A.: A-488 Jiménez-Fonseca P.: B-0090 Kaltsi E.: B-0378
Jacob-Heutmann D.: B-0389 Jin C.: B-1110 Kamal H.A.: B-0910
Jacobi V.: B-0186 Jin H.: B-0048 Kamel M.-E.: B-0661, B-1114
Jacobs A.H.: A-048 Jin Y.: B-0021 Kamenicky P.: B-0395
Jacobs C.: B-0540 Jin Z.: B-0939, B-0976 Kamitani T.: B-0986
Jacobs R.: B-0680 Jin Z.-Y.: B-0606, B-1167 Kammer N.N.: B-0273, B-0275, B-0486, B-0822
Jacobsen E.: B-0545 Jinnouchi M.: B-0986 Kamphuis-Van Ulzen K.: B-0203, B-0383
Jacobson J.A.: B-0387, B-0569 Jobke B.: B-1210 Kandel S.: B-0716
Jacquier A.: A-614, B-0049 Jobst B.: LBCT Kanematsu M.: B-1197
Jäger H.R.: A-176, A-259, A-403 Jochelson M.: B-1180 Kang C.H.: B-0288, B-0497
Jagia P.: B-0129 Johannsen F.E.: B-0572 Kang E.-J.: B-0747
Jahoda J.: B-0740 John B.: B-1286 Kang J.: B-0795
Jain R.: B-0500 Johnson K.J.: A-086 Kang Y.H.: B-0153
Jakab A.: B-0522 Johst S.: B-1230 Kannan R.: B-1123
Jäkälä P.: B-1058 Jonas E.: LBCT Kannengießer S.: B-0002, B-0317, B-0554
Jakobs T.F.: A-055 Jones N.: B-0407 Kantarci F.: B-1204
Jakobsen J.Å.: A-756 Joo I.: B-0009, B-0423, B-1092, B-1121 Kantarci M.: A-704
Jalaguier-Coudray A.: B-0766 Jordan E.: A-679 Kapetas P.: B-0444, B-0920, B-1158
James K.: B-0020 Jorge J.: B-0146 Kaposi P.N.: B-0070
James S.L.J.: A-578 Jørgensen D.R.: B-0212 Kappelle J.L.: B-0815
Jang J.: B-0201 Joseph S.: B-0198 Kappelle L.J.: B-0950
Jang M.-S.: B-0709 Jost G.: B-0773 Karacin A.: B-0829
Jang Y.: B-0288 Jowi J.: B-0820 Karani J.B.: A-197
Jang Y.-J.: B-1231 Joyce E.A.: B-0017 Karanikas G.: B-0132, B-0935, B-1158, B-1160
Janig C.M.: B-0399 Jud S.M.: B-0206 Karantanas A.: B-0293
Jankowski A.: B-0538 Junaid I.: B-1133 Karcaaltincaba M.: A-130, B-1198
Jans L.B.O.: A-087 Jung C.S.L.: B-0934 Karch A.: LBCT
Jansen F.H.: B-1031 Jung E.M.: B-1203 Kardeh M.: B-0324
Jansen N.: A-612 Jung H.-Y.: B-1122 Karelskaya N.A.: B-0006
Jansen O.: B-1223 Jung J.-Y.: B-0802 Karimi M.: B-0279, B-0476, B-1252
Janvier A.: B-1003 Jung S.L.: B-0201 Karimi M.A.: B-1057
Jara H.: B-0761 Junghanss T.: B-0424 Karkas A.: B-0369
Jargiello T.: A-549, B-0057 Juras V.: A-650 Karlas T.: B-0980
Jarraya M.: B-0646, B-1071 Justo N.: LBCT Karlinger K.: B-0070
Jaschke W.R.: B-0002, B-0071, B-0076, B-0305, Jüttner B.: B-0709 Karlo C.A.: B-1009, B-1010
B-0317 Juvekar S.L.: B-0804 Karlsson S.: B-0671
Javor D.: B-1170 Karmazanovsky G.G.: B-0006, B-0630, B-0776
Jee W.-H.: B-0802 K Karoly M.: B-1062
Jeevanandham B.: B-0420 K G.: B-0915 Károlyi M.: B-0266
Jegonday M.-A.: B-1090 Kaakinen J.K.: B-1188 Karpenko A.: B-0589
Jenniskens S.F.M.: B-1140 Kaasalainen T.: B-0321 Karssemeijer N.: B-0212, B-0228, B-0232, B-0233,
Jensen C.J.: B-0045 Kabasakal L.: B-1204 B-0758, B-1028
Jensen J.S.: B-1152 Kachelrieß M.: A-141, A-349, A-643, B-0103, B-0319, Karul M.: B-0188, B-1213
Jensen-Kondering U.: B-1223 B-0670, B-0674, B-0675, B-0678 Karumathil Pullara S.: B-1123
Jeon I.: B-0310 Kachenoura N.: B-0395 Kasakura S.: B-0184
Jeon Y.S.: B-1285 Kaczorowski K.: B-0227 Kasi Arunachalam V.: B-0159
Jeong B.C.: B-1141 Kadavigere R.: B-0914 Kasmai B.: B-0637
Jeong J.: B-0453 Kaercher D.: B-0999 Kasprian G.: B-0379, B-0502, B-0522, B-0524
Jeong W.K.: B-1243 Kahn C.E.: A-080, A-756 Kassai Y.: B-0686, B-0964
Jeong Y.K.: B-0135, B-0977 Kahn T.: B-0980 Kassem H.M.: B-0530
Jeong Y.-K.: B-0679 Kaijzel E.L.: A-590 Kastner J.: B-0653
Jereczek-Fossa B.: B-0560 Kainberger F.: B-0249, B-0917 Kathemann S.: B-0462
Jermendy A.L.: B-0607, B-1062 Kaireit T.: B-0039, B-0222, B-0451, B-0999 Kato T.: B-0139
Jermendy G.: B-0607 Kaiser C.G.: B-1161, B-1184 Katorza E.: B-0521, B-0525
Jessop S.A.: B-0146 Kajander S.: A-114, A-654 Katsanos K.: B-0124
Jestin-Mayer G.: B-0710 Kakkar R.: B-0429 Katsari K.: A-585
Jeukens C.R.L.P.: B-0782 Kakollu M.: B-0407 Katsaros V.: B-1227
Jeung M.-Y.: B-0681 Kala P.: B-0665 Katsifarakis D.: A-157
Jeurissen B.: B-1219 Kalender W.A.: A-271, A-744 Katulska K.: A-124, B-0459
Kauczor H.-U.: A-165, A-266, A-634, B-0096, B-0099, Kim D.W.: B-1168 Klingmüller V.: B-0322
B-0398, B-0424, B-0450, B-0480, B-0688, B-0788, Kim E.-K.: B-0114, B-0157, B-0234, B-0881 Klink C.: B-0697, B-0856
B-0991, LBCT Kim E.Y.: B-1084 Kloeckner R.: B-0997
Kaufmann S.: B-1055 Kim G.C.: B-1231 Klompenhouwer E.G.: B-1027, B-1030, B-1031,
Kaul M.: B-0558, B-0934 Kim G.M.: B-0692 B-1032
Kaup M.: B-0088, B-0729, B-0730, B-0731, B-0770, Kim G.R.: B-0881 Klop W.M.C.: B-0025
B-0847 Kim H.-C.: B-1000 Kloppenburg M.: B-1210
Kavgaci H.: B-0829 Kim H.J.: B-0536, B-1168, B-1231 Klos G.: B-1186
Kavroulakis E.: B-0293 Kim H.-J.: B-0453, B-0691 Kloska S.: B-0239
Kawanami S.: B-0252, B-0986 Kim H.S.: B-0504 Kloth C.: B-0402, B-1253, B-1256
Kawashima H.: B-0105 Kim I.: B-0081 Klotz E.: B-0098, B-0613, B-0792, B-0799
Kaya H.: B-1156 Kim I.-O.: B-0886 Kløw N.-E.: B-1196
Kazemier G.: B-0862 Kim J.: B-0647 Klumpp B.: B-0392
Kazmierczak P.M.: B-0938 Kim J.H.: B-0421, B-0501, B-0819, B-1120, B-1169 Knaup M.: B-0670, B-0678
Kecskes K.: B-1064 Kim J.-H.: B-0501 Knebel J.-F.: B-0256
Keil V.C.: B-0648 Kim J.M.: B-0590, B-1265 Knight H.: B-1023
Kekelidze M.: B-0562 Kim J.S.: B-0597 Knobloch G.: B-0905
Kelekis A.D.: A-189, A-246, B-0339 Kim K.A.: B-0007, B-0593 Knoflach M.: B-0549
Kelekis N.: B-0339 Kim K.W.: B-1168 Knogler T.: B-0669
Keller S.: B-0223, B-0225, B-0808 Kim M.D.: B-0692 Knutsson L.: A-402
Kelley D.A.C.: B-1083 Kim M.-D.: B-1265 Knyshov G.: B-0722
Kelly J.: B-1026, B-1148 Kim M.H.: B-0747 Ko J.: B-0983
Kelly K.M.: B-0435 Kim M.J.: B-0114, B-0234 Ko M.-S.: B-0156
Kendler D.: B-0305 Kim M.-J.: LBCT Ko S.M.: B-0597
Kendziorra C.: B-0173, B-0243, B-0791 Kim M.Y.: B-1251 Kobayashi Y.: B-0861
Kenkel D.: B-0909 Kim N.: B-0334, B-0335 Kocer N.: A-182
Kennedy M.J.: B-0017 Kim N.H.: B-0153 Koch J.A.: B-0349
Keravnou C.: B-0636 Kim R.: B-0423 Koelemay M.: A-244
Kerbaol A.: B-0220 Kim S.H.: A-195, B-0423, B-1121, B-1165, B-1173, Koff D.: A-755
Kerl J.M.: B-0731 B-1271 Koh D.-M.: A-674
Kerl M.: B-0088 Kim S.-H.: B-1251 Koizumi J.: B-0693
Kerl M.J.: B-0193 Kim S.J.: B-0504, B-0879, B-0880 Kok E.M.: B-1257, B-1258
Kershaw L.E.: B-0662 Kim S.-J.: B-1173 Kok M.: B-0600, B-0773, B-0775
Kessler E.: B-0854 Kim S.K.: B-0568 Kokovic T.: B-0126
Keßler W.: B-0744 Kim S.M.: B-0790 Kollias K.: B-0550
Keymeulen K.: B-0115, B-0118 Kim S.Y.: B-1049 Kolossváry I.: B-1061
Khaledian L.: B-0148 Kim T.H.: B-0597 Kolossváry M.: B-0266, B-1061, B-1062
Khalil A.: B-1255 Kim W.S.: B-0886 Kolta S.: B-0284
Khalmukhamedova A.E.: B-0134 Kim Y.: B-0416, B-0802 Komárek V.: B-1077
Khan A.M.: B-0748 Kim Y.H.: B-1122 Komarova M.: B-0183, B-0851
Khan M.F.: B-0550 Kim Y.J.: B-0691 Komljenovic D.: B-0313
Khandelwal N.: B-0164, B-0205, B-0574 Kim Y.K.: B-1243 Komnatska I.: B-0660
Khanna J.: B-0979 Kincses T.Z.: B-1077 Kondratyev E.V.: B-0630, B-0776
Khanna M.: B-0190, B-0979 Kind M.: B-0800, B-0803 Konen E.: B-1040, B-1041
Kharabish A.E.: B-0596 Kindermann K.: B-0318 Koning G.: B-0930
Kharlap M.: B-0901 Kinkel K.: A-394, K-03 Kono A.: B-0753
Khayrutdinov E.: B-1261 Kinner S.: B-0031, B-0165, B-0255, B-0462, B-1097, Konopka M.: B-0656
Khazaie K.: B-0933 B-1159, B-1183 Konovalov R.: B-0083
Khodair S.A.Z.: B-0345 Kirchin M.A.: B-0281 Konstantatou E.: B-0892
Khouri Chalouhi C.: B-0170 Kirkham A.: B-0967 Kooijman H.: B-0273, B-0486, B-0822
Khrichenko D.: B-0894 Kiss J.: B-0070 Kooijman-Kurfuerst H.: B-0275
Khung S.: B-0336 Kitagawa K.: A-471, A-595 Kool D.R.: A-477
Kickuth R.: B-1290 Kitamura Y.: B-0826 Koopmanschap D.H.J.L.: B-0203, B-0383
Kiefer T.: B-1067 Kitslaar P.: B-0266, B-1061 Koops A.: B-1286
Kienle P.: B-1232 Kittner T.: B-0353 Kooraki S.: B-0605, B-0875
Kiessling F.M.A.: A-561 Kivistö S.H.: B-0145 Kopp F.: B-0285
Kietselaer B.L.J.H.: B-0600, B-0775 Klang E.: B-0119, B-1040, B-1041 Koprivsek K.: A-663
Kijowski R.: B-1216 Klasa L.: B-0668 Kornienko V.: B-0658
Kilburn-Toppin F.: B-1029 Klauser A.: A-341, A-697, B-0071, B-0076 Koshida K.: B-0105
Kilic I.-B.: B-0426 Klauß M.: B-0788 Koshy S.M.: B-0962
Kilickesmez O.: B-1277 Klein S.: B-0244 Koskinen S.: B-0405
Kim B.H.: B-0288, B-0497 Klein W.M.: B-0203, B-0383 Kosucu P.: B-0829
Kim B.-S.: B-0201 KleinJan G.H.: B-0025, B-0033 Kotek G.: B-0930
Kim C.K.: B-0133, B-1006, B-1141 Klemenčič T.: B-0150 Kotiaho A.: B-0145
Lee D.Y.: B-0692 Lesyuk O.: B-0365, B-1021 Liukkonen E.: B-1190
Lee E.: B-0647, B-0691 Levrini G.: B-0922 Liuzzi R.: B-0038
Lee E.S.: B-0423 Levy R.: B-1275 Ljubisavljevic S.: B-0079
Lee H.: B-0109 Lewandowski R.J.: B-0933 Llopis E.: A-588, B-0073
Lee H.C.: B-1049 Lewerich B.: A-378, A-399 Lo Bello M.: B-0724
Lee H.-K.: B-0568 Ley S.: B-0398 Lo Bue G.: B-1236
Lee H.Y.: B-0153 Leygnac S.: B-1255 Lo J.: B-1099
Lee J.: B-0007, B-0593, B-0769 Li F.: B-0080, B-0890 Lo Russo F.: B-0809
Lee J.B.: B-0679 Li F.-H.: B-1202 Lobbes M.: A-269, B-0113, B-0115, B-0118
Lee J.H.: B-0135, B-0156, B-0157, B-0532, B-0690, Li H.: B-0944, B-1279 Loberg C.: B-0701
B-0886, B-0977, B-1000, B-1120 Li L.: B-1007 Loeckx D.: B-1219
Lee J.-H.: B-0747 Li M.: B-0036, B-0732 Loegager V.: B-0960, B-0968
Lee J.M.: B-0008, B-0009, B-0423, B-0613, B-0679, Li P.: B-1283 Loewe C.: A-699, B-0177, B-0632
B-1051, B-1092, B-1169 Li T.: B-1118 Loffroy R.: B-0346
Lee K.: B-0413 Li X.: B-0836, B-0976 Logager V.: A-107, B-0461
Lee K.H.: B-0161, B-0733 Li Y.: B-1110 Loguercio M.: B-0467
Lee K.-N.: B-0747 Liang S.: B-0578 Loh T.: B-0578
Lee K.S.: A-537 Liao W.: B-0080 Lollert A.: B-0389
Lee M.J.: A-445 Liberali S.: B-0764 Lomax S.: B-1038
Lee N.: B-0287 Liberati D.: B-1172 Lombardi M.: B-0511, B-0576
Lee S.: B-0427, B-0508 Liccardo I.: B-0038 Lombardi S.: B-0464
Lee S.A.: B-0288, B-0497 Lichtinghagen R.: B-0709 Lomovtseva K.K.: B-0006
Lee S.J.: B-0692, B-1049 Liebergall M.: B-0248 Loney E.: A-021
Lee S.-L.: B-0590 Liebig T.: B-0545 Longo D.L.: A-406
Lee S.M.: B-0334, B-0335, B-0690, B-0886 Ligabue G.: B-0316, B-1113 Longo F.: B-0900
Lee S.W.: B-0334, B-0335 Lightfoot C.B.: B-0236, B-0237 Lonn L.: B-0824
Lee S.Y.: B-0568 Liguori T.L.: B-0178 Lönnemark M.: B-0721
Lee T.Y.: B-1271 Lilholm M.: B-0212 Loose R.W.R.: A-376
Lee V.: B-1248 Lilholt H.J.: B-0828 Lopci E.: B-0027, B-0307
Lee W.J.: B-1243 Lillholm M.: B-0077 Lopes Dias J.: A-196, B-0137
Lee Y.S.: B-1049 Lim A.: B-0112 Lopes F.: B-1016
Leehy N.: B-0578 Lim A.K.P.: A-136 Lopes N.: B-0147
Leen E.: B-0636 Lim H.K.: B-0453 Lópes R.: B-0503
Lefebvre G.: B-0947 Lim J.: B-0283 Lopez A.: B-0458
Lefort M.: B-0158 Lim J.W.: B-0840 Lopez Rendon X.: B-0787
Legou F.: B-0108 Lim J.Y.: B-0153 Lorenzoni A.: B-1054
Legrand L.: B-0336 Lim M.K.: B-0153 Lori N.: B-0526
Lehmann H.: B-0044 Lim S.H.: B-1243 Lorusso F.: B-0043
Lehnert T.: B-0372, B-0428, B-0730, B-0770 Lim T.-H.: A-536, B-0795 Löschmann Y.: B-1250
Leichsenring C.: B-0735 Lim Y.-J.: B-1173 Losio C.: B-0015
Leichter I.: B-0104, B-0248 Lim Y.-S.: B-1049 Lotter M.: B-1149
Leidecker C.: K-30 Lima E.N.P.: B-0830 Lotz J.: B-0400
Leidner B.: B-0100 Limbu H.H.: B-0253 Lourido D.: B-0955
Leijtens J.: B-0834 Lin J.: B-0570 Louwman M.W.: B-1031
Leiner T.: A-291, B-0270, B-0755 Lin S.: B-0370 Lovblad K.-O.: A-181
Leipsic J.: B-1113 Linda A.: A-741, B-0116 Low K.Y.: B-0677
Leitgeb N.: A-432 Lindell E.: B-0386 Löwik C.W.G.M.: A-590
Leithner D.: B-1153 Linder F.: B-0405, B-0406 Lu A.: B-0982
Lell M.: A-372, B-0242, B-0674, B-0675 Linder N.: B-0980 Lu J.: B-0065
Lemaitre L.: B-1011 Lindner A.: B-0419 Lu M.: B-0492
Lembcke A.: B-0262 Lindner T.: B-1223 Lubbers M.M.: B-0753
Lencioni R.: A-295, A-569 Linke K.: B-0459 Lubner M.: B-0974
Lentschig M.: A-401 Linsenmaier U.: A-061, A-297 Luca A.: B-0163, B-0277, B-0696
Lenzen H.: B-0222 Linz D.: B-0478 Lucas R.N.: B-0137
Leonardi B.: B-0166 Lipschuetz T.: B-0104 Lucatelli P.: B-0993
Leone F.: B-1164, B-1166 Liro M.: B-0668 Lucchina N.: B-1287
Leone M.B.: B-0850 Lisachenko I.: B-0913 Luciani A.: B-0108
Leong L.: B-0207 Lishmanov Y.B.: B-0789 Luciani M.L.: B-0621, B-0762, B-0764
Leppek R.: B-0727 Littleford R.: B-0481 Lucic M.A.: A-082, A-261
Leppink J.: B-1258 Liu Q.: B-0065 Lucidarme O.: B-0158, B-0311, B-1096
Lequin M.: B-0893 Liu S.: B-0944, B-1072, B-1112 Lücke C.: A-470
Leroy V.: B-0611 Liu X.: B-0625, B-0671 Ludvík J.: B-1205
Leschka S.: A-706, B-0107, B-0268, B-0772 Liu X.-S.: B-1202 Ludvik M.: A-428
Leschka S.C.: B-0303 Liu Y.: A-493, B-0094, B-0685 Lüers G.: B-1213
Luhur R.: B-0262 Mahdavirad H.: B-0476 Marcon M.: B-0116, B-0615
Lui S.: B-0080 Maher M.M.: A-489, B-0171, B-0447, B-0448, B-0455 Marconi M.: B-0343
Luk M.Y.: B-1248 Mahesh M.: A-746 Maresky H.S.: B-0377
Lukyanchenko A.: B-0432 Mahfoud F.: B-0478 Margarita B.: B-0286
Lumish H.: B-0751 Mahlke C.: B-1130 Mariani A.: B-0191
Luna A.: B-0902 Mahmoud M.: B-0958 Mariani S.: B-0066, B-0068, B-0072, B-0075, B-0338,
Lund G.: B-0898 Mahnken A.H.: B-0322 B-0347, B-0487, B-0573, B-1208, B-1209, B-1211
Lundbom N.: B-1188 Maier A.: A-615 Marias K.: B-0832
Lundell L.: B-0044 Maier J.: B-0258 Marie P.-Y.: B-0472
Lundervold A.: B-0708 Maieron M.: B-0615 Marignani M.: B-1050
Lundsgaard M.: B-0824 Maiettini D.: B-1268 Marijnissen A.-K.: B-1210
Luo B.: B-0823 Mainovskaya O.: B-1234 Marin M.A.: B-0403
Luo X.: B-0217 Maira A.: B-0343 Marinova M.: B-0943
Luo Y.: B-1206 Makanyanga J.: B-0460 Mariscotti G.: B-0022
Lupo F.A.: B-0454 Mäkelä T.: B-0321 Markali B.: B-0146
Lupo P.: B-0454 Makowski M.: B-0905 Markhardt B.K.: B-1216
Lupsor-Platon M.: B-1200 Maksimovic R.: B-0016 Markiet K.: B-0154
Lurie D.J.: A-627, B-0315 Malamateniou C.: A-661 Markl M.: B-0064
Lutat C.: B-0039, B-0999 Malavasi S.: B-0246 Markonis D.: B-1037
Lutz B.: B-0278 Malekzadeh R.: B-0605 Maroldi R.: A-278, A-645, B-0174, B-1089
Lv F.: B-0254 Malekzadeh S.: B-1114 Marom E.: B-0842
Lynch J.: B-0646 Maleux G.: B-0058, B-0695 Marra P.: B-1172
Lyons J.: B-0662 Malgorzata S.: B-1177 Marraccini P.: B-0269
Lysák D.: B-1205 Mali W.P.T.M.: B-0533, B-0601 Marrelli D.: B-0667
Maliakas V.: B-0702 Marsden M.E.R.: B-0408
M Malich A.: B-0553, B-0969, B-1034, B-1194 Marshall N.: B-0020, B-1102
Ma J.: B-1110 Malik A.B.: B-0349 Marshall N.W.: B-1100
Ma S.: B-0939 Malikova M.: B-0761 Marstrand J.: B-0301
Ma W.: B-1148 Malkowski B.: B-0306 Marten-Engelke K.: A-519
Ma Y.B.: B-0021 Maller V.V.: B-0973 Martens M.: B-0834
Maalej A.: B-0295 Malone D.E.: B-1195 Martens M.H.: B-0832
Maas A.: B-0294 Maltzeff N.: B-0062 Martí de Gracia M.: B-0061
Maas M.: A-222, A-544, A-577, A-659, B-0385, Malva M.: B-0865 Martí R.: B-0232
B-0567, B-0737, B-0832, B-0834, B-0836 Maly Sundgren P.C.: A-084, A-366, A-687 Martí-Bonmatí L.: A-583, K-15
Maataoui A.: B-0550 Mamoun I.: B-1133 Martin Noguerol T.: B-0902
Mac Mahon P.: B-1245 Manabe T.: B-0139 Martin Suarez S.: B-0850
Macaigne V.: B-0953, B-1275 Manavaki R.: B-1154 Martin V.: B-1177
Maccabelli G.: B-0180, B-0182 Mancini A.: B-0068, B-1065 Martincich L.: B-0620
Maccagni D.: B-1017 Mancini P.: B-0343 Martin-Duverneuil N.: A-560
Maccari P.: B-1181 Manciocco V.: B-0579 Martineau A.: B-0988
Macchi E.: B-1287 Mandolesi A.: B-1054 Martinez de la Haza D.: B-0090
Maccioni F.: A-423, B-0041 Mandry D.: B-0472 Martinez Gómez I.: B-0760, B-0765
MacGillivray T.: B-0055 Manenti G.: B-0561 Martinez Rubio C.: B-0760, B-0765
Machann J.: B-0609 Manfredi R.: A-004, A-074, A-322, B-0354, B-1171, Martínez-Miravete P.: B-0211, B-0923, B-0926
Machnikowska-Sokolowska M.: B-0656 B-1174 Martini K.: B-0531
Mack M.G.: A-038, A-375 Manganaro L.: B-0140, B-0520, B-0523 Martino A.: B-0611
MacKay J.W.: B-0637 Mangold S.: B-0051, B-0272, B-0445, B-0752 Martino G.: B-1212
MacRae A.: B-0194 Manikis G.C.: B-0832 Martinoli C.: B-0071, B-0076, B-0496, B-0642,
Macron L.: B-0175 Manipadam M.T.: B-0882 B-0643, B-0644, B-0805
Maderwald S.: B-1230 Manka R.: A-116, A-472, B-0896 Martins N.: B-0945
Maeda T.: B-0810 Mann P.: B-0103 Maruoka Y.: B-0826
Maeder P.: B-0527 Mann R.M.: A-227, A-633, B-0228, B-0232, B-0233, Maruzzelli L.: B-0163, B-0696
Maegerlein C.: B-0278 B-0758, B-1028 Marzi S.: B-0579, B-1233
Magee L.V.: B-0868 Manoliou A.: B-1074 Masarwah A.N.J.: B-0210
Magerkurth O.: B-0387, B-0569 Manoliu A.: B-0373, B-0374, B-1070 Masciocchi C.: B-0066, B-0068, B-0072, B-0075,
Maggio S.: B-0277 Manos D.: B-0097 B-0338, B-0347, B-0487, B-0573, B-1065, B-1208,
Maglione F.: B-1267 Mansour R.: B-0069 B-1209, B-1211
Magne N.: B-0953 Mantarro A.: B-0741 Mashaly E.: B-0345
Magnusson A.: A-041, B-0721 Mao F.: B-0715 Maslov L.N.: B-0789
Magometschnigg H.: B-0767, B-1158, B-1160 Mao Y.: B-0254 Massimo B.: B-0350
Magyar P.: B-0070 Marano R.: A-542, A-669 Massimo G.: B-0805
Mahajan A.: B-0205 Marcelin C.: B-1289 Massmann A.: B-0478, B-1282, B-1284
Mahajan M.D.: B-0429, B-0915, B-1078 Marchiano A.: B-0682 Masterson L.: B-1017, B-1024
Mahajan P.S.: B-1207, B-1214 Marckmann G.: A-553 Matheoud R.: B-0664
Mathers S.: A-523 Meijer F.J.A.: B-0085 Mihl C.: B-0600, B-0773, B-0775
Mathieu M.-C.: A-270 Meijer S.: B-0862 Mikaszewski B.: B-0154
Mathuriya S.N.: B-0205 Meijerink M.R.: B-0862 Mikines K.: B-0968
Matin T.N.H.: B-1111, B-1119 Meineke A.: B-0449 Mildenberger P.: A-078, A-457, A-747, B-1186
Matos C.: A-073, A-487 Meinel F.G.: B-0102, B-0265, B-0323, B-0445, Miller A.B.: A-241
Matouskova T.: B-0756 B-0628, B-0748, B-0752, B-0793, B-0794, B-1101 Milles J.: B-0106, B-0567
Matsubara K.: B-0105 Meisinger C.: B-0001 Millican-Slater R.: B-0014
Matsumaru Y.: B-0541 Mejean A.: B-0659 Millington S.: B-1026, B-1148
Matsumoto K.: B-0555 Mekiš N.: B-0150, B-1022 Millor M.: B-0923, B-0926
Matsumoto S.: B-0686, B-0689, B-0937, B-0982 Melchiorre F.: B-0170, B-1124 Millor Muruzábal M.: B-0211
Matsunaga N.: B-1197 Melees M.: B-0874 Milne H.: B-0149
Matthew W.G.: B-0019 Melendez J.: B-0232 Milos R.-I.: B-0444
Mattiuz C.: B-0488 Melendres G.: B-0192 Milosavljevic T.: B-0992, B-1222
Mauge L.: B-0659 Meliadò G.: B-0216, B-1157 Milosevic Z.: B-0016
Maurer M.H.: B-0860 Melis L.: B-0344 Mincarelli C.: B-1054
Mauri G.: B-0723, B-1124 Melleiro C.: B-0297 Mineiro J.D.: B-0945
Maurovich-Horvat P.: B-0266, B-0607, B-1061, Mellerio C.: B-0023 Minicucci L.: B-1131
B-1062 Melo J.I.F.D.: B-1139 Minisola S.: B-0883, B-0884
Maurus S.: B-0273 Meloni A.: B-0046, B-0226, B-0393, B-0899 Minutolo O.: B-0309, B-0774, B-0835
Maus J.: B-0513 Mendelson D.S.: B-1036 Miraglia R.: B-0163, B-0696
Mawrin C.: B-0655 Mendelson R.M.: A-620 Miranda I.: B-0441
Maxeiner A.: B-0703 Méndez J.C.: B-0955 Mironova N.: B-0181
Mayer F.: A-375 Mengel M.: B-1135 Mirsadraee S.: B-0055
Mayer J.-F.: B-0710 Mensel B.: B-0318, B-0744, B-1130 Misirli M.: B-0734
Mayerhoefer M.E.: B-0669 Menu Y.: A-546, A-679, A-683 Missere M.: B-0393
Mayo-Smith W.W.: A-282 Menys A.: B-0460 Mistelbauer G.: B-0632
Mayrhofer T.: B-0751 Mera D.: B-0796 Mitchell D.P.: B-1245
Mazaheri Y.: B-0348, B-0555, B-1010 Meradji M.: B-0893 Mittal B.R.: B-0574
Mazonakis M.: B-0241 Merat S.: B-0605 Mitter C.: B-0379
Mazza E.: B-0251 Mercer C.E.: B-1026 Miyamoto H.: B-0071
Mazzamurro F.: B-0041 Merchan L.: B-1098 Miyasaka M.: B-0252
Mazzei F.G.: B-0667, B-1237 Mercuri P.: B-1237 Miyazaki M.: B-0937, B-0982
Mazzei M.A.: B-0667, B-1237 Merkely B.: B-0266, B-0607, B-1061, B-1062, B-1064 Mizandari M.: B-1128
Mazzoni L.: B-0325 Merli I.: B-0990 Mochizuki T.: B-1197
Mc Fadden S.: A-345 Mershin K.: B-0851 Modregger P.: B-0746
McCall I.W.: A-068, K-22 Mershina E.A.: B-0183, B-0473, B-0851, B-0901 Moelker A.: B-0697, B-0856
McDougall E.E.: B-0236 Mertelmeier T.: B-1025 Moerup S.: B-0872
McGowan D.R.: B-1119 Messana D.: B-0046, B-0226 Mogensen H.: B-1152
McGrath C.: A-628 Messina C.: B-0946, B-0990 Mohamed Hoesein F.A.A.: B-0683, B-1109
McGurk S.: B-0386 Messina M.: B-1005 Moio A.: B-0807
McHugo J.: A-392 Messmer-Wullen M.: A-740 Molfetta L.: B-0642
McKean D.: B-0069 Metaxa L.: B-0207 Molinari F.: A-099
McKinnon T.: B-0636 Metens T.: A-745 Moll A.: B-0527
McKnight L.: A-682 Meuli R.: B-0185, B-0256 Møller-Madsen B.: B-0247
McLaren C.: B-1024 Meuwly J.-Y.: B-1011 Moloney F.: B-0171
McLean M.A.: B-0019, B-1154 Mews J.: B-0261, B-0262 Momoniat H.: B-1146
McMahon M.: B-0014 Meyer B.: B-0999 Monfardini L.: B-1124
McMorrow J.P.: B-0017 Meyer B.C.: B-1001 Monnier L.: B-0465
McNulty J.: A-573, B-1017, K-07 Meyer H.: B-0243 Monssen J.A.: B-0708
McQuiston A.: B-0265 Meyer M.: B-0264, B-0452, B-0598 Montauban van Swijndregt A.: B-0736
McWilliams R.G.: B-0712 Mezzanotte L.: A-590 Monteleone A.: B-0178
Meaney J.F.: B-0017 Michel B.: B-1074 Montemezzi S.: B-0216, B-0961, B-1157, LBCT
Mechl M.: K-29 Michell M.J.: B-0924, B-0925 Montet X.: K-11
Meckel S.: B-0303 Michelozzi C.: B-1124 Monti L.: B-0889, B-1236
Meder J.F.: B-0297 Michoux N.: B-1088 Montlahuc C.: B-0988
Meder J.-F.: B-0023 Middeldorp S.: B-0844 Montorsi P.: B-0777
Medici M.: B-0538, B-0611 Middendorp M.: B-0550 Moon H.J.: B-0114
Medvedeva B.: B-0432 Midiri F.: B-0515 Moon M.H.: B-1285
Mehndiratta A.: A-466 Midiri M.: B-0393, B-0505, B-0507, B-0515, B-0899 Moon S.J.: B-1231
Mehrabi S.: B-1171, B-1174 Miele V.: A-122 Moon S.K.: B-0840
Mehrian P.: B-1252 Miese F.: B-0936, B-1068 Moore C.M.: B-0967
Meier M.: B-1135 Migazzo E.: B-0086 Moore N.: B-0448
Meierhofer C.: B-0596 Miglāne E.: B-0818 Moorthy S.: B-1123
Meier-Meitinger M.: B-0206 Miglio E.: B-0762, B-0764 Moosdorff M.: B-0113
Morales Vargas A.M.: B-0061 Murphy J.: B-0020 Nelemans P.J.: B-0091
Morasca A.: B-1269 Murphy K.: B-0447, B-0448, B-0455 Nemec U.: B-0379
Moreau-Gaudry A.: B-0611 Murphy R.: B-1149 Nenning K.-H.: B-0502
Morel J.: B-0924, B-0925 Murray M.P.: B-1180 Nensa F.: B-0045, B-0827
Morelli J.N.: B-0554 Murray P.: B-0637 Nerad E.: B-0737, B-1229
Moreschi L.: B-0707 Murtaza A.: B-0213 Nergården M.: B-0921
Morgan D.: B-0281 Mus R.D.M.: B-0228 Neri E.: A-015, A-163, A-749, B-0269, B-0741,
Morgan S.: B-0289 Musch M.: B-0349 B-0841, B-1044, B-1045
Mori C.A.: B-0437, B-0922, B-1103 Muscogiuri G.: B-0051, B-0265, B-0272, B-0474, Neri F.: B-0956
Mori N.: B-0693 B-0779, B-0793, B-0794 Neriman D.: B-0093
Mori T.: B-0184 Mushtaq S.: B-0179, B-0467, B-0626, B-0777 Nestle U.: A-668
Morita K.: B-0431 Muto M.: A-718 Nestola M.: B-0059, B-1136
Moritake T.: B-0541 Muuronen A.: B-1058 Nestorov N.: B-1192
Moriyasu F.: B-0861 Myasnikov R.: B-0901 Netam S.B.: B-0592
Morley N.: B-0846 Mytsyk Y.: B-0660 Neudorf U.: B-1056
Morozov S.: A-751 Neumaier K.: B-0036, B-0732
Morris E.A.: B-1180 N Neuwelt E.: B-0650
Morris R.: B-0529 N’Guyen S.: B-0195 Nevens F.: B-0695
Morsbach F.: B-0746, B-0896 Na D.: B-0288, B-0497 Neves M.D.G.P.M.S.: B-0360
Mosca S.: B-1268 Nadolski G.J.: B-0698, B-0853 Newby D.E.: B-0055
Moscatelli M.: B-0575 Nadrljanski M.: B-0016 Newstead G.: B-1177
Moschetta M.: B-0189, B-0616, B-0622, B-1182 Nagao M.: B-0986 Ng Wong Y.K.: B-0441
Moser M.: B-0938 Nagarajah J.: B-1159, B-1183 Ngo Ikeng D.: B-1089
Moskowitz C.S.: B-0348, B-0555, B-1009, B-1010 Nagaria T.: B-0592 Ni Ainle F.: B-1245
Mosquera N.J.: B-1284 Nagel H.-D.: B-0784 Ni H.: B-1080
Mostbeck G.: A-305 Nagel S.N.: B-1250 Niazi I.K.: B-0213
Motton M.: B-0961 Nagl G.: B-0920 Nicholson A.: A-449
Moulin G.: A-560 Naguib N.N.N.: B-0186, B-0372, B-0858, B-0859 Nicholson P.: B-0020, B-0455
Moulopoulos L.A.: B-0663 Nagurney J.T.: B-0750, B-0751 Nickol A.: B-1111, B-1119
Moumtzouoglou A.: B-0649 Nagy J.G.: B-1098 Nicolini D.: B-1054
Moura A.P.C.: B-0927 Nam I.C.: B-1173 Niederstadt T.: B-0548
Mousseaux E.: B-0395 Nam J.G.: B-0532, B-0977 Niehues S.M.: B-0543, B-0728
Mraity H.A.A.B.: B-0141 Nam S.Y.: B-0156 Nielsen K.: B-0862
Mtvaradze A.: B-1128 Nana M.P.: B-0529 Nielsen K.J.: B-0461
Mu J.: B-0485 Nannini G.: B-0238 Nielsen M.: B-0077, B-0212
Mück F.: B-0911 Nanz D.: B-0373, B-0374, B-0559, B-1070 Nielsen M.L.: B-0828
Mueller D.: B-0567 Napoli A.: A-435, B-0337, B-0586 Nieman K.: B-0753
Mueller J.: B-0424 Napolitano C.: B-0166 Niemann M.: B-0896
Muellerleile K.: B-0469, B-0898 Nappi C.: A-325, A-465 Nieminen M.: B-1190
Mueller-Lisse U.G.: B-0095, B-0378, B-0556 Narayan G.: B-0665 Niesen S.: B-0782
Muir K.: B-0846 Narayanasamy S.: B-0160, B-0489 Niessen C.: B-1203
Mukherjee B.: B-1241 Nardis P.: B-1280 Niessen H.W.M.: B-0862
Mulè A.: B-0515 Narula M.: B-0885 Niessen W.J.: K-28, B-0244, B-0856
Mulé S.: B-1003 Nasatti A.: B-1091 Nievelstein R.A.J.: A-572
Muley T.: B-0096 Nasirudin R.A.: B-0285 Nighoghossian N.: B-0811
Mulimani N.: B-0198 Nassar M.: B-1079 Nijssen E.C.: B-0600
Mulimani N.M.: B-0574 Nassenstein K.: B-0045, B-0786, B-1056, B-1159, Nikitovic M.: B-0016
Mulkens T.H.: B-1239 B-1240 Nikolaou K.: B-0024, B-0028, B-0323, B-0381,
Müller A.: B-0478, B-0502 Nasserinejad K.: B-0168 B-0392, B-0402, B-0556, B-0609, B-0854, B-0938,
Müller G.: B-0562 Nasti G.: B-1267 B-1055, B-1253, B-1256
Müller H.: B-1037, B-1039, B-1088 Naumann D.N.: B-0408 Nilsson A.: A-121, A-436
Müller O.: B-0026 Nautsch F.: B-0750 Nio Y.: B-0736
Müller-Forell W.S.: A-103 Navas Canete A.: A-586 Niola R.: B-1267
Müller-Hübenthal J.: B-0078 Navin P.: B-0842 Nishie A.: B-0252, B-0431
Müller-Lutz A.: B-0936 Nawaz A.: B-1133 Nishimuta Y.: B-0252
Müller-Schimpfle M.: A-632, K-18 Nazeri M.: B-0279 Nitrosi A.: B-0437, B-0918, B-0922, B-1103
Müller-Wille R.: B-0060 Ndlovu J.: B-0143 Niu J.: B-0646, B-1071
Mumoli M.C.: B-0309, B-0835 Nedelcu C.: B-0410 Nobili E.: B-0626, B-0777
Mungai V.: B-0238 Nederend J.: B-1031, B-1032 Nocchi Cardim L.: B-1287
Munkholm P.: B-0461 Nederveen A.J.: B-1104 Nocchi L.: B-0720
Münzel D.: B-0797 Neff K.W.: B-0169, B-0172, B-1249 Nocetti L.: B-0316
Murakami T.: B-0298 Negrelli R.: B-1174 Noebauer-Huhmann I.-M.: A-258
Murchison J.: B-0846 Nekolla S.G.: A-051, A-354 Noël P.B.: B-0285
Murphy D.: A-499 Nelemans P.: B-0115, B-0118, B-0737 Nordlohne M.: B-1001
Pozzi Mucelli R.: B-0354, B-0371, B-0956, B-1171, R Rehwald W.G.: B-0051
B-1174, B-1201 Raaijmakers R.: B-0266 Reid J.H.: B-0846
Pozzi-Mucelli R.: A-003 Rabenalt R.: B-0351, B-0357 Reid S.: B-1154
Prabhu N.K.: B-1123 Radlgruber I.: B-0669 Reider L.: B-0177
Pradella M.: B-0562 Radmard A.R.: B-0605 Reijnierse M.: B-0941, B-1073, B-1075, B-1076,
Prahladan A.: B-0962 Radtke J.: B-0304 B-1210
Prayer D.: B-0379, B-0502, B-0522, B-0524 Radunski U.K.: B-0469, B-0898 Reimar R.: B-0610
Precht C.: B-0725 Radzina M.: B-0818 Reimold M.: B-0381
Preda L.: B-0575 Raff G.L.: B-0628 Reinboldt M.P.: B-1097
Preim B.: B-0595 Ragab Y.: B-0477, B-0594, B-0640 Reiner C.S.: B-0004, B-1046
Raghavan B.: B-0877 Reiners C.: B-0095
Prell J.: B-0655
Rahim R.: B-0924, B-0925 Reinhold F.: B-0595
Přibáň V.: B-0653
Rahman N.: B-1111, B-1119 Reinwald M.: B-1249
Price E.R.: B-1180
Rahmanian M.S.: B-0605 Reis C.S.D.: B-0143
Pricolo P.: B-0560 Reis J.: B-0199
Rahmouni A.: B-0108
Prinz F.: B-0997 Reischauer C.: B-0768
Raimondi E.: B-0838
Prisacariu A.: B-1191 Reischl G.: B-0024
Raimondi S.: B-0560, B-0575
Probst F.A.: B-0378 Rainford L.A.: B-0208, B-0866, B-1017, B-1024, Reiser M.F.: A-439, B-0001, B-0095, B-0101, B-0102,
Probst M.: B-0378 B-1142, B-1149, B-1151 B-0123, B-0273, B-0275, B-0286, B-0323, B-0417,
Prokop M.: A-603, A-725, B-0035, B-0401, B-0537, Raiola G.: B-0224 B-0480, B-0486, B-0556, B-0610, B-0732, B-0814,
B-0540 Raissaki M.: A-360 B-0822, B-0938, B-1012, B-1101, B-1134, B-1187,
Prokop W.M.: B-0203 Rajesh S.: B-0219 B-1264, B-1288
Prola Netto J.: B-0650 Ramanathan S.: B-0190, B-0979 Reiter A.: B-0801
Pronin I.: B-0658 Ramazan A.: B-1156 Reiter G.: B-0052, B-0399
Prosch H.: A-097, A-502 Ramirez-GarciaLuna J.L.: B-0247 Reiter U.: B-0052, B-0399
Prothmann S.: B-0545 Ramon F.: A-512 Rella L.: B-0622
Protin-Catteau L.: B-0259 Ramos I.: B-1042 Remedios D.: A-347
Provenzano E.: B-0019 Rampoldi A.: A-112 Rempp H.: B-0024, B-0854
Pruvo J.-P.: B-0503 Ramseier L.E.: B-0639 Remy J.: B-0336, B-0852
Przegalinski J.: B-0845 Raneri F.: B-0027 Rémy-Jardin M.: A-702, B-0336, B-0852
Pua U.: B-0340, B-0341 Rank C.: B-0319 Ren F.: B-1085
Ranschaert E.R.: A-018 Renganathan R.: B-0159
Pucheux J.: B-0700
Rao B.S.: B-0190 Rengier F.: B-0398
Puech P.A.: A-105
Rao S.-X.: B-0836, B-1094 Rengo M.: A-001, B-0833, B-1233
Puelacher W.: B-1244
Raslan S.: B-0311 Renker M.: B-0272, B-0628, B-0752
Puglielli E.: B-0821, B-0951, B-0957
Rasmussen F.: B-0734 Renne G.: B-0560
Pugliese F.: B-0799 Renne S.: B-0393
Raso G.: B-1033
Puig J.: B-0500 Rennert J.: B-1203
Rasper M.: B-0278, B-0754, B-0797, B-0798
Puigdemont M.: B-0500 Raszkowski A.M.: B-0864 Rentsch M.: A-479
Pul C.V.: B-0526 Rathmann E.: B-0907 Repa I.: B-0657
Pullens P.: B-0294 Rathmann N.: B-0554, B-1232 Reppas L.: B-0339
Pulsone P.: B-0742 Ratib O.: A-017, A-081, A-180 Repussard J.: A-413
Purcell Y.: B-1195 Rau P.: B-0940 Resta E.C.: B-0602, B-0604, B-0897
Pursani A.: B-0751 Raudner M.: B-0942 Restaino G.: B-0226
Pusceddu C.: B-0344 Rausch I.: B-0320 Restaino M.C.: B-0899
Putineanu D.: B-0916 Rautou P.-E.: B-0220 Reu S.: B-0095
Putzer D.: B-0305 Ravaioli S.: B-0437, B-0922 Revel M.-P.: A-601, B-0989
Puzakov K.B.: B-1234 Ravanelli M.: B-0174, B-1089 Reymond E.: B-0538
Pyatigorskaya N.: B-1045 Rebecca K.: B-0907 Reyre A.: A-560
Pyfferoen L.: B-1239 Rebellato C.: B-0018 Rezanavaz-Gheshlagh B.: B-0461
Rebonato A.: B-1268 Reznek R.H.: K-18
Reda M.S.R.: B-0299 Ribeiro L.P.: B-0365, B-0869, B-0871, B-1021, B-1145
Q Reddy P.: B-1078 Ricart E.: B-0458
Qi W.: B-0685
Redheuil A.: B-0395 Ricart Selma V.: B-0760, B-0765
Qiao Y.: B-0645 Ricchi P.: B-0046
Reekers J.A.: A-088, A-090, A-243
Qiu L.: B-1072 Reeps C.: B-0278 Ricci E.: B-0707
Qiu W.: B-1283 Rega A.: A-359 Richard P.: B-0108
Quagliozzi M.: B-0511 Regge D.: A-723, B-0620, B-1044, B-1045, LBCT Richard S.: B-1108
Quaia E.: B-0456 Regier M.: B-0558, B-0565, B-0725, B-0974 Richter F.: B-0173
Quentin M.: B-0351, B-0357 Regini E.: B-0022 Riddell A.M.: A-621
Querques G.: B-0308, B-1091 Regnard N.-E.: B-0284 Ridereau-Zins C.: B-0410
Quick H.H.: A-053, A-143, B-0092, B-0320, B-0563, Regnaud A.: B-0661 Riederer S.: B-1107
B-0566 Rehman I.: B-0213 Rief M.: B-0063, B-0176, B-0791
Qurashi A.A.: B-0866 Rehnitz C.: A-649 Riffel P.: B-0554
Righi D.: B-0608, B-0966 Rosenbaum-Krumme S.: B-0516 Ryu M.-H.: B-1120
Righi L.: B-1237 Rosenberg M.: B-1177
Riis R.: B-0948 Rosenberg M.L.: B-1176 S
Rimassa L.: B-0307 Rosenberger K.D.: B-0424 Saam T.: B-0101, B-0273, B-0275, B-0417, B-0483,
Rimola J.: A-002, A-534, B-0458 Ross J.: B-0315 B-0486, B-0822, B-1012
Rimondi E.: B-0831, B-1266 Rossi A.: A-047, A-125, A-236, A-734, B-0629, Sabatier F.: B-0187
Rinaldi P.: B-0618, B-1179 B-0799, B-1089 Sablayrolles J.-L.: B-0175
Rinde H.: LBCT Rossi G.: B-1266 Sabouri S.: B-0476
Rinelli G.: B-0166 Rossi P.: B-0889 Sabri A.: B-0097
Ringe K.I.: B-0039, B-0222 Rosskopf A.B.: B-0491, B-0494, B-0639 Sacarea I.: B-0078
Ringelstein A.: B-0786, B-1240, B-1241 Rosso A.: B-0921 Sacchetti G.M.: B-0664
Rinne J.O.: A-611 Roth P.: B-0599 Sacconi B.: B-0883, B-0884, B-0888
Rio J.: A-717 Rothe J.H.: B-0003 Sack I.: B-0356, B-0394
Rio Tinto H.: A-356 Rotili A.: B-0230 Sadotti G.: B-1237
Rispo A.: B-0038 Rotzinger D.: B-0940 Saering D.: B-0469
Ritschl L.: B-0670 Rousseau H.: B-0058 Safran O.: B-0248
Ritzenthaler T.: B-0811 Rousset P.: B-0989 Safriel Y.: B-0084
Riva M.: B-0027 Rousset-Jablonski C.: B-0989 Safsaf A.: B-1275
Rixe J.: B-0599 Roustit M.: B-0369 Saghatchian M.: A-270
Rizzati R.: B-0838 Rouvelas I.: B-0044 Saguatti G.: B-0919
Rizzo G.: B-0180 Roux C.: B-0284, B-0395 Saha S.: B-0933
Ro S.-R.: B-0583 Roux M.: B-0940 Saida Y.: B-1162
Robben S.G.F.: A-482, B-1257, B-1258 Rovira-Cañellas A.: A-608 Saint-Lèbes B.: B-0058
Roberto E.: B-0724 Rowan M.: B-1245 Sainz Barriga M.: B-0700
Robertson N.L.: B-0967 Rowbotham E.L.: A-025 Sajja S.: B-1108
Robinson S.: A-277 Rowiński O.: B-0202 Sakman B.: B-0138
Robusto V.: B-0505 Rowlands P.: B-1038 Sakuda K.: B-0105
Roca P.: B-0297 Rowley H.A.: A-228, A-230 Salama M.: B-1133
Roccia S.: B-0224 Roy C.: B-0672, B-0681, B-1278 Salazar J.P.: B-0441
Roček M.: B-1077 Roy Choudhury S.: B-0333 Saldari M.: B-0140, B-0520, B-0523
Rocher L.: A-206 Roy-Choudhury S.: B-0333 Salem R.: B-0064
Rockall A.G.: A-138, A-462, A-527, B-0517 Rozendorn N.: B-1040, B-1041 Salgado R.: A-593, A-719, B-0984
Rödel S.: B-0353 Rozengarten O.: B-0248 Salhi M.: B-0710
Roden Y.: B-0231 Rua C.H.S.: B-1083 Salnikova S.: B-0705
Rodighiero M.: B-0015 Rubbert C.: B-0092, B-1068 Salpietro D.: B-0887
Rodrigues S.: B-0365, B-0869, B-0871, B-1021, Rubio I.: B-0441 Salsano M.: B-0889
B-1145 Rubtsova N.: B-1234 Salut C.: B-0857
Rodrigues T.: B-0817 Ruckes C.: B-0997 Salvador R.: B-0441
Rodríguez P.: A-313 Rud E.: B-0552 Salvatore M.: B-0038, B-0534
Rodríguez S.: B-0458 Rudas G.: B-0200 Salvetti M.: B-1124
Rodt T.: B-0999, B-1001 Rudas M.: B-0444, B-1160 Samanci C.: B-1204
Rodzyanko M.: B-0355 Rudolph J.: B-0278 Sameer H.: B-0345
Roebuck D.J.: A-481 Ruhlmann M.: B-1097 Samei E.: B-1099
Roemer F.W.: B-0646, B-1069, B-1071 Ruhlmann V.: B-0029, B-0031, B-0092, B-0516, Sanavi C.: B-1275
Roessle M.: B-0064 B-0827 Sanchez M.: B-0090
Roethke M.C.: A-205, A-530, B-0304 Ruibal A.: A-709 Sanchez-Gonzalez J.: B-0902
Rofsky N.M.: B-0281 Ruju F.: B-0575 Šanda J.: B-1077
Rogalla P.: B-0716 Rummeny E.J.: B-0278, B-0285, B-0754, B-0797, Sandbæk G.: B-0037, B-1259
Rohit M.K.: B-0164 B-0798 Sandek A.: B-0905
Roller F.C.: B-0053, B-0599 Rundstein A.: B-0119, B-0438 Sanderud A.: B-0864
Romano F.: B-0038 Runge J.H.: B-1104 Sandhu R.S.: B-0517
Romano L.: B-0035 Runge V.M.: B-0909 Sandolo F.: B-0586
Romano S.: A-010, K-08 Ruprela V.: B-0915, B-1078 Sanmillán J.: B-0955
Romanos O.: B-0892 Russo E.: B-0179 Santagostino A.: B-0511
Romman Z.: B-0104 Russo P.: B-1009, B-1010 Santangelo T.: B-0166
Rong S.: B-1135 Ruszniewski P.: A-162 Santiago A.R.: B-0146
Ronot M.: A-162, A-562, B-0220, B-1262 Rutten M.J.C.M.: B-0228 Santiago I.: B-0735
Rook J.W.: B-0864 Rutz E.: B-0387 Santoni M.: A-427
Roos J.E.: B-0768 Ruzzenente A.: B-1201 Santoro A.: B-1113
Rørvik J.: B-0708 Ryan J.: B-0208, B-0447 Santoro M.: B-0121
Ros P.R.: A-221, A-563, A-666 Ryan M.: B-0084 Santos A.: B-0365
Rosado E.: B-0735 Ryan M.F.: B-0020 Santos J.: A-346, B-0147, B-0362, B-0865, B-0867,
Rosato E.: B-0054 Ryeom H.: B-1125, B-1231 B-1016
Rosella F.: B-0328, B-0993 Ryu J.: B-0161, B-0733 Santos R.: B-0151
Sapoval M.: B-1263 Schima W.: A-028, A-547, A-622, A-680 Schuijf J.D.: B-0261
Saraux A.: B-1075 Schimmöller L.: B-0351, B-0357, B-0627 Schuknecht B.F.: A-174
Sardanelli F.: A-150, A-242, A-518, A-655, B-0397, Schindl M.: B-1170 Schüller S.: B-0675
B-0602, B-0603, B-0604, B-0757, B-0897, B-0919, Schindler A.: B-0484 Schullian P.: B-1244
B-0946, B-0990, B-1175, B-1176 Schindler K.: B-0813 Schultheis N.: B-0847
Sardo E.: B-0022 Schipper R.J.: B-0113, B-0115, B-0118 Schultheiss M.: B-0064
Sarifov R.: B-0388 Schlamann M.: B-0026, B-1241 Schulz A.: B-1196
Sarin S.K.: B-0219 Schlattmann P.: B-0176 Schulz B.: B-0193, B-0729, B-1270
Säring D.: B-0898 Schleich C.: B-0449, B-0936, B-1068 Schulz V.: A-049
Sasaki M.: B-0826 Schlemmer H.-P.: A-104, B-0096, B-0304, B-0674, Schulz-Wendtland R.: B-0206, K-21
Satchithananda K.: B-0112, B-0924, B-0925 K-06 Schumacher M.: B-0303
Sathiadoss P.A.R.P.: B-0160 Schlett C.L.: B-0424, B-0480 Schupp N.: B-1134
Sattler B.: B-0320 Schliebus J.: LBCT Schuster A.: B-0400
Saturnino P.P.: B-0745 Schlosser T.: B-0045, B-0786, B-1056, B-1240 Schütz T.: B-0980
Saude E.: B-0194 Schmachtenberg C.: B-0209 Schwaiger M.: B-0484
Sauer A.: B-1290 Schmeding M.: B-0701 Schwartz E.: B-0522
Saushkin V.V.: B-0789 Schmerber S.: B-0369 Schwartz S.: B-1250
Sauvanet A.: B-1262 Schmidt B.: B-0098, B-0676 Schweiger B.: B-0165
Saviolo C.: B-0510, B-0512 Schmidt G.: B-0286 Schweitzer N.: B-1001
Savlovskis J.: B-0818 Schmidt H.: B-0028 Schwenck J.: B-0024
Savolainen S.: B-0321 Schmidt M.: B-0239, B-1109 Schwenzer N.: A-352, A-379, B-0028, B-0381
Sawall S.: B-0675, B-0678 Schmidt S.: B-0185, B-0256 Schymik G.: B-0631
Sawangsilpa T.: B-1093 Schmidt T.: B-0808 Scialpi M.: B-1268
Sawicki M.: B-0202 Schmidtke C.: B-0276 Scionti A.: B-0430
Saxena A.K.: B-0164 Schmitt B.: B-0936 Sconfienza L.M.: B-0990
Sbarbati S.: B-1280 Schmitt C.: B-0558 Screaton N.J.: A-600
Scaglione M.: A-059 Schmitzberger F.: B-0436 Sdao S.: B-0577
Scaglioni R.: B-0316, B-1113 Schmücker R.: A-255 Seaton T.: B-0112
Scalise P.: B-0430, B-0741 Schnabel P.: B-0096 Sebag G.: A-359
Scandiffio R.: B-0841 Schnapauff D.: B-0860 Seboui S.: B-0231
Scaperotta G.: B-0229 Schneider C.: B-0053, B-0599 Secchi F.: B-0397, B-0602, B-0603, B-0604, B-0897,
Scarabello M.: B-0397 Schneider G.K.: B-0478, B-1282 B-0990
Scardapane A.: B-0043 Schneider J.F.: A-238, A-358 Sechopoulos I.: B-1098
Scarsbrook A.: A-179, A-722 Schnerr R.S.: B-0782 Secinaro A.: B-0166
Schaab F.: B-1272 Schnitzer A.: B-1161, B-1184 Seddon B.: A-675
Schaafs L.-A.: B-0728 Schoenberg S.O.: B-0169, B-0172, B-0631, B-0801, Sedelaar J.P.M.: B-1140
Schaake W.: B-1023 B-1161, B-1180, B-1184, B-1249 Sedivy J.: B-0756
Schaal M.: B-0681 Schoenecker A.: B-1056 Sedlaczek O.L.: A-275
Schaarschmidt B.M.: B-0029, B-0031, B-0092, B-0516 Schoepf U.J.: B-0051, B-0265, B-0272, B-0445, Seehofer D.: B-0011, B-0426
Schabel C.: B-0402, B-0609 B-0474, B-0628, B-0748, B-0752, B-0779, B-0793, Seehofnerova A.: B-0773, B-0775
Schad L.R.: A-407 B-0794 Segnan N.: LBCT
Schaefer- Prokop C.M.: A-204 Schoepf V.: B-0177 Seidel R.: B-1282
Schaefer-Prokop C.M.: A-036, A-203, A-448, A-550, Schöllchen M.: B-0725 Seidl R.: B-0524
A-568, B-0535, B-0537, B-0844 Scholten E.T.: B-0535, B-0537, B-0540 Seith F.: B-0028
Schaeffeler C.: A-442 Scholtz J.-E.: B-0088, B-0193, B-0729, B-0730, Seitz G.: B-0381
Schäfer J.F.: B-0381, B-0392 B-0731, B-0770, B-0847, B-1270 Seiwerts C.: B-0558
Schäfers H.-J.: B-1282 Schön G.: B-0725 Seki S.: B-0686, B-0689, B-0937, B-0982
Schaper N.C.: A-245 Schönberg S.O.: B-0390, B-0391, B-0452, B-0480, Sekiguchi T.: B-0693
Schara U.: B-1056 B-0554, B-0598, B-1232, B-1276 Seliverstov Y.: B-0083
Schaudinn A.: B-0980 Schonenberg D.: B-0385 Seliverstova E.: B-0083
Scheffer H.J.: B-0862 Schönnagel B.: B-0225 Sellars M.: B-0892
Schegerer A.A.: B-0169, B-0784 Schöpf V.: B-0522, B-0524 Semeraro V.: B-1269
Schek J.: B-1004 Schoppmann S.: B-0250 Senan S.: A-570
Schelhorn J.: B-0165, B-1056, B-1097 Schott E.: B-0426 Sengel C.: B-1011
Schemuth H.P.: B-0165 Schouman-Claeys E.: B-1255 Senol U.: A-756
Schenal G.: B-0961 Schouten W.R.: B-0839 Senoner M.: B-1274
Schepers-Bok R.: B-0074 Schramm C.: B-0223 Senore C.: LBCT
Schernthaner R.E.: B-0632 Schreiber A.: B-1130 Seo B.K.: B-0763
Schiani E.: B-0015 Schreiner M.M.: B-0632 Seo J.B.: A-541, B-0334, B-0335
Schiavone M.V.: B-0612 Schröder D.: B-1286 Seo J.W.: B-0881
Schick F.: B-0609 Schroeder J.: B-0710 Seo M.: B-0879, B-0880
Schiel S.: B-0378 Schroefel H.: B-0631 Sepp D.: B-0484
Schild H.H.: B-0648, B-0943, B-1215 Schubert T.: B-0916 Seracchioli R.: B-0587
Schilham A.M.R.: B-0270 Schueller-Weidekamm C.: A-508 Serafin Z.: B-0457, B-1086
Serfaty J.-M.: B-0903 Sigurdsson S.: B-0415 Snider F.: B-0059, B-0121
Sergeeva O.N.: B-0005, B-1127 Sijens P.E.: B-0617, B-0624 Sodhi K.S.: B-0164
Serova N.S.: B-0726 Silber G.: B-0324 Soekamto H.: B-0372
Serrenho C.: B-0143 Silingardi E.: B-0848 Sofikitis N.: B-0702
Sertdemir M.: B-0554 Silva D.: B-0867 Soglia G.: B-0889
Servadio Y.: B-0119, B-0438 Silva D.H.: B-1139 Sohn C.-H.: B-0204, B-0501
Severac F.: B-0672, B-0681 Silva D.H.C.: B-1139 Sohn Y.-M.: B-0109
Sewerin P.: B-1068 Silva Jr. J.-R.: B-1071 Soize S.: A-720
Seyfer P.: B-0322 Silva M.: B-0682 Sojer M.: B-0549
Sghedoni R.: B-0437, B-0922, B-1103 Silvestre M.: B-1267 Sojka M.: B-0057
Shaban A.: B-0791 Simakova L.: B-0740 Sokolova N.: B-0705
Shah A.R.: B-0290 Simeonidou C.: B-1087 Solà O.: B-0500
Shahabpour M.: A-509 Simmaco M.: A-164 Solbiati L.: B-0723
Shaheen E.: B-1100 Simon M.: B-0648 Sołek-Pastuszka J.: B-0202
Shahnazi M.: B-1057 Simonelli M.: B-0027 Solis M.P.: B-0090
Shaida N.: B-0125 Simonetti A.: B-0889 Solomou G.: B-1247
Shalmon A.: B-0119, B-0438 Simonetti C.: B-0343 Solomyanyy V.: B-0749
Shankar S.: B-0973 Simonetti G.: B-0561 Solopova A.: B-1138
Sharfman Z.: B-0377 Simonetto I.: B-0366 Solyanik O.: B-0451
Shariat A.: B-0279 Simons D.: B-0674 Sommer G.: A-335
Sharifian H.: B-0875 Simos P.: B-0293 Sommer W.H.: B-0323, B-0610, B-0814, B-1187
Sharma N.: B-0014 Singh A.: B-0592 Son R.C.: B-0568
Sharma S.: B-0129 Singhal M.: B-0164 Son Y.: B-0802
Sharp P.: A-348 Singhal S.: B-0296 Sondern M.: B-0936
Shatynska-Mytsyk I.: B-0660 Sinitsyn V.: B-0183, B-0473, B-0851, B-0901 Soneji N.: B-1115
Sheehy M.: B-0171, B-0447, B-0455 Sinitsyn V.E.: A-459, A-551 Soneji S.: B-0429
Sheehy N.: B-1192 Sinn M.: B-0469 Song E.: B-0109
Sheir K.: B-1013 Sipilä O.: B-0321 Song H.: B-0416
Shen C.: B-0890 Sipola P.: B-1058 Song H.-Y.: B-1120, B-1122
Shen S.: B-1072 Sirachainan E.: B-1093 Song J.: B-0413
Shen W.: B-1080 Sirin S.: B-0165, B-0462 Sorantin E.: A-575
Shetty A.: B-0915 Sironi S.: B-0191, B-0274, B-0308, B-0309, B-0464, Sørensen L.: B-0077
Shetty M.: B-0915 B-0518, B-0612, B-0774, B-0835, B-1053, B-1091, Sormani M.P.: B-0642
Shetty N.: B-0915, B-1078 B-1164, B-1166 Sosna J.: A-350, B-0104
Shi C.: B-0260 Sitoci-Ficici K.H.: B-0506 Sotgia B.: B-0344
Shiguetomi-Medina J.M.: B-0247 Sivasubramanian S.: B-1221 Souahli N.: B-0131
Shim S.W.: B-0135, B-0532 Sivit C.J.: A-298 Soubeyran V.: B-0661, B-1114
Shimizu C.: B-0111 Sjölin M.: B-0671 Souillard-Scemama R.: B-0023
Shin C.-I.: B-0423, B-1121, B-1165 Skanjeti A.: B-0030 Soulen M.C.: B-0698, B-0853
Shin H.J.: B-0157, B-0593 Skehan S.: A-673 Soulez G.: B-0281
Shin H.-O.: B-0451, B-0999 Sklair-Levy M.: B-0119, B-0438 Sourbron S.: B-0286
Shin H.S.: B-0763 Skogen K.: B-1196 Sousa A.L.: B-0817
Shin J.H.: B-0283 Skoglund M.: B-0367 Sousa P.: B-0869, B-0871, B-1021
Shin J.K.: B-0597 Skondras E.: B-0332 Soyer P.: B-0023, B-0259, B-1106
Shin K.-M.: B-1231 Skornitzke S.: B-0099, B-0788 Sözmen Cılız D.: B-0138
Shin N.-Y.: B-0081 Skov- Hansen D.: B-0872 Spagnolli F.: B-0371
Shin S.H.: B-0977 Skrami E.: B-0711 Sparacia G.: B-0505, B-0507
Shin S.-M.: B-0886 Skripkin D.: B-0042 Spearman J.V.: B-0445
Shin S.Y.: B-0334, B-0335 Skrobisz-Balandowska K.: B-0668 Spelle L.: B-0545
Shin Y.S.: B-0153 Skrzywanek P.: B-0202 Sperk E.: B-1161
Shirokov V.: B-0630, B-0776 Slanetz P.J.: B-0761 Spick C.: B-0767, B-1170
Shmeleva L.: B-1081 Sloots C.: B-0893 Spielmann R.P.: B-0655
Shmueli H.: B-0849 Slump C.H.: B-1060 Spies L.: B-0078
Sibert A.: B-1262 Smaldone F.: B-0347, B-1065, B-1209 Spinarelli A.: B-1212
Sidhu P.: B-0892 Smeets P.: B-0781 Spinazzi A.: B-0281
Sidorov D.: B-1234 Smet M.: B-1102 Spink C.: B-1286
Siedentopf C.M.: B-0076 Smidt M.: B-0113, B-0115, B-0118 Spinnato P.: B-0807, B-0831, B-1266
Siegel E.: B-1036 Smit R.S.: B-0404 Spinner G.: B-0373, B-0374, B-1070
Siegmann K.: B-1176 Smith F.W.: B-0289 Splendiani A.: B-1224
Siek E.: B-0845 Smith I.M.: B-0408 Splettstößer A.: B-0550
Sieverding L.: B-0392 Smith M.: B-0281 Sprengel K.: B-0409
Sievers H.-H.: B-0276 Smits M.: A-050, A-229, A-230, A-260, A-495, B-0244 Springer E.: B-0813
Signor M.A.: B-0350 Smugala A.: B-0154 Sramek M.: B-0632
Signori A.: B-0642 Sneige N.: B-0439 Srinivasan S.: B-0954
Sripathi S.: B-0914 Struffert T.: B-0422 Tagliafico A.: B-0071, B-0496, B-0642, B-0643,
Srutek E.: B-0306 Struthers A.D.: B-0466, B-0479, B-0481 B-0644, B-0805
Ssingh P.: B-0574 Studniarek M.: B-0306, B-0668, B-0719 Tagliafico G.: B-0496, B-0642, B-0643, B-0644,
Staatz G.: B-0389 Stukalova O.: B-0181 B-0805
Stabile Ianora A.A.: B-0189, B-0616, B-0622, B-1182 Sturdza A.: B-0132, B-0935 Tahir E.: B-0469, B-0898, B-1213
Stachs O.: B-0908 Sturm N.: B-0611 Taina M.: B-1058
Stahnke T.: B-0908 Suaris T.: B-0207 Takahashi H.: B-0298
Stahnke V.: B-0400 Suchá D.: B-0601 Takahashi S.: B-0964
Stajgis M.: A-058, A-200, B-0459 Sudah M.: B-0210 Takata T.: B-0105
Stajgis P.: B-0459 Sudarski S.: B-0390, B-0391, B-0452 Takayama Y.: B-0431
Stallknecht S.: B-0572 Suetterlin M.: B-1161 Takx R.A.P.: B-0755
Stamm G.: B-0784 Sugihara N.: B-0689 Tal S.: B-0377
Stampanoni M.: B-0746 Sugimoto K.: B-0861 Talei Franzesi C.R.G.L.: B-0274, B-0308, B-0309,
Stankiewicz C.: B-0154 Sugimura K.: B-0686, B-0689, B-0810, B-0937, B-0464, B-0518, B-0612, B-0774, B-0835, B-1053,
Stankovic Z.: B-0064 B-0964, B-0982 B-1091
Stappers P.J.: B-0697 Suhai F.: B-1064 Tali E.T.: A-415
Staskiewicz G.: B-0845 Süleyman S.: B-0829 Tamandl D.: B-0250, B-1170
Staudacher C.: B-0251 Sullivan C.: B-0448 Tamas A.: B-1200
Stavem K.: B-1259 Sullivan F.: B-0481 Tammi M.: B-0210
Stavrou S.: B-0702 Sullivan F.M.: B-0466 Tan G.: B-0341
Stecco A.: B-0086, B-0511, B-0576, B-0664 Sumbunnanondha K.: B-1093 Tan M.M.L.: B-0954
Steck V.: B-0452 Summers P.: B-0560 Tanaka C.: B-0693, B-1220
Stecker F.F.: B-0786, B-1240, B-1241 Sun H.: B-0976, B-1167 Tanaka H.: B-0298
Steenbakkers A.C.L.F.: B-0401 Sun L.: B-0541 Tanase A.: A-359
Stefanescu H.: B-1200 Sun Y.: B-0685 Tang Y.: B-1007
Stefani E.: B-0364, B-1018 Sundaram D.: B-0877 Tanno Y.: B-0184
Steffen I.G.: B-0003, B-0394, B-0426 Sundin A.E.: A-159 Tao H.: B-0645
Stehning C.: B-0469, B-0898 Suntharalingam S.: B-0786, B-1240, B-1241 Taori K.B.: B-0130
Steinbach F.: B-0353 Sunwoo L.: B-0204 Tappero C.M.S.O.: B-0331
Steinberg D.H.: B-0752 Suppa P.: B-0078 Taravari V.: B-0388
Steinberger G.: B-1087 Suranyi P.: B-0051, B-0396 Tardieu M.: A-064
Steins M.: B-0096 Šurlan Popovič K.: B-0155 Tardivel A.-M.: A-389
Stelter L.: B-0011 Surov A.: B-0655 Tardivon A.: A-067
Stelzeneder D.: B-0942 Susac A.: B-1269 Tarella C.: B-0510, B-0512
Stemerdink T.A.: B-0815 Susani M.: B-0352 Tarnoki A.D.: B-0607, B-1062
Stenson M.: B-0440 Sutela A.: B-0210 Taschner C.: B-0303
Stentarelli C.: B-0316 Sutter R.: B-0641 Tateishi U.: B-1162
Štepán-Buksakowska I.L.: B-1077 Svegliati Baroni G.: B-1054 Taverna G.G.: B-0331
Stephan C.: B-0703 Svensson A.: B-0100 Tavoletta A.: B-0742
Stepniewski K.: B-1184 Sverzellati N.: A-169, A-726, B-0682 Taylor A.M.: A-705
Sticchi G.: B-0454 Sweeney J.: B-0080 Taylor S.A.: A-474, A-535, B-0460, B-0785
Stief T.: B-0322 Swi S.: A-371 Taymour T.: B-0912
Stijnen M.: B-0792 Symersky P.: B-0601 Tchekmeister Abitbol V.: B-0521
Stiller W.: B-0099, B-0788 Symms M.R.: B-1083 Teggi S.: B-1033
Stødkilde-Jørgensen H.: B-0247 Synek A.: B-0911 Teh H.S.: B-0954
Stodulski D.: B-0154 Szabó Á.: B-0200 Teh J.: A-507, B-0069
Stojanov D.: B-0079 Szabó N.: B-1077 Tehrai M.: B-1057
Stojanovic I.: B-0079 Szalai Z.: B-0657 Teichgräber U.K.M.: A-286
Stojanovic S.: B-0126 Szczepura K.: B-1026 Teixeira P.A.C.: B-0111
Stojkovic M.: B-0424 Szczerbo-Trojanowska M.: B-0057, K-32 Telegrafo M.: B-0189, B-0616, B-0622, B-1182
Stoker J.: A-069, A-533, B-0736, B-0844, B-1104 Szendrői M.: B-0070 Telesca M.: B-0621, B-0762, B-0764
Stokke M.V.: B-0037, B-1259 Szilveszter B.: B-0266 Tennstrand A.L.: B-0037, B-1259
Stolzmann P.: B-0107, B-0746 Szlezak P.: B-0306, B-0719 ter Horst S.: B-0941
Stoupis C.: A-006, A-545 Szomolanyi P.: A-650 Ter Minassian A.: B-0195
Strasilla C.: B-0545 Szurowska E.: B-0154 Ternovoj S.K.: B-0181, B-1138
Stratakis J.: B-0241, B-1247 Szymańska K.: B-0227 Terrazzino F.: B-0046, B-0226, B-0899
Stratis A.: A-014, B-0680 Szymanska-Dubowik A.: B-0306 Terribile D.: B-0012
Strickland N.H.: A-089 Szymczak A.: B-0227 Tervonen O.: B-1190
Strijkers R.: B-0635 Testa F.: B-0724
Strobbe L.J.A.: B-1027, B-1030, B-1031, B-1032 T Testelmans D.: B-0326
Strobl F.F.: B-0417, B-1264 Tacelli N.: B-0852 Tewes S.: B-0709
Stroeder J.: B-0478 Tacher V.: B-0718 Thaher F.: B-0196
Strojan P.: B-0155 Tack D.: A-501, B-0785, B-0987 Thali M.: B-0746
Stroszczynski C.: B-0060, B-0218, B-1203 Tafaro C.: B-0696 Thanh N.: B-0239
Thasler W.: B-0610 Treitl K.M.: B-0123, B-0273, B-0275, B-0486, B-0822, Umutyan L.: B-0428
Theias R.: B-0735 B-1288 Ünal Ö.: B-0162
Theisen D.: B-0556 Treitl M.: B-0123, B-0273, B-0275, B-1288 Unsöld R.: B-0412
Theysohn J.M.: B-0563, B-0564, B-0566, B-0786, Třeška V.: B-1205 Unterberg-Buchwald C.: B-0400
B-1240, B-1241 Treyvaud M.-O.: B-0256 Unterhinninghofen R.: B-0398
Thiefin G.: B-0259 Triantopoulou C.: A-076, A-616 Unterhumer S.: B-0177, B-0632
Thierens H.: B-0781 Tricarico E.: B-0622 Uprimny C.: B-0305
Thierfelder K.M.: B-0323, B-0556, B-0814 Trillaud H.: B-0857 Ursu S.C.: B-0621
Thiounn N.: B-1263 Trimboli R.M.: B-0757, B-0919, B-1175, B-1176 Usenko E.: B-0355
Thiruchelvam P.: B-0112 Trinidad C.: B-0796 Ushijima Y.: B-0431
Thoeny H.C.: A-029, A-310 Triphan S.: LBCT Ustabasioglu F.: B-1204
Thomas P.: B-0783 Troeltzsch M.: B-0378 Uusi-Simola J.: B-0321
Thomassin-Naggara I.: A-526, B-0131, B-0766 Trojanowska A.: A-019, A-646 Uysal M.: B-0221
Thomassin-Piana J.: B-0766 Troost E.G.C.: B-0091
Thomeer M.G.: B-0425, B-0736, B-0893 Tropres I.: B-0369 V
Thomsen H.S.: B-0461, B-0960, B-0968 Trumm C.G.: B-1264 Vacondio R.: B-0437, B-0922
Thorskog M.: B-0143 Truong M.: B-0842 Vago H.: B-1064
Thurnher M.M.: A-511, A-736 Truong Q.: B-0751 Vahldiek J.: B-0543
Tian B.: B-0065 Trybou J.: B-0144 Valbousquet L.: B-0128
Tiberi G.: B-1083 Tsang W.S.S.: B-0370 Valcanover S.: B-1201
Tiddens H.A.W.M.: B-0168, B-1117 Tselikas L.: A-248 Valcke J.: B-0582
Tietz S.: B-0994 Tsetis D.K.: A-443 Valdés Olmos R.A.: B-0025, B-0033
Till V.: B-0126 Tshibanda L.: B-1227 Valdés Solís P.: A-756
Timmers J.M.H.: B-1144 Tsiflikas I.: B-0381 Válek V.: A-118, A-319, B-1126
Timon G.: B-0970 Tsili A.: B-0702 Valentini V.: A-338
Timonen M.: B-0321 Tsitskari M.: B-0339 Valentinitsch A.: B-0249
Timpani M.: B-0742 Tso W.K.: B-1248 Valeri G.: B-0393
Ting E.: B-0578 Tsougos I.: A-629 Valerio D.: B-0587
Tirumalai A.: B-0855 Tsuboi K.: B-0541 Valla D.: B-0220
Tischler V.: B-0746 Tsurkan V.: B-1261 Vallati G.: B-0993
Tkacz J.N.: B-0761 Tsuruda K.M.: B-0236, B-0237 Vallinga A.: B-0864
Tobias S.: B-0484 Tsurumaru D.: B-0252 Vallone N.: B-0899
Tohamy Y.M.: B-0912 Tudisca C.: B-0393, B-0899 van Beek E.J.R.: A-460, A-701, B-0055, B-0846
Tohmad U.: B-1093 Tudor G.: B-0529 Van Beers B.: A-306
Tolan D.J.M.: A-009, A-490 Tufman A.: B-0095 van Berlo C.: B-0834
Tollard E.: B-0953 Tumino M.: B-0117, B-0623 Van de Heyning P.H.: B-1219
Tomà P.: B-0166, B-0889 Tuncay V.: B-1060 van de Looi P.: B-1144
Tomás B.: B-1145 Tupikina N.: B-1138 van de Vijver K.: B-0115
Tomaszewski A.: B-0845 Tupý R.: B-0653 van Delden O.M.: A-011, A-363
Tomiyama N.: B-0298 Turek J.: B-0600, B-0773, B-0775 van den Berg J.M.: B-0385
Toms A.P.: B-0637 Turkay R.: B-0221 van den Berg N.S.: B-0025, B-0033
Tomson A.: B-0044 Tutein Nolthenius C.J.: B-0736 van den Broek W.J.M.: A-716
Tondelli G.: B-0918 Tuteinnolthenius C.: B-0460 van den Hauwe L.: A-177, A-183, A-512, A-719
Tong M.C.F.: B-0370 Twomey M.: B-0171, B-0447, B-0448, B-0455 van den Hoff J.: B-0513
Toniolo M.: B-1074 Tyrrell P.N.M.: A-211 van den Hout J.H.W.: B-0704
Tonoyan A.S.: B-0658 Tyurin I.E.: A-100, B-0005 van den Tol P.(.: B-0862
Tonsok K.: B-1197 Tzavara C.: B-0663 Van der Graaf Y.: B-0815, B-0950
Topcuoglu E.D.: B-1198 van der Heijde D.: B-0941, B-1073, B-1075, B-1076
Topcuoglu O.: B-1198 U van der Lugt A.: A-323
Topilsky Y.: B-0849 Uberoi R.: A-444 van der Meer F.: B-0527
Toriihara A.: B-1162 Uchevatkin A.: B-0913 van der Poel H.G.: B-0033
Torre G.: B-0889 Uder M.: A-375, B-0206, B-0242 van der Valk S.B.A.: B-0074
Torricelli P.: B-0316, B-1113 Udiya A.K.: B-0296 van der Velde D.: B-0404
Torzilli G.: B-0307 Udodov V.: B-0633 van der Woude H.-J.: A-484
Toscano W.: B-0629 Ueda Y.: B-0964 Van der Zijden T.: A-177, A-183, A-719
Tosetti M.: B-0082, B-1083 Ueno Y.: B-0964 Van Dyck P.: A-256
Tosi E.: B-1033 Ugurlu M.U.: B-1156 van Geuns R.-J.: B-0753
Tot T.: A-152 Uhlig S.: B-0845 van Gils C.H.: B-1028
Toth A.: B-1064 Ukmar M.: B-0956 van Ginneken B.: A-451, B-0535, B-0537, B-0540,
Totsuka T.: B-0541 Ulbrich E.J.: B-0373, B-0374, B-1046, B-1070 B-0683
Tran A.: B-1276 Ullah E.: B-0160 Van Goethem J.: A-177, A-183, A-512, A-719
Trattnig S.: A-264, A-647, A-650, B-0942, B-1153 Ullrich T.: B-0351 Van Gompel G.: B-1199
Travaini L.L.: B-0575 Umutlu L.: A-464, B-0026, B-0029, B-0031, B-0255, van Hecke W.: B-0294
Trecate G.: B-0229 B-0516, B-0806, B-0827, B-1159, B-1183, B-1230 van Heeswijk M.M.: B-0836, B-0837, B-1094
van Herwerden L.A.: B-0601 Venstermans C.: A-177, A-183, A-512, A-719 Voormolen M.: A-177, A-183, A-719
van Landsveld-Verhoeven C.: B-1144 Ventriglia A.: B-1174 Vorontsov I.: B-1261
van Leenders G.J.: B-0839 Venugopal V.: B-0981, B-1082 Voros S.: B-0607, B-1062
van Leeuwen F.W.B.: B-0025, B-0033 Venuta F.: B-0713 Vouillamoz A.: B-0864
van Merriënboer J.J.G.: B-1258 Verardi N.: B-0488, B-0919 Vreemann S.: B-0232, B-0233, B-0758
Van Muylem A.: B-0785 Verbist B.: A-022 Vriesema J.L.J.: B-0704
Van Muylen A.: B-0987 Verellen D.: A-626 Vucaj-Cirilovic V.: B-0126
van Netten J.J.: B-0404 Verhagen M.V.: B-1226 Vullierme M.-P.: A-162
Van Ombergen A.: B-1219 Verheij J.: B-1104 Vyberg M.: B-0828
van Ommen V.V.A.: B-0600 Verheyden J.: B-0294 Vydrová R.: B-1077
Van Ooijen P.M.A.: B-0533, B-1060 Verloh N.: B-0218
van Oosterhout M.: B-0941 Verma R.K.: B-0813 W
van Osch J.A.C.: B-0567 Verschakelen J.: B-1254 W Duffy S.: B-0207
van Osch M.J.P.: B-1223 Verschuuren S.I.: B-0839 Wacker F.: B-0039, B-0222, B-0999, B-1001, B-1135
van Oudenaarde K.: B-1210 Verslype C.: B-0695 Wadhwani A.: B-0034, B-0194, B-0463
van Riel S.: B-0540 Verstraete K.: A-505, A-558, B-0363, B-0781 Wadsak W.: B-0132, B-0935, B-1158
van Riel S.J.: B-0535, B-0537 Verstraeten T.R.G.M.: B-0498, B-0499 Wafaie A.: B-0530
van Rikxoort E.M.: B-0683, B-1109 Veryser J.: A-256 Wagenblast J.: B-0730
van Roozendaal L.: B-0118 Vicari M.: B-0303 Waggershauser T.: B-1264
van Rumund A.: B-0085 Vicente D.: B-0867 Wagner A.: B-1134
van Seeters T.: B-0812, B-0950 Vichter T.: B-0104 Wagner F.: B-0813
van Swieten J.C.: B-0244 Vidano G.: B-0970 Wagner M.: B-0311
van Tilborg A.A.J.M.: B-0862 Vidiri A.: B-0579 Wahab S.: B-0160
Van Tuijl S.: B-0792 Vieveen J.M.: B-0862 Waldeck W.: B-0313
van Walsum T.: B-0697 Viganò S.: B-0019, B-0229 Waldman A.D.: B-0517
van Westerveld P.P.: B-0704 Vikestad K.G.: A-525 Walecka A.: B-0202
van Zandwijk J.K.: B-1060 Vilanova A.: B-0526 Walecki J.: A-365, B-0202, B-0656
van Zelst J.C.M.: B-0228 Vilar J.: A-035, A-500, A-684 Walker-Samuel S.: A-469
Vanbeckevoort D.: B-1246 Vilela P.: A-201 Wallace A.B.: B-0446, B-0783
Vande Berg B.: A-024, A-742, B-0916 Vilgrain V.: A-162, A-294, B-0220, B-1262 Wallis M.: B-1029
Vandenbroucke F.: A-626 Villeirs G.M.: A-232, A-418 Walsh D.: A-740
Vander Plaetsen S.: B-0363 Villers A.: A-419 Walsum T.V.: B-0856
Vandevoorde C.: B-0781 Vincent V.: B-1260 Walter T.C.: B-0011, B-0905
Vandromme L.: B-0465 Vinci V.: B-0140, B-0520, B-0523 Waltering K.U.: B-0349
Vandulek C.: A-396, A-662, B-0657 Vindigni C.: B-1237 Wanambiro K.W.: B-0820
Vanel D.: A-332 Vining D.J.: B-1191 Wanders J.O.P.: B-1028
Vanhevel F.: B-1219 Virgolini I.J.: B-0305 Wang C.: B-0470
Vanhoenacker F.M.H.M.: A-485, A-576 Visconti E.: B-0544 Wang F.: B-0939, B-1072
Vaniet C.: B-0376 Visser R.: B-1023 Wang G.: B-1085
Vanninen R.: B-0210, B-1058 Vivarelli M.: B-1054 Wang H.: B-0094, B-1007, B-1238
Vano Y.: B-0659 Viviani A.: B-0707 Wang J.: B-0225, B-0312, B-0808
Vanzulli A.: B-0035, B-0191 Vlassenbroek A.: B-0567 Wang L.: B-1279
Varallyay C.: B-0650 Vliegen R.F.A.: B-1094 Wang L.-J.: B-0411
Varga E.: B-0697 Vliegenthart R.: B-0263, B-0264, B-0329, B-0452, Wang M.: B-0065
Varga-Szemes A.: B-0051, B-0265, B-0272, B-0474, B-0533, B-0540, B-0792, B-1060, B-1109, K-05 Wang R.: B-0752
B-0793, B-0794 Vochteloo A.J.H.: B-0074 Wang S.-T.: B-0606
Varlamov G.: B-0705 Vock P.: A-387, A-410, A-743 Wang W.-P.: B-0715
Varoquaux A.D.: A-560 Voelker M.: B-0322 Wang X.: B-0606, B-1108, B-1167
Vasilevska Nikodinovska V.: A-441 Vogel A.: B-0999, B-1001 Wang Y.: B-0793, B-0794, B-0944, B-1238
Vasselli F.: B-0561 Vogelgesang A.M.: B-0648 Wang Z.: B-0254
Vázquez M.: B-0796 Vogelsang L.: B-1108 Wanner G.: B-0409
Veit-Haibach P.: A-284 Vogl T.: B-0931 Warnecke G.: B-0709
Vela A.: B-0403 Vogl T.J.: B-0088, B-0186, B-0193, B-0324, B-0372, Warth A.: B-0096, B-0991
Velasco A.: B-0548 B-0428, B-0539, B-0550, B-0628, B-0729, B-0730, Wasan R.: B-0924, B-0925
Veldhoen S.: B-0725 B-0731, B-0770, B-0847, B-0858, B-0859, B-0994, Wasser K.: B-1161, B-1184
Veldhuis W.B.: B-1028 B-1270 Watanabe Y.: B-0298
Vella A.: B-0229 Vogt F.M.: B-1176 Watson E.: B-1180
Velonakis G.: B-0339 Voigt J.: B-0727 Watts M.M.: B-0996
Velroyen A.: B-0102 Vojinovic S.: B-0079 Weavers P.T.: B-1107
Velthuis B.K.: B-0812, B-0815, B-0950, B-1063 Volterrani L.: B-0325, B-0667, B-1181, B-1237 Webber N.: B-0483
Veltman J.: B-0704 von Kummer R.: B-0506 Weber C.N.: B-0698, B-0853, B-0996
Veltri A.: B-0030, B-0900 von Tengg-Kobligk H.: B-0398 Weber M.: B-0524, B-0632, B-0669, B-0917, B-1160,
Vembar M.: B-0754, B-0797 Vonder M.: B-0263, B-0264 B-1170
Venancio J.: A-231 Voogd A.C.: B-1027, B-1030, B-1031, B-1032 Weber M.-A.: A-649, B-1039
Weber R.J.P.: B-1027, B-1030, B-1031, B-1032 Winterstein M.: B-1039 Yang L.: B-1206
Weber T.F.: B-0424 Wirth S.: A-479 Yang S.: B-0048
Weber-Donat G.: B-0128 Wirths S.: B-1256 Yang S.B.: B-0691
Weckbach S.: B-0480 Witjes J.A.: B-1140 Yang Z.: B-0421, B-0819, B-0823
Ween B.: B-0361, B-0367 Wittens C.H.A.: B-0635 Yang Z.-G.: B-0475
Weidner A.: B-0554 Woitek R.: B-0524 Yaniv G.: B-0521, B-0525
Weidner M.: B-0169, B-0172 Woldringh G.H.: B-0228 Yankelevitz D.: B-0534
Weigel M.: B-0303, B-0562 Wolf A.: B-0534 Yao L.: B-0080
Weinheimer O.: B-0450 Wolf F.: B-0177 Yaqub M.: B-0320
Weinmann A.: B-0997 Wolfschmidt F.: B-1290 Yarar S.: B-1213
Weir N.: B-0055 Wolke S.: B-0631 Yaroshenko A.: B-0102, B-1101
Weir-McCall J.: B-0466, B-0481 Won H.J.: B-1049 Yazdani N.: B-0875
Weir-McCall J.R.: B-0479 Won J.Y.: B-0692 Yazici G.: B-0581
Weishaupt D.: A-424, A-582, B-1242 Won Y.: B-0416 Ye H.: B-1007
Weiß J.: B-0036, B-0556, B-0732, B-0854 Wong H.: B-0750 Ye L.: B-1283
Weiß R.: B-0368 Wong K.K.: B-1248 Ye Z.: B-0094
Weissmann T.: B-0003 Wong Y.-C.: B-0411 Yekeler E.: B-0388
Weisstanner C.: B-0813 Woo O.: B-0763 Yenihayat F.: B-1218
Weldon T.: B-0529 Wörner B.: B-0123 Yeong C.H.: B-0855
Wellenberg R.H.H.: B-0567 Woussen S.E.: B-1246 Yeow K.K.: B-0954
Wells A.: B-1115 Woznitza N.H.: B-1143 Yildirim A.Ö.: B-1101
Wen L.-Y.: B-0475 Wragg A.: B-0799 Yilmaz E.: B-0388
Wengert G.: B-0767 Wrede K.: B-0026 Yin J.: B-1080
Wenkel E.: B-1177 Wu C.-H.: B-0411 Yip R.: B-0534
Werner J.: B-0727 Wu C.X.: B-0528 Yonezawa M.: B-0986
Werquin C.: B-1275 Wu L.-M.: B-0047, B-0963 Yong Q.: B-0485, B-0570
Weskott H.-P.: A-140 Wu W.: B-1238 Yoo J.I.: B-0880
Wesseling J.: B-1210 Wu Y.: B-0235, B-1193 Yoo M.-W.: B-1120
Wessling J.: A-075 Wu Z.: B-0939 Yoon I.K.: B-0416
West D.J.: A-447 Wuyts F.L.: B-1219 Yoon J.: B-0568
Westwood T.D.: B-0662 Wydra D.: B-0668 Yoon J.H.: B-0114, B-1121
White R.D.: B-0479 Wykrętowicz M.: B-0459 Yoon J.-H.: B-0613
Wibmer A.: B-1010 Yoon R.G.: B-0156
Wyss M.: B-0373, B-0374, B-1070
Wicher M.: B-0656 Yoong P.: B-0069
Wichmann J.: B-0474 Yoshida H.: B-0139
Wichmann J.L.: B-0051, B-0088, B-0265, B-0428,
X Yoshida M.: B-0139
Xavier J.: B-0817 Yoshikawa T.: B-0686, B-0689, B-0937, B-0982
B-0445, B-0539, B-0729, B-0730, B-0731, B-0752,
Xia J.-G.: B-1202 Yoshioka K.: B-0184, B-1197
B-0770, B-0779, B-0793, B-0794
Xia W.: B-1279 Yousry T.A.: A-607, K-02
Widmann G.: B-1244
Xia Y.: B-1112 Yserbyt J.: B-0326
Wielandner A.: B-0177
Wielema M.: B-0617, B-0624 Xiao Y.: B-0080, B-0625, B-0944 Yu J.: B-1066
Wielpütz M.O.: A-171, B-0099, B-0450 Xing J.: B-0253 Yu M.H.: B-1169
Wienke A.: B-0655 Xu B.: B-0065 Yu N.: B-1110
Wiesmann M.: B-0421, B-0819 Xu H.-Y.: B-0475 Yu S.C.: B-0714
Wiessler M.: B-0313 Xu J.-R.: B-0047, B-0963 Yuan J.: B-0485
Wiest R.: B-0813 Xu X.: B-1111, B-1119 Yui M.: B-0686, B-0937, B-0964, B-0982
Wiggermann P.: B-0218 Xu Z.: B-0097 Yüksel N.: B-1218
Wiklund E.: B-0405 Xue H.: B-0939 Yulek F.: B-0162
Wikström J.: B-0418 Xue H.-D.: B-0606, B-1167 Yun H.: B-0048
Wildberger J.E.: A-367, B-0118, B-0600, B-0635, Yun S.J.: B-0109
B-0773, B-0775, B-0782, B-0792 Y Yun T.J.: B-0501
Wildermuth S.: B-0268 Yabuuchi H.: B-0986
Wilkens R.: B-0463 Yagil Y.: B-0438
Wille M.M.: B-0537 Yakar D.: B-0706 Z
Willeit J.: B-0549 Yamamura J.: B-0188, B-0223, B-0225, B-0808, Zabeck H.: B-0688
Willemink M.J.: B-0270 B-1213 Zaccagna F.: B-0337, B-0586, B-0888
Willemssen F.: B-0425 Yamanouchi T.: B-0986 Zackrisson S.: B-0921
Williams M.C.: B-0055, B-0846 Yamasaki Y.: B-0986 Zagdanski A.-M.: B-0187, B-0465
Willinek W.A.: B-1215 Yamashita Y.: B-1197 Zagoria R.J.: A-192, A-193
Willner M.: B-0101, B-0483, B-1012 Yamini D.: B-0855 Zaim S.: B-1096
Wilson D.J.: A-188, A-315, B-0067, B-0282 Yan F.: B-0217 Zalazar R.: B-0923
Wilson S.: B-0034, B-0463 Yan J.: B-0217, B-0260 Zaleska-Dorobisz U.: B-0227
Windhager R.: B-0942 Yang D.H.: B-0795 Zamora D.: A-498
Winklhofer S.: B-0746 Yang J.: B-0823 Zampella E.: A-325
347
List of Moderators
W
Wattjes M.P.: RC 511
Weckbach S.: SS 1810
Weishaupt D.: E³ 1222
Wibmer A.: SS 1807
Wieczorek J.: SS 314
Wildberger J.E.: SS 304
Wildgruber M.: SS 1406
Williams M.: RC 403
Wirth S.: RC 417
Wörtler K.: RC 1310
Y
Yakimov A.: SS 1010a
Z
Zampakis P.: RC 515
Zins M.: E³ 1722